MDR_REPORT_KEY|MDR_TEXT_KEY|TEXT_TYPE_CODE|PATIENT_SEQUENCE_NUMBER|DATE_REPORT|FOI_TEXT|BRAND_NAME|CATALOG_NUMBER|DATE_RECEIVED|DATE_REMOVED_FLAG|DATE_RETURNED_TO_MANUFACTURER|DEVICE_AGE_TEXT|DEVICE_AVAILABILITY|DEVICE_EVALUATED_BY_MANUFACTUR|DEVICE_EVENT_KEY|DEVICE_OPERATOR|DEVICE_REPORT_PRODUCT_CODE|DEVICE_SEQUENCE_NO|EXPIRATION_DATE_OF_DEVICE|GENERIC_NAME|IMPLANT_FLAG|LOT_NUMBER|MANUFACTURER_D_ADDRESS_1|MANUFACTURER_D_ADDRESS_2|MANUFACTURER_D_CITY|MANUFACTURER_D_COUNTRY_CODE|MANUFACTURER_D_NAME|MANUFACTURER_D_POSTAL_CODE|MANUFACTURER_D_STATE_CODE|MANUFACTURER_D_ZIP_CODE|MANUFACTURER_D_ZIP_CODE_EXT|MODEL_NUMBER|OTHER_ID_NUMBER|filter
6315557|66927054|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL UNKNOWN SIDE EXPLANT SURGERY OCCURRED PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6315557|66927053|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6233845|68040031|D|1||PHYSICIAN REPORTS SLIGHT AMOUNT EFFUSION AROUND RIGHT IMPLANT HARDENING CAPSULAR CONTRACTURE GRADE III DISTORTING BREAST GOES STATE FAIRLY THICK CAPSULE FLUID WITHIN ALTHOUGH FLUID CLEAR WAY MILKY TOTAL CAPSULECTOMY CARRIED SENT HISTOLOGY HISTOPATHOLOGY REPORTS SPECIMEN COMPRISES FIBROUS CAPSULE ADHESIONS IRREGULARITY EXTERNAL SURFACE WELL SECTIONS CAPSULE SHOW FIBROUS TISSUE PATCHY MIXED INFLAMMATION HISTOPATHOLOGY CONFIRMS CD30+ ALK- CONFIRMED CASE ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 110|01/09/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6233845|64197776|D|1||PHYSICIAN REPORTS PATIENT SLIGHT SWELLING CAPSULAR CONTRACTION BAKER GRADE UNKNOWN UNKNOWN SIDE PHYSICIAN ADDITIONALLY REPORTS HISTOLOGY CAPSULE CONFIRMED PRESENCE BIA-ALCL NECESSARY PATHOLOGICAL MARKERS YET RECEIVED EVENT CAPTURED LYMPHOMA TIME|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 110|01/09/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6233845|64197775|N|1||EVENTS LYMPHOMA CAPSULAR CONTRACTURE EDEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST FORMATION FIBROUS TISSUE AROUND IMPLANTED DEVICE NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY ONE COMMON REASONS REOPERATION CAUSE CAPSULAR CONTRACTURE UNKNOWN HOWEVER LIKELY MULTIFACTORIAL MAY COMMON FOLLOWING INFECTION HAEMATOMA SEROMA CONTRACTURE DEVELOPS VARYING DEGREES UNILATERALLY BILATERALLY MAY OCCUR WITHIN WEEKS YEARS SURGERY CONTRACTURE FIBROUS CAPSULAR TISSUE SURROUNDING IMPLANT MAY CAUSE RANGE SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES CONSIDERED CLINICALLY SIGNIFICANT MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT CORRECTIVE SURGICAL PROCEDURES TREAT CAPSULAR CONTRACTURE EXTERNAL COMPRESSION MASSAGE MAY RESULT IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 110|01/09/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6540530|74301793|D|1||HEALTHCARE PROFESSIONAL REPORTED Â¿PATIENT PRESENTED SEROMA LEFT BREAST CAUSING DISCOMFORTÂ¿ Â¿SEROMA LARGE ENOUGH CAUSE PATIENT CONCERN DISCOMFORT ALCL DX SEROMA FLUID TREATMENT SPECIFIED Â¿SURGICAL INTERVENTION ONLYÂ¿ DEVICE EXPLANTED CAPSULECTOMY PERFORMED|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-401|05/03/2017||||N|R||0HP|FTR|1.0|07/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2010555|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6540530|74301792|N|1||EVENTS LYMPHOMA ALCL SEROMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY RECORD DHR PROVIDES REVIEW DHR B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MAY ASSOCIATED REPORTED DEVICE EVENT GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY |STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-401|05/03/2017||||N|R||0HP|FTR|1.0|07/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2010555|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247187|66742201|N|1||EVENTS LYMPHOMA-ALCL LATE SEROMA INFLAMMATION PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY RECORD DHR SUMMARY REVIEW DHR WORK ORDER 1321464 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER 1321464 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS REPORTED EVENTS ADDRESSED DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6247187|64666747|D|1||REGULATORY AGENCY REPORTED PHYSICIAN REPORTED BIA-ALCL SIDE UNKNOWN EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6247187|66742202|D|1||ADDITIONAL INFORMATION RECEIVED HEALTH PROFESSIONAL REGARDING EVENT MRI REPORT DATED B6 2016 ADDITIONAL REPORTED EVENT IMPLANT SURROUNDED LARGE COLLECTION FLUID PATHOLOGY RESULTS B6 2016 REVEALED LEFT PERIPROSTHETIC CAPSULE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT PATHOLOGY SHOWS ALCL MARKERS CD30+ ALK- PHYSICIAN ADDITIONALLY REPORTED EVENTS PAIN FEELING LOCALIZED INFLAMMATION AROUND IMPLANT EVENT PAIN DEVICE RELATED SECONDARY SYMPTOM REPORTED EVENTS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6247187|64666746|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6751756|81359984|D|1||COMPETENT AUTHORITY REPORTED CASE ALCL TREATMENT AFFECTED SIDE UNKNOWN PATHOLOGICAL MARKERS UNKNOWN UNCONFIRMED CASE ALCL REPORTED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FX-410495|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6751756|81359983|N|1||FOLLOW-UP COMPLETE REPORTING COMPETENT AUTHORITY PROVIDE INFORMATION SAFEGUARD PRIVACY INVOLVED PATIENTSÂ¿ EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FX-410495|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6751766|81359645|D|1||COMPETENT AUTHORITY REPORTED CASE ALCL TREATMENT AFFECTED SIDE UNKNOWN PATHOLOGICAL MARKERS UNKNOWN UNCONFIRMED CASE ALCL REPORTED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410FX|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6751766|81359644|N|1||FOLLOW-UP COMPLETE REPORTING COMPETENT AUTHORITY PROVIDE INFORMATION SAFEGUARD PRIVACY INVOLVED PATIENTSÂ¿ EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410FX|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6663009|78283521|D|1||CONFIRMED CASE BI-ALCL PT RECEIVED BREAST RECONSTRUCTION SUBCUTANEOUS MASTECTOMY 2011 VIA SILICONE GEL IMPLANTS CYTOLOGY PERIPROSTHETIC FLUID IMPLANT CAPSULE COULD IDENTIFY CD 30 DATES USE 6 YEARS DIAGNOSIS REASON USE BREAST CANCER|MCGHAN SILCONE BREAST IMPLANTS||06/22/2017||||Y|I||0HP|FTR|1.0||SILICONE BREAST IMPLANTS||||||US|MCGHAN|||||MCGHAN||True
6663009|78283521|D|1||CONFIRMED CASE BI-ALCL PT RECEIVED BREAST RECONSTRUCTION SUBCUTANEOUS MASTECTOMY 2011 VIA SILICONE GEL IMPLANTS CYTOLOGY PERIPROSTHETIC FLUID IMPLANT CAPSULE COULD IDENTIFY CD 30 DATES USE 6 YEARS DIAGNOSIS REASON USE BREAST CANCER|MCGHAN SILCONE BREAST IMPLANTS||06/22/2017||||*|I||I|FTR|2.0||SILICONE BREAST IMPLANTS||||||US|MCGHAN|||||MCGHAN||True
6378780|69092151|N|1||RESPONSE FDA REPORT NUMBER MW5067421 EVENTS LYMPHOMA ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY RECORD DHR REPORTS BASED RISK ANALYSIS PERFORMED AE TERM CODE LYMPHOMA-ALCL SELECTED ANALYSIS REPRESENTS HIGHEST RISK FALLING MONITOR RISK REGION APPLICABLE INVESTIGATION LEVEL 3 REVIEW DHR WORK ORDER 1157904 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MAY ASSOCIATED REPORTED DEVICE EVENT SALINE BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT ORACLE VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS QMS LISTING REPORT INDICATES NCMRS ERS UNITS MANUFACTURED WORK ORDER 1157904 ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER 1157904 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-300|03/04/2017||||Y|*||0HP|FWM|1.0|09/24/2009|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1157904|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6378780|69092152|D|1||HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE SEROMA LYMPHOMA ALCL CAPSULECTOMY PERFORMED DEVICE EXPLANTED PATIENT CURRENTLY WORKED ONCOLOGISTS WELL GENETICISTS|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-300|03/04/2017||||Y|*||0HP|FWM|1.0|09/24/2009|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1157904|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6257136|64954239|N|1||DEVICE HISTORY RECORD DHR IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS EVENTS LATE SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|STYLE 150 EXPANDABLE BREAST IMPLANT|N-27-150386|01/17/2017||||N|R||0HP|FTR|1.0|03/26/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2262674|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6257136|64954240|D|1||PHYSICIAN REPORTED RIGHT SIDE LATE SEROMA POSITIVE CYTOLOGY ANAPLASTIC LARGE CELL LYMPHOMA CYTOLOGICAL MARKERS NECESSARY DIAGNOSIS CONFIRMED EVENT ALCL CAPTURED LYMPHOMA TIME MENTION EXPLANT|STYLE 150 EXPANDABLE BREAST IMPLANT|N-27-150386|01/17/2017||||N|R||0HP|FTR|1.0|03/26/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2262674|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6559362|74887820|N|1||B4 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY RECORD REVIEW REVIEW DHR WORK ORDER 2183997 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER 2183997 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS REPORTED EVENTS ADDRESSED LABELING PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENT CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT RUPTURE ONE COMMON REASONS REOPERATION ALLERGAN TESTED EFFECTS RADIATION THERAPY PATIENTS BREAST IMPLANTS LITERATURE SUGGESTS RADIATION THERAPY MAY INCREASE LIKELIHOOD CAPSULAR CONTRACTURE NECROSIS IMPLANT EXTRUSION POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT PERFORM SELF-EXAMINATION BREASTS EVERY MONTH CANCER SCREENING HOWEVER MAY DIFFICULT IMPLANTS ASK SURGEON HELP DISTINGUISH IMPLANT BREAST TISSUE PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGES IMPLANT SHAPE MAY SIGNS RUPTURE IMPLANT SIGNS REPORTED SURGEON POSSIBLY EVALUATED MRI BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM445|05/10/2017||||N|R||0HP|FTR|1.0|10/11/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2183997|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6559362|74887821|D|1||PHYSICIAN REPORTED CASE LYMPHOMA ALCL PAIN RUPTURE LARGE SEROMA PRESENT 2 YEARS CAPSULAR CONTRACTURE BAKER GRADE II CD30+ ALK- CONFIRMED MICROSCOPIC ANALYSIS FOUND CHRONIC INFLAMMATION AROUND CAVITATION PATIENT LEFT SIDE CAPSULECTOMY IMPLANT REMOVAL REPLACEMENT EVENTS OCCURRED LEFT SIDE|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM445|05/10/2017||||N|R||0HP|FTR|1.0|10/11/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2183997|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6576687|75473263|D|1||HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE Â¿ENLARGEMENT CONTRACTURE RIGHT BREAST BAKER GRADE IV TREATMENT INCLUDED RIGHT TOTAL CAPSULECTOMY IMPLANT REMOVAL EXPLANT SURGERY RIGHT SIDE SIGNIFICANT INTRACAPSULAR DEBRIS GROSSLY THICKENED CAPSULE NOTED HEALTHCARE PROFESSIONAL ADDITIONALLY NOTED PATH DEMONSTRATES BIA-ALCL PATIENT UNDERGOING SERIAL PET-CT SCANS Q 6 MONTHS DEVICE INFORMATION PROVIDED MCGHAN 500 CC TEXTURED ROUND SILICONE BREAST IMPLANT|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/18/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6576687|75473262|N|1||EVENTS LYMPHOMA ALCL CAPSULAR CONTRACTURE EDEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES NATRELLEÂ® SILICONE-FILLED BREAST IMPLANTS NATRELLE INSPIRAÂ¿ BREAST IMPLANTS INDICATED WOMEN FOLLOWING BREAST AUGMENTATION WOMEN LEAST 22 YEARS OLD BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT RUPTURE ONE COMMON REASONS REOPERATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/18/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6576687|75536783|D|1||HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE Â¿ENLARGEMENT CONTRACTURE RIGHT BREAST BAKER GRADE IV TREATMENT INCLUDED RIGHT TOTAL CAPSULECTOMY IMPLANT REMOVAL EXPLANT SURGERY RIGHT SIDE SIGNIFICANT INTRACAPSULAR DEBRIS GROSSLY THICKENED CAPSULE NOTED HEALTHCARE PROFESSIONAL ADDITIONALLY NOTED PATH DEMONSTRATES BIA-ALCL PATIENT UNDERGOING SERIAL PET-CT SCANS Q 6 MONTHS DEVICE INFORMATION PROVIDED MCGHAN 500CC TEXTURED ROUND SILICONE BREAST IMPLANT|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/18/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6460137|71714491|N|1||ARTICLE CITATION Â¿A CASE SUSPECTED LATE-STAGE RECURRENCE ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANT INSERTION SITEÂ¿ FUKUSHIMA ISHII INOUE SAKURAI PUBLISHED JOURNAL JAPANESE PATHOLOGY ASSOCIATION VOL 102 NUMBER 1 PG 137 APR 2013 EVENTS LYMPHOMA LUMPNODULE PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/05/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6460137|71714494|D|1||REPORTED EVENT PATIENT DIAGNOSED Â¿ALCLÂ¿ Â¿SUBCUTANEOUS TUMORÂ¿ FOUND Â¿A CASE SUSPECTED LATE-STAGE RECURRENCE ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANT INSERTION SITE PUBLISHED JOURNAL JAPANESE PATHOLOGY ASSOCIATION VOL 102 NUMBER 1 PG 137 APR 2013 TREATMENT Â¿ANTIBIOTICSÂ¿ PROVIDED DEVICE LATER EXPLANTED MANUFACTURER DEVICE UNKNOWN MEDWATCH REPRESENTS LEFT SIDE SEE MFR 9617229-2017-00129 RIGHT SIDE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/05/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6654587|78019288|D|1||HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE Â¿CHRONICÂ¿ SEROMA LYMPHOMA ALCL PATIENT DEVELOPED RIGHT BREAST ABSCESS SEROMA Â¿PURPLISH EXOPHYTIC SKIN MASSÂ¿ OBSERVED DEVICE REMOVAL CAPSULECTOMY PERFORMED CAPSULE DEVICE SENT PATHOLOGY PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL RECEIVED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-300|06/20/2017||||N|R||0HP|FTR|1.0|12/27/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2232205|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6654587|78019287|N|1||B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY REVIEW DHR REPORTS REVIEW DHR B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-300|06/20/2017||||N|R||0HP|FTR|1.0|12/27/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2232205|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6323445|67166355|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6323445|67166356|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL UNKNOWN SIDE EXPLANT SURGERY OCCURRED PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6744780|81082640|D|1||PHYSICIAN REPORTED LATE SEROMA IMPLANT BEARING FOUND PHYSICIAN REPORTED CASE ALCL CONFIRMED VIA CYTOLOGY FLUID IMPLANT CAPSULE LEFT SIDE CD30+ CONFIRMED PATHOLOGICAL MARKERS CONFIRMED EVENT REPORTED LYMPHOMA TREATMENT UNKNOWN|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSM520|07/26/2017||||N|R||0HP|FTR|1.0|10/04/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180982|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6744780|81082639|N|1||EVENTS LYMPHOMA LATE SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSM520|07/26/2017||||N|R||0HP|FTR|1.0|10/04/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180982|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6745299|81111775|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|07/26/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6745299|81111776|D|1||HEALTHCARE PROFESSIONAL REPORTED FIRST ALCL CASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|07/26/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6331755|67482135|N|1||CLARIFICATION REGARDING EVENT EVENT CASE CONSIDERED LYMPHOMA EVENT STATED RECEIVED PROFILE REGISTRY DATABASE DEDICATED CAPTURING REPORTS ALCL EVENT LYMPHOMA PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED UPON ADDITIONAL FOLLOW PHYSICIAN DETERMINED ADDITIONAL INFORMATION AVAILABLE DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/15/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6331760|67507919|N|1||CLARIFICATION REGARDING EVENT EVENT CASE CONSIDERED LYMPHOMA EVENT STATED RECEIVED PROFILE REGISTRY DATABASE DEDICATED CAPTURING REPORTS ALCL EVENT LYMPHOMA PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED UPON ADDITIONAL FOLLOW PHYSICIAN DETERMINED ADDITIONAL INFORMATION AVAILABLE DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/15/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6497135|72921040|D|1||PATIENT REPORTED LEFT SIDE MASSIVE SWELLING LEFT BREAST DOUBLED SIZE PATIENT ADDITIONALLY REPORTED GETTING REALLY SICK DIAGNOSED BREAST IMPLANT ANAPLASTIC LARGE CELL LYMPHOMA B6 2016 PATIENT ADDITIONALLY REPORTED PATHOLOGY SHOWED LEFT SIDE MASS SPREAD OUTSIDE CAPSULE HEALTHCARE PROFESSIONAL CONFIRMED REPORTED EVENTS HEALTHCARE PROFESSIONAL ADDITIONALLY REPORTED LEFT SIDE Â¿PERIPROSTHETIC FLUID TIME DIAGNOSISÂ¿ SPONTANEOUS LARGE LEFT SIDED SEROMA TOTAL CAPSULECTOMY EXPLANTATION PERFORMED PATHOLOGY RESULTS SHOWED ALCL WITHIN LEFT CAPSULE SMALL LEFT BREAST MASS|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRF415|04/17/2017||||N|R||0HP|FTR|1.0|04/29/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2109766|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6497135|72921039|N|1||B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY RECORD DHR REPORTS BASED RISK ANALYSIS PERFORMED AE TERM CODE LYMPHOMA ALCL SELECTED ANALYSIS REPRESENTS HIGHEST RISK FALLING MONITOR RISK REGION APPLICABLE INVESTIGATION LEVEL THREE REVIEW DHR WORK ORDER B4 IDENTIFY ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS QUERY PERFORMED QMS SYSTEM DEVIATIONS NON-CONFORMANCES FOUND RELATED WORK ORDER B4  ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRF415|04/17/2017||||N|R||0HP|FTR|1.0|04/29/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2109766|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6634993|81178349|D|1||B4 ARTICLE TITLED Â¿A SHOCKING DIAGNOSIS BREAST IMPLANTS Â¿GAVE CANCERÂ¿Â¿ REPORTED 2012 PATIENT BECAME SHORT BREATH PAIN SWELLING PATIENT BREAST LUMP PATIENT CHEST SWOLLEN LYMPH NODES PATIENT CHEST NECK PATIENT HOSPITALIZED TWO MONTHS WORSENING STEADILY DOCTORS STRUGGLED DETERMINE WRONG TESTING LYMPHOMA SUGGESTED DIAGNOSIS FINALLY MADE PATIENT CRITICALLY ILL VENTILATOR PATIENT IMPROVED CHEMOTHERAPY CAME HOME HOSPITAL PATIENT CONSIDERED STRONG ENOUGH SURGERY PATIENT WENT BACK HOSPITAL IMPLANT REMOVED PATIENTÂ¿S HEART STOPPED OPERATING TABLE PATIENT RESUSCITATED DIED TWO WEEKS LATERÂ¿ PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CAPTURED LYMPHOMA SIDE EXPERIENCING EVENTS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/12/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6634993|77375388|N|1||B4 CLARIFICATION PATIENTS EXACT DATE DEATH PROVIDED KNOWN INFORMATION YEAR 2012 ARTICLE CITATION SHOCKING DIAGNOSIS BREAST IMPLANTS GAVE CANCER DENISE GRADY NEW YORK TIMES MAY 14 2017 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT DETAILS CANNOT OBTAINED PATIENT EXPLANTING PHYSICIAN CONTACT INFORMATION PROVIDED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT MISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/12/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6634993|77375389|D|1||NEW YORK TIMES ARTICLE TITLED Â¿A SHOCKING DIAGNOSIS BREAST IMPLANTS Â¿GAVE CANCERÂ¿Â¿ REPORTED 2012 PATIENT BECAME SHORT BREATH PAIN SWELLING PATIENT BREAST LUMP PATIENT CHEST SWOLLEN LYMPH NODES PATIENT CHEST NECK PATIENT HOSPITALIZED TWO MONTHS WORSENING STEADILY DOCTORS STRUGGLED DETERMINE WRONG TESTING LYMPHOMA SUGGESTED DIAGNOSIS FINALLY MADE PATIENT CRITICALLY ILL VENTILATOR PATIENT IMPROVED CHEMOTHERAPY CAME HOME HOSPITAL PATIENT CONSIDERED STRONG ENOUGH SURGERY PATIENT WENT BACK HOSPITAL IMPLANT REMOVED PATIENTÂ¿S HEART STOPPED OPERATING TABLE PATIENT RESUSCITATED DIED TWO WEEKS LATERÂ¿ PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CAPTURED LYMPHOMA SIDE EXPERIENCING EVENTS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/12/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6498449|72963714|D|1||FDA REPORTS Â¿THE FDA RECEIVED TOTAL 359 MEDICAL DEVICE REPORTS MDRS BIA-ALCL INCLUDING NINE DEATHSÂ¿ MEDIAN REPORTED AGE PATIENTS 53 RANGE 25-91 WITHIN SPECIFIED REPORTS MEDIAN REPORTED TIME IMPLANT ALCL DIAGNOSIS 7 YEARS RANGE 0-40 YEARS WITHIN SPECIFIED REPORTS 203 REPORTED DEVICES SPECIFIED TEXTURED 28 SMOOTH 128 SPECIFIED 186 REPORTED DEVICES SPECIFIED SILICONE 126 SALINE 47 SPECIFIED PRESENTATION ALCL INCLUDED SEROMA 158 REPORTS CAPSULAR CONTRACTURE 21 REPORTS PERI-IMPLANT MASS 21 REPORTS Â¿OTHERSÂ¿ 46 REPORTS 119 CASES TESTED NEGATIVE ALK 240 UNSPECIFIED 120 CASES TESTED POSITIVE CD30 239 UNSPECIFIED MANUFACTURER DEVICES UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6498449|72963713|N|1||REPORT SUBMITTED RESPONSE FDA NOTICE TITLED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCL PROVIDED 21MAR2017 TOTAL NUMBER CASES REFERENCED NOTICE 359 INCLUDING 9 DEATHS INFORMATION PROVIDED NOTICE CLASSIFIES ALCL EVENTS DIFFERENT CATEGORIES INCLUDING TYPES DEVICE ASSOCIATED ADVERSE EVENTS PRESENTATION DIAGNOSIS DETAILS IDENTIFY SPECIFIC DEVICES PATIENTS POSSIBLE INDIVIDUALIZE INFORMATION SPECIFIC REPORTS DEFINITION ALREADY INCLUDES EVENTS REPORTED ALLERGAN PAST THEREFORE ACCORDANCE 21 CFR 803 REPORT REPRESENT ACKNOWLEDGEMENT RECEIPT NOTICE DOCUMENTATION ALLERGANS ATTEMPT INVESTIGATE ADVERSE EVENTS IDENTIFIED NOTICE REPORT SUBSTITUTE INVESTIGATION COMPLAINTS RECEIVED INDIVIDUAL PATIENTS ALLERGAN DEVICES IDENTIFIED INCLUSIVE EXCLUSIVE 359 CASES MENTIONED NOTICE B4 EVENTS DEATH LYMPHOMA-ALCL LYMPHOMA SEROMA CAPSULAR CONTRACTURE BREAST LUMPS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS SALINE DEVICE LABELING RADIATION BREAST Â¿ ALLERGAN TESTED VIVO EFFECTS RADIATION THERAPY PATIENTS BREAST IMPLANTS LITERATURE SUGGESTS RADIATION THERAPY MAY INCREASE LIKELIHOOD CAPSULAR CONTRACTURE NECROSIS IMPLANT EXTRUSION POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY CAPSULAR CONTRACTURE Â¿ PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT DEFLATION ONE COMMON REASONS REOPERATION PATIENTS ALSO ADVISED ADDITIONAL SURGERY MAY NEEDED CASES PAIN ANDOR FIRMNESS SEVERE SURGERY RANGES REMOVAL IMPLANT CAPSULE TISSUE REMOVAL POSSIBLE REPLACEMENT IMPLANT SURGERY MAY RESULT LOSS BREAST TISSUE CAPSULAR CONTRACTURE MAY HAPPEN ADDITIONAL SURGERIES CAPSULAR CONTRACTURE MAY INCREASE RISK DEFLATION ADDITIONAL COMPLICATIONS Â¿ BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS PASS STUDY LEAST 1 REOPERATION PERFORMED 315 PATIENTS 365 10 YEARS TOTAL 424 REOPERATIONS PERFORMED PRIMARY REASON REOPERATION 10 YEARS AUGMENTATION PATIENTS IMPLANT DEFLATION 217 PERCENTAGE REOPERATIONS DUE LUMPMASSCYST INCREASED 85 293 REOPERATIONS 5 YEARS 139 424 REOPERATIONS 10 YEARS OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PATIENTS AGE COULD EXPLANATION INCREASE BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFORMATION FDAÂ¿S ANALYSIS REVIEW ALCL PATIENTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM ALSO REQUIRED REPORT PRODUCT PROBLEM SERIOUS ADVERSE EVENT ALLERGAN DEATHS MUST REPORTED ALLERGAN FDA SILICONE DEVICE LABELING ONE KEY COMPLICATIONS REPORTED CALLED Â¿CAPSULAR CONTRACTUREÂ¿ CAPSULAR CONTRACTURE TIGHTENING SCAR TISSUE ALSO CALLED CAPSULE NORMALLY FORMS AROUND BREAST IMPLANT HEALING PROCESS SURGERY WOMEN SCAR TISSUE CAPSULE SQUEEZES IMPLANT RESULTS FIRMNESS HARDENING BREAST RISK IMPLANT RUPTURE DEGREES CAPSULAR CONTRACTURE CLASSIFIED BAKER GRADING SCALE1 CAPSULAR CONTRACTURE BAKER GRADES III IV SEVERE BAKER GRADE III OFTEN RESULTS NEED ADDITIONAL SURGERY REOPERATION PAIN POSSIBLY ABNORMAL APPEARANCE BAKER GRADE IV USUALLY RESULTS NEED REOPERATION PAIN UNACCEPTABLE APPEARANCE TREAT CAPSULAR CONTRACTURE CLOSED CAPSULOTOMY FORCEFUL EXTERNAL COMPRESSION LIKELY RESULT IMPLANT DAMAGE RUPTURE FOLDS ANDOR HEMATOMA ALLERGAN TESTED EFFECTS RADIATION THERAPY PATIENTS BREAST IMPLANTS LITERATURE SUGGESTS RADIATION THERAPY MAY INCREASE LIKELIHOOD CAPSULAR CONTRACTURE NECROSIS IMPLANT EXTRUSION POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT PERFORM SELF-EXAMINATION BREASTS EVERY MONTH CANCER SCREENING HOWEVER MAY DIFFICULT IMPLANTS ASK SURGEON HELP DISTINGUISH IMPLANT BREAST TISSUE PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGES IMPLANT SHAPE MAY SIGNS RUPTURE IMPLANT SIGNS REPORTED SURGEON POSSIBLY EVALUATED MRI BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFORMATION FDAÂ¿S ANALYSIS REVIEW ALCL PATIENTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6571801|75326411|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE RUPTURE IMPLANTED PATIENT ADDITIONALLY EXPERIENCED Â¿PATIENT ALSO DIAGNOSED PALPITATION AROUND TIME PATIENT SURGERY 2 ABLATIONS YEAR 2000Â¿ Â¿PATIENT DEVELOPED NONSPECIFIC SYMPTOMS INCLUDE GENERALIZED ACHES PAINS FATIGUE DRY EYES DRY MOUTH PATIENT DIAGNOSED NONSPECIFIC CONNECTIVE TISSUE DISEASE 2005Â¿ PATIENT RECEIVED PLAQUENIL TREATMENT 2010 PAST 2 YEARS PATIENT ADDITIONALLY STARTED LOT DISCOMFORT PATIENT LEFT BREAST FATIGUE WEAKNESS WEIGHT CHANGES PATIENT ALSO GAVE HISTORY LEAST Â¿2 EPISODES SEVERE SOAKING NIGHT SWEATS SINCE LAST 2-3 MONTHS LEAST 2-3 TIMES WEEK DRENCHING NIGHT SWEATS REQUIRING PATIENT CHANGE PATIENT NIGHTGOWNÂ¿ Â¿PATIENT CHILLS SUBJECTIVE FEVER PATIENT ALSO COMPLAINS SKIN RASH PATIENT LATERAL ASPECT OUTER UPPER QUADRANT LEFT BREAST WELL POSTERIOR ASPECT PATIENT LEFT THIGH LAST 1 MONTH PATIENT SYMPTOMS GOTTEN PROGRESSIVELY WORSE INCREASE SIZE PATIENT LEFT BREAST PATIENT NOTED PEA-SIZED NODULES LEFT AXILLA 2 YEARS ADDITIONAL REPORT Â¿THERE FLUID COLLECTION SURROUNDING RUPTURED IMPLANTÂ¿ Â¿LARGE SWOLLEN LEFT BREAST FLUID WAVEÂ¿ PATIENT REPORTED Â¿LYMPHOMA ALCLÂ¿ HEALTHCARE PROFESSIONAL STATED Â¿PT ALCLÂ¿ PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL RECEIVED|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-420|05/17/2017||||N|R||0HP|FTR|1.0|04/15/2004|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||49463|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6571801|75326410|N|1||CONCOMITANT MEDICAL PRODUCTS NITROGLYCERIN VALIUM 2 ZOLOFT B4 INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY RECORD DHR REPORTS REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MAY ASSOCIATED REPORTED DEVICE EVENT GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANTS LIFETIME DEVICES BREAST IMPLANTS RUPTURE SHELL DEVELOPS TEAR HOLE RUPTURES OCCUR TIME IMPLANTATION LIKELY OCCUR LONGER IMPLANT IMPLANTED FOLLOWING THINGS MAY CAUSE IMPLANTS RUPTURE DAMAGE SURGICAL INSTRUMENTS STRESSING IMPLANT IMPLANTATION WEAKENING FOLDING WRINKLING IMPLANT SHELL EXCESSIVE FORCE CHEST EG CLOSED CAPSULOTOMY CONTRAINDICATED TRAUMA COMPRESSION MAMMOGRAPHIC IMAGING SEVERE CAPSULAR CONTRACTURE BREAST IMPLANTS MAY ALSO SIMPLY WEAR TIME LABORATORY STUDIES IDENTIFIED CAUSES RUPTURE ALLERGANÂ¿S PRODUCT CONCLUSIVELY KNOWN WHETHER TESTS IDENTIFIED CAUSES RUPTURE LABORATORY STUDIES IDENTIFY ADDITIONAL CAUSES RUPTURE ONGOING SILICONE GEL-FILLED IMPLANT RUPTURES OFTEN SILENT MEANS TIME NEITHER PATIENT KNOW IMPLANT TEAR HOLE SHELL MRI EXAMINATION CURRENTLY BEST METHOD SCREEN RUPTURE SOMETIMES SYMPTOMS ASSOCIATED GEL IMPLANT RUPTURE SYMPTOMS INCLUDE HARD KNOTS LUMPS SURROUNDING IMPLANT ARMPIT CHANGE LOSS SIZE SHAPE BREAST IMPLANT PAIN TINGLING SWELLING NUMBNESS BURNING HARDENING BREAST MRI SIGNS RUPTURE FOUND SUBCAPSULAR LINES CHARACTERISTIC FOLDED WAVY LINES TEARDROP SIGN KEYHOLE SIGN NOOSE SIGN SIGNS SYMPTOMS RUPTURE REMOVE IMPLANT GEL DETERMINE PATIENT WITHOUT REPLACEMENT IMPLANT ALSO MAY NECESSARY REMOVE TISSUE CAPSULE ALSO CONSEQUENCES RUPTURE RUPTURE OCCURS SILICONE GEL MAY EITHER REMAIN WITHIN SCAR TISSUE CAPSULE SURROUNDING IMPLANT INTRACAPSULAR RUPTURE MOVE OUTSIDE CAPSULE EXTRACAPSULAR RUPTURE MOVE OUTSIDE BREAST GEL MIGRATION ALSO POSSIBILITY RUPTURE MAY PROGRESS INTRACAPSULAR EXTRACAPSULAR BEYOND|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-420|05/17/2017||||N|R||0HP|FTR|1.0|04/15/2004|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||49463|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6670624|78496499|N|1||INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ADDRESSES REPORTED EVENT FOLLOWS BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/27/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6670624|78496500|D|1||COMPANY REPRESENTATIVE REPORTED Â¿A CASEÂ¿ Â¿BIA-ALCLÂ¿ PATIENT SIDE UNKNOWN PATHOLOGICAL REPORTS INCLUDED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/27/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6460158|71723777|D|1||REPORTED EVENT PATIENT DIAGNOSED Â¿ALCLÂ¿ Â¿SUBCUTANEOUS TUMORÂ¿ FOUND Â¿A CASE SUSPECTED LATE-STAGE RECURRENCE ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANT INSERTION SITE PUBLISHED JOURNAL JAPANESE PATHOLOGY ASSOCIATION VOL 102 NUMBER 1 PG 137 APR 2013 TREATMENT Â¿ANTIBIOTICSÂ¿ PROVIDED DEVICE LATER EXPLANTED MANUFACTURER DEVICE UNKNOWN MEDWATCH REPRESENTS RIGHT SIDE SEE MFR 9617229-2017-00128 LEFT SIDE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/05/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6460158|71723776|N|1||ARTICLE CITATION Â¿A CASE SUSPECTED LATE-STAGE RECURRENCE ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANT INSERTION SITEÂ¿ FUKUSHIMA ISHII INOUE SAKURAI PUBLISHED JOURNAL JAPANESE PATHOLOGY ASSOCIATION VOL 102 NUMBER 1 PG 137 APR 2013 EVENTS LYMPHOMA LUMPNODULE PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/05/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6732214|80691506|D|1||ALCL PREVIOUS BREAST AUGMENTATION TEXTURED DEVICE|INAMED||07/20/2017||||N|I||0HP|FTR|1.0||BREAST IMPLANT||||||US|INAMED|||||INAMED 410 TEXTURED IMPLANT||True
6734621|80749897|N|1||DEVICE REMAINS IMPLANTED EVENT BREAST CANCER PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REVIEW DEVICE HISTORY RECORD INITIATED NEW CHANGED CORRECTED INFORMATION NOTED SUPPLEMENTAL MEDWATCH SUBMITTED INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY CANCER PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFORMATION FDAÂ¿S ANALYSIS REVIEW ALCL PATIENTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM|STYLE 68 SALINE FILLED BREAST IMPLANT|68-240|07/21/2017||||N|R||0HP|FWM|1.0|04/05/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1257756|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6293034|66256105|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOÂ¬MA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/01/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6293034|66256106|D|1||RECEIVED REPORT THERAPEUTIC GOODS ADMINISTRATION REPORTING Â¿CONFIRMED ALCLÂ¿ UNKNOWN Â¿ALLERGANMCGHANÂ¿ DEVICE SIDE UNKNOWN DEVICE EXPLANTED PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CONFIRMED ALCL CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/01/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6323429|67161072|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL UNKNOWN SIDE EXPLANT SURGERY OCCURRED PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6323429|67161071|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6638620|77500427|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/13/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6638620|77500428|D|1||HEALTHCARE PROFESSIONAL REPORTED CONFIRMED CASE ALCL UNKNOWN SIDE PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL RECEIVED EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/13/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6315868|67108884|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL UNKNOWN SIDE EXPLANT SURGERY OCCURRED PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6315868|67108883|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6752720|81359776|D|1||COMPETENT AUTHORITY REPORTED CASE ALCL TREATMENT AFFECTED SIDE UNKNOWN PATHOLOGICAL MARKERS UNKNOWN UNCONFIRMED CASE ALCL REPORTED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410MF|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6752720|81359775|N|1||FOLLOW-UP COMPLETE REPORTING COMPETENT AUTHORITY PROVIDE INFORMATION SAFEGUARD PRIVACY INVOLVED PATIENTSÂ¿ EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410MF|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6460781|74854380|D|1||HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE ALCL LYMPHOMA PATIENT ADDITIONALLY EXPERIENCED Â¿SEVERE SEROMAÂ¿ SWOLLEN RIGHT BREAST SEROMA ASPIRATED B6 2016 PATIENT RECEIVED ALCL DIAGNOSIS B6 2016 MARKERS FOUND SEROMA FLUID CAPSULE DEVICE INFORMATION PROVIDED TEXTURED ROUND SALINE MCGHAN 350CC DEVICE CAPSULECTOMY PERFORMED DEVICE EXPLANTED PATIENT RECEIVE REPLACEMENT DEVICES PATIENTS STATUS REPORTED WELL THUS FAR RETURN SYMPTOMS REMAINS DISEASE FREE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|04/05/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6460781|74854379|N|1||EVENTS LYMPHOMA ALCL SEROMA EDEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|04/05/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6460781|71746777|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|04/05/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6460781|71746778|D|1||HEALTHCARE PROFESSIONAL REPORTED ALCL UNKNOWN SIDE EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|04/05/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6744036|81049027|D|1||HEALTHCARE PROFESSIONAL REPORTED ALCL TREATMENT AFFECTED LOCATION UNKNOWN PATHOLOGICAL MARKERS PROVIDED CONFIRMED CASE ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/26/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6744036|81049026|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/26/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6677037|78706810|N|1||INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENT PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTED EVENT ADDRESSED LABELING ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/29/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6677037|78706811|D|1||COMPANY REPRESENTATIVE REPORTED CONFERENCE LEARNED CASE ALCL EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS UNKNOWN SIDE UNKNOWN TREATMENT UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/29/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6341238|67800491|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6341238|67800492|D|1||PHYSICIAN REPORTS BREAST IMPLANT ASSOCIATED ALCL RIGHT SIDE DEVICE EXPLANTED PATHOLOGICAL MARKERS RECEIVED CONFIRM ALCL DIAGNOSIS EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6498277|72952111|N|1||EVENTS LYMPHOMA EDEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6498277|72952112|D|1||PATIENT REPORTED LEFT BREAST DOUBLED SIZE SUDDEN SWELLING LYMPHOMA ALCL PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED THEREFORE EVENT CAPTURED LYMPHOMA EXPLANT SURGERY OCCURRED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6247063|64661472|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME EVENTS SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/12/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6247063|64661472|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME EVENTS SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSLP280|01/12/2017|||DA|*|*||0HP|FTR|1.0|05/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1845063|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247063|64661473|D|1||PHYSICIAN REPORTS CHRONIC IMPLANT RELATED SEROMA EXCISED SUBSEQUENTLY DIAGNOSED ALCL CYTOLOGY SIDE UNKNOWN HEALTHCARE PROFESSIONAL REPORTED CAPSULECTOMY PERFORMED PROCESS TREATING PATIENT WITHOUT SPECIFYING TYPE TREATMENT EVENT ALCL CAPTURED LYMPHOMA TIME REQUIRED CYTOLOGICAL MARKERS REPORTED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/12/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6247063|64661473|D|1||PHYSICIAN REPORTS CHRONIC IMPLANT RELATED SEROMA EXCISED SUBSEQUENTLY DIAGNOSED ALCL CYTOLOGY SIDE UNKNOWN HEALTHCARE PROFESSIONAL REPORTED CAPSULECTOMY PERFORMED PROCESS TREATING PATIENT WITHOUT SPECIFYING TYPE TREATMENT EVENT ALCL CAPTURED LYMPHOMA TIME REQUIRED CYTOLOGICAL MARKERS REPORTED MANUFACTURER DEVICE UNKNOWN|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSLP280|01/12/2017|||DA|*|*||0HP|FTR|1.0|05/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1845063|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247063|73823203|D|1||ADDITIONAL INFORMATION RECEIVED HEALTHCARE PROFESSIONAL CONFIRMING EVENT LEFT SIDE DEVICE CYTOLOGICAL MARKERS ALK- CD30+ REPORTED CONFIRMED CASE ALCL PHYSICIAN ADDITIONALLY REPORTED EVENT CAPSULAR CONTRACTURE PRESENTATION BAKER GRADE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/12/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6247063|73823203|D|1||ADDITIONAL INFORMATION RECEIVED HEALTHCARE PROFESSIONAL CONFIRMING EVENT LEFT SIDE DEVICE CYTOLOGICAL MARKERS ALK- CD30+ REPORTED CONFIRMED CASE ALCL PHYSICIAN ADDITIONALLY REPORTED EVENT CAPSULAR CONTRACTURE PRESENTATION BAKER GRADE UNKNOWN|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSLP280|01/12/2017|||DA|*|*||0HP|FTR|1.0|05/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1845063|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247160|68260911|D|1||PHYSICIAN REPORTS PATIENT PRESENTED ER ANEMIA WEIGHT LOSS B6 2016 PATIENT DIAGNOSED BIA-ALCL B6 2016 PHYSICIAN REPORTED RIGHT SIDE RUPTURE RIGHT SIDE CAPSULAR CONTRACTURE BAKER GRADE SPECIFIED EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2017-00006 LEFT SIDE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247160|64710080|N|1||B6 -WEIGHT FLUCTUATIONS EVENTS WEIGHT LOSS ANEMIA CAPSULAR CONTRACTURE LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST FORMATION FIBROUS TISSUE AROUND IMPLANTED DEVICE NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY ONE COMMON REASONS REOPERATION CAUSE CAPSULAR CONTRACTURE UNKNOWN HOWEVER LIKELY MULTIFACTORIAL MAY COMMON FOLLOWING INFECTION HAEMATOMA SEROMA CONTRACTURE DEVELOPS VARYING DEGREES UNILATERALLY BILATERALLY MAY OCCUR WITHIN WEEKS YEARS SURGERY CONTRACTURE FIBROUS CAPSULAR TISSUE SURROUNDING IMPLANT MAY CAUSE RANGE SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES CONSIDERED CLINICALLY SIGNIFICANT MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT CORRECTIVE SURGICAL PROCEDURES TREAT CAPSULAR CONTRACTURE EXTERNAL COMPRESSION MASSAGE MAY RESULT IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247160|64710081|D|1||PHYSICIAN REPORTS PATIENT PRESENTED ER ANEMIA WEIGHT LOSS B6 2016 PATIENT DIAGNOSED BIA-ALCL B6 2016 PHYSICIAN REPORTED RIGHT SIDE RUPTURE RIGHT SIDE CAPSULAR CONTRACTURE BAKER GRADE SPECIFIED EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2017-00006 LEFT SIDE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6395062|73128949|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DIAGNOSED RIGHT SIDE Â¿ALCLÂ¿ FOUND WITHIN Â¿PERI-IMPLANT MASSÂ¿ Â¿SEROMAÂ¿ 13 YEARS BREAST AUGMENTATION SURGERY PATHOLOGICAL MARKERS INCLUDED PATIENT RECEIVED CHEMOTHERAPY SPECIFIED Â¿CHOPÂ¿ CHEMOTHERAPY DEVICE EXPLANTED PATIENT RECEIVED ADDITIONAL TREATMENT RADIATION THERAPY SPECIFIED Â¿30 GREYÂ¿ PATIENT CURRENTLY EVIDENCE ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/10/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6395062|69619795|N|1||EVENTS LYMPHOMA SEROMA LUMPNODULE PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/10/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6395062|69619796|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DIAGNOSED RIGHT SIDE Â¿ALCLÂ¿ FOUND WITHIN Â¿PERI-IMPLANT MASSÂ¿ Â¿SEROMAÂ¿ 13 YEARS BREAST AUGMENTATION SURGERY PATHOLOGICAL MARKERS INCLUDED PATIENT RECEIVED CHEMOTHERAPY SPECIFIED Â¿CHOPÂ¿ CHEMOTHERAPY DEVICE EXPLANTED PATIENT RECEIVED ADDITIONAL TREATMENT RADIATION THERAPY SPECIFIED Â¿30 GREYÂ¿ PATIENT CURRENTLY EVIDENCE ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/10/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6309206|66741539|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/07/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6309206|66741540|D|1||RECEIVED REPORT THERAPEUTIC GOODS ADMINISTRATION REPORTING Â¿CONFIRMED ALCLÂ¿ UNKNOWN Â¿ALLERGANMCGHANÂ¿ DEVICE SIDE UNKNOWN DEVICE EXPLANTED PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CONFIRMED ALCL CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/07/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6595799|76126751|D|1||HEALTHCARE PROFESSIONAL REPORTED 5 ALCL CASES Â¿PREVIOUSLY REPORTEDÂ¿ FOREIGN COMPETENT HEALTH AUTHORITY EVENT DETAILS MANUFACTURER TREATMENT INFORMATION UNKNOWN TIME HISTOLOGICAL MARKERS UNCONFIRMED CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/26/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6595799|76126751|D|1||HEALTHCARE PROFESSIONAL REPORTED 5 ALCL CASES Â¿PREVIOUSLY REPORTEDÂ¿ FOREIGN COMPETENT HEALTH AUTHORITY EVENT DETAILS MANUFACTURER TREATMENT INFORMATION UNKNOWN TIME HISTOLOGICAL MARKERS UNCONFIRMED CAPTURED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410LX|05/26/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6595799|76126750|N|1||FOLLOW-UP PERFORMED INFORMATION REGARDING REPORT NEW INFORMATION RECEIVED REPORTED SUPPLEMENTAL REPORT REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/26/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6595799|76126750|N|1||FOLLOW-UP PERFORMED INFORMATION REGARDING REPORT NEW INFORMATION RECEIVED REPORTED SUPPLEMENTAL REPORT REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410LX|05/26/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6617685|76841699|D|1||MEDICAL STAFF REPORTED PERIPROSTHETIC SEROMA PERIPROSTHETIC LINE OBSERVED MAMMOGRAPHY RESULTED SUSPICION INTRACAPSULAR RUPTURE PATIENT EXPERIENCED VOLUME INCREASE RIGHT BREAST RIGHT PROSTHESIS REMOVED CAPSULECTOMY PERFORMED ALK- ALCL DIAGNOSED CAPSULE PATHOLOGICAL ANALYSIS PATHOLOGICAL MARKERS CONFIRMED CASE ALCL REPORTED LYMPHOMA|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|06/07/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6617685|76841698|N|1||ALLERGAN UNABLE CONFIRM HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL EVENT PRODUCT PATIENT DETAILS ATTAINABLE REPORTED EVENTS LYMPHOMA SEROMA EDEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING PATIENT TOLD PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGE IMPLANT SHAPE MAY SIGNS SYMPTOMATIC RUPTURE IMPLANT PATIENT SIGNS TOLD REPORT POSSIBLY MRI EVALUATION SCREEN RUPTURE POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|06/07/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6309203|66741187|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/07/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6309203|66741188|D|1||RECEIVED REPORT THERAPEUTIC GOODS ADMINISTRATION REPORTING Â¿CONFIRMED ALCLÂ¿ UNKNOWN Â¿ALLERGANMCGHANÂ¿ DEVICE SIDE UNKNOWN DEVICE EXPLANTED PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CONFIRMED ALCL CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/07/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6431321|70907894|D|1||B6 2004 MENTOR SALINE IMPLANTS PUT DR B6 B6 B6 TIME EXACTLY 3 MONTHS LATER BEGAN PAIN SWELLING NECK DIAGNOSED ACUTE THYROIDITIS NEXT 6 MONTHS 12 MONTHS WENT HYPERTHYROIDISM HYPOTHYROIDISM DIAGNOSED GRAVES DISEASE EVENTUALLY HASHIMOTOS DISEASE SICK COUNTLESS SINUS INFECTIONS GERD LEAKY GUT SYNDROME LOSS VISION HEADACHES VERTIGO DECREASED LIBIDO HORMONAL IMBALANCE FOOD ALLERGIES HAIR LOSS BREAST MASSES LAST THREE MAMMOGRAMS NEVER EXPLAINED POSSIBLE HEALTH RISKS IMMUNE SYSTEM QUALITY LIFE LOST LAST 13 YEARS SICK APPOINTMENT TOMORROW ANOTHER MAMMOGRAM ULTRASOUNDS BEGIN TESTING BIA-ALCL BREAST IMPLANT ILLNESS REAL CONDITION NEEDS EXPLORED PUBLIC HEALTH CONCERN IMPLANTS CAUSE IMMUNE SYSTEM CANCER RECENTLY RELEASED ADMINISTRATION BEGINS SNOWFALL EFFECT DAMAGE IMMUNE SYSTEM|MENTOR SALINE SMOOTH||03/22/2017||||Y|I||I|FWM|2.0||BREAST IMPLANTS|||||||MENTOR|||||||True
6431321|70907894|D|1||B6 2004 MENTOR SALINE IMPLANTS PUT DR B6 B6 B6 TIME EXACTLY 3 MONTHS LATER BEGAN PAIN SWELLING NECK DIAGNOSED ACUTE THYROIDITIS NEXT 6 MONTHS 12 MONTHS WENT HYPERTHYROIDISM HYPOTHYROIDISM DIAGNOSED GRAVES DISEASE EVENTUALLY HASHIMOTOS DISEASE SICK COUNTLESS SINUS INFECTIONS GERD LEAKY GUT SYNDROME LOSS VISION HEADACHES VERTIGO DECREASED LIBIDO HORMONAL IMBALANCE FOOD ALLERGIES HAIR LOSS BREAST MASSES LAST THREE MAMMOGRAMS NEVER EXPLAINED POSSIBLE HEALTH RISKS IMMUNE SYSTEM QUALITY LIFE LOST LAST 13 YEARS SICK APPOINTMENT TOMORROW ANOTHER MAMMOGRAM ULTRASOUNDS BEGIN TESTING BIA-ALCL BREAST IMPLANT ILLNESS REAL CONDITION NEEDS EXPLORED PUBLIC HEALTH CONCERN IMPLANTS CAUSE IMMUNE SYSTEM CANCER RECENTLY RELEASED ADMINISTRATION BEGINS SNOWFALL EFFECT DAMAGE IMMUNE SYSTEM|MENTOR SALINE SMOOTH||03/22/2017||||Y|I||I|FWM|1.0||BREAST IMPLANTS|||||||MENTOR|||||||True
6663360|78278939|N|1||FOLLOW-UP PERFORMED INFORMATION REGARDING EVENT NEW INFORMATION RECEIVED REPORTED SUPPLEMENTAL REPORT REPORTED EVENT PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTED EVENTS ADDRESSED LABELING ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|TSF385|06/23/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6574813|75416230|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PATIENTS AGE COULD EXPLANATION INCREASE ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL REPORTS MEDICAL LITERATURE INDICATE PATIENTS BREAST IMPLANTS GREATER RISK WITHOUT BREAST IMPLANTS DEVELOPING BREAST CANCER REPORTS SUGGESTED BREAST IMPLANTS MAY INTERFERE DELAY BREAST CANCER DETECTION MAMMOGRAPHY ANDOR BIOPSY HOWEVER REPORTS PUBLISHED MEDICAL LITERATURE INDICATE BREAST IMPLANTS NEITHER SIGNIFICANTLY DELAY BREAST CANCER DETECTION ADVERSELY AFFECT CANCER SURVIVAL WOMEN BREAST IMPLANTS LARGE FOLLOW-UP STUDY REPORTED EVIDENCE ASSOCIATION BREAST IMPLANTS CANCER EVEN SHOWED DECREASED INCIDENCE BREAST CANCER COMPARED GENERAL POPULATION ONE STUDY REPORTED INCREASED INCIDENCE BRAIN CANCER WOMEN BREAST IMPLANTS COMPARED GENERAL POPULATION INCIDENCE BRAIN CANCER HOWEVER SIGNIFICANTLY INCREASED WOMEN BREAST IMPLANTS COMPARED WOMEN PLASTIC SURGERIES PUBLISHED REVIEW 4 LARGE STUDIES WOMEN COSMETIC IMPLANTS ADDITIONAL LONG-TERM FOLLOW-UP STUDY CONCLUDED EVIDENCE SUPPORT ASSOCIATION BRAIN CANCER BREAST IMPLANTS EPIDEMIOLOGICAL REVIEW ALSO LENT SUPPORT LACK CAUSATION IMPLANTS TYPE CANCER STUDIES REPORTED INCREASED INCIDENCE RESPIRATORYLUNG CANCER WOMEN BREAST IMPLANTS STUDIES WOMEN SWEDEN DENMARK FOUND WOMEN GET BREAST IMPLANTS LIKELY CURRENT SMOKERS WOMEN GET BREAST REDUCTION SURGERY TYPES COSMETIC SURGERY SEVERAL LARGE STUDIES FOUND ASSOCIATION BREAST IMPLANTS RESPIRATORYLUNG CANCER TWO STUDIES REPORTED INCREASED INCIDENCE CERVICALVULVAR CANCER WOMEN BREAST IMPLANTS ANOTHER LONG-TERM FOLLOW-UP STUDY SHOWED EQUIVALENT INCIDENCES CERVICAL CANCER WOMEN BREAST IMPLANTS COMPARED GENERAL POPULATION RECENT LARGE STUDIES CONCLUDED EVIDENCE SUPPORT ASSOCIATION REPRODUCTIVE SYSTEM CANCERS BREAST IMPLANTS SEVERAL STUDIES PUBLISHED EXAMINED RISK TYPES CANCERS EG THYROID CANCERS URINARY SYSTEM CANCERS SARCOMA ENDOCRINE CANCER CONNECTIVE TISSUE CANCER CANCER EYE UNSPECIFIED CANCERS WOMEN BREAST IMPLANTS STUDIES FOUND INCREASED RISK WOMEN BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574813|75416231|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS Â¿PATIENTS PRESENTED STAGE IIA DISEASE ONE PATIENTS BBA PRESENTED MASS ADJACENT IMPLANT PROGRESSED RAPIDLY NEOADJUVANT CHOP DEVELOP LIFE THREATENING CHEST WALLTHORACIC CAVITY INVOLVEMENT PATIENT ACHIEVED COMPLETE PATHOLOGICAL RESPONSE SIX CYCLES BRENTUXIMAB FOLLOWED BILATERAL TOTAL CAPSULECTOMY IMPLANT REMOVAL FIRST REPORTED CASE NEO-ADJUVANT ANTIBODY THERAPY BIA-ALCLÂ¿ EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574824|75417105|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS Â¿PATIENTS PRESENTED STAGE IIA DISEASE ONE PREVIOUS RRM IMPLANT RECONSTRUCTION PRESENTED MASS TREATMENT CHOP+ ECHELON2 TRIAL RADIOTHERAPY IMPLANT REMOVALREMAINS WELL TWO YEARSÂ¿ EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574824|75417104|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PATIENTS AGE COULD EXPLANATION INCREASE ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6597657|76167628|D|1||DEVELOPED ALCL ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS TEXTURED SILICONE DEVICES PREVIOUS RIGHT BREAST IMPLANT ALSO NATRELLE 120-300 SERIAL NUMBER B4 IMPLANTED B6 2008 IMPLANT REMOVED SEROMA FLUID EXAMINED FOUND NORMAL|NATRELLE||05/26/2017||||*|I||I|FTR|2.0||SILICONE-FILLED TEXTURED BREAST|||||GOLETA|US|ALLERGAN|93117|CA|93117||||True
6597657|76167628|D|1||DEVELOPED ALCL ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS TEXTURED SILICONE DEVICES PREVIOUS RIGHT BREAST IMPLANT ALSO NATRELLE 120-300 SERIAL NUMBER B4 IMPLANTED B6 2008 IMPLANT REMOVED SEROMA FLUID EXAMINED FOUND NORMAL|NATRELLE|120-300|05/26/2017||||Y|I||0HP|FTR|1.0||SILICONE-FILLED TEXTURED BREAST|||||GOLETA|US|ALLERGAN|93117|CA|93117||120-300||True
6315886|67108821|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6315886|67108822|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL UNKNOWN SIDE EXPLANT SURGERY OCCURRED PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6323469|67162001|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL UNKNOWN SIDE EXPLANT SURGERY OCCURRED PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6323469|67162000|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6584653|75765031|N|1||B4 EVENTS LYMPHOMA LUMPNODULE SKIN RASHDERMATITIS CAPSULAR CONTRACTURE BAKER GRADE III PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFORMATION FDAÂ¿S ANALYSIS REVIEW ALCL PATIENTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM LITERATURE REPORTS ALSO MADE ASSOCIATING SILICONE BREAST IMPLANTS VARIOUS RHEUMATOLOGICAL SIGNS SYMPTOMS SKIN RASHES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE CAPSULAR CONTRACTURE PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT RUPTURE ONE COMMON REASONS REOPERATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/23/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6584653|75765032|D|1||EMAIL RECEIVED HEALTH PROFESSIONAL CONTAINING REPORT PATIENT DIAGNOSED RIGHT SIDE Â¿ALCLÂ¿ Â¿ENLARGEMENT HARDENING RIGHT BREASTÂ¿ SKIN LESIONS INFERIOR RIGHT BREASTÂ¿ Â¿CAPSULAR CONTRACTUREÂ¿ BAKER GRADE III Â¿PALPABLE BREAST MASSÂ¿ DEVICE REMOVED REPLACED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/23/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6613947|76724095|N|1||B4 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX140-520|06/06/2017|||DA|N|R||0HP|FTR|1.0|10/31/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1777073|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6613947|81168106|D|1||PHYSICIAN REPORTS CASE RIGHT SIDE ALK- ALCL PHYSICIAN ADDITIONALLY REPORTED SENSATION SWELLING PERIPROSTHETIC TISSUES LOCAL DISCOMFORT MILD ASTHENIA FINDINGS PERIPROSTHETIC FLUID PATHOLOGICAL MARKERS CONFIRMED CASE ALCL CAPTURED LYMPHOMA DEVICE EXPLANTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX140-520|06/06/2017|||DA|N|R||0HP|FTR|1.0|10/31/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1777073|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6613947|76724096|D|1||PHYSICIAN REPORTS CASE RIGHT SIDE ALK- ALCL PHYSICIAN ADDITIONALLY REPORTED SENSATION SWELLING PERIPROSTHETIC TISSUES LOCAL DISCOMFORT MILD ASTHENIA FINDINGS PERIPROSTHETIC FLUID PATHOLOGICAL MARKERS CONFIRMED CASE ALCL CAPTURED LYMPHOMA DEVICE EXPLANTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX140-520|06/06/2017|||DA|N|R||0HP|FTR|1.0|10/31/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1777073|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247152|64673721|D|1||PHYSICIAN REPORTS PATIENT PRESENTED ER ANEMIA WEIGHT LOSS B6 2016 PATIENT DIAGNOSED BIA-ALCL B6 2016 PHYSICIAN REPORTED LEFT SIDE CAPSULAR CONTRACTURE BAKER GRADE SPECIFIED PATIENT ADDITIONALLY FOUND LEFT AXILLARY LYMPH NODE LYMPHOMA CELLS EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED MEDWATCH REPRESENTS LEFT SIDE SEE MFR  9617229-2017-00007 RIGHT SIDE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247152|68396193|D|1||PHYSICIAN REPORTS PATIENT PRESENTED ER ANEMIA WEIGHT LOSS B6 2016 PATIENT DIAGNOSED BIA-ALCL B6 2016 PHYSICIAN REPORTED LEFT SIDE CAPSULAR CONTRACTURE BAKER GRADE SPECIFIED PATIENT ADDITIONALLY FOUND LEFT AXILLARY LYMPH NODE LYMPHOMA CELLS EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED MEDWATCH REPRESENTS LEFT SIDE SEE MFR  9617229-2017-00007 RIGHT SIDE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247152|64673720|N|1||B4 EVENTS WEIGHT LOSS ANEMIA CAPSULAR CONTRACTURE LYMPHADENOPATHY LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST FORMATION FIBROUS TISSUE AROUND IMPLANTED DEVICE NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY ONE COMMON REASONS REOPERATION CAUSE CAPSULAR CONTRACTURE UNKNOWN HOWEVER LIKELY MULTIFACTORIAL MAY COMMON FOLLOWING INFECTION HAEMATOMA SEROMA CONTRACTURE DEVELOPS VARYING DEGREES UNILATERALLY BILATERALLY MAY OCCUR WITHIN WEEKS YEARS SURGERY CONTRACTURE FIBROUS CAPSULAR TISSUE SURROUNDING IMPLANT MAY CAUSE RANGE SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES CONSIDERED CLINICALLY SIGNIFICANT MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT CORRECTIVE SURGICAL PROCEDURES TREAT CAPSULAR CONTRACTURE EXTERNAL COMPRESSION MASSAGE MAY RESULT IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6551502|74631918|N|1||B4 INFORMATION REPORTER REGARDING EVENT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME EVENTS LYMPHOMA LATE SEROMA LYMPHADENOPATHY BREAST LUMPS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY ADDITIONAL COMPLICATIONS Â¿ BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PATIENTS AGE COULD EXPLANATION INCREASE BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/08/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6551502|74631919|D|1||PHYSICIAN REPORTED COMPLETE RIGHT CAPSULECTOMY BIOPSY THREE MACROSCOPICALLY AFFECTED LYMPH NODES PERFORMED PATIENT COMPLAINED CHRONIC SEROMA UNDERWENT REMOVAL IMPLANT RESULT SEROMA RESOLVED PATIENT NOTICED NODULE RIGHT BREAST CONFIRMED ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING CORE NEEDLE BIOPSY CASE ALCL REPORTED LYMPHOMA NECESSARY PATHOLOGICAL MARKERS CONFIRMED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/08/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6380550|69150039|D|1||DIAGNOSED BIA ALCL|BREAST IMPLANT||03/05/2017||||Y|I||0LP|FWM|2.0||BREAST IMPLANT|||||||MENTOR|||||||True
6380550|69150039|D|1||DIAGNOSED BIA ALCL|BREAST IMPLANT||03/05/2017||||Y|I||0LP|FWM|1.0||BREAST IMPLANT|||||||MENTOR|||||||True
6323298|67155236|N|1||B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS DEVICE CURRENTLY REMAINS IMPLANTED REQUESTED PLANNED EXPLANT EVENTS LYMPHOMA PLEURAL EFFUSION LATE SEROMA COLLAPSED IPSILATERAL LUNG LYMPHADENOPATHY BREAST LUMPS DYSPNEA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING DEVICE DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY|INSPIRA SMOOTH SILICONE GEL FILLED BREAST IMPLANT|SSF370|02/10/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6323298|67155237|D|1||PHYSICIAN REPORTS TUMOR SOFT TISSUE LOWER INNER QUADRANT LEFT BREAST PLEURITIC PAIN PROGRESSIVE DYSPNEA SECONDARY SEVERE LEFT PLEURAL EFFUSION COLLAPSE IPSILATERAL LUNG ADDITIONALLY PHYSICIAN REPORTED MASSIVE NODE LEFT INTERNAL MAMMARY NODAL CHAIN RESULTS TESTING SHOW CYTOLOGY FLOW CYTOMETRY EXUDATIVE PLEURAL EFFUSION FLUID NEGATIVE LYMPHOMATOUS INFILTRATION ADENOPATHY ADDITIONALLY REPORTED THOUGH TRANSLATION STATES PLEURAL EFFUSION FLUID NEGATIVE LYMPHOMATOUS INFILTRATION PHYSICIAN REPORTED B6 2016 DATE DIAGNOSIS ALCL TIME ALCL CONFIRMED PATHOLOGICAL MARKERS ALLERGAN RECEIVES CONFIRMATION MARKERS TERM CODED LYMPHOMA DEVICE REMAINS IMPLANTED REMOVAL PENDING CASE ORIGINALLY REPORTED MFR  9617229-2016-00250 FOLLOW-UP REVEALED COMPLAINT SUBSEQUENT DEVICE|INSPIRA SMOOTH SILICONE GEL FILLED BREAST IMPLANT|SSF370|02/10/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6752840|81359305|D|1||COMPETENT AUTHORITY REPORTED CASE ALCL TREATMENT AFFECTED SIDE UNKNOWN PATHOLOGICAL MARKERS UNKNOWN UNCONFIRMED CASE ALCL REPORTED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410MX|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6752840|81359304|N|1||FOLLOW-UP COMPLETE REPORTING COMPETENT AUTHORITY PROVIDE INFORMATION SAFEGUARD PRIVACY INVOLVED PATIENTSÂ¿ EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410MX|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6574800|75414969|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574800|75414970|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS Â¿STAGE CASES PRESENTED RECURRENT SEROMA TREATED SUCCESSFULLY IMPLANT REMOVAL TOTAL CAPSULECTOMY FOUR PATIENTS BILATERAL BREAST AUGMENTATION BBAÂ¿ MEDWATCH REPORT REPRESENTS FOUR STAGE CASES PATIENTS BILATERAL BREAST AUGMENTATION REGARDING TREATMENT ABSTRACT REPORTS CASES Â¿HAD SURGERY REMOVE IMPLANTS IPSILATERAL TOTAL CAPSULECTOMY OTHERS CONTRALATERAL CAPSULECTOMY PATHOLOGY BENIGN UNILATERAL CAPSULECTOMY BILATERAL EXCHANGE IMPLANTSÂ¿ CURRENT INFORMATION PROVIDED IMPOSSIBLE KNOW SPECIFIC TREATMENT USED CASES EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6434492|70859690|N|1||B4 EVENTS LYMPHOMA ALCL SEROMA LUMPNODULE EDEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY RECORD DHR REPORTS BASED RISK ANALYSIS PERFORMED AE TERM CODE LYMPHOMA-ALCL SELECTED ANALYSIS REPRESENTS HIGHEST RISK FALLING MONITOR RISK REGION APPLICABLE INVESTIGATION LEVEL 3 REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER 2493185 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410535|03/24/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2493185|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6434492|70859691|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE SWELLING FLUID COLLECTION PATHOLOGY ADDITIONALLY PROVIDES EVENT Â¿UNSPECIFIED LUMP BREASTÂ¿ PATHOLOGICAL MARKERS ALK- CD30+ CONFIRMING LYMPHOMA ALCL RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410535|03/24/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2493185|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6751820|81359311|D|1||COMPETENT AUTHORITY REPORTED CASE ALCL TREATMENT AFFECTED SIDE UNKNOWN PATHOLOGICAL MARKERS UNKNOWN UNCONFIRMED CASE ALCL REPORTED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6751820|81359250|N|1||FOLLOW-UP COMPLETE REPORTING COMPETENT AUTHORITY PROVIDE INFORMATION SAFEGUARD PRIVACY INVOLVED PATIENTSÂ¿ EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6641177|77604162|N|1||FOLLOW-UP PERFORMED INFORMATION REGARDING EVENT NEW INFORMATION RECEIVED REPORTED SUPPLEMENTAL REPORT REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REVIEW DHR WORK ORDER 2436682 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MAY ASSOCIATED REPORTED DEVICE EVENT GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS QMS LISTING REPORT INDICATES NCMRS DEVIATIONS RELATED UNITS MANUFACTURED WORK ORDER 2436682 ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER 2436682 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS REPORTED EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF130-375|06/14/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2436682|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6638628|77497013|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/13/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6638628|77497014|D|1||HEALTHCARE PROFESSIONAL REPORTED CONFIRMED CASE ALCL UNKNOWN SIDE PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL RECEIVED EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/13/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6544056|74409596|D|1||PHYSICIAN REPORTED EVENT LEFT SIDE ALCL B6 CD30+ MARKER CONFIRMED PHYSICIAN REPORTED EVENTS PAIN LOSS 10 KG 1 YEAR RECURRENT LYMPHORREA INCREASE VOLUME TIGHTENING PERIPHERAL INFLAMMATION FIBRINOID NECROSIS AXILLARY ADENOPATHY ABUNDANT INTRACAPSULAR EFFUSION MASS ADENOFIBROMA PHYSICIAN ADDITIONALLY REPORTED HYPERVASCULAR TISSUE THICKENING VISIBLE QUASI-CIRCUMFERENTIAL CAPSULE PREDOMINANT INFERIOR-INTERNAL SUPERIOR-EXTERNAL PROJECTION ALCL CASE CAPTURED LYMPHOMA ALK NEGATIVE MARKER CONFIRMED DEVICE EXPLANTED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|TRM310|05/04/2017||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1327562|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6544056|74409595|N|1||B4 FOLLOW-UP CURRENTLY PERFORMED DETAILS REGARDING CASE NEW INFORMATION RECEIVED SENT SUPPLEMENTAL MEDWATCH REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REVIEW DHR DEVICE HISTORY RECORD WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR WORK ORDER B4 INDICATES REPROCESS TWO UNITS PRIMARY PACKAGING OPERATION HOWEVER COMPLETED DIFFERENT SERIAL NUMBER UNIT RELATION NEITHER CAUSE REPORTED EVENT DHR ASSEMBLY REPORT ORACLE VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS REPORTED EVENTS ADDRESSED LABELING ALLERGAN TESTED EFFECTS RADIATION THERAPY PATIENTS BREAST IMPLANTS LITERATURE SUGGESTS RADIATION THERAPY MAY INCREASE LIKELIHOOD CAPSULAR CONTRACTURE NECROSIS IMPLANT EXTRUSION POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT PERFORM SELF-EXAMINATION BREASTS EVERY MONTH CANCER SCREENING HOWEVER MAY DIFFICULT IMPLANTS ASK SURGEON HELP DISTINGUISH IMPLANT BREAST TISSUE PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGES IMPLANT SHAPE MAY SIGNS RUPTURE IMPLANT SIGNS REPORTED SURGEON POSSIBLY EVALUATED MRI BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|TRM310|05/04/2017||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1327562|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6439143|71165412|D|1||RECENTLY READ ARTICLES BREAST IMPLANTS LINKED ALCL SIMILAR CONDITION CALLED APLASTIC ANEMIA MORPHED PNH B6 2004 RECEIVED BREAST IMPLANTS B6 2004 DIAGNOSED APLASTIC ANEMIA ALWAYS WONDERED BREAST AUGMENTATION COULD LINKED CONDITION COMPLETELY HEALTHY PRIOR LIVING CRITICAL TERMINAL ILLNESS LIFE NEVER ALCL APLASTIC ANEMIA SIMILAR CONDITIONS CONCERNED MAY LINK WANTED REPORT PROPER CHANNELS ENSURE COMPLETE INVESTIGATION BREASTS IMPLANTS AFFECTS BLOOD CANCERS DISEASES|BREAST IMPLANTS||03/24/2017||||Y|I||I|FWM|1.0||BREAST IMPLANTS|||||||ALLERGAN|||||||True
6439143|71165412|D|1||RECENTLY READ ARTICLES BREAST IMPLANTS LINKED ALCL SIMILAR CONDITION CALLED APLASTIC ANEMIA MORPHED PNH B6 2004 RECEIVED BREAST IMPLANTS B6 2004 DIAGNOSED APLASTIC ANEMIA ALWAYS WONDERED BREAST AUGMENTATION COULD LINKED CONDITION COMPLETELY HEALTHY PRIOR LIVING CRITICAL TERMINAL ILLNESS LIFE NEVER ALCL APLASTIC ANEMIA SIMILAR CONDITIONS CONCERNED MAY LINK WANTED REPORT PROPER CHANNELS ENSURE COMPLETE INVESTIGATION BREASTS IMPLANTS AFFECTS BLOOD CANCERS DISEASES|BREAST IMPLANTS||03/24/2017||||Y|I||I|FWM|2.0||BREAST IMPLANTS|||||||ALLERGAN|||||||True
6574799|75414182|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574799|75414183|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS STAGE CASE ALCL TWO BILATERAL RISK-REDUCING MASTECTOMIES RRM IMPLANT RECONSTRUCTION MEDWATCH REPORT REPRESENTS TWO STAGE CASES PATIENTS BILATERAL RISK-REDUCING MASTECTOMIES IMPLANT RECONSTRUCTION REGARDING TREATMENT ABSTRACT REPORTS CASES Â¿HAD SURGERY REMOVE IMPLANTS IPSILATERAL TOTAL CAPSULECTOMY OTHERS CONTRALATERAL CAPSULECTOMY PATHOLOGY BENIGN UNILATERAL CAPSULECTOMY BILATERAL EXCHANGE IMPLANTSÂ¿ CURRENT INFORMATION PROVIDED IMPOSSIBLE KNOW SPECIFIC TREATMENT USED CASES EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574818|75418664|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS STAGE ALCL CASE PATIENT UNILATERAL MASTECTOMY IMPLANT RECONSTRUCTION BREAST CANCER REGARDING TREATMENT ABSTRACT STATES STAGE CASES PRESENTED RECURRENT SEROMA TREATED SUCCESSFULLY IMPLANT REMOVAL TOTAL CAPSULECTOMY EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574818|75418663|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6677493|78721415|D|1||MENTOR SALINE BREAST IMPLANTS RUPTURED BEGAN LEAK CAUSING ILLNESS INFECTION PAIN ACCIDENT IMPACT CAUSE IMPLANTS LEAK SYMPTOMS FATIGUE CHRONIC FATIGUE COGNITIVE DYSFUNCTION BRAIN FOG DIFFICULTY CONCENTRATING MEMORY LOSS MUSCLE PAIN WEAKNESS JOINT PAIN HAIR LOSS DRY SKIN HAIR PREMATURE AGING WEIGHT PROBLEMS INFLAMMATION POOR SLEEP INSOMNIA DRY EYES DECLINE VISION VISION DISTURBANCES HYPOHYPER THYROID SYMPTOMS HYPOHYPER ADRENAL SYMPTOMS ESTROGENPROGESTERONE IMBALANCE DIMINISHING HORMONES LOW LIBIDO SLOW HEALING CUTS SCRAPES EASY BRUISING THROAT CLEARING COUGH DIFFICULTY SWALLOWING CHOKING REFLUX METALLIC TASTES VERTIGO GASTROINTESTINAL DIGESTIVE ISSUES FEVERS NIGHT SWEATS INTOLERANT HEATCOLD NEW PERSISTENT BACTERIAL VIRAL INFECTIONS SLOW CLEARING COMMON COLDS FLUS FUNGAL INFECTIONS YEAST INFECTIONS CANDIDA SINUS INFECTIONS SKIN RASHES EAR RINGING SUDDEN FOOD INTOLERANCE ALLERGIES HEADACHES SLOW MUSCLE RECOVERY ACTIVITY HEART PALPITATIONS CHANGES NORMAL HEART RATE HEART PAIN SORE ACHING JOINTS SHOULDERS HIPS BACKBONE HANDS FEET SWOLLEN TENDER LYMPH NODES BREAST AREA UNDERARM THROAT NECK GROIN BOUTS DEHYDRATION REASON FREQUENT URINATION NUMBNESSTINGLING SENSATIONS UPPER LOWER LIMBS COLD DISCOLORED LIMBS HANDS FEET GENERAL CHEST DISCOMFORT SHORTNESS BREATH PAIN ANDOR BURNING SENSATION AROUND IMPLANT ANDOR UNDERARM LIVER KIDNEY DYSFUNCTION CRAMPING TOXIC SHOCK SYMPTOMS ANXIETY DEPRESSION PANIC ATTACKS LEAKY GUT IBS SIBO SYMPTOMS DIAGNOSIS FIBROMYALGIA SYMPTOMS DIAGNOSIS LYME DISEASE SYMPTOMS DIAGNOSIS AUTO-IMMUNE DISEASES RAYNAUDS SYNDROME HASHIMOTOS THYROIDITIS RHEUMATOID ARTHRITIS SCLERODERMA LUPUS SJOGRENS SYNDROME NONSPECIFIC CONNECTIVE TISSUE DISEASE MULTIPLE SCLEROSIS SYMPTOMS DIAGNOSIS BIA-ALCL LYMPHOMA IMPLANTS 5 YO SON BORN HEALTH ISSUES RELATED TOXIC EXPOSURE WOMB LEAKING IMPLANTS|SM ROUND MOD PLUS PROFILE SALINE||06/28/2017||||Y|I||I|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||5770513|||||MENTOR|||||||True
6677493|78721415|D|1||MENTOR SALINE BREAST IMPLANTS RUPTURED BEGAN LEAK CAUSING ILLNESS INFECTION PAIN ACCIDENT IMPACT CAUSE IMPLANTS LEAK SYMPTOMS FATIGUE CHRONIC FATIGUE COGNITIVE DYSFUNCTION BRAIN FOG DIFFICULTY CONCENTRATING MEMORY LOSS MUSCLE PAIN WEAKNESS JOINT PAIN HAIR LOSS DRY SKIN HAIR PREMATURE AGING WEIGHT PROBLEMS INFLAMMATION POOR SLEEP INSOMNIA DRY EYES DECLINE VISION VISION DISTURBANCES HYPOHYPER THYROID SYMPTOMS HYPOHYPER ADRENAL SYMPTOMS ESTROGENPROGESTERONE IMBALANCE DIMINISHING HORMONES LOW LIBIDO SLOW HEALING CUTS SCRAPES EASY BRUISING THROAT CLEARING COUGH DIFFICULTY SWALLOWING CHOKING REFLUX METALLIC TASTES VERTIGO GASTROINTESTINAL DIGESTIVE ISSUES FEVERS NIGHT SWEATS INTOLERANT HEATCOLD NEW PERSISTENT BACTERIAL VIRAL INFECTIONS SLOW CLEARING COMMON COLDS FLUS FUNGAL INFECTIONS YEAST INFECTIONS CANDIDA SINUS INFECTIONS SKIN RASHES EAR RINGING SUDDEN FOOD INTOLERANCE ALLERGIES HEADACHES SLOW MUSCLE RECOVERY ACTIVITY HEART PALPITATIONS CHANGES NORMAL HEART RATE HEART PAIN SORE ACHING JOINTS SHOULDERS HIPS BACKBONE HANDS FEET SWOLLEN TENDER LYMPH NODES BREAST AREA UNDERARM THROAT NECK GROIN BOUTS DEHYDRATION REASON FREQUENT URINATION NUMBNESSTINGLING SENSATIONS UPPER LOWER LIMBS COLD DISCOLORED LIMBS HANDS FEET GENERAL CHEST DISCOMFORT SHORTNESS BREATH PAIN ANDOR BURNING SENSATION AROUND IMPLANT ANDOR UNDERARM LIVER KIDNEY DYSFUNCTION CRAMPING TOXIC SHOCK SYMPTOMS ANXIETY DEPRESSION PANIC ATTACKS LEAKY GUT IBS SIBO SYMPTOMS DIAGNOSIS FIBROMYALGIA SYMPTOMS DIAGNOSIS LYME DISEASE SYMPTOMS DIAGNOSIS AUTO-IMMUNE DISEASES RAYNAUDS SYNDROME HASHIMOTOS THYROIDITIS RHEUMATOID ARTHRITIS SCLERODERMA LUPUS SJOGRENS SYNDROME NONSPECIFIC CONNECTIVE TISSUE DISEASE MULTIPLE SCLEROSIS SYMPTOMS DIAGNOSIS BIA-ALCL LYMPHOMA IMPLANTS 5 YO SON BORN HEALTH ISSUES RELATED TOXIC EXPOSURE WOMB LEAKING IMPLANTS|SM ROUND MOD PLUS PROFILE SALINE||06/28/2017||||*|I||I|FWM|2.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||5770513|||||MENTOR|||||||True
6635007|77400540|D|1||B6 ARTICLE TITLED Â¿A SHOCKING DIAGNOSIS BREAST IMPLANTS Â¿GAVE CANCERÂ¿Â¿ REPORTS Â¿PATIENT LEARNED LAST MAY PATIENT LYMPHOMA TEXTURED IMPLANTS PATIENT 10 YEARS INSTEAD REMOVING IMPLANTS CAPSULES IMMEDIATELY PATIENT DOCTOR PRESCRIBED SIX ROUNDS CHEMOTHERAPY 25 ROUNDS RADIATION YEAR LATER PATIENT STILL IMPLANTSÂ¿ PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CAPTURED LYMPHOMA AFFECTED LOCATION UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/12/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6635007|77400539|N|1||ARTICLE CITATION SHOCKING DIAGNOSIS BREAST IMPLANTS GAVE CANCER B6 B6 MAY 14 2017 EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT DETAILS CANNOT OBTAINED PATIENT EXPLANTING PHYSICIAN CONTACT INFORMATION PROVIDED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/12/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6545873|74473872|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE ANAPLASTIC LARGE CELL LYMPHOMA PATIENTÂ¿S INITIAL DIAGNOSIS PROVIDED Â¿FIBROCYSTIC BREAST DISEASEÂ¿ AMENDED LYMPHOMA ALCL PATIENT ADDITIONALLY EXPERIENCED LEFT SIDE SWELLING SEROMA CAPSULECTOMY PERFORMED DEVICE REMOVED APPROXIMATELY 200 RNL CHALKY WHITE FLUID FOUND UPON ENTERING CAPSULE PHYSICIAN ADDITIONALLY REPORTED LARGE THICK RIND AROUND CAPSULE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410740|05/04/2017||||N|R||0HP|FTR|1.0|08/24/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||236550|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6545873|74473871|N|1||B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY RECORD DHR PROVIDES REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MAY ASSOCIATED REPORTED DEVICE EVENT GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY |STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410740|05/04/2017||||N|R||0HP|FTR|1.0|08/24/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||236550|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6529881|74123089|D|1||BREAST DEFORMITY CHILDTEENAGER BORN INSURANCE PAID SURGERIES IMPLANTED MUSCLE SMOOTH SALINE 1993 1994 STARTED MAJOR FATIGUE WEIRD CHEMICAL SENSITIVITIES GROIN CYST DEVELOPED EVERYONE SAID FAT NEVER TESTED INTERSTITIAL CYSTITIS INFLAMMATION BLADDER 1995 THYROID CANCER WELL THYROID REMOVED 1996 CAPSULAR CONTRACTURE REMOVED IMPLANTS PUT MUSCLE TEXTURED SALINE PS SURGERY GOT LICENSE TAKEN AWAY YEARS LATER CRYSTAL METH SEX PATIENTS PUTTING IMPLANTS BIGGER GIRLS WANTED EVEN GAUZE FOUND INSIDE ONE GIRLS BREASTS YEARS LATER LOT PAIN COULDNT FIGURE SAID MAKE IMPLANTS LARGER SMALL C ASKED LARGE C WOKE DD TODAY DDD IVE GAINED WEIGHT DIAGNOSED CHRONIC FATIGUE SYNDROME LATER FIBROMYALGIA TWENTY TWO YEARS CHRONIC NECK PAIN STIFFNESS ARTHRITIS NECK WEIRD ONION ALLERGY DEVELOPED 1997 FREEZING COLD TINGLING NUMBNESS RIGHT HAND FINGERS RIGHT FOOT TOES WEIRD RANDOM ITCHING CREEPY CRAWLY FEELINGS SCALP PARTS BODY CHRONIC BODY CHILLS CHRONIC CERVICAL MIGRAINES MAJOR WEIGHT GAIN CANT LOSE WEIGHT DESPITE DIETING EXTREME DRY SCALP FIBROIDS LOW SEX DRIVE GETTING WORSE BLURRY VISION RANDOM TOOTH SENSITIVITIES CHOLESTASIS PREGNANCY BREASTS PAINS CHRONIC INSOMNIA DONT GO 4TH STAGE SLEEP DARK EYE CIRCLES GETTING WORSE YEAR YEAR UPPER ARM PAIN IMPLANTS KNEE PAIN WEIRD RANDOM ELBOW PAIN JOINT PAINS MUSCLE STIFFNESS ARM PIT SWOLLEN LYMPH NODES MAJOR EXERCISE INTOLERANCE IBS ISSUES UNEXPLAINED RAISED LIVER ENZYMES HIGH CHOLESTEROL CHRONIC CONSTIPATION GASTRITIS BLEEDING STOMACH ACID ISSUES CHRONIC SORE THROATS BEGINNING WEIRD EYE TWITCHING SWOLLEN LYMPH NODES WEAKNESS HAIR LOSS RIGHT HAND PAINSTIFFNESS WRITING ISCHEMIC COLITIS PASSING EXPLAINED REASON MAJOR BRAIN FOG MAJOR CONCENTRATION ISSUES MAJOR MEMORY ISSUES CHRONIC UNEXPLAINED POST NASAL DRIP 20 PLUS YEARS SOMETIMES BLACK STREAKS HIATAL HERNIA COMPLETE NUMBNESS BOTTOM RIGHT THUMB EATING DRINKING SOMETHING COLD INABILITY SECOND CHILD RANDOM HEART PALPITATIONS WOLF PARKINSONS WHITE HEART ABLATION GALLSTONES POSSIBLE GALLBLADDER REMOVAL POSSIBLE POLYP IM SCARED CANCER CALLED ALCL LINKED BREASTS IMPLANTS ESPECIALLY TEXTURED ONE IM MESS USE LOST LIFE QUALITY LIFE CAREER ILLNESSES PUT DEBT BARELY WORK TAKE CARE DAUGHTER LEAST CANT OTS ONE THANK GOD HUSBAND STEP MOM HOUSE KEEPER COOK ETC IVE FOCUSED EVERY BODY PART EVERY SPECIALIST EVERY FIELD NEVER FOCUSED BREASTS ALWAYS TOLD COULDNT IMPLANTS LAST WEEK BREAST SONOGRAM SHOWED 7CM SWOLLEN LYMPH NODE RIGHT BREAST SUSPICIOUS CANCER TODAY DIAGNOSED BAKER GRADE 4 CAPSULAR CONTRACTURE RIGHT BREAST RECONSTRUCTIVE BREAST SURGEON GOD KNOWS LONG IVE SOMETHING DONE SOMEONE NEEDS HELD ACCOUNTABLE THOUSANDS WOMEN LOSING LIVES QUALITY LIVES EITHER SALINE SILICONE BREAST IMPLANTS IMPORTANT INFORMATION MCGHAN SILTEX SALINE FILLED MAMMARY PROTHESIS LOT FW7879 LEFT 390CC LOT FW2756 RIGHT 390CC IMPLANTED DR B6 B6 B6 1993 MUSCLE RECONSTRUCTION CAPSULAR CONTRACTURE IMPLANT RUPTURES MCGHAN STYLE 468 TEXTURED SALINE IMPLANTS CAT 27-468561 LEFT HK6992 650CCS RIGHT LOT GK5386 700CCS IMPLANTED DR B6 B6 B6 1996 B6 2017 CAPSULAR CONTRACTION IMPLANTS REMOVED TOTAL ENBLOC CAPSULECTOMY SOON HOPEFULLY B6 GROUP 17800 WOMEN CONSTANTLY GROWING SIMILAR STORIES MINE EITHER SILICONE SALINE BREASTS IMPLANTS EXPLANT VIA ENBLOC CAPSULECTOMY SYMPTOMS ILLNESSES GO AWAY TESTS GO BACK NORMAL WOMENS EYES FACES SKIN START LOOK BETTER HEALTHIER WOMENS AUTOIMMUNE ISSUES DISAPPEAR START DETOX HEAL START REGAIN LIVES IMPLANTS COME MOLD TOXINS IMPLANTS WOMENS BODIES TESTED FOUND TOXINS MOLDS SILICONE CHEMICALS MAKE SILICONE BREAST IMPLANT INDUSTRY KNOWS PUTTING WOMENS BODIES HAPPENING NEEDS PROVEN COURT LAW TIME CANCER LINKED BREAST IMPLANTS WAY KNOW TYPE CANCER LATE TAKE IMPLANTS TEST FLUID AROUND IMPLANTS WOMEN DYING NEED FDAS HELP PLEASE|SALINE TEXTURED BREAST IMPLANT|27-468561|04/26/2017||||Y|I||0HP|FWM|4.0||BREAST IMPLANTS||L-HK6992 R-GK5386|||||MCGHAN|||||468||True
6529881|74123089|D|1||BREAST DEFORMITY CHILDTEENAGER BORN INSURANCE PAID SURGERIES IMPLANTED MUSCLE SMOOTH SALINE 1993 1994 STARTED MAJOR FATIGUE WEIRD CHEMICAL SENSITIVITIES GROIN CYST DEVELOPED EVERYONE SAID FAT NEVER TESTED INTERSTITIAL CYSTITIS INFLAMMATION BLADDER 1995 THYROID CANCER WELL THYROID REMOVED 1996 CAPSULAR CONTRACTURE REMOVED IMPLANTS PUT MUSCLE TEXTURED SALINE PS SURGERY GOT LICENSE TAKEN AWAY YEARS LATER CRYSTAL METH SEX PATIENTS PUTTING IMPLANTS BIGGER GIRLS WANTED EVEN GAUZE FOUND INSIDE ONE GIRLS BREASTS YEARS LATER LOT PAIN COULDNT FIGURE SAID MAKE IMPLANTS LARGER SMALL C ASKED LARGE C WOKE DD TODAY DDD IVE GAINED WEIGHT DIAGNOSED CHRONIC FATIGUE SYNDROME LATER FIBROMYALGIA TWENTY TWO YEARS CHRONIC NECK PAIN STIFFNESS ARTHRITIS NECK WEIRD ONION ALLERGY DEVELOPED 1997 FREEZING COLD TINGLING NUMBNESS RIGHT HAND FINGERS RIGHT FOOT TOES WEIRD RANDOM ITCHING CREEPY CRAWLY FEELINGS SCALP PARTS BODY CHRONIC BODY CHILLS CHRONIC CERVICAL MIGRAINES MAJOR WEIGHT GAIN CANT LOSE WEIGHT DESPITE DIETING EXTREME DRY SCALP FIBROIDS LOW SEX DRIVE GETTING WORSE BLURRY VISION RANDOM TOOTH SENSITIVITIES CHOLESTASIS PREGNANCY BREASTS PAINS CHRONIC INSOMNIA DONT GO 4TH STAGE SLEEP DARK EYE CIRCLES GETTING WORSE YEAR YEAR UPPER ARM PAIN IMPLANTS KNEE PAIN WEIRD RANDOM ELBOW PAIN JOINT PAINS MUSCLE STIFFNESS ARM PIT SWOLLEN LYMPH NODES MAJOR EXERCISE INTOLERANCE IBS ISSUES UNEXPLAINED RAISED LIVER ENZYMES HIGH CHOLESTEROL CHRONIC CONSTIPATION GASTRITIS BLEEDING STOMACH ACID ISSUES CHRONIC SORE THROATS BEGINNING WEIRD EYE TWITCHING SWOLLEN LYMPH NODES WEAKNESS HAIR LOSS RIGHT HAND PAINSTIFFNESS WRITING ISCHEMIC COLITIS PASSING EXPLAINED REASON MAJOR BRAIN FOG MAJOR CONCENTRATION ISSUES MAJOR MEMORY ISSUES CHRONIC UNEXPLAINED POST NASAL DRIP 20 PLUS YEARS SOMETIMES BLACK STREAKS HIATAL HERNIA COMPLETE NUMBNESS BOTTOM RIGHT THUMB EATING DRINKING SOMETHING COLD INABILITY SECOND CHILD RANDOM HEART PALPITATIONS WOLF PARKINSONS WHITE HEART ABLATION GALLSTONES POSSIBLE GALLBLADDER REMOVAL POSSIBLE POLYP IM SCARED CANCER CALLED ALCL LINKED BREASTS IMPLANTS ESPECIALLY TEXTURED ONE IM MESS USE LOST LIFE QUALITY LIFE CAREER ILLNESSES PUT DEBT BARELY WORK TAKE CARE DAUGHTER LEAST CANT OTS ONE THANK GOD HUSBAND STEP MOM HOUSE KEEPER COOK ETC IVE FOCUSED EVERY BODY PART EVERY SPECIALIST EVERY FIELD NEVER FOCUSED BREASTS ALWAYS TOLD COULDNT IMPLANTS LAST WEEK BREAST SONOGRAM SHOWED 7CM SWOLLEN LYMPH NODE RIGHT BREAST SUSPICIOUS CANCER TODAY DIAGNOSED BAKER GRADE 4 CAPSULAR CONTRACTURE RIGHT BREAST RECONSTRUCTIVE BREAST SURGEON GOD KNOWS LONG IVE SOMETHING DONE SOMEONE NEEDS HELD ACCOUNTABLE THOUSANDS WOMEN LOSING LIVES QUALITY LIVES EITHER SALINE SILICONE BREAST IMPLANTS IMPORTANT INFORMATION MCGHAN SILTEX SALINE FILLED MAMMARY PROTHESIS LOT FW7879 LEFT 390CC LOT FW2756 RIGHT 390CC IMPLANTED DR B6 B6 B6 1993 MUSCLE RECONSTRUCTION CAPSULAR CONTRACTURE IMPLANT RUPTURES MCGHAN STYLE 468 TEXTURED SALINE IMPLANTS CAT 27-468561 LEFT HK6992 650CCS RIGHT LOT GK5386 700CCS IMPLANTED DR B6 B6 B6 1996 B6 2017 CAPSULAR CONTRACTION IMPLANTS REMOVED TOTAL ENBLOC CAPSULECTOMY SOON HOPEFULLY B6 GROUP 17800 WOMEN CONSTANTLY GROWING SIMILAR STORIES MINE EITHER SILICONE SALINE BREASTS IMPLANTS EXPLANT VIA ENBLOC CAPSULECTOMY SYMPTOMS ILLNESSES GO AWAY TESTS GO BACK NORMAL WOMENS EYES FACES SKIN START LOOK BETTER HEALTHIER WOMENS AUTOIMMUNE ISSUES DISAPPEAR START DETOX HEAL START REGAIN LIVES IMPLANTS COME MOLD TOXINS IMPLANTS WOMENS BODIES TESTED FOUND TOXINS MOLDS SILICONE CHEMICALS MAKE SILICONE BREAST IMPLANT INDUSTRY KNOWS PUTTING WOMENS BODIES HAPPENING NEEDS PROVEN COURT LAW TIME CANCER LINKED BREAST IMPLANTS WAY KNOW TYPE CANCER LATE TAKE IMPLANTS TEST FLUID AROUND IMPLANTS WOMEN DYING NEED FDAS HELP PLEASE|SALINE TEXTURED BREAST IMPLANT|27-468561|04/26/2017||||Y|I||0HP|FWM|3.0||BREAST IMPLANTS||L-HK6992 R-GK5386|||||MCGHAN|||||468||True
6529881|74123089|D|1||BREAST DEFORMITY CHILDTEENAGER BORN INSURANCE PAID SURGERIES IMPLANTED MUSCLE SMOOTH SALINE 1993 1994 STARTED MAJOR FATIGUE WEIRD CHEMICAL SENSITIVITIES GROIN CYST DEVELOPED EVERYONE SAID FAT NEVER TESTED INTERSTITIAL CYSTITIS INFLAMMATION BLADDER 1995 THYROID CANCER WELL THYROID REMOVED 1996 CAPSULAR CONTRACTURE REMOVED IMPLANTS PUT MUSCLE TEXTURED SALINE PS SURGERY GOT LICENSE TAKEN AWAY YEARS LATER CRYSTAL METH SEX PATIENTS PUTTING IMPLANTS BIGGER GIRLS WANTED EVEN GAUZE FOUND INSIDE ONE GIRLS BREASTS YEARS LATER LOT PAIN COULDNT FIGURE SAID MAKE IMPLANTS LARGER SMALL C ASKED LARGE C WOKE DD TODAY DDD IVE GAINED WEIGHT DIAGNOSED CHRONIC FATIGUE SYNDROME LATER FIBROMYALGIA TWENTY TWO YEARS CHRONIC NECK PAIN STIFFNESS ARTHRITIS NECK WEIRD ONION ALLERGY DEVELOPED 1997 FREEZING COLD TINGLING NUMBNESS RIGHT HAND FINGERS RIGHT FOOT TOES WEIRD RANDOM ITCHING CREEPY CRAWLY FEELINGS SCALP PARTS BODY CHRONIC BODY CHILLS CHRONIC CERVICAL MIGRAINES MAJOR WEIGHT GAIN CANT LOSE WEIGHT DESPITE DIETING EXTREME DRY SCALP FIBROIDS LOW SEX DRIVE GETTING WORSE BLURRY VISION RANDOM TOOTH SENSITIVITIES CHOLESTASIS PREGNANCY BREASTS PAINS CHRONIC INSOMNIA DONT GO 4TH STAGE SLEEP DARK EYE CIRCLES GETTING WORSE YEAR YEAR UPPER ARM PAIN IMPLANTS KNEE PAIN WEIRD RANDOM ELBOW PAIN JOINT PAINS MUSCLE STIFFNESS ARM PIT SWOLLEN LYMPH NODES MAJOR EXERCISE INTOLERANCE IBS ISSUES UNEXPLAINED RAISED LIVER ENZYMES HIGH CHOLESTEROL CHRONIC CONSTIPATION GASTRITIS BLEEDING STOMACH ACID ISSUES CHRONIC SORE THROATS BEGINNING WEIRD EYE TWITCHING SWOLLEN LYMPH NODES WEAKNESS HAIR LOSS RIGHT HAND PAINSTIFFNESS WRITING ISCHEMIC COLITIS PASSING EXPLAINED REASON MAJOR BRAIN FOG MAJOR CONCENTRATION ISSUES MAJOR MEMORY ISSUES CHRONIC UNEXPLAINED POST NASAL DRIP 20 PLUS YEARS SOMETIMES BLACK STREAKS HIATAL HERNIA COMPLETE NUMBNESS BOTTOM RIGHT THUMB EATING DRINKING SOMETHING COLD INABILITY SECOND CHILD RANDOM HEART PALPITATIONS WOLF PARKINSONS WHITE HEART ABLATION GALLSTONES POSSIBLE GALLBLADDER REMOVAL POSSIBLE POLYP IM SCARED CANCER CALLED ALCL LINKED BREASTS IMPLANTS ESPECIALLY TEXTURED ONE IM MESS USE LOST LIFE QUALITY LIFE CAREER ILLNESSES PUT DEBT BARELY WORK TAKE CARE DAUGHTER LEAST CANT OTS ONE THANK GOD HUSBAND STEP MOM HOUSE KEEPER COOK ETC IVE FOCUSED EVERY BODY PART EVERY SPECIALIST EVERY FIELD NEVER FOCUSED BREASTS ALWAYS TOLD COULDNT IMPLANTS LAST WEEK BREAST SONOGRAM SHOWED 7CM SWOLLEN LYMPH NODE RIGHT BREAST SUSPICIOUS CANCER TODAY DIAGNOSED BAKER GRADE 4 CAPSULAR CONTRACTURE RIGHT BREAST RECONSTRUCTIVE BREAST SURGEON GOD KNOWS LONG IVE SOMETHING DONE SOMEONE NEEDS HELD ACCOUNTABLE THOUSANDS WOMEN LOSING LIVES QUALITY LIVES EITHER SALINE SILICONE BREAST IMPLANTS IMPORTANT INFORMATION MCGHAN SILTEX SALINE FILLED MAMMARY PROTHESIS LOT FW7879 LEFT 390CC LOT FW2756 RIGHT 390CC IMPLANTED DR B6 B6 B6 1993 MUSCLE RECONSTRUCTION CAPSULAR CONTRACTURE IMPLANT RUPTURES MCGHAN STYLE 468 TEXTURED SALINE IMPLANTS CAT 27-468561 LEFT HK6992 650CCS RIGHT LOT GK5386 700CCS IMPLANTED DR B6 B6 B6 1996 B6 2017 CAPSULAR CONTRACTION IMPLANTS REMOVED TOTAL ENBLOC CAPSULECTOMY SOON HOPEFULLY B6 GROUP 17800 WOMEN CONSTANTLY GROWING SIMILAR STORIES MINE EITHER SILICONE SALINE BREASTS IMPLANTS EXPLANT VIA ENBLOC CAPSULECTOMY SYMPTOMS ILLNESSES GO AWAY TESTS GO BACK NORMAL WOMENS EYES FACES SKIN START LOOK BETTER HEALTHIER WOMENS AUTOIMMUNE ISSUES DISAPPEAR START DETOX HEAL START REGAIN LIVES IMPLANTS COME MOLD TOXINS IMPLANTS WOMENS BODIES TESTED FOUND TOXINS MOLDS SILICONE CHEMICALS MAKE SILICONE BREAST IMPLANT INDUSTRY KNOWS PUTTING WOMENS BODIES HAPPENING NEEDS PROVEN COURT LAW TIME CANCER LINKED BREAST IMPLANTS WAY KNOW TYPE CANCER LATE TAKE IMPLANTS TEST FLUID AROUND IMPLANTS WOMEN DYING NEED FDAS HELP PLEASE|SILTEX SALINE FILLED MAMMARY PROSTHESIS||04/26/2017||||Y|I||0HP|FWM|1.0||PROSTHESIS, BREAST||L-FW7879 R-FW2756|||||MCGHAN|||||||True
6529881|74123089|D|1||BREAST DEFORMITY CHILDTEENAGER BORN INSURANCE PAID SURGERIES IMPLANTED MUSCLE SMOOTH SALINE 1993 1994 STARTED MAJOR FATIGUE WEIRD CHEMICAL SENSITIVITIES GROIN CYST DEVELOPED EVERYONE SAID FAT NEVER TESTED INTERSTITIAL CYSTITIS INFLAMMATION BLADDER 1995 THYROID CANCER WELL THYROID REMOVED 1996 CAPSULAR CONTRACTURE REMOVED IMPLANTS PUT MUSCLE TEXTURED SALINE PS SURGERY GOT LICENSE TAKEN AWAY YEARS LATER CRYSTAL METH SEX PATIENTS PUTTING IMPLANTS BIGGER GIRLS WANTED EVEN GAUZE FOUND INSIDE ONE GIRLS BREASTS YEARS LATER LOT PAIN COULDNT FIGURE SAID MAKE IMPLANTS LARGER SMALL C ASKED LARGE C WOKE DD TODAY DDD IVE GAINED WEIGHT DIAGNOSED CHRONIC FATIGUE SYNDROME LATER FIBROMYALGIA TWENTY TWO YEARS CHRONIC NECK PAIN STIFFNESS ARTHRITIS NECK WEIRD ONION ALLERGY DEVELOPED 1997 FREEZING COLD TINGLING NUMBNESS RIGHT HAND FINGERS RIGHT FOOT TOES WEIRD RANDOM ITCHING CREEPY CRAWLY FEELINGS SCALP PARTS BODY CHRONIC BODY CHILLS CHRONIC CERVICAL MIGRAINES MAJOR WEIGHT GAIN CANT LOSE WEIGHT DESPITE DIETING EXTREME DRY SCALP FIBROIDS LOW SEX DRIVE GETTING WORSE BLURRY VISION RANDOM TOOTH SENSITIVITIES CHOLESTASIS PREGNANCY BREASTS PAINS CHRONIC INSOMNIA DONT GO 4TH STAGE SLEEP DARK EYE CIRCLES GETTING WORSE YEAR YEAR UPPER ARM PAIN IMPLANTS KNEE PAIN WEIRD RANDOM ELBOW PAIN JOINT PAINS MUSCLE STIFFNESS ARM PIT SWOLLEN LYMPH NODES MAJOR EXERCISE INTOLERANCE IBS ISSUES UNEXPLAINED RAISED LIVER ENZYMES HIGH CHOLESTEROL CHRONIC CONSTIPATION GASTRITIS BLEEDING STOMACH ACID ISSUES CHRONIC SORE THROATS BEGINNING WEIRD EYE TWITCHING SWOLLEN LYMPH NODES WEAKNESS HAIR LOSS RIGHT HAND PAINSTIFFNESS WRITING ISCHEMIC COLITIS PASSING EXPLAINED REASON MAJOR BRAIN FOG MAJOR CONCENTRATION ISSUES MAJOR MEMORY ISSUES CHRONIC UNEXPLAINED POST NASAL DRIP 20 PLUS YEARS SOMETIMES BLACK STREAKS HIATAL HERNIA COMPLETE NUMBNESS BOTTOM RIGHT THUMB EATING DRINKING SOMETHING COLD INABILITY SECOND CHILD RANDOM HEART PALPITATIONS WOLF PARKINSONS WHITE HEART ABLATION GALLSTONES POSSIBLE GALLBLADDER REMOVAL POSSIBLE POLYP IM SCARED CANCER CALLED ALCL LINKED BREASTS IMPLANTS ESPECIALLY TEXTURED ONE IM MESS USE LOST LIFE QUALITY LIFE CAREER ILLNESSES PUT DEBT BARELY WORK TAKE CARE DAUGHTER LEAST CANT OTS ONE THANK GOD HUSBAND STEP MOM HOUSE KEEPER COOK ETC IVE FOCUSED EVERY BODY PART EVERY SPECIALIST EVERY FIELD NEVER FOCUSED BREASTS ALWAYS TOLD COULDNT IMPLANTS LAST WEEK BREAST SONOGRAM SHOWED 7CM SWOLLEN LYMPH NODE RIGHT BREAST SUSPICIOUS CANCER TODAY DIAGNOSED BAKER GRADE 4 CAPSULAR CONTRACTURE RIGHT BREAST RECONSTRUCTIVE BREAST SURGEON GOD KNOWS LONG IVE SOMETHING DONE SOMEONE NEEDS HELD ACCOUNTABLE THOUSANDS WOMEN LOSING LIVES QUALITY LIVES EITHER SALINE SILICONE BREAST IMPLANTS IMPORTANT INFORMATION MCGHAN SILTEX SALINE FILLED MAMMARY PROTHESIS LOT FW7879 LEFT 390CC LOT FW2756 RIGHT 390CC IMPLANTED DR B6 B6 B6 1993 MUSCLE RECONSTRUCTION CAPSULAR CONTRACTURE IMPLANT RUPTURES MCGHAN STYLE 468 TEXTURED SALINE IMPLANTS CAT 27-468561 LEFT HK6992 650CCS RIGHT LOT GK5386 700CCS IMPLANTED DR B6 B6 B6 1996 B6 2017 CAPSULAR CONTRACTION IMPLANTS REMOVED TOTAL ENBLOC CAPSULECTOMY SOON HOPEFULLY B6 GROUP 17800 WOMEN CONSTANTLY GROWING SIMILAR STORIES MINE EITHER SILICONE SALINE BREASTS IMPLANTS EXPLANT VIA ENBLOC CAPSULECTOMY SYMPTOMS ILLNESSES GO AWAY TESTS GO BACK NORMAL WOMENS EYES FACES SKIN START LOOK BETTER HEALTHIER WOMENS AUTOIMMUNE ISSUES DISAPPEAR START DETOX HEAL START REGAIN LIVES IMPLANTS COME MOLD TOXINS IMPLANTS WOMENS BODIES TESTED FOUND TOXINS MOLDS SILICONE CHEMICALS MAKE SILICONE BREAST IMPLANT INDUSTRY KNOWS PUTTING WOMENS BODIES HAPPENING NEEDS PROVEN COURT LAW TIME CANCER LINKED BREAST IMPLANTS WAY KNOW TYPE CANCER LATE TAKE IMPLANTS TEST FLUID AROUND IMPLANTS WOMEN DYING NEED FDAS HELP PLEASE|SILTEX SALINE FILLED MAMMARY PROSTHESIS||04/26/2017||||Y|I||0HP|FWM|2.0||PROSTHESIS, BREAST||L-FW7879 R-FW2756|||||MCGHAN|||||||True
6315895|67104048|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6315895|67104049|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL UNKNOWN SIDE EXPLANT SURGERY OCCURRED PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6574798|75415102|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574798|75415103|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS STAGE ALCL CASE PATIENT UNILATERAL MASTECTOMY IMPLANT RECONSTRUCTION BREAST CANCER REGARDING TREATMENT ABSTRACT STATES STAGE CASES PRESENTED RECURRENT SEROMA TREATED SUCCESSFULLY IMPLANT REMOVAL TOTAL CAPSULECTOMY EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574819|75418485|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PATIENTS AGE COULD EXPLANATION INCREASE ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574819|75418486|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS Â¿PATIENTS PRESENTED STAGE IIA DISEASE ONE PATIENT PREVIOUS BBA FOLLOWING ROUTINE IMPLANT EXCHANGE DEVELOPED BIA-ALCL MASS DRAIN SITE PATIENT TREATED LOCAL EXCISION ADJUVANT CHOP RADIOTHERAPY PATIENT WELL FOUR YEARSÂ¿ EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6498283|72956470|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6498283|72956471|D|1||PATIENT LYMPHOMA ALCL UNKNOWN SIDE PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED THEREFORE EVENT CAPTURED LYMPHOMA MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6498189|72956287|D|1||B6 FEMALE BREAST AUGMENTATION 1995 MCGHAN 350CC TEXTURED SALINE BREAST IMPLANTS PT NOTED SWOLLEN RIGHT BREAST B6 2016 US GUIDED ASPIRATION FLUID SENT PATH ALCL DX CONFIRMED B6 2016 SURGERY B6 2016 REMOVE IMPLANTS COMPLETE OPEN CAPSULECTOMIES PET CT DONE PRE-OPERATIVELY SHOWED DISSEMINATED DISEASE CHEMO RADIATION INDICATED PT WELL THUS FAR RETURN SYMPTOMS REMAINS DISEASE FREE|MCGHAN||04/16/2017||||Y|I||0HP|FWM|2.0||SALINE BREAST IMPLANTS||||||US|MCGHAN|||||||True
6498189|72956287|D|1||B6 FEMALE BREAST AUGMENTATION 1995 MCGHAN 350CC TEXTURED SALINE BREAST IMPLANTS PT NOTED SWOLLEN RIGHT BREAST B6 2016 US GUIDED ASPIRATION FLUID SENT PATH ALCL DX CONFIRMED B6 2016 SURGERY B6 2016 REMOVE IMPLANTS COMPLETE OPEN CAPSULECTOMIES PET CT DONE PRE-OPERATIVELY SHOWED DISSEMINATED DISEASE CHEMO RADIATION INDICATED PT WELL THUS FAR RETURN SYMPTOMS REMAINS DISEASE FREE|MCGHAN||04/16/2017||||Y|I||0HP|FWM|1.0||SALINE BREAST IMPLANTS||||||US|MCGHAN|||||||True
6352879|68133174|D|1||HEALTHCARE PROFESSIONAL REPORTED PATIENT REFERRED TREATMENT DUE Â¿CONFIRMED ALCLÂ¿ PATIENT ALLERGAN IMPLANT ADDITIONAL INFORMATION PROVIDED PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/23/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6352879|68133173|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/23/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6275633|65693785|D|1||PT MCGHAN 363LF SALINE FILLED IMPLANTS PLACED B6 2016 PRESENTED LARGE RIGHT BREAST SEROMA B6 2016 ULTRASOUND GUIDED ASPIRATION SEROMA PERFORMED B6 2016 ULTRASOUND MRI SHOWED LARGE LOCULATED RIGHT BREAST FLUID COLLECTION ASPIRATED FLUID SHOWED CD30+ ALK1 - CELLS LEADING DIAGNOSIS ALCL BILATERAL CAPSULECTOMIES REMOVAL IMPLANTS B6 2017 PATHOLOGY REVEAL EXTENSION ALCL CAPSULAR CURRENTLY WORKED ONCOLOGISTS WELL GENETICISTS|MCGHAN 363 LF||01/23/2017||||*|*||I|FWM|2.0||SALINE FILLED BREAST IMPLANTS||1262358|||||MCGHAN|||||363LF-300||True
6275633|65693785|D|1||PT MCGHAN 363LF SALINE FILLED IMPLANTS PLACED B6 2016 PRESENTED LARGE RIGHT BREAST SEROMA B6 2016 ULTRASOUND GUIDED ASPIRATION SEROMA PERFORMED B6 2016 ULTRASOUND MRI SHOWED LARGE LOCULATED RIGHT BREAST FLUID COLLECTION ASPIRATED FLUID SHOWED CD30+ ALK1 - CELLS LEADING DIAGNOSIS ALCL BILATERAL CAPSULECTOMIES REMOVAL IMPLANTS B6 2017 PATHOLOGY REVEAL EXTENSION ALCL CAPSULAR CURRENTLY WORKED ONCOLOGISTS WELL GENETICISTS|MCGHAN 363 LF||01/23/2017||||Y|*||0HP|FWM|1.0||SALINE FILLED BREAST IMPLANTS||1157904|||||MCGHAN|||||363LF-300||True
6436022|70908687|D|1||BREAST IMPLANTS SINCE 1993 2016 BREAST REDUCTION OLD IMPLANTS REMOVED NEW IMPLANTS PUT DIAGNOSED ALCL 2016 WENT CHEMO STEM CELL TRANSPLANT B6 2016|SX RND MPP GEL-FILLED MAMMORY PROSTH||03/24/2017||||Y|I||I|FTR|1.0||"GEL-FILLED BREAST IMPLANT: DEVICE 1 -2"""||265879|||||MENTOR|||||||True
6436022|70908687|D|1||BREAST IMPLANTS SINCE 1993 2016 BREAST REDUCTION OLD IMPLANTS REMOVED NEW IMPLANTS PUT DIAGNOSED ALCL 2016 WENT CHEMO STEM CELL TRANSPLANT B6 2016|SX RND MPP GEL-FILLED MAMMORY PROSTH||03/24/2017||||Y|I||I|FTR|2.0||"GEL-FILLED BREAST IMPLANT: DEVICE 1 -2"""||265879|||||MENTOR|||||||True
1888850|1687082|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE SEROMA ANAPLASTIC LARGE CELL LYMPHOMA ALCL FU FINDINGS PT TEXTURED SALINE BREAST IMPLANT MFR UNK ALLERGAN TAKES CONSERVATIVE APPROACH REPORTING FU FINDINGS PT WELL CARE APPOINTMENT TWO MONTHS MULTIPLE BIOPSIES TWO DAYS LATER DEVELOPED BREAST SWELLING PT GENERAL SURGERY CONSULTATION EVAL THREE PERCUTANEOUS DRAINAGE PROCEDURES BIOPSIES DIAGNOSIS ALCL MADE PRIMARY VS SECONDARY BREAST ALCL UNCLEAR STAGE IV DIAGNOSIS MULTI-AGENT CHEMOTHERAPY PROVIDED REFRACTORY CHEMOTHERAPY MEDIASTINAL LYMPH NODES IDENTIFIED CT SCAN FU FINDINGS PT SUPRA CLAVICULAR AXILLARY NODES ADDITION PRESENTING SWOLLEN BREAST LIVER CHEST WALL MEDIASTINAL LYMPHADENOPATHY RIGHT PLEURAL EFFUSION LUNG NODULES ABDOMINAL WALL RETROPERITONEAL LYMPH NODES FINDINGS INVESTIGATION CONTINUES|UNKNOWN SALINE IMPLANT|UNK SALINE IMPLANT|10/19/2010|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
1735704|1340867|D|1||HEALTHCARE PROFESSIONAL REPORTS DIAGNOSED CASE ALCL DEATH PATIENT|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/23/2010|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210599|16933173|N|1||MEDWATCH SUBMITTED B6 2011 PT EDUCATION LABELING ADDRESS LUMPMASS CYST FOLLOWING BREAST AUGMENTATION CONTINUE PERFORM BREAST SELF-EXAMINATION MONTHLY MAY DIFFICULT BREAST IMPLANT PLACE CONTINUE PERFORM MONTHLY BREAST SELF EXAMINATION EFFICIENTLY ASK SURGEON HELP IDENTIFY DIFFERENCE IMPLANT BREAST TISSUE ABLE IDENTIFY IMPLANT BREAST TISSUE DECREASE NECESSITY EXCESSIVE SQUEEZING IMPLANT EXAMINATION NEW LUMPS EVALUATED BIOPSY APPROPRIATE BIOPSY PERFORMED SURE INFORM MEDICAL PROFESSIONAL PERFORMING BIOPSY BREAST IMPLANTS CARE TAKEN AVOID INJURING IMPLANT DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2392146|9736636|N|1||MEDWATCH SUBMITTED B4 2011 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS CORE STUDY 7 YEAR ADVERSE EVENT RATES PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120401|12/21/2011|||DA|N|R||0HP|FTR|1.0|05/30/2010|nan||413555|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2392146|2455460|D|1||RECEIVED PRODUCT FIELD NOTES PFN VIA E-MAIL ALLERGAN B4 REPORTING ALCL SURGEON COULD PROVIDE MUCH INFO TIME REPORT B6 2011 PT PRESENTED PAIN SWELLING RIGHT BREAST EFFUSION SERUM PRESENTED ULTRA SOUND ASPIRATION CYSTOLOGY SHOWED ALCL AUGMENTATION B6 2006 SILICON IMPLANTS SUBMUSCULAR PLACEMENT REMOVAL CAPSULE IMPLANTS B6 2011 PATHOLOGY CYTOLOGY STILL PENDING ONGOING INVESTIGATION CARRIED ADDITIONAL INFO REGARDING EVENTS UPDATED FILE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120401|12/21/2011|||DA|N|R||0HP|FTR|1.0|05/30/2010|nan||413555|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2328800|9385172|N|1||B4  DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 68 SALINE FILLED BREAST IMPLANT|68HP-550|11/04/2011|||DA|N|R||0HP|FWM|1.0|07/14/2011|nan||1470830|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2112878|2143713|D|1||ALCL CASE REPORT B6 FEMALE B6 ALCL DIAGNOSIS DATE DIAGNOSIS - B6 2011 ANATOMIC SITE ALCL LEFT BREAST IMPLANT CAPSULE PRIMARY SITE CONFIRMED PATHOLOGY INITIAL CLINICAL PRESENTATION B6 2010 B6 FEMALE HISTORY DUCTAL CARCINOMA SITU LEFT BREAST DIAGNOSED 1998 SUBSEQUENTLY UNDERWENT LEFT MASTECTOMY SPECIMEN WEIGHT 596 GRAMS UNDERWENT IMMEDIATE RECONSTRUCTION PLACEMENT SUBMUSCULAR TISSUE EXPANDER PLASTIC SURGEON 1 TISSUE EXPANDER PLACED COMPLETELY SUBPECTORAL ALSO SUBSERRATUS POCKET EXPANDER REMOVED 1999 REPLACED MCGHAN 440 ML DUAL-CHAMBER SILICONE SALINE-FILLED IMPLANT RECEIVED POSTOPERATIVE CHEMOTHERAPY RADIATION THERAPY WITHIN YEAR DEVELOPED SIGNIFICANT HARDENING DISTORTION LEFT RECONSTRUCTED BREAST GRADUAL ELEVATION IMPLANT TIGHTENING TISSUE AROUND IMPLANT DISCOMFORT LEFT CHEST WALL SEEN EVALUATION 2006 PLASTIC SURGEON 2 RE-OPERATED LEFT BREAST REMOVED EXISTING IMPLANT PERFORMED PERIPROSTHETIC CAPSULOTOMIES SPECIFIED OPERATIVE NOTE SUBMITTED CAPSULAR TISSUE HISTOLOGIC EXAMINATION INTERPRETED NEGATIVE REPLACED SMALLER SALINE IMPLANT ALLERGAN-STYLE 68MP SALINE IMPLANT SIZE 390-420 ML RECONSTRUCTION SOFT SEVERAL MONTHS WITHIN 1 YEAR RECURRENCE CAPSULAR CONTRACTURE TIGHTENING TISSUE AROUND IMPLANT GRADUAL ELEVATION IMPLANT LOCATION DISCOMFORT LEFT CHEST WALL SEEN EVALUATION 2009 PLASTIC SURGEON 4 RECOMMENDED CONSIDER REVISION RECONSTRUCTION ADDITION CELLULAR DERMAL MATRIX REDUCE POTENTIAL RECURRENCE CAPSULAR CONTRACTURE AROUND DEVICE PLASTIC SURGEON 4 ALSO RECOMMENDED AUTOLOGOUS ABDOMINAL FLAP RECONSTRUCTION PROCEDURES PT INTERESTED CONSIDERING DIEP FLAP PLASTIC SURGEON 4 REFERRED B6 SURGEON 5 EVALUATION CONSIDERATION FREE FLAP BREAST RECONSTRUCTION PROCEDURE PTS PAST MEDICAL HISTORY ADDITIONALLY SIGNIFICANT HISTORY HYPOTHYROIDISM BLADDER PROLAPSE MEDICATIONS INCLUDED SYNTHROID 88 MCG DAILY VITAMIN ADVIL NONSMOKER DRINKS ALCOHOL RARELY INITIAL PHYSICAL EXAMINATION B6 2010 SHOWED PT 155 CM TALL 703 KG LEFT BREAST ABSENT TRANSVERSE STEWART-TYPE MASTECTOMY INCISION IMPLANT PRESENT SUBPECTORAL POSITION LEFT SIDE BAKER GRADE IV CAPSULE CONTRACTURE AROUND DEVICE RIGIDLY AFFIXED CHEST WALL SOMEWHAT TENDER MANIPULATION WOUNDS WELL HEALED EVIDENCE SCAR HYPERTROPHY RIGHT BREAST PTOTIC DEGREE PSEUDOPTOSIS LATERAL BOTTOMING WISE-PATTERN SCAR PREVIOUS MASTOPEXY - RESULTING SUBSTANTIAL SHAPE VOLUME ASYMMETRY LEFT SIDE STERNAL NOTCH INFRAMAMMARY FOLD DISTANCE 20 CM RIGHT SIDE STERNAL NOTCH INFRAMAMMARY FOLD DISTANCE 23 CM MID-CLAVICULAR POINT NIPPLE DISTANCE RIGHT 21 CM EXAMINATION ABDOMEN SHOWED GENEROUS AMOUNT TISSUE LOWER 13 ABDOMEN ABDOMINAL FLAP CONSIDERATION INITIAL IMPRESSION B6 2010 B6 FEMALE RECURRENT CAPSULAR CONTRACTURE FOLLOWING 2 PREVIOUS IMPLANT-BASED RECONSTRUCTION SURGERIES LEFT SIDE LEFT BREAST RECONSTRUCTION SHOWED ELEVATION INFRAMAMMARY FOLD SEVERE CAPSULAR CONTRACTURE AROUND EXISTING IMPLANT RECOMMENDED REMOVAL EXISTING LEFT BREAST IMPLANT RECONSTRUCTION ORIGINS LEFT PECTORALIS MAJOR MUSCLE RECONSTRUCTION LEFT BREAST FREE ABDOMINAL FLAP OPERATIVE FINDINGS B6 2011 LEFT BREAST IMPLANT CAPSULE OPENED CONTAINED CLOUDY YELLOW FLUID ENORMOUS PRESSURE FLUID SQUIRTED CAPSULAR INCISION TRAVELED LEAST 56 INCHES COLLECTION GELATINOUS MATERIAL WITHIN CAPSULE WELL INTACT SALINE BREAST IMPLANT CAPSULE THICKENED COVERED PLAQUE-LIKE LESIONS INTERNALLY TOTAL CAPSULECTOMY PERFORMED PECTORALIS MAJOR MUSCLE REATTACHED 5TH RIB ORIGINS PERIPROSTHETIC FLUID CAPTURED MATERIAL SENT PATHOLOGIC CYTOLOGIC EVALUATION INCLUDING FROZEN SECTION CONSISTENT DIAGNOSIS ALCL REMAINING RECONSTRUCTION ABANDONED PENDING FINAL PATHOLOGY EVALUATION SPECIMEN DETAILED PATHOLOGY FINDINGS LEFT BREAST PERI-PROSTHETIC MATERIAL LARGE ATYPICAL CELLS PRESENT CONSISTENT INVOLVEMENT ANAPLASTIC LARGE CELL LYMPHOMA IMPLANT LEFT BREAST IMPLANT CAPSULE INVOLVEMENT ANAPLASTIC LARGE CELL LYMPHOMA B6|MODERATE PROFILE SMOOTH ROUND SALINE BREAST IMPLANT||05/27/2011||||Y|||0HP|FWM|1.0||68MP 390CC||1316501|||||MCGHAN|||||68MP 390CC||True
2097844|18413658|D|1||COMPANY SALES REPRESENTATIVE REPORTED ANAPLASTIC LARGE CELL LYMPHOMA ALCL RIGHT BREAST CONFIRMED HEALTH PROFESSIONAL CYTOLOGY CONFIRMED DIAGNOSIS CD30 POSITIVE ALK NEGATIVE PATIENT HISTORY LEFT SIDE BREAST CANCER PATIENT PRESENTED SEROMA SYSTEMIC SYMPTOMS|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|05/04/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2097844|18737137|N|1||SUBMITTED MEDWATCH B4 2011 EXTENSION GRANTED TODAY B4 2011 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS CORE STUDY 7 YEAR ADVERSE EVENT RATES PRIMARY AUGMENTATION PATIENTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PATIENTS = 10 COMPLICATIONS SWELLING = 71 REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE - FILLED BREAST IMPLANT LABELING|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|05/04/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2162357|9192360|N|1||B4 DEVICE LABELING ADDRESSES DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS B4 3 YEAR 5 YEAR CUMULATIVE FIRST OCCURRENCE KAPLAN-MEIER ADVERSE EVENT RATES 95 CONFIDENCE INTERVAL PT SEROMA 26 3 YEARS 26 5 YEARS DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 110|07/07/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210614|15724252|N|1||MEDWATCH SUBMITTED B6 2011 PT EDUCATION LABELING ADDRESS LUMPMASS CYST FOLLOWING BREAST AUGMENTATION CONTINUE PERFORM BREAST SELF-EXAMINATION MONTHLY MAY DIFFICULT BREAST IMPLANT PLACE CONTINUE PERFORM MONTHLY BREAST SELF EXAMINATION EFFICIENTLY ASK SURGEON HELP IDENTIFY DIFFERENCE IMPLANT BREAST TISSUE ABLE IDENTIFY IMPLANT BREAST TISSUE DECREASE NECESSITY EXCESSIVE SQUEEZING IMPLANT EXAMINATION NEW LUMPS EVALUATED BIOPSY APPROPRIATE BIOPSY PERFORMED SURE INFORM MEDICAL PROFESSIONAL PERFORMING BIOPSY BREAST IMPLANTS CARE TAKEN AVOID INJURING IMPLANT DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210614|15512186|D|1||RECEIVED ABSTRACT ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA BREAST OCCURRING PTS SILICONE BREAST IMPLANTS PUBLISHED FINAL ARTICLE ENTITLED LEUKEMIA LYMPHOMA AUG 20115281481-1487 WITHIN ARTICLE PT IDENTIFIED PT 6 COSMETIC AUGMENTATION PT FOUND NODULE INFRAMAMMARY FOLD LEFT BREAST GREW SEVERAL MONTHS NEGATIVE MAMMOGRAM LEFT IMPLANT REMOVED TISSUE FIBROUS CAPSULE DIAGNOSED ALCL PT TREATED 6 CYCLES CHOP EXPERIENCED TUMOR REGROWTH WITHIN 2 WEEKS COMPLETION ICE SALVAGE GIVEN RADIATION INEFFECTIVE FINALLY RECEIVED AUTOLOGUS TRANSPLANT USING CBV CYCLOPHOSPHAMIDE CARMUSTINE ETOPOSIDE CONDITIONING REGIMEN REMISSION 75 YEARS LAST FU MW LEFT SIDE REFER MFR REPORT 2024601-2011-00674 RIGHT SIDE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2297493|9366847|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 10 SILICONE GEL FILLED BREAST IMPLANT|10-300|10/11/2011|||DA|N|R||0HP|FTR|1.0|09/10/2010|nan||1151040|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
1821178|1710428|D|1||B6 YEAR OLD WOMAN DIAGNOSED ALCL RIGHT BREAST 2008 HISTORY REPORTED DR B6 2002 RIGHT BREAST ADENOCARCINOMA RECONSTRUCTED BILATERAL MCGHAN SALINE IMPLANTS 2007 UNDERWENT BILATERAL CAPSULECTOMIES IMPLANTS REPLACED MENTOR SMOOTH GEL STYLE 350-5504BC 2008 UNDERWENT CAPSULECTOMY RIGHT IMPLANT REPLACED MENTOR 550CC HIGH PROFILE IMPLANT REF 350-5504BC SERIAL B4 LOT 5765778 UPON DIAGNOSIS ALCL TREATED EXPLANTATION CHEMOTHERAPY RADIOTHERAPY SEEN SOCIALLY EARLIER YEAR DR B6|MENTOR|350-5504BC|08/25/2010||||N|R||0HP|FTR|1.0||GEL-FILLED MAMMARY PROSTHESIS||5765778|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR|75038|TX|75038||||True
2230846|19185696|D|1||B61988 PT SEEN HEALTHCARE PROFESSIONAL DIAGNOSED RIGHT BREAST CANCER DECIDED BILATERAL MASTECTOMY B6 1988 MCGHAN TE PLACED 30-35650 PLACED BILATERALLY B61989 MCGHAN SILICONE BREAST STYLE 120-600CC IMPLANTS PLACED BILATERALLY USING SERIAL NUMBER B4 B4 B61989 PT SEEN NIPPLE RECONSTRUCTION B6 2005 PT SEEN DIFFERENT HEALTHCARE PROFESSIONAL REVISION SURGERY DUE ASYMMETRY WOULD APPEAR REMOVED DUE POSSIBLE CAPSULAR CONTRACTURE SURGERY DEVICES FOUND INTACT B6 2005 REVISION SURGERY REPLACES MENTOR DEVICES B4 LEFT B4 RIGHT SILTEX GEL IMPLANTS POST-OP COURSE UNREMARKABLE B6 2007 PT PRESENTS POSSIBLE LEAK LEFT SIDE LEFT SIDE LOOKED LARGER RIGHT STATES HISTORY TRAUMA POSSIBLE SEROMA SUGGESTED PT TAKEN SURGERY B6 2007 PT TAKEN SURGERY EXPLORATION LEFT BREAST DRAINAGE SEROMA PARTIAL CAPSULECTOMY INCISION MADE 600CC SEROUS FLUID REMOVED IMPLANT ALSO REMOVED FOUND INTACT FIBROUS MATERIAL INTACT B6 2007 DIAGNOSIS ALCL MADE|25-00501|25-00501|08/22/2011|||DA|N|R||0HP|FWM|1.0||nan||9-107475|||GOLETA|US|ALLERGAN||CA|||||True
2230846|19428992|N|1||MEDWATCH SUBMITTED 08222011 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS CORE STUDY 7 YEAR ADVERSE EVENT RATES PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71  BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|25-00501|25-00501|08/22/2011|||DA|N|R||0HP|FWM|1.0||nan||9-107475|||GOLETA|US|ALLERGAN||CA|||||True
2348478|15756117|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE ALCL RIGHT CHEST WALL MASS VIA VOLUNTARY MW B4 HEALTHCARE PROFESSIONAL REPORTS PT IMPLANTED B6 1994 BILATERAL AUGMENTATION PT PRESENTED OFFICE B6 2011 RIGHT BREAST ENLARGEMENT CHEST MALL MASS BIOPSY MASS CARRIED CAPSULAR CONTRACTURE NOTED TIME BIOPSY DIAGNOSIS ALCL MADE PT RETURNED EXPLANATION DEVICE B6 2011 TIME SEROMA ENCOUNTERED SEROMA SENT CYTOLOGICAL EVAL PET SCAN ALSO CARRIED REVEALED ABDOMINAL WALL MASS TWO AXILLARY NODES PT BEGUN CHOP THERAPY B6 2011|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|09/30/2011|||DA|N|R||0HP|FWM|1.0|07/01/1998|nan||2-514321|||GOLETA|US|ALLERGAN||CA|||||True
2348478|15824003|N|1||MEDWATCH SUBMITTED B6 2011 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS B6 STUDY 3 YEAR 5 YEAR CUMULATIVE FIRST OCCURRENCE B4 ADVERSE EVENT RATES 95 CONFIDENCE INTERVAL PT SEROMA 26 3 YEARS 26 5 YEARS UNUSUAL SYMPTOMS OCCUR SURGERY FEVER NOTICEABLE SWELLING REDNESS ONE BREAST CONTACT SURGEON IMMEDIATELY ALLERGAN SALINE BREAST IMPLANT LABELING DEVICE LABELING REPORTED EVENTS LYMPHOMAALCL PTS B6 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|09/30/2011|||DA|N|R||0HP|FWM|1.0|07/01/1998|nan||2-514321|||GOLETA|US|ALLERGAN||CA|||||True
2149068|9282200|N|1||MEDWATCH SUBMITTED B4 2011 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS CORE STUDY 7 YEAR ADVERSE EVENT RATES PRIMARY AUGMENTATION PATIENTS SEROMA RATE = 16 SWELLING = 71 BREAST IMPLANT SURGERY PATIENTS CORE STUDY LABELING SALINE IMPLANTS FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SALINE IMPLANTS|STYLE 468 SALINE FILLED BREAST IMPLANT|468-380|06/13/2011|||DA|N|R||0HP|FWM|1.0|12/19/2003|nan||548477|||GOLETA, NE|US|ALLERGAN||CA|||||True
2029741|1917664|D|1||ALCL CASE REPORT B6 TEXTURED SILICONE BREAST IMPLANTS IMPLANTED 12 YEARS AGO DEVELOPED LEFT BREAST SWELLING 2 YEARS AGO DRAINED PT WELL TWO MONTHS AGO NOTED SWELLING LEFT BREAST SUBSEQUENTLY DRAINED SENT PATHOLOGY SYMPTOMS|TEXTURED SALINE BREAST IMPLANTS||03/21/2011||||N|||0|FWM|1.0||NONE|||||||nan|||||||True
2097862|20792559|D|1||HEALTHCARE PROFESSIONAL REPORTS MEDICAL AFFAIRS CASE POSSIBLE LYMPHOMA CALL PLACED HEALTHCARE PROVIDER ABLE PROVIDE FOLLOWING INFORMATION PATHOLOGY SPECIMEN SENT PATIENT ALLEGEDLY POSITIVE ALCL STATUS CYTOLOGY UNKNOWN ONGOING INVESTIGATION CARRIED ADDITIONAL INFORMATION REGARDING EVENTS UPDATED FILE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/04/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2231123|19947863|N|1||MEDWATCH EXTENSION REQUESTED 04JUN2011 GRANTED 29AUG2011 MEDWATCH SUBMITTED 26AUG2011 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS DEVICE LABELING ADDRESSES BREAST PAIN FOLLOWS CORE STUDY 7 YR ADVERSE EVENT RATES PRIMARY AUGMENTATION PTS PAIN RATE = 114 DEVICE ANALYSIS ANALYSIS NOTED SHARP CURVED UNIDENTIFIED OPENING POSTERIOR SHELL ETIOLOGY UNK|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110271|08/26/2011||07/11/2011|DA|Y|Y||0HP|FTR|1.0|07/15/2009|nan||323772|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2328812|18201205|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 68 SALINE FILLED BREAST IMPLANT|68HP-500|11/04/2011|||DA|N|R||0HP|FWM|1.0|10/14/2011|nan||1513170|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2210613|9398152|N|1||MEDWATCH SUBMITTED B6 2011 DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210613|2193837|D|1||ABSTRACT RECEIVED ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA BREAST OCCURRING PTS SILICONE BREAST IMPLANTS REPORTED PUBLISHED FINAL ARTICLE ENTITLED LEUKEMIA LYMPHOMA AUG 20115281481-1487 WITHIN ARTICLE PT IDENTIFIED PT 1 INDICATES COSMETIC AUGMENTATION ORIGINALLY PRESENTED SWELLING LEFT BREAST DRAINAGE FLUID FLUID SHOWED LARGE AMOUNTS ATYPICAL LYMPHOCYTES FLUID ACCUMULATION RECUR 2 YEARS TIME EXPERIENCED RAPID SWELLING LEFT BREAST WORK-UP YIELDED DIAGNOSIS ALCL ALK- PT PRESENTED CITY HOPE SECOND OPINION CHOP RECOMMENDED TREATMENT CARRIED ELSEWHERE OUTCOME UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210610|17039805|N|1||MEDWATCH SUBMITTED B6 2011 DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2027271|1955552|D|1||B6 FEMALE DIAGNOSED BREAST-IMPLANT RELATED ANAPLASTIC LARGE CELL LYMPHOMA PT BILATERAL MASTECTOMIES SALINE IMPLANT RECONSTRUCTION 1992 DEVELOPED LEFT SIDED IDIOPATHIC LARGE VOLUME SEROMA 2009 IMPLANTS REMOVED PARTIAL CAPSULECTOMY PERFORMED DIFFERENT PLASTIC SURGEON REPLACEMENT IMPLANTS TIME PATHOLOGY REPORTS NEGATIVE TIME RECURRENT SEROMA FOLLOWING EXPLANTATION REQUIRING REPEAT CAPSULECTOMY DRAIN PLACEMENT B6 2010 NEGATIVE PATHOLOGY REPORT PT PRESENTED DELAYED TWO-STAGE RECONSTRUCTION PRACTICE PERFORMED B6 2011 LEFT BREAST SEROMA SMALL CAPSULE IDENTIFIED COMPLETELY REMOVED PATHOLOGY REPORTS CONFIRMED ALCL LEFT BREAST CAPSULE ALK-1 NEGATIVE SALINE BREAST IMPLANT UNKNOWN MANUFACTURER SURE TEXTURED SMOOTH PT RECORDS SURGEON REMOVED IMPLANTS RECALL SALINE PATHOLOGY REPORT INDICATE TEXTURED VS SMOOTH|UNK||03/17/2011||||N|||0|FWM|1.0||SALINE BREAST IMPLANT||UNK|||||UNK|||||||True
1976504|1728474|D|1||B6 FEMALE PRESENTS PERICAPSULAR INFECTION AROUND MCGHAN STYLE 68 TEXTURED SALINE IMPLANTS INSERTED MID 1990S POST REMOVAL IMPLANTS PT FOUND ALCL RIGHT BREAST CAPSULE PT UNDERWENT COMPLETE BILATERAL CAPSULECTOMIES B6 2010 POST OPERATIVE PET SCAN NEGATIVE LYMPHOMA CAPSULE FLUID SENT B6 ADDITIONAL MATERIAL HELD B6 DATES USE 1 2 - B6 1993 - B6 2010 DIAGNOSIS REASON USE HYPOMASTIA RIGHT  LEFT BREASTS|MCGHAN TEXTURED SALINE IMPLANTS||01/26/2011||||N|||0HP|FWM|1.0||SAME 800 CC SALINE IMPLANTS||GA9039|||||MCGHAN|||||||True
1976504|1728474|D|1||B6 FEMALE PRESENTS PERICAPSULAR INFECTION AROUND MCGHAN STYLE 68 TEXTURED SALINE IMPLANTS INSERTED MID 1990S POST REMOVAL IMPLANTS PT FOUND ALCL RIGHT BREAST CAPSULE PT UNDERWENT COMPLETE BILATERAL CAPSULECTOMIES B6 2010 POST OPERATIVE PET SCAN NEGATIVE LYMPHOMA CAPSULE FLUID SENT B6 ADDITIONAL MATERIAL HELD B6 DATES USE 1 2 - B6 1993 - B6 2010 DIAGNOSIS REASON USE HYPOMASTIA RIGHT  LEFT BREASTS|MCGHAN TEXTURED SALINE IMPLANTS||01/26/2011||||N|||0HP|FWM|2.0||SAME 800CC SALINE IMPLANTS||GB6620|||||MCGHAN|||||||True
2150825|9283213|N|1||MEDWATCH SUBMITTED B4 2011 EXTENSION GRANTED B4 B4 2011 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS B4 STUDY 3 YEAR 5 YEAR CUMULATIVE FIRST OCCURRENCE B4 ADVERSE EVENT RATES 95 CONFIDENCE INTERVAL PATIENT SEROMA 26 3 YEARS 26 5 YEARS UNUSUAL SYMPTOMS OCCUR SURGERY FEVER NOTICEABLE SWELLING REDNESS ONE BREAST CONTACT SURGEON IMMEDIATELY DEVICE LABELING ADDRESSES REPORTED EVENT CAPSULAR CONTRACTURE FOLLOWS 3 YEARS 9 5 YEARS 11 SCAR TISSUE CAPSULE NORMALLY FORMS AROUND IMPLANT MAY TIGHTEN SQUEEZE IMPLANT CALLED CAPSULAR CONTRACTURE ADDITIONAL SURGERY NEEDED CASE PAINFIRMNESS SEVERE SURGERY RANGES REMOVAL IMPLANT CAPSULE TISSUE REMOVAL POSSIBLY REPLACEMENT IMPLANT CAPSULAR CONTRACTURE MAY HAPPEN ADDITIONAL SURGERIES LABELING REVIEW REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 163 SALINE FILLED BREAST IMPLANT|163-360|06/02/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2348477|18501906|D|1||HEALTHCARE PROFESSIONAL REPORTS VIA VOLUNTARY MW B4 CASE ALCL INFECTION PAIN BREAST ENLARGEMENT HEALTH PROFESSIONAL REPORTS WHITE FEMALE PRESENTED OFFICE 2010 INFECTED RIGHT BREAST IMPLANT PREVIOUS SILICONE BREAST IMPLANTS 17 YRS PRIOR LITTLE YR SYMPTOMS INCLUDING PAIN ENLARGEMENT RECENTLY REDNESS FAILED COURSE ANTIBIOTIC THERAPY TIME PRESENTATION ALSO EPIDERMOLYSIS HANDS FEET PERIAREOLAR REGION EXAM CONSISTENT INFECTED BREAST IMPLANT THEREFORE IMPLANT REMOVED OFFICE LOCAL ANESTHESIAS EPIDERMOLYSIS EVENTUALLY CLEARED INFECTION IMPROVED HOWEVER DEVELOPED INFLAMMATORY ABSCESS INFRAMAMMARY PORTION RIGHT BREAST REQUIRED OPERATIVE EXCISION DEBRIDEMENT ANESTHESIA TISSUE REMOVED SENT LABORATORY CAME BACK ANAPLASTIC LARGE CELL LYMPHOMA PT CONSULT TREATMENT RECEIVED CHEMOTHERAPY REQUESTED REMOVAL LEFT BREAST IMPLANT WELL UNEVENTFUL FOUND RUPTURED UPON REMOVAL PRODUCT RETAINED AVAILABLE EXAMINATION PT CONTINUED CARE TIME|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/30/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2348477|62765167|D|1||HEALTHCARE PROFESSIONAL REPORTED CASE ANAPLASTIC LARGE CELL LYMPHOMA CAPTURED LYMPHOMA PATHOLOGY REPORT AVAILABLE CONFIRM DIAGNOSIS ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/30/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2348477|18743764|N|1||MEDWATCH SUBMITTED B6 2011 CORE STUDY 7 YRS ADVERSE EVENT RATE PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 BREAST PAIN = 114 INFECTION = 14 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/30/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2100509|21351847|N|1||MED WATCH SUBMITTED VIA FED-EX B4 2011 FILE EXTENSION GRANTED B4 2011 DEVICE LABELING REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS FOLLOWING LIST POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY RISKS INCLUDE IMPLANT DEFLATIONLEAKAGE ADDL SURGERY CAPSULAR CONTRACTURE INFECTION TOXIC SHOCK SYNDROME NECROSIS HEMATOMA SEROMA EXTRUSION BREAST PAIN CHANGES NIPPLE SENSATION CHANGES BREAST SENSATION DISSATISFACTION COSMETIC RESULTS WRINKLING FOLDING DISPLACEMENT ASYMMETRY PALPABILITY VISIBILITY PTOSIS SLOSHING CALCIFIC DEPOSITS IRRITATIONINFLAMMATION DELAYED WOUND HEALING HYPERTROPHIC SCARRING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY DIFFICULTYINABILITY BREAST FEEDING INABILITY ADEQUATELY VISUALIZE BREAST LESIONS MAMMOGRAPHY ADDITION POTENTIAL ADVERSE EVENTS CONCERNS CERTAIN SYSTEMIC DISEASES|STYLE 468 SALINE FILLED BREAST IMPLANT|468-380|05/16/2011|||DA|N|R||0HP|FWM|1.0|07/12/2006|nan||579142|||GOLETA|US|ALLERGAN||CA|||||True
2100509|21426777|D|1||PT REPORTED VOLUNTARY MW FORM 2010 DIAGNOSED ALCL ALK NEGATIVE POSSIBLY RELATED CAUSED BREAST IMPLANTS RECEIVED 2002 AUGMENTATION LEFT BREAST CAPSULAR CONTRACTURE NOTED PT LEFT IMPLANT REPLACED 2008 STILL EXPERIENCING CAPSULAR CONTRACTURE REPLACEMENT 2010 NEEDLE BIOPSY PERFORMED DIAGNOSIS LYMPHOMA MADE ALSO 2010 SURGICAL BIOPSY PERFORMED DIAGNOSIS ALCL MADE PT PREPARING STEM-CELL TRANSPLANT SCHEDULED 2011 WITHIN VOLUNTARY FORM IMPLANTING EXPLANTING SURGEON INFO GIVEN INFO GATHERED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-380|05/16/2011|||DA|N|R||0HP|FWM|1.0|07/12/2006|nan||579142|||GOLETA|US|ALLERGAN||CA|||||True
2251798|20956603|D|1||PATIENT REPORTS VIA EMAIL CASE LYMPHOMA REPORTS AUGMENTATION PATIENT IMPLANTED 2007 STATES NOTICED IMPLANT GETTING HARD WENT SEE DOCTOR B6 2011 SURGEON CALLS PROVIDE ADDITIONAL INFORMATION PATIENT PRESENTS HISTORY RECONSTRUCTION PATIENT DIAGNOSED RIGHT BREAST CANCER PRIOR IMPLANTATION RECONSTRUCTION SURGERY TOOK PLACE B6 2007 LEFT SIDE DONE PROPHYLACTIC PURPOSES B6 2011 PRESENTED CAPSULAR CONTRACTURE BAKER GRADE IV RIGHT BREAST EXPLANTED DIAGNOSIS ALCL MADE RIGHT BREAST CAPSULE SAMPLE B6 2011 SURGERY PATIENT SCHEDULED DEVICES REMOVED BILATERALLY B6 2011|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 115|09/13/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2251798|21222330|N|1||MEDWATCH SUBMITTED B4 2011 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA CAPSULAR CONTRACTURE FOLLOWS CORE STUDY 7 YEAR ADVERSE EVENT RATES PRIMARY AUGMENTATION PATIENTS SEROMA RATE = 16 PERCENT CAPSULAR CONTRACTURE 155 PERCENT SWELLING = 71 PERCENT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 115|09/13/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2231135|17182337|N|1||MEDWATCH EXTENSION REQUESTED 04JUN2011 GRANTED 29AUG2011 MEDWATCH SUBMITTED 26AUG2011 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS DEVICE LABELING ADDRESSES BREAST PAIN FOLLOWS CORE STUDY 7 YR ADVERSE EVENT RATES PRIMARY AUGMENTATION PTS PAIN RATE = 114 DEVICE ANALYSIS ANALYSIS NOTED FLAT CREASE SHELL ALSO NOTED SHARP UNIDENTIFIED OPENING POSTERIOR SHELL EXTENDED RADIUSANTERIOR ETIOLOGY UNK|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110271|08/26/2011||07/11/2011|DA|Y|Y||0HP|FTR|1.0|08/15/2009|nan||330799|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2341596|2363207|D|1||PT BILATERAL SALINE BREAST IMPLANTS PLACED 10 YRS AGO B6 NOTED RIGHT BREAST SWELLING MAMMOGRAM SHOWED FLUID PT INFORMED PT CAME SEE DATE EVENT SENT ULTRASOUND GUIDED ASPIRATION 200 CC SEROUS FLUID REMOVED CYTOLOGY CONFIRMS ALCL SINCE REFERRED EMORY WORK ANTICIPATE REMOVAL IMPLANTS CAPSULES WORKUP BONE MARROW PET SCAN COMPLETED|UNKNOWN||11/10/2011||||N|||0|FWM|1.0||TEXTURED SALINE IMPLANTS. DO NOT KNOWN IF SILICONE||UNKNOWN|UNKNOWN||UNKNOWN||UNK|||||||True
2003941|1715828|D|1||ALCL CASE REPORT PT BREAST AUGMENTATION B6 2001 PT PRESENTED 4 CM MASS 6 OCLOCK POSTERIOR POSITION LEFT BREAST B6 2003 PATHOLOGY REVIEWED CD30 POSITIVE T-CELL ALCL ALK NEGATIVE PT LEFT BREAST IMPLANT REMOVED B6 2003 INITIAL THERAPY CHOP BEGINNING B6 2003 INITIAL RESPONSE PROGRESSED 3 CYCLES PT GIVEN DHAP LAST WEEK B6 2003 RESPONSE IMMEDIATELY DHAP DEVELOPED INFECTIONABSCESS LEFT BREAST PT LEFT TOTAL MASTECTOMY B6 2004 EVENTUALLY COMPLETED 2 COURSES DHAP B6 2004 FOLLOWING PROGRESSION PT RECEIVED HYPER CVAD ONE COURSE END B6 PROGRESSION B6 2004 PT STARTED INVESTIGATIONAL THERAPY SGN 30 ACHIEVED COMPLETE REMISSION SUSTAINED TIME THOUGH XRT LEFT CHEST WALL B6 2004 PREVENTATIVE METHOD|UNKNOWN||02/23/2011|||||||0|FTR|1.0||UNKNOWN||UNK|UNK||UNK||UNK|||||||True
2210616|9219649|N|1||MEDWATCH SUBMITTED B6 2011 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
1985458|1846143|D|1||ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS RECONSTRUCTION BREAST CANCER DATES USE B6 2007 DIAGNOSIS REASON USE REPLACING SALINE IMPLANTS 1 RUPTURE MENTOR SILICONE BREAST IMPLANTS PUT B6 2007 RIGHT BREAST REMOVED B6 2008 REPLACED DAY MENTOR SILICONE IMPLANT REMOVED B6 2008 VIA RADICAL MASTECTOMY FOUR WRONG DIAGNOSES BREAST CANCER MADE 9 WEEKS MASTECTOMY ALCL DIAGNOSIS MADE TREATED HIGH DOSING CHEMO SEVERAL KINDS STEM CELL TRANSPLANT ADDL CHEMO RADIATION EVENT ABATED USE EVENT REAPPEARED REINTRODUCTION YES|MENTOR||02/07/2011||||N|||0HP|FTR|1.0||SILICONE BREAST IMPLANTS|||||||MENTOR|||||||True
2111241|17147643|D|1||PT PRESENTED LEFT SEROMA PRESENTING EMERGENCY ROOM THOUGHT DEFLATION CALL PLACED SURGEON OFFICE SPEAKING OFFICE STAFF CONFIRMS DIAGNOSIS ALCL PTS MED RECORDS REQUESTED REVIEWED ACTUAL CYTOLOGY REPORT HOWEVER INCLUDED NOTES RECD PT EXPLANTED BILATERALLY WITHOUT REPLACEMENT SEEN ONCOLOGIST PLAN CHEMOTHERAPY TIME TISSUE SENT EVAL FINAL RESULTS PENDING|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|05/16/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2111241|17183682|N|1||MED WATCH SUBMITTED B4 2011 DEVICE LABELING ADDRESSES REPORTED EVENT LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS UNUSUAL SYMPTOMS OCCUR SURGERY FEVER NOTICEABLE SWELLING REDNESS ONE BREAST CONTACT SURGEON IMMEDIATELY|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|05/16/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210612|9219648|N|1||MEDWATCH SUBMITTED B6 2011 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210600|9398638|N|1||MEDWATCH SUBMITTED B6 2011 DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2119773|2014999|D|1||BILATERAL SILICONE BREAST IMPLANTS IMPLANTED B6 1990 DEVELOPED SWELLING REDNESS RIGHT BREAST 2002 FOLLOWED ENLARGED LYMPH NODES SKIN NODULES DIAGNOSED NODULAR SCLEROSING HODGKINS RIGHT AXILLA SPREAD SKIN SIX MONTHS LATER TREATED CHEMO RADIATION HOWEVER TWO MONTHS LATER RECURRED TREATED STEM CELL TRANSPLANT WITHIN 60 DAYS DEVELOPED 7 CM TUMOR CHEST WALL SURROUNDING RIGHT BREAST IMPLANT ENLARGED ANTERIOR MAXILLARY LYMPH NODES DIAGNOSED RECURRENCE TREATED RADIATION FOUR MONTHS LATER DEVELOPED MULTIPLE PAINFUL BLISTERING LESIONS RIGHT BREAST BIOPSIED DIAGNOSED ALCL ONCOLOGIST PATHOLOGIST SAID STRONG POSSIBILITY PREVIOUS DIAGNOSIS HODGKINS DISEASE INCORRECT INDEED COULD SYSTEMIC ALCL ALONG READING ASSOCIATION ALCL BREAST IMPLANTS WANT MAKE SURE CASE INCLUDED RESEARCH PURPOSES CORRELATION IMPLANT DISEASE TIME REMOVED 2008 REASON USE AESTHETIC|MCGHAN TEXTURED||06/03/2011||||N|||0LP|FTR|1.0||SILICONE BREAST IMPLANT|||||||MCGHAN|||||||True
2348522|61100522|D|1||HEALTHCARE PROFESSIONAL REPORTED VIA MEDWATCH LEFT SIDE GRADUAL ELEVATION IMPLANT LOCATION ADDITIONAL INFORMATION NOTED LEFT SIDE DEVICE RIGIDLY AFFIXED PATIENTS CHEST WALL PATHOLOGY REPORT PROVIDED CONFIRM DIAGNOSIS ALCL THEREFORE EVENT CAPTURED LYMPHOMA|STYLE 68 SALINE FILLED BREAST IMPLANT|68-390|09/30/2011|||DA|N|R||0HP|FWM|1.0|07/30/2010|nan||1316501|||GOLETA|US|ALLERGAN||CA|||||True
2348522|9492534|N|1||MEDWATCH SUBMITTED B6 2011 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS B4 STUDY 3 YR 5 YR CUMULATIVE FIRST OCCURRENCE B4 ADVERSE EVENT RATES 95 CONFIDENCE INTERVAL PT SEROMA 26 3 YRS 26 5 YRS PRIMARY AUGMENTATION PTS SEROMA RATE = 16  BREAST PAIN = 114 CAPSULAR CONTRACTURE = 19 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 68 SALINE FILLED BREAST IMPLANT|68-390|09/30/2011|||DA|N|R||0HP|FWM|1.0|07/30/2010|nan||1316501|||GOLETA|US|ALLERGAN||CA|||||True
2348522|2273259|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE ALCL RECURRENT CAPSULAR CONTRACTURE VIA VOLUNTARY MW B4 WITHIN REPORT SURGEON REPORTS PT HISTORY LEFT SIDE BREAST CANCER DCIS LEFT SIDE MASTECTOMY PT IMMEDIATE RECONSTRUCTION PLACEMENT TISSUE EXPANDER PLACED 1998 PT CHEMOTHERAPY RADIATION TREATMENT POST RECONSTRUCTION PTS PAST MEDICAL HISTORY SIGNIFICANT HYPOTHYROIDISM BLADDER PROLAPSE 1999 EXPANDER REMOVED GELSALINE DEVICE STYLE 440 PLACED MFG MCGHAN WITHIN YR DEVELOPED SIGNIFICANT HARDENING LEFT CHEST WALL DEVICE REMAINS PLACE 2006 PT PRESENTED COMPLAINTS PAIN CAPSULAR CONTRACTURE SURGEON PERFORMED CAPSULECTOMY DEVICE EXCHANGE ALLERGAN B4 RECONSTRUCTION SOFT SEVERAL MONTHS WITHIN YR DEVELOPED TIGHTENING TISSUE DISCOMFORT LEFT CHEST WALL EVALUATED 2009 ANOTHER SURGEON RECOMMENDED CONSIDER REVISION RECONSTRUCTION ADDITION ACELLULAR DERMAL MATRIX RECOMMENDED AUTOLOGOUS FLAP PROCEDURE DIEP 2011 LEFT BREAST CAPSULE OPENED CONTAINED CLOUDY YELLOW FLUID ENORMOUS PRESSURE FLUID SQUIRTED CAPSULAR INCISION TRAVELED LEAST 56 INCHES COLLECTION GELATINOUS MATERIAL WITHIN CAPSULE WELL INTACT SINGLE BREAST IMPLANT CAPSULE THICKENED COVERED PLAQUE-LIKE LESIONS INTERNALLY TOTAL CAPSULECTOMY PERFORMEDALL MATERIALS SENT PATHOLOGIC CYTOLOGICAL EVAL INCLUDING FROZEN SECTION FROZEN SECTION CONSISTENT ALCL|STYLE 68 SALINE FILLED BREAST IMPLANT|68-390|09/30/2011|||DA|N|R||0HP|FWM|1.0|07/30/2010|nan||1316501|||GOLETA|US|ALLERGAN||CA|||||True
2348522|61100521|N|1||MEDWATCH SUBMITTED FDA 07162015 ADVERSE EVENT ALCL REPORTED PREVIOUSLY PATHOLOGY FOLLOW-UP CONFIRMING CD30+ ALK- EVENT REMAIN REPORTABLE LYMPHOMA|STYLE 68 SALINE FILLED BREAST IMPLANT|68-390|09/30/2011|||DA|N|R||0HP|FWM|1.0|07/30/2010|nan||1316501|||GOLETA|US|ALLERGAN||CA|||||True
2140645|2119287|D|1||ALK NEGATIVE ALCL - ANAPLASTIC LARGE CELL LYMPHOMA POSSIBLY RELATED BREAST IMPLANTS HX HL - TREATED MANTLE FIELD RADIATION THERAPY BREAST CANCER TREATED SURGERY CHEMO TAMOXIFEN|BREAST IMPLANTS||06/22/2011||||N|||0|FWM|1.0||BREAST IMPLANTS|||||||nan|||||||True
2076644|2025896|D|1||SALES REPRESENTATIVE CALLED REPORT CASE ALCL REPORTED PATIENT HISTORY LEFT BREAST CANCER 17-18 YEARS AGO UNDERGONE BILATERAL MASTECTOMY RIGHT SIDE PROPHYLACTIC PURPOSES PATIENT ALLERGAN TISSUE EXPANDERS PLACED EXPANSION COMPLETE 168 DEVICES IMPLANTED HOWEVER 3-4 YEARS AGO PATIENT REMOVAL REPLACEMENT 168 68 DEVICE TIME REASON REPLACEMENT UNKNOWN B6 2011 PATIENT PRESENTED RIGHT SIDE REDNESS EDEMA DRAIN PLACED FLUID SENT LAB ANALYSIS CYTOLOGY ALCL+ SURGEON PLANNING LYMPH NODE BIOPSY PENDING REMAINDER CYTOLOGY ADDITIONAL INFORMATION REQUESTED HEALTHCARE PROFESSIONAL CLARIFICATION MEDICAL RECORDS FORWARDED DATE BACK B6 1987 PATIENT ORIGINALLY DIAGNOSED LEFT BREAST INTRADUCTAL CARINOMA PATIENT IMPLANTED DOW-CORNING TISSUE EXPANDER 500 CC DEVICE PLACED FILLED 60 CC SALINE B6 1988 PATIENT RETURNED OPERATING ROOM FIRST STAGE RECONSTRUCTION RIGHT SIDE DOW-CORNING TISSUE EXPANDER 600CC TISSUE EXPANDER PLACED FILLED 180CC B6 1988 BILATERAL SECOND STAGE RECONSTRUCTION CARRIED TISSUE EXPANDERS REMOVED SURGITEK HIGH PROFILE RECONSTRUCTIVE IMPLANTS PLACED CONTAINING 200CC GEL 50CC SALINE CENTRAL COLUMN TOTAL VOLUMES 250CC RIGHT 270CC LEFT PATIENT TAKEN BACK OPERATING ROOM B6 1994 RIGHT RUPTURED BREAST IMPLANT RECENT MRI REVEALS BILATERAL IMPLANT ABNORMALITIES INCISION MADE SILICONE ENCOUNTERED NOTED TYPICAL COHESIVE GEL FLUID CONSISTENCY HONEY AUTOMOBILE OIL FLOWED FREELY MCGHAN SALINE FILLED TEXTURED IMPLANTS 168 EMPLOYED SIDES 27-168-271 B4 LEFT 27-168-241 B4 RIGHT B6 2011 PATIENT LEFT IMPLANT FAILURE CAPSULECTOMY IMPLANT REMOVAL REPLACEMENT PERFORMED DEVICE B4 27-168-271 IMPLANTED LEFT SIDE PATIENT RETURNS B6 2011 COMPLAINTS RIGHT SIDE SPONTANEOUS EXPANSION BEGAN ONE MONTH PRIOR AFEBRILE REDNESS PRESENT REPRESENTED SEROMA HOWEVER RESOLVED SIGNIFICANT DEGREE PAST FOUR WEEKS THEREFORE ELECTED TIME EXPLORE AREA OBTAIN CYTOLOGY CULTURES PLACE DRAIN CAPSULE WINDOWED YELLOW FLUID ENCOUNTERED ASPIRATED CYTOLOGY AEROBIC ANAEROBIC CULTURES OBTAINED MCGHAN IMPLANT ENCOUNTERED REMOVED WOUND OVERT ABNORMALITY SURFACE PATHOLOGY RETURNED CONFIRMS CD30+ CD45 SUBSET CD4 CD25 VIMENTIN ALK - |STYLE 168 SALINE FILLED BREAST IMPLANT|168-240|04/12/2011|||DA|N|R||0HP|FWM|1.0|09/01/1997|nan||2-507710|||GOLETA|US|ALLERGAN||CA|||||True
2338306|9467740|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS DEVICE LABELING ADDRESSES ABLE IDENTIFY IMPLANT BREAST TISSUE DECREASE NECESSITY EXCESSIVE SQUEEZING IMPLANT EXAMINATION NEW LUMPS EVALUATED BIOPSY APPROPRIATE BIOPSY PERFORMED SURE INFORM MEDICAL PROFESSIONAL PERFORMING BIOPSY BREAST IMPLANTS CARE TAKEN AVOID INJURING IMPLANT|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|11/09/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2338306|2365004|D|1||REPORT LYMPHOMA BREAST CAPSULE SILICONE IMPLANT-RECONSTRUCTED PT PUBLISHED AMERICAN SURGEON SEPT 2010 VOL 76 PG 1030-31 REVIEWED ADDL INFO REQUESTED AUTHOR AUTHOR RESPONDED DATE WITHIN ARTICLE AUTHOR NOTES B6 WOMAN TISSUE DIAGNOSIS ADENOCARCINOMA LEFT BREAST UNDERWENT LEFT MODIFIED RADICAL MASTECTOMY PROPHYLACTIC RIGHT BREAST SIMPLE MASTECTOMY 1999 IMMEDIATELY FOLLOWED PRIMARY RECONSTRUCTION SILICONE IMPLANTS LYMPH NODE BASIN FREE DISEASE PT RECEIVED CHEMOTHERAPY RADIATION THERAPY SIX YEARS LATER PRESENTED PRIMARY CARE LUMP RECONSTRUCTED RIGHT BREAST EXAMINATION 3CM NON-TENDER MOBILE CYSTIC MASS RIGHT BREAST 9 OCLOCK POSITION COMPRESSION IMPLANT CAUSED ENLARGEMENT LESION REPORT NIPPLE DISCHARGE RETRACTION SKIN AREOLA COMPLEX NORMAL PALPABLE LYMPH NODES PRIMARY CARE PHYSICIAN PERFORMED NEEDLE ASPIRATION MASS ORANGE COLOR CYTOLOGIC FEATURES ADENOCARCINOMA UNDERWENT BILATERAL IMPLANT REMOVAL EXCISION CYSTIC MASS BIOPSIES CAPSULES LEFT BREAST IMPLANT INTACT CAPSULE NORMAL APPEARANCE RIGHT BREAST IMPLANT INTACT WELL HOWEVER ANTERIOR POSTERIOR WALLS CAPSULE COATED NECROTIC HETEROGENEOUS MATERIAL INITIAL BIOPSIES RIGHT BREAST CAPSULE SHOWED POORLY DIFFERENTIATED ADENENOCARCINOMA IMMUNOPOSITIVE CD30 EMA T-CELL MARKERS CD45RO CD43 FINAL PATHOLOGY MASS REVIEW SECOND PATHOLOGIST UNIVERSITY HOSPITAL ANAPLASTIC LARGE CELL LYMPHOMA ALK- CELL PHENOTYPE POST OP RECOVER UNEVENTFUL PT COURSE CHOP PROTOCOL PTS LYMPHOMA DISCOVERED CYSTIC LESION INVOLVING RIGHT BREAST CAPSULE PRELIMINARY CYTOLOGIC FEATURE LESION POORLY DIFFERENTIATED ADENENOCARCINOMA SIMILAR PRIOR DIAGNOSIS LEFT BREASTONLY IMMUNOHISTOCHEMISTRY SPECIMEN CORRECTLY DIAGNOSED ALCL T-CELL LYMPHOMA TREATED CHOP CHEMOTHERAPY PROTOCOL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|11/09/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2030915|1919205|D|1||B6 2010 DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL ALK-NEGATIVE POSSIBLY RELATED CAUSED BREAST IMPLANTS RECEIVED B6 2002 AUGMENTATION EXPERIENCED COMPLICATIONS LEFT IMPLANT DIAGNOSED CAPSULAR CONTRACTION IMPLANT REPLACED B6 2008 STILL EXPERIENCING CAPSULAR CONTRACTION REPLACEMENT B6 2010 - B6 2011 RECEIVED 12 DOSES CHEMOTHERAPY RECEIVED 20 DOSES RADIATION THERAPY PREPARING STEM CELL TRANSPLANT SCHEDULED B6 2011 B6 2010 NEEDLE BIOPSY - DIAGNOSIS LYMPHOMA B6 2010 SURGICAL BIOPSY - DIAGNOSIS ALCL B6 2010 SURGICAL BIOPSY - DIAGNOSIS ALCL|NATRELLE||03/17/2011||||N|||0HP|FWM|1.0||SALINE - FILLED BREAST IMPLANT||RIGHT: 579142|||IRVINE|US|ALLERGAN||CA|||STYLE # 468||True
2030915|1919205|D|1||B6 2010 DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL ALK-NEGATIVE POSSIBLY RELATED CAUSED BREAST IMPLANTS RECEIVED B6 2002 AUGMENTATION EXPERIENCED COMPLICATIONS LEFT IMPLANT DIAGNOSED CAPSULAR CONTRACTION IMPLANT REPLACED B6 2008 STILL EXPERIENCING CAPSULAR CONTRACTION REPLACEMENT B6 2010 - B6 2011 RECEIVED 12 DOSES CHEMOTHERAPY RECEIVED 20 DOSES RADIATION THERAPY PREPARING STEM CELL TRANSPLANT SCHEDULED B6 2011 B6 2010 NEEDLE BIOPSY - DIAGNOSIS LYMPHOMA B6 2010 SURGICAL BIOPSY - DIAGNOSIS ALCL B6 2010 SURGICAL BIOPSY - DIAGNOSIS ALCL|NATRELLE||03/17/2011||||N|||0HP|FWM|2.0||SALINE - FILLED BREAST IMPLANT|||||IRVINE|US|ALLERGAN||CA|||STYLE # 468||True
1976502|1898383|D|1||PATIENT DIAGNOSED ALCL - ANAPLASTIC LARGE CELL LYMPHOMA - AROUND RIGHT SALINE BREAST IMPLANT IMPLANTS ORIGINALLY PLACED 1998 IMPLANTS REMOVED TREATED LYMPHOMA|SALINE BREAST IMPLANT||01/26/2011||||N|||0LP|FWM|1.0||SALINE BREAST IMPLANT|||||||ALLERGAN|||||||True
2297509|9366849|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 10 SILICONE GEL FILLED BREAST IMPLANT|10-300|10/11/2011|||DA|N|R||0HP|FTR|1.0|06/23/2012|nan||1465636|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2210597|9219172|N|1||B4 DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PT B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2163717|9254654|N|1||MEDWATCH SUBMITTED B4 2011 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B6 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|06/28/2011|||DA|N|R||0HP|FWM|1.0|02/27/2007|nan||560018|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2162376|9134405|N|1||B4 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS B4 3 YEAR 5 YEAR CUMULATIVE FIRST OCCURRENCE KAPLAN-MEIER ADVERSE EVENT RATES 95 CONFIDENCE INTERVAL PATIENT SEROMA 26 3 YEARS 26 5 YEARS UNUSUAL SYMPTOMS OCCUR SURGERY FEVER NOTICEABLE SWELLING REDNESS ONE BREAST CONTACT SURGEON IMMEDIATELY ALLERGAN SALINE BREAST IMPLANT LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 168 SALINE FILLED BREAST IMPLANT|168-420|07/07/2011|||DA|N|R||0HP|FWM|1.0|10/23/2008|nan||1046378|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2121010|9126852|N|1||MEDWATCH MAILED VIA B6 26MAY2011 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|05/26/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2121010|2056222|D|1||RECEIVED VOLUNTARY B4 FDA STATING PATIENT DIAGNOSED ALCL  ANAPLASTIC LARGE CELL LYMPHOMA - AROUND RIGHT SALINE BREAST IMPLANT CALL PLACED SURGEONS OFFICE GATHER ADDL INFO DEVICE PT DEMOGRAPHICS PATHOLOGY DEVICE PLACED 1998 DEVICES REMOVED TREATED LYMPHOMA TIME SUBMISSION ADDL INFO RECEIVED OFFICE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|05/26/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2261241|2158948|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE ALCL PAIN SEROMA VIA VOLUNTARY FORM B4 ADDL INFO GATHERED SURGEONS OFFICE PT PRESENTS COMPLAINTS PAIN ITCHING SWELLING LEFT BREAST MAMMOGRAMSONOGRAM REVEALED CIRCUMFERENTIAL FLUID COLLECTION SURROUNDING ENTIRE BREAST EXTENDING AXILLARY REGION ULTRASOUND GUIDED FLUID ASPIRATION PERFORMED 2011 REVEALED ATYPICAL LYMPHOID PROLIFERATION CONSISTENT CD30+ ALK-ALCL EXPLANT SURGERY PERFORMED REMOVE IMPLANT ADDL TREATMENT UNK TIME|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|09/21/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2261241|9327553|N|1||B4 DEVICE LABELING B4 STUDY B6 ADVERSE EVENT RATES PRIMARY AUGMENTATION PTS SEROMA RATE = 16 BREAST PAIN = 114 PRIMARY RECONSTRUCTION PTS BREAST PAIN = 48 SWELLING = 71 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY LABELING SALINE IMPLANTS|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|09/21/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2292800|22097964|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE ALCL SEROMA ACCORDING CASE NOTES PROVIDED PT AUGMENTATION PT IMPLANTED 2002 PT PRESENTED OFFICE COMPLAINTS SWOLLEN TENDER LEFT BREAST PT ALSO ULTRASOUND DONE CONFIRMED SEROMA EXPLANT SURGERY TOOK PLACE B6 2011 BILATERALLY TIME DIAGNOSIS MADE LEFT SIDE DEVICES REMOVED MCGHAN SALINE FILLED TEXTURED 390 CC IMPLANT PT SEEN ONCOLOGIST TREATMENT SCHEDULED TIME PET SCAN DISCUSSED CARRIED DATE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|10/07/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2292800|21977291|N|1||B4 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS B4 UNUSUAL SYMPTOMS OCCUR SURGERY FEVER NOTICEABLE SWELLING REDNESS ONE BREAST CONTACT SURGEON IMMEDIATELY ALLERGAN SALINE BREAST IMPLANT LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 INCLUDED LABELING SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|10/07/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
1999354|14966427|D|1||INITIALLY PT REPORTED RIGHT SIDE LYMPHOMA DEFLATION INFECTION IRRITATIONINFLAMMATION RIGHT BREAST IMPLANT FU IMPLANTING SURGEONS OFFICE NOTED PT SEEN EMERGENCY ROOM THOUGHT RIGHT BREAST ABSCESS INFECTION PT SENT SEE IMPLANTING SURGEON PERFORMED ANTIBIOTIC WASH PT ULTRASOUND WELL OPERATIVE NOTES REQUESTED STATE RIGHT SIDE INCISED ENCOUNTERED LARGE VOLUME PURULENT FLUID SENT CULTURE FOUND COMPLETELY DEFLATED SALINE IMPLANT CAPSULE ANGRY INFLAMED PATHOLOGY FINAL DIAGNOSIS ALCL CD30+ ALK- INCLUDING CD45+ PT SEE ONCOLOGIST LATER DATE ADDITIONAL INFO PROVIDED SURGEONS OFFICES NOTES PT SEEN ONCOLOGIST BREAST IMPLANT REMOVED DISCARDED|STYLE 168 SALINE FILLED BREAST IMPLANT|168-800|02/14/2011||||N|R||0HP|FWM|1.0|08/01/1997|nan||2-505392|||GOLETA|US|ALLERGAN||CA|||||True
1994929|1712741|D|1||ALCL REPORT CASE ILLNESS BEGAN SOMETIME LATE B6 2009 NOTICED MASS NEAR RIGHT BREAST WENT PRIMARY CARE PHYSICIAN DR B6 MRI TEST CAME BACK NEGATIVE BEGAN FEEL TIRED LAZY AROUND B6 2009 HISTORY ASTHMA THOUGHT MIGHT COMING BRONCHITIS WENT BACK LATE B6 GIVEN STEROID SHOT HELPED AWHILE FIRST WEEK B6 2010 BEGAN SHORTNESS BREATH FELT ASTHMA ALSO BAD LOWER BACK STOMACH PAIN WENT SEE DR B6 SYMPTOMS B6 2010 DONE CHEST X-RAY DETERMINED PNEUMONIA SHOWING FLUID LEFT LUNG PUT ANTIBIOTICS TOOK WORK GAVE FOLLOW APPOINTMENT REALLY NEVER FELT BETTER WENT BACK 1 WEEK LATER NOTICED FLUID GOTTEN WORSE CONTACTED PULMONARY SPECIALIST B6 HOSPITAL B6 DR B6 FLUID REMOVED FELT MUCH BETTER COUPLE WEEKS WHITE BLOOD COUNTS HIGH 11000 22000 TIME FLUID CAME BACK EARLY B6 SEEN B6 EMERGENCY ROOM FLUID REMOVED ADMITTED RAN MULTIPLE TESTS CT SCANS MRIS TOOK BIOPSIES LUNGS STOMACH CHEST TUBE PUT 7 10 DAYS DRAIN FLUID SPENT 12 14 DAYS RELEASED IN-HOME ANTIBIOTICS PIC LINE FELT BETTER WEAK ALSO CONTINUED BAD BACK PAIN TESTS DONE HOSPITAL CAME BACK NEGATIVE SAW DOCTOR B6 DR B6 ABLE RELIEVE PAIN PAIN SHOTS BACK ASSUMING SPINAL AREA WORKING ANYMORE LATE B6 STILL WORK DUE PAIN SWELLING STOMACH SURE OCCURRING WENT BACK DR B6 SUGGESTED MRI BACK AREA SUGGESTED SEE EMPLOYEES EXECUTIVE PHYSICAL DOCTOR B6 REVIEW MEDICAL RECORDS B6 RELATING ULTRA SOUND DONE SAW DR B6 SAW AROUND END B6 REVIEWED MEDICAL RECORDS THOUGHT MIGHT FOREIGN OBJECT LEFT STOMACH AREA PRIOR SURGERY SURGERY IMPLANTS PUT LIPO SUCTION DONE 1996 REFERRED PLASTIC SURGEON B6 NAMED DR B6 SAW AFTERNOON AGREED DR B6 SEEING FOREIGN OBJECT LOWER STOMACH AREA WANTED SURGERY REMOVE FOLLOWING DAY MUCH PAIN OPEN ANYTHING SCHEDULED B6 MEDICAL CENTER FOLLOWING DAY B6 2010 B6 ANOTHER CT SCAN NOTICED SWOLLEN LYMPH NODE LEFT ARMPIT SCHEDULED DR B6 DR B6 REMOVE BREAST IMPLANTS LYMPH NODE B6 REFERRED DR B6 FIRST TREATMENT CEDARS INCLUDED CHEMOTHERAPY RADIATION CHEMO SHOTS SPINE DR B6 DR B6 REFERRED ANOTHER ONCOLOGY DOCTOR CLOSER HOME NAME DR B6 FINISHED CHEMO TREATMENTS ALSO REFERRED B6 RELATING POSSIBILITY BONE MARROW TRANSPLANT CURRENTLY SEEING UNDERGOING BONE MARROW TRANSPLANT DR B6 BREAST IMPLANTS PUT AROUND B6 1996 DR B6 REACHED DR B6 REGARDING DETAILS RELATED IMPLANTS YET HEAR B6 PLASTIC SURGERY CENTER B6 NAME SILIMED SIENTRA|SILICON BREAST IMPLANTS||02/13/2011|||||||0|FTR|2.0||BREAST IMPLANTS|||||||nan|||||||True
1994929|1712741|D|1||ALCL REPORT CASE ILLNESS BEGAN SOMETIME LATE B6 2009 NOTICED MASS NEAR RIGHT BREAST WENT PRIMARY CARE PHYSICIAN DR B6 MRI TEST CAME BACK NEGATIVE BEGAN FEEL TIRED LAZY AROUND B6 2009 HISTORY ASTHMA THOUGHT MIGHT COMING BRONCHITIS WENT BACK LATE B6 GIVEN STEROID SHOT HELPED AWHILE FIRST WEEK B6 2010 BEGAN SHORTNESS BREATH FELT ASTHMA ALSO BAD LOWER BACK STOMACH PAIN WENT SEE DR B6 SYMPTOMS B6 2010 DONE CHEST X-RAY DETERMINED PNEUMONIA SHOWING FLUID LEFT LUNG PUT ANTIBIOTICS TOOK WORK GAVE FOLLOW APPOINTMENT REALLY NEVER FELT BETTER WENT BACK 1 WEEK LATER NOTICED FLUID GOTTEN WORSE CONTACTED PULMONARY SPECIALIST B6 HOSPITAL B6 DR B6 FLUID REMOVED FELT MUCH BETTER COUPLE WEEKS WHITE BLOOD COUNTS HIGH 11000 22000 TIME FLUID CAME BACK EARLY B6 SEEN B6 EMERGENCY ROOM FLUID REMOVED ADMITTED RAN MULTIPLE TESTS CT SCANS MRIS TOOK BIOPSIES LUNGS STOMACH CHEST TUBE PUT 7 10 DAYS DRAIN FLUID SPENT 12 14 DAYS RELEASED IN-HOME ANTIBIOTICS PIC LINE FELT BETTER WEAK ALSO CONTINUED BAD BACK PAIN TESTS DONE HOSPITAL CAME BACK NEGATIVE SAW DOCTOR B6 DR B6 ABLE RELIEVE PAIN PAIN SHOTS BACK ASSUMING SPINAL AREA WORKING ANYMORE LATE B6 STILL WORK DUE PAIN SWELLING STOMACH SURE OCCURRING WENT BACK DR B6 SUGGESTED MRI BACK AREA SUGGESTED SEE EMPLOYEES EXECUTIVE PHYSICAL DOCTOR B6 REVIEW MEDICAL RECORDS B6 RELATING ULTRA SOUND DONE SAW DR B6 SAW AROUND END B6 REVIEWED MEDICAL RECORDS THOUGHT MIGHT FOREIGN OBJECT LEFT STOMACH AREA PRIOR SURGERY SURGERY IMPLANTS PUT LIPO SUCTION DONE 1996 REFERRED PLASTIC SURGEON B6 NAMED DR B6 SAW AFTERNOON AGREED DR B6 SEEING FOREIGN OBJECT LOWER STOMACH AREA WANTED SURGERY REMOVE FOLLOWING DAY MUCH PAIN OPEN ANYTHING SCHEDULED B6 MEDICAL CENTER FOLLOWING DAY B6 2010 B6 ANOTHER CT SCAN NOTICED SWOLLEN LYMPH NODE LEFT ARMPIT SCHEDULED DR B6 DR B6 REMOVE BREAST IMPLANTS LYMPH NODE B6 REFERRED DR B6 FIRST TREATMENT CEDARS INCLUDED CHEMOTHERAPY RADIATION CHEMO SHOTS SPINE DR B6 DR B6 REFERRED ANOTHER ONCOLOGY DOCTOR CLOSER HOME NAME DR B6 FINISHED CHEMO TREATMENTS ALSO REFERRED B6 RELATING POSSIBILITY BONE MARROW TRANSPLANT CURRENTLY SEEING UNDERGOING BONE MARROW TRANSPLANT DR B6 BREAST IMPLANTS PUT AROUND B6 1996 DR B6 REACHED DR B6 REGARDING DETAILS RELATED IMPLANTS YET HEAR B6 PLASTIC SURGERY CENTER B6 NAME SILIMED SIENTRA|SILICON BREAST IMPLANTS||02/13/2011|||||||0|FTR|1.0||BREAST IMPLANTS||UNKNOWN|||||nan|||||||True
2210596|2193346|D|1||RECEIVED ABSTRACT ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA BREAST OCCURRING PATIENTS SILICONE BREAST IMPLANTS PUBLISHED FINAL ARTICLE ENTITLED LEUKEMIA LYMPHOMA AUG 20115281481-1487 WITHIN ARTICLE PT IDENTIFIED PT 8 COSMETIC AUGMENTATION CASE PT PRESENTED FLUID ACCUMULATION LEFT BREAST SECOND DRAINAGE LARGE VOLUME FLUID WAITING CYTOLOGY REPORT TEXTURED IMPLANTS REMOVED REPLACED SMOOTH SALINE IMPLANTS DIAGNOSIS ALCL ALK-WAS MADE CONFIRMED B4 T-CELL REARRANGEMENT STUDIES TREATMENT CHOP RECOMMENDED TREATED ELSEWHERE OUTCOME UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210596|9405524|N|1||DEVICE LABELING ADDRESS EVENT B4 PRIMARY AUGMENTATION PATIENTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PATIENTS = 10 COMPLICATIONS SWELLING = 71 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2452703|2538792|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE PAIN SEROMA POSSIBLE LYMPHOMA ADDITIONAL INFORMATION NOTES PATIENT PRESENTED COMPLAINT PAIN RIGHT BREAST SWELLING EXPLANT REPLACEMENT TOOK PLACE B6 2011 SILICONE DEVICES PRELIMINARY RESULTS SHOW POSSIBLE ALCL CAPSULE PATIENT RETURNS OFFICE DISCUSSING RESULTS PATIENT SURGEON DECIDE BILATERAL EXPLANT SURGERY NEW DEVICES EXPLANT SURGERY TOOK PLACE B6 2011 FINAL DIAGNOSIS EXTRANODAL NK CELL LYMPHOMA NASAL TYPE MADE USING CAPSULE BLOCK SECTIONS PATHOLOGIST NOTES ALCL|STYLE 40 SILICONE GEL FILLED BREAST IMPLANT|40-400|02/09/2012|||DA|N|R||0HP|FTR|1.0|08/24/2007|nan||581167|||GOLETA|US|ALLERGAN||CA|||||True
2452703|9630861|N|1||DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS CORE STUDY 7 YEAR ADVERSE EVENT RATES PRIMARY AUGMENTATION PATIENTS SEROMA RATE = 16 PERCENT PRIMARY RECONSTRUCTION PATIENTS = 10 PERCENT COMPLICATIONS SWELLING = 71 PERCENT UNUSUAL SYMPTOMS OCCUR SURGERY FEVER NOTICEABLE SWELLING REDNESS ONE BREAST CONTACT SURGEON IMMEDIATELY ALLERGAN SILICONE BREAST IMPLANT LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS A95R95 STUDY INCLUDED LABELING SILICONE BREAST IMPLANTS|STYLE 40 SILICONE GEL FILLED BREAST IMPLANT|40-400|02/09/2012|||DA|N|R||0HP|FTR|1.0|08/24/2007|nan||581167|||GOLETA|US|ALLERGAN||CA|||||True
2702777|10172371|N|1||MEDWATCH SUBMITTED B4 2012 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 20 SILICONE GEL FILL BREAST IMPLANT|20-325|08/13/2012|||DA|N|R||0HP|FTR|1.0|03/31/2014|nan||1721856|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2612780|9904116|N|1||MEDWATCH SUBMITTED B4 2012 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS B4 STUDY 3 YR 5 YR CUMULATIVE FIRST OCCURRENCE KAPLAN-MEIER ADVERSE EVENT RATES 95 CONFIDENCE INTERVAL PT SEROMA 26 3 YRS 26 5 YRS UNUSUAL SYMPTOMS OCCUR SURGERY FEVER NOTICEABLE SWELLING REDNESS ONE BREAST CONTACT SURGEON IMMEDIATELY ALLERGAN SALINE BREAST IMPLANT LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|05/31/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2612780|2672263|D|1||HEALTHCARE PROFESSIONAL REPORTS VIA MAUDE REPORT CASE LYMPHOMA SEROMA SURGEON REPORTS PT BREAST IMPLANT RECONSTRUCTION 11 YRS AGO PRESENTS CHRONIC SEROMA LEFT SIDE PT TAKEN OPERATING ROOM EVAL SEROMAHEMATOMA INTRAOPERATIVELY FLUID LOOKED SUSPICIONS THICK CAPSULE IMPLANT TEXTURED SALINE REMOVED PERFORMED FULL COMPLETE CAPSULECTOMY FLUID TAKEN PATHOLOGYCYTOLOGY FROZEN PERMANENT CAPSULE ALSO TAKEN PATHOLOGY CONFIRMED ALCL PERMANENT PATHOLOGY PT REPLACEMENT TIME SMOOTH SILICONE SEVERAL CALLS MADE SURGEONS OFFICE TRY OBTAIN DEVICE INFO DATE INFO PROVIDED ALLERGAN ONGOING INVESTIGATION CARRIED ADDL INFO REGARDING EVENTS UPDATED SUBMITTED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|05/31/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2536445|9853820|N|1||MEDWATCH SUBMITTED B4 2012 DEVICE LABELING ADDRESSES CAPSULAR CAPSULAR CONTRACTURE SCAR TISSUE CAPSULE NORMALLY FORMS AROUND IMPLANT MAY TIGHTEN SQUEEZE IMPLANT CALLED CAPSULAR CONTRACTURE CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA ALSO COMMON SUBGLANDULAR PLACEMENT BEHIND MAMMARY GLAND TOP CHEST SYMPTOMS RANGE MILD FIRMNESS MILD DISCOMFORT SEVERE PAIN DISTORTED SHAPE PALPABILITY IMPLANT ANDOR MOVEMENT IMPLANT ADDL SURGERY NEEDED CASES PAIN ANDOR FIRMNESS SEVERE SURGERY RANGES REMOVAL IMPLANT CAPSULE TISSUE REMOVAL POSSIBLY REPLACEMENT IMPLANT CAPSULAE CONTRACTURE MAY HAPPEN ADDL SURGERIES RUPTURE 114 DEVICE LABELING REVIEW REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/03/2012|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNK||CA|||||True
2842518|20004808|D|1||HEALTHCARE PROFESSIONAL REPORTED ALLERGAN EMPLOYEE EVENTS ALCL SEROMA EVENT REPORTED INITIALLY EASR B6 2009 B6 2011 B6 2011 SUPPLEMENTAL REPORTS|STYLE 163 SALINE FILLED BREAST IMPLANT|163-655|11/15/2012|||DA|N|R||0HP|FWM|1.0|12/06/2003|nan||548191|||GOLETA|US|ALLERGAN|93117|CA|93117||||True
2842518|20339383|N|1||B4 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS B4 ADDÂ¿L DEVICE LABELING ADDRESSES SEROMA Â¿IF UNUSUAL SYMPTOMS OCCUR SURGERY FEVER NOTICEABLE SWELLING REDNESS ONE BREAST CONTACT SURGEON IMMEDIATELYÂ¿ ALLERGAN SALINE BREAST IMPLANT LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS A95R95 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 163 SALINE FILLED BREAST IMPLANT|163-655|11/15/2012|||DA|N|R||0HP|FWM|1.0|12/06/2003|nan||548191|||GOLETA|US|ALLERGAN|93117|CA|93117||||True
2675981|18977587|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE SUSPICIOUS SEROMA-ASSOCIATED ALCL COMPLETELY CLEAR SIDE AFFECTED TIME LYMPHOMA REPRESENTED RIGHT SIDE LEFT SIDE NOTED REMOVAL DEVICE INFORMATION PATHOLOGY CYTOLOGY CLARIFICATION AFFECTED SIDE NOTED TIME MULTIPLE ATTEMPTS MADE CONFIRM AFFECTED SIDE GATHER ADDITIONAL INFORMATION CASE ADDITIONAL INFORMATION REGARDING EVENTS UPDATED FILE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/26/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN|93117|CA|93117||||True
2675981|18804542|N|1||MED WATCH SUBMITTED B6 2012 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS CORE STUDY 7 YEAR ADVERSE EVENT RATES PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING REPORT EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/26/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN|93117|CA|93117||||True
2517651|20917029|D|1||CASE ALCL ASSOCIATED RUPTURED SILICONE BREAST IMPLANT PT PRESENTED GROSS INFECTION R BREAST 30 YRS FOLLOWING BILATERAL MASTECTOMY RECONSTRUCTIONS SILICONE BREAST PROSTHESES RUPTURED SILICONE IMPLANTS REMOVED SUCCESSFULLY SIDES GROSS INFECTION NOTED R EXCESS SKIN TRIMMED PATHOLOGY SKIN SHOWED ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT PT DEMENTED DAUGHTER STATES SURGERY SOMETIME EARLY 1980S DETAILS UNK PT MADE FULL RECOVERY SURGERY PLANS CHEMOTHERAPY PTS FAMILY REPORTS WEIGHT LOSS LAST YEAR QUESTION LESIONS SEEN SPLEENLIVER INCIDENTALLY CT SCAN LAST 2 YRS - NEVER COULD LOCATE REPORT PREOP PHOTOS AVAILABLE UNFORTUNATELY IMPLANT DISCARDED FAR KNOW IMPLANT DISINTEGRATED|UNKNOWN|UNK|04/01/2012||||N|||0|FTR|1.0||SILICONE BREAST IMPLANT||UNK|UNK||UNK||UNK|||||UNK||True
2337179|9490843|N|1||MEDWATCH SUBMITTED B4 2011 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMALALCL PTS CORE STUDY LABELING SILICONE IMPLANTS DEVICE LABELING ADDRESSES REPORTED EVENT SWELLING FOLLOWS CORE STUDY 7 YEAR ADVERSE EVENT RATES PRIMARY AUGMENTATION PTS BREAST SWELLING 92|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/26/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2337179|2356522|D|1||RECEIVED VOLUNTARY MEDWATCH FORM B4 PT REPORTED BILATERAL SILICONE IMPLANTS IMPLANTED 1990 DEVELOPED SWELLING REDNESS RIGHT BREAST 2002 FOLLOWED ENLARGED LYMPH NODES SKIN NODULES DIAGNOSED NODULAR SCLEROSIS HODGKINS RIGHT MAXILLARY SPREAD SKIN SIX MONTHS LATER TREATED CHEMO RADIATION HOWEVER TWO MONTHS LATER RECURRED TREATED STEM CELL TRANSPLANT WITHIN 60 DAYS DEVELOPED 7CM TUMOR CHEST WALL SURROUNDING RIGHT BREAST IMPLANT ENLARGED ANTERIOR MAXILLARY LYMPH NODES DIAGNOSED RECURRENCE TREATED RADIATION FOUR MONTHS LATER DEVELOPED MULTIPLE PAINFUL BLISTERING LESIONS RIGHT BREAST MULTIPLE DIAGNOSED ALCL ONCOLOGIST PATHOLOGIST SAID STRONG POSSIBILITY PREVIOUS DIAGNOSIS HODGKINS DISEASE INCORRECT INDEED COULD SYSTEMIC ALCL ALONG READING ASSOCIATION ALCL BREAST IMPLANTS WANTED MAKE SURE CASE INCLUDED RESEARCH PURPOSES CORRELATION IMPLANT DISEASE TIME REMOVED 2008 FU CALLS MADE SURGEONS OFFICE GATHER ADDITIONAL INFO UNABLE PROVIDE DEVICE INFO SURGEON INFORMS PRODUCT SUPPORT AWARE PTS DIAGNOSIS ALCL ANOTHER CALL PLACED PT ABLE PROVIDE PATHOLOGY REPORT CONFIRM DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/26/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2444288|15298145|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 168 SALINE FILLED BREAST IMPLANT|168-210|02/07/2012|||DA|N|R||0HP|FWM|1.0|05/05/2004|nan||553218|||GOLETA|US|ALLERGAN||CA|||||True
2444288|14886239|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE ALCL VIA MAUDE REPORT B6 FOLLOW INFO ABLE OBTAINED SURGEON WANT SUPPLY ADDL INFO TIME REPORT|STYLE 168 SALINE FILLED BREAST IMPLANT|168-210|02/07/2012|||DA|N|R||0HP|FWM|1.0|05/05/2004|nan||553218|||GOLETA|US|ALLERGAN||CA|||||True
2674744|21102358|N|1||B4 PER PT LABELING BREAST-EXAMINATIONS FOLLOWING BREAST AUGMENTATION CONTINUE PERFORM BREAST SELF-EXAMINATION MONTHLY MAY DIFFICULT BREAST IMPLANT PLACE CONTINUE PERFORM MONTHLY BREAST SELF EXAMINATION EFFICIENTLY ASK SURGEON HELP IDENTIFY DIFFERENCE IMPLANT BREAST TISSUE ABLE IDENTIFY IMPLANT BREAST TISSUE DECREASE NECESSITY EXCESSIVE SQUEEZING IMPLANT EXAMINATION NEW LUMPS EVALUATED BIOPSY APPROPRIATE BIOPSY PERFORMED SURE INFORM MEDICAL PROFESSIONAL PERFORMING BIOPSY BREAST IMPLANTS CARE TAKEN AVOID INJURING IMPLANT DEVICE LABELING ADDRESSES INFECTION SIGNS ACUTE INFECTION INCLUDE ERYTHEMA TENDERNESS FLUID ACCUMULATION PAIN FEVER PTS ADVISED CONTACT PHYSICIAN IMMEDIATELY DIAGNOSIS TREATMENT SYMPTOMS DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-390|07/24/2012|||DA|N|R||0HP|FTR|1.0|06/21/2011|nan||1302863|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2702778|10172372|N|1||MED WATCH SUBMITTED B4 2012 REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-325|08/13/2012|||DA|N|R||0HP|FTR|1.0|03/31/2014|nan||1721856|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2718829|3055395|D|1||PT B6 FEMALE UNDERWENT LEFT MASTECTOMY 1996 DUCTAL CARCINOMA SITU TISSUE EXPANDER SALINE IMPLANT RECONSTRUCTION PRESENTED B6 2010 PERI-IMPLANT HEMATOMA THOUGHT POSSIBLY POST-TRAUMATIC UNDERWENT EVACUATION HEMATOMA CHANGE SILICONE GEL IMPLANT PATHOLOGY SPECIMENS NEGATIVE TUMOR PRESENTED B6 2012 SPONTANEOUS HEMATOMA SURGERY MULTIPLE BIOPSIES REVEALED ANAPLASTIC LARGE CELL LYMPHOMA ALCL LIMITED PERIPROSTHETIC CAPSULE HEMATOMA FLUID EXTENSIVE HEMATOLOGIC METASTATIC WORKUP NEGATIVE UNDERWENT REMOVAL IMPLANT TOTAL PERIPROSTHETIC CAPSULECTOMY CAPSULAR PATHOLOGY SHOWED ALCL|MENTOR SMOOTH ROUND HIGH PROFILE GEL, 450CC|350-4505BC|08/23/2012||||Y|||0HP|FTR|1.0||SILICONE GEL BREAST IMPLANT||6004844|||SANTA BARBARA|US|MENTOR||CA|||350-4505BC||True
2505402|9840533|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY LABELING SILICONE IMPLANTS|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-339|03/23/2012|||DA|N|R||0HP|FTR|1.0|04/05/2013|nan||1592141|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2674766|2837807|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE ALCL UNK SIDE DEVICE INFO ALSO UNK TIME MULTIPLE ATTEMPTS MADE GATHER INFO REGARDING CASE DATE INFO FORTHCOMING NEW INFO BECOMES AVAILABLE UPDATED FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/24/2012|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
2674766|54676584|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE ALCL UNKNOWN SIDE DEVICE INFORMATION ALSO UNKNOWN TIME MULTIPLE ATTEMPTS MADE GATHER INFORMATION REGARDING CASE DATE INFORMATION FORTHCOMING NEW INFORMATION BECOMES AVAILABLE UPDATED FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/24/2012|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
2674766|10112334|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/24/2012|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
2578247|9847923|N|1||MED WATCH SUBMITTED B4 2012 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SALINE IMPLANTS PRIMARY AUGMENTATION PATIENTS SEROMA RATE = B4 PRIMARY RECONSTRUCTION PATIENTS = B4 COMPLICATIONS SWELLING = B4|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|05/09/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2578247|2650283|D|1||ADDITIONAL INFORMATION PROVIDED RECEIVED LITERATURE ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS FIVE B6 CASES PUBLISHED PLASTIC RECONSTRUCTIVE SURGERY B6 2012 B4 WITHIN ARTICLE AUTHOR DESCRIBES SEROMA WITHIN ARTICLE AUTHOR DESCRIBES B6 UNDERWENT RIGHT MASTECTOMY AXILLARY DISSECTION IMMEDIATE BEAST RECONSTRUCTION LATISSIMUS DORSI FLAP TISSUE EXPANDER B6 1996 REQUIRE ADJUVANT THERAPY EXPANDER REPLACED 390CC ROUND SMOOTH IMPLANT B6 1996 REVISION PERFORMED RIGHT BREAST CAPSULE B6 1997 B6 1999 SALINE DEVICE REPLACED TEXTURED SALINE IMPLANT B4 B6 2007 PATIENT DEVELOPED SEROMA SEROMA ASPIRATED REVEALED ALCL DEVICE LEFT PLACE CHEMOTHERAPY SEROMA RECURRED THUS UNDERWENT TOTAL CAPSULECTOMY IMPLANT REMOVAL B6 2007 TREATMENT COMPLETED CHEMOTHERAPY RADIATION DISEASE FREE EVENT ORIGINALLY REPORTED VIA EASR B6 2011|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|05/09/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2505398|18743473|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-339|03/23/2012|||DA|N|R||0HP|FTR|1.0|11/14/2013|nan||1690722|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2786161|19472093|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|09/24/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2564353|2651879|D|1||ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS FIVE B6 CASES PUBLISHED PLASTIC RECONSTRUCTIVE SURGERY B6 2012 B4 WITHIN ARTICLE AUTHOR DESCRIBES B6 WOMAN PRESENTED 2011 RIGHT BREAST LUMP HISTORY NOTES WIDE LOCAL EXCISION RIGHT BREAST DUCTAL CARCINOMA SITU FOLLOWED RADIOTHERAPY 1995 1998 MASTECTOMY RECURRENT DISEASE RECONSTRUCTION PEDICLED LATISSIMUS DORSI FLAP 2006 REVISION RIGHT BREAST AUGMENTATION SUBPECTORALIS LATISSIMUS DORSI FLAP LEFT BREAST AUGMENTATION SYMMETRY SUBFASCIAL TEXTURED MCGHAN IMPLANTS UNDERWENT OPEN BIOPSY TWO MASSES FOUND ONE MEDIAL ONE LATERAL MEDIAL MASS FOUND IMPLANT RUPTURED IMMEDIATELY IMPLANT REMOVED TOTAL CAPSULECTOMY PERFORMED IMPLANT REPLACED ASSUMPTION MASS SILICOMA HISTOPATHOLOGIC ANALYSIS REVEALED MASSES ALK- ALCL CD30+ REMAINDER CAPSULE NEGATIVE REMAINDER WOUND FAILED HEAL RIGHT BREAST IMPLANT REMOVED CT SCAN PET SCAN NORMAL BONE MARROW BEGAN CHEMOTHERAPY CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE AWAITING RADIATION CURRENTLY RECURRENCE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/01/2012|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2564353|9851019|N|1||MED WATCH SUBMITTED B6 2012 DEVICE LABELING ADDRESSES BREAST LUMP FOLLOWING BREAST AUGMENTATION CONTINUE PERFORM BREAST SELF-EXAMINATION MONTHLY MAY DIFFICULT BREAST IMPLANT PLACE CONTINUE PERFORM MONTHLY BREAST SELF EXAMINATION EFFICIENTLY ASK SURGEON HELP IDENTIFY DIFFERENCE IMPLANT BREAST TISSUE ABLE IDENTIFY IMPLANT FORM BREAST TISSUE DECREASE NECESSITY EXCESSIVE SQUEEZING IMPLANT EXAMINATION NEW LUMPS EVALUATED BIOPSY APPROPRIATE BIOPSY PERFORMED SURE INFORM MEDICAL PROFESSIONAL PERFORMING BIOPSY BREAST IMPLANTS CARE TAKEN AVOID INJURING IMPLANT RUPTURE RATE B4 PRIMARY RECONSTRUCTION PTS MRI COHORTS CORE STUDY DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/01/2012|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2433975|9616800|N|1||MEDWATCH SUBMITTED B4 2012 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS CORE STUDY 7 YEAR ADVERSE EVENT RATES PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 CAPSULAR CONTRACTURE = 155 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-575|01/30/2012|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2433975|2512555|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA VIA VOLUNTARY B4 FOLLOW INFORMATION SURGEON NOTES PT AUGMENTATION 1986 EXACT DATE UNK PT PRESENTED OFFICE B6 2006 LEFT BREAST SEROMA CAPSULAR CONTRACTURE OFFICE NOTES SEROMA NEGATIVE ALCL PT PRESENTS REMOVAL REPLACEMENT 168-650 DEVICE B6 2007 15-575 DEVICES PLACED POST-OP COURSE UNREMARKABLE SEP 2011 PT PRESENTS RECURRENT SEROMA NOTICED MONTH PRIOR EXPLANT REMOVAL REPLACEMENT CARRIED COMPLETE CAPSULECTOMY B6 2011 ALLERGAN 15-575 IMPLANTED 30CC STRAW COLORED FLUID SENT CYTOLOGY DIAGNOSIS ALCL MADE B6 2011|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-575|01/30/2012|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2800314|3086420|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA VIA VOLUNTARY REPORT B4 ALCL ASSOCIATED SALINE TYPE BREAST IMPLANT 2 YEAR HISTORY RECURRENT EFFUSION SURROUNDING PROSTHESIS REMOVAL LYMPHOMA CELLS CONFIRMED FIBRINOUS EFFUSION WITHOUT MEASURABLE MASS IMPLANT CAPSULE SOFT TISSUE INVASION LYMPHADENOPATHY PROGNOSIS FAVORABLE DATES USE 2 YEARS REASON USE RECURRENT BREAST ABSCESS MULTIPLE ATTEMPTS MADE GATHER ADDITIONAL INFO REGARDING CASE ADDITIONAL INFO REGARDING CASE FORWARDED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|10/09/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2800314|10238949|N|1||B4 DEVICE LABELING ADDRESSES BREAST LUMPS DISTINGUISHING IMPLANT BREAST TISSUE BREAST SELF-EXAMINATION PERFORM BREAST SELF-EXAMINATION MONTHLY IMPLANTED BREAST ORDER EFFECTIVELY ASK SURGEON HELP DISTINGUISH IMPLANT BREAST TISSUE NEW LUMPS ABNORMAL FINDING MAMMOGRAM EVALUATED BIOPSY BIOPSY PERFORMED CARE MUST TAKEN AVOID PUNCTURING IMPLANT B6 PT PLANNER SALINE DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B6 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|10/09/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2702764|18052649|N|1||MEDWATCH SUBMITTED B4 2012 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B6 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71|UNK SALINE IMPLANT|UNK SALINE IMPLANT|08/13/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2578281|9847932|N|1||MEDWATCH SUBMITTED 9MAY2012 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS PRIMARY AUGMENTATION PATIENTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PATIENTS = 10 COMPLICATIONS SWELLING= 71|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/09/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2578281|2650718|D|1||ADDITIONAL INFORMATION RECEIVED LITERATURE ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS FIVE AUSTRALIAN CASES PUBLISHED PLASTIC RECONSTRUCTIVE SURGERY APRIL 2012 PG 610E-617E WITHIN ARTICLE AUTHOR DESCRIBES B6 AUGMENTATION PATIENT SURGERY 25 YEARS PRIOR PRESENTED PRIMARY CARE PHYSICIAN GENERAL MALAISE LETHARGY DETAILS UNAVAILABLE AUTHOR NOTES PERFORMED HOST INVESTIGATIONS MAMMOGRAM ULTRASOUND SUGGEST RUPTURE PERIPROSTHETIC FLUID COLLECTION THICK CAPSULE SURGERY SCHEDULED REMOVE REPLACE RUPTURED IMPLANTS TIME SURGERY IMPLANTS FOUND INTACT CAPSULE GRANULOMATOUS GROWTHS WITHIN MODERATE AMOUNT SEROMA DRAINED NEW IMPLANTS INSERTED CAPSULECTOMIES PERFORMED OLD IMPLANTS FOUND ROUND TEXTURED SILICONE GEL-FILLED UNKNOWN MAKE HISTOLOGICAL ANALYSIS RIGHT BREAST CAPSULE CONSISTENT LOCALIZED SYSTEMIC ALCL ALK- SYMPTOMS LETHARGY MALAISE RESOLVED WENT CHEMOTHERAPY DECLINED RADIATION LAST SEEN DISEASE FREE EVENT ORIGINALLY SENT VIA B4 24JAN2011|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/09/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2888498|60381986|N|1||MEDWATCH SUBMITTED B6 2012 EVENTS INITIALLY SUBMITTED VIA PSR Q1 B6 2010 Q4 B6 2011 DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PATIENTS SEROMA RATE = 16 PERCENT PRIMARY RECONSTRUCTION PATIENTS = 10 PERCENT COMPLICATIONS SWELLING = 71 PERCENT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELINGDEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/20/2012|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
2645572|10069955|N|1||MEDWATCH SUBMITTED 29JUNE2012 DEVICE LABELING ADDRESS SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 Â¿AFTER BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMAÂ¿Â¿ ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS LAB ANALYSIS FINDINGS DEVICE WEIGHED 337 GMS BROWN PARTICLES OBSERVED SHELL DEVICE BIOLOGICAL TISSUE ALSO NOTED SHELL CREASES OBSERVED DEVICE SURFACE|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-330|06/29/2012||05/31/2012|DA|R|Y||0HP|FTR|1.0|03/15/2003|nan||40897|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2844629|10319648|N|1||MEDWATCH SUBMITTED B4 2012 EVENT SUBMITTED INITIAL B4 2011 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS B4 STUDY 3 YEAR 5 YEAR CUMULATIVE FIRST OCCURENCE KAPLAN-MEIER ADVERSE EVENT RATES 95 CONFIDENCE INTERVAL PT SEROMA 26 3 YEARS 26 5 YEARS UNUSUAL SYMPTOMS OCCUR SURGERY FEVER NOTICEABLE SWELLING REDNESS ONE BREAST CONTACT SURGEON IMMEDIATELY ALLERGAN SALINE BREAST IMPLANT LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 68 SALINE FILLED BREAST IMPLANT|68HP-350|11/16/2012|||DA|N|R||0HP|FWM|1.0|07/06/2010|nan||1309976|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2888497|60334271|N|1||MEDWATCH SUBMITTED 12202012 DEVICE LABELING ADDRESS EVENT SEMORA PRIMARY AUGMENTATION PATIENTS SEROMA RATE = 16 PERCENT PRIMARY RECONSTRUCTION PATIENTS = 10 PERCENT COMPLICATIONS SWELLING = 71 PERCENT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEW REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/20/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2888497|60334272|D|1||RESEARCH REVIEW RN PRODUCT SUPPORT SPECIALIST FOLLOWING ARTICLE CAME ATTENTION RARE LYMPHOID MALIGNANCIES BREAST REPORT TWO CASES ILLUSTRATING POTENTIAL DIAGNOSTIC PITFALLS CASE REPORT JOURNAL HEMATOPATHOLOGY 2009 2237-244 WITHIN ARTICLE AUTHOR DESCRIBES ALLEGED EVENTS SEMORA ALK NEG ALCL LYMPHOMA SALINE FILLED DEVICE UNCLEAR DEVICE ALLERGAN DEVICE INVESTIGATION CONTINUING|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/20/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2578282|9861408|N|1||MED WATCH SUBMITTED B4 2012 DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PATIENTS SEROMA RATE = B4 PRIMARY RECONSTRUCTION PATIENTS = B4 COMPLICATIONS SWELLING = B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SALINE IMPLANTS|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-360|05/09/2012|||DA|N|R||0HP|FTR|1.0||nan||334454|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2578282|2650719|D|1||HEALTH PROFESSIONAL REPORTED SEROMA RIGHT SIDE ALCL CALL PLACED SURGEONS ADDITIONAL INFORMATION OBTAINED PROVIDE FOLLOWING INFORMATION PATIENT DIAGNOSED RIGHT SIDE BREAST CANCER B6 2001 CARCINOMA SITU PATIENT UNDERWENT RECONSTRUCTION SURGERY B6 2001 B4 DEVICE B6 2004 PROPHYLACTIC MASTECTOMY LEFT SIDE ALLERGAN B4 PLACED B6 2004 PATIENT ANOTHER REVISION SURGERY REPLACING ORIGINAL IMPLANT REMOVING TE REPLACED B4 RIGHT B4 LEFT B4 PATIENT PRESENT RIGHT BREAST SWELLING MRI SHOWED MASSIVE AMOUNT FLUID AROUND RIGHT BREAST IMPLANT SMALL AMOUNT LEFT PORTION MASTECTOMY SCAR EXCISED SENT PATHOLOGY DISSECTION CARRIED MUSCLE LARGE AMOUNT FLUID ENCOUNTERED SENT CYTOLOGY IMPLANT REMOVED PORTION CAPSULE TAKEN SENT PATHOLOGY STYLE B4 PLACED PATIENT LAST SEEN B6 2012 REFERRED SEE MEDICAL ONCOLOGIST PATIENT SCHEDULED PET SCAN BONE MARROW ASPIRATION|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-360|05/09/2012|||DA|N|R||0HP|FTR|1.0||nan||334454|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2612781|9939606|N|1||MEDWATCH SUBMITTED B4 2012 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/31/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2844637|10296854|N|1||B4 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS A95R95 STUDY 3 YEAR 5 YEAR CUMULATIVE FIRST OCCURRENCE KAPLAN-MEIER ADVERSE EVENT RATES 995 CONFIDENCE INTERVAL PT SEROMA 26 3 YEARS 26 5 YEARS UNUSUAL SYMPTOMS OCCUR SURGERY FEVER NOTICEABLE SWELLING REDNESS ONE BREAST CONTACT SURGEON IMMEDIATELY ALLERGAN SALINE BREAST IMPLANT LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS A95R95 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/16/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2617539|20736854|D|1||ALCL INVOLVING BREAST IMPLANT PERIPROSTHETIC SEROMA PT B6 FEMALE STATUS POST PLACEMENT BREAST IMPLANTS 1999 DEVELOPED RIGHT PERIPROSTHETIC SEROMA APPROX 5 MONTHS PRIOR SURGERY DUE PRESENCE LATE SEROMA LACK CLINICAL SIGNS INFECTION PLASTIC SURGEON FOLLOWED RECOMMENDED MGMT ALGORITHMS - PLASTIC RECONSTRUCTIVE SURGERY B6 2011 VOL 128-1-PP-17-25 IMPLANTS REMOVED B6 2012 PER OPERATIVE NOTE RIGHT IMPLANT INTACT CAPSULE SLIGHTLY THICKENED ADHERENT WHITE DEBRIS INTERNAL SURFACE 500 CC FLUID ASPIRATED PERIPROSTHETIC SEROMA FLUID SUBMITTED CULTURE FLOW CYTOMETRIC EVAL CYTOLOGIC EVAL LEFT IMPLANT CAPSULE THIN SOMEWHAT EDEMATOUS LEFT IMPLANT INTACT CAPSULES SUBMITTED PATHOLOGIC EXAMINATION REASON USE BREAST AUGMENTATION|SILICONE BREAST IMPLANT 330 ML||06/11/2012||||N|||0HP|FWM|2.0||SILICONE BREAST IMPLANT 330 ML||40897|||||MCGHAN|||||||True
2617539|20736854|D|1||ALCL INVOLVING BREAST IMPLANT PERIPROSTHETIC SEROMA PT B6 FEMALE STATUS POST PLACEMENT BREAST IMPLANTS 1999 DEVELOPED RIGHT PERIPROSTHETIC SEROMA APPROX 5 MONTHS PRIOR SURGERY DUE PRESENCE LATE SEROMA LACK CLINICAL SIGNS INFECTION PLASTIC SURGEON FOLLOWED RECOMMENDED MGMT ALGORITHMS - PLASTIC RECONSTRUCTIVE SURGERY B6 2011 VOL 128-1-PP-17-25 IMPLANTS REMOVED B6 2012 PER OPERATIVE NOTE RIGHT IMPLANT INTACT CAPSULE SLIGHTLY THICKENED ADHERENT WHITE DEBRIS INTERNAL SURFACE 500 CC FLUID ASPIRATED PERIPROSTHETIC SEROMA FLUID SUBMITTED CULTURE FLOW CYTOMETRIC EVAL CYTOLOGIC EVAL LEFT IMPLANT CAPSULE THIN SOMEWHAT EDEMATOUS LEFT IMPLANT INTACT CAPSULES SUBMITTED PATHOLOGIC EXAMINATION REASON USE BREAST AUGMENTATION|SILICONE BREAST IMPLANT 330ML||06/11/2012||||N|||0HP|FWM|1.0||SILICON BREAST IMPLANT 330ML||40897|||||MCGHAN|||||||True
2935848|10444389|N|1||MEDWATCH SUBMITTED B4 2013 DEVICE LABELING ADDRESSES REPORTED EVENTS FOLLOWS B4 STUDY 7 YEAR ADVERSE EVENT RATES - PRIMARY AUGMENTATION PTS HEMATOMA RATE = B4 PRIMARY RECONSTRUCTION PTS = B4 COMPLICATIONS PRIMARY AUGMENTATION PTS CAPSULAR CONTRACTURE RATE = B4 PRIMARY RECONSTRUCTION RATES = B4 REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY LABELING SILICONE IMPLANTS BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING PTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME ALLERGAN SILICONE LABELING|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/22/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2935848|3235921|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA VIA INVOLUNTARY MW B4 PT PRIOR BILATERAL IMPLANTS MCGHAN 390 ML IMPLANTS CURRENTLY KNOWN ALLERGAN INAMED EXPERIENCING BILATERAL CAPSULAR CONTRACTURE ENLARGING RIGHT BREAST SURGEON SUSPECTED SEVERE RIGHT BREAST IMPLANT RUPTURE RADIOLOGICAL STUDIES ELECTED REMOVE IMPLANTS REPLACEMENTS IMPLANTS DONE PATHOLOGY REPORT SURGICAL FINDINGS INCLUDED RIGHT BREAST FOUND RESOLVING HEMATOMA EXTRUDED IMPLANT APPEARED INTACT PATHOLOGY RIGHT BREAST IMPLANT CAPSULE REVEALED ALCL PT CURRENTLY RECEIVING TREATMENT LYMPHOMA PATH REPORT B6 2012 LEFT BREAST IMPLANT CAPSULE EXCISION BENIGN FIBROUS PSEUDOCAPSULE BENIGN BREAST PARENCHYMA CONSISTENT BREAST IMPLANT CAPSULE RIGHT BREAST IMPLANT CAPSULE EXCISION ALCL INVESTIGATION SURGEON ABLE LOCATED GATHER TRY GATHER INFO REGARDING CASE DATE ALLERGAN ABLE GATHER ADDL INFO REGARDING CASE HOWEVER INFO BECOMES AVAILABLE REPORT REVIEWED UPDATED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/22/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3428792|15542667|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENT CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|10/18/2013|||DA|N|I||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3139659|3524107|D|1||HEALTH PROFESSIONAL REPORTED LEFT SIDE IMPLANT REMOVAL DUE POSSIBLE ALCL INFORMATION RECEIVED TIME|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/29/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3139659|10791507|N|1||MEDWATCH SUBMITTED B4 2013 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/29/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3030985|21403153|N|1||MEDWATCH SUBMITTED B4 2012 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY LABELING SILICONE IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|11/29/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3487103|16685068|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA B-SYMPTOMS VIA MW B4 MW NOTES REPORTER CALLED BEHALF PT DIAGNOSED ALCL PT PRESENTED ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED 2013 HISTORY HODGKINS LYMPHOMA DIAGNOSED 2011 TWO EVENTS CAME PT UNDERWENT BREAST AUGMENTATION 1994 2010 PT PRESENTED ABNORMAL MAMMOGRAM PERFORMED 2010 BREAST PAIN SKIN COLOR CHANGE SKIN TEXTURE CHANGE INFLOWING DIFFUSION FORM RIGHT BREAST RIGHT NECK SHOULDER PT RUNNING FEVER THROUGHOUT ENTIRE PROCESS MRI SUBSEQUENT TEST PT DIAGNOSED HODGKINS LYMPHOMA UNDERWENT MANTLE RADIATION 2012 PT UNDERWENT SURGERY ESSENTIALLY BREAST MASS PT ALSO DESIRED MASTECTOMY REMOVAL RIGHT LEFT IMPLANTS CAPSULES PATHOLOGY OPERATION SOON REPORTED PT ALSO ALCL MASS COME LYMPHOMA|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/07/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||BOLETA|US|ALLERGAN||CA|||||True
3487103|16377709|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS A95R95 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS FOLLOWING LIST POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY RISKS INCLUDE IMPLANT DEFLATIONLEAKAGE ADDITIONAL SURGERY CAPSULAR CONTRACTURE  INFECTION TOXIC SHOCK SYNDROME NECROSIS HEMATOMA SEROMA EXTRUSION BREAST PAIN CHANGES NIPPLE SENSATION CHANGES BREAST SENSATION DISSATISFACTION COSMETIC RESULTS WRINKLING FOLDING DISPLACEMENT ASYMMETRY PALPABILITY VISIBILITY PTOSIS SLOSHING CALCIFIC DEPOSITS IRRITATIONINFLAMMATION DELAYED WOUND HEALING HYPERTROPHIC SCARRING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY DIFFICULTYINABILITY BREAST FEEDING INABILITY ADEQUATELY VISUALIZE BREAST LESIONS MAMMOGRAPHY ADDITION POTENTIAL ADVERSE EVENTS CONCERNS CERTAIN SYSTEMIC DISEASES|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/07/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||BOLETA|US|ALLERGAN||CA|||||True
3165371|62390606|D|1||HEALTH PROFESSIONAL REPORTED  SUBPECTORAL SALINE IMPLANT IDENTIFIED RIGHT CAPSULAR INFOLDING - CAPSULAR CONTRACTURES IDENTIFIED SMALL-MODERATE VOLUME FLUID SEEN AROUND IMPLANT ADDITIONALLY PATIENT REPORTS HEALTH PROFESSIONAL ITCHING RIGHT BREAST PATIENT MASTECTOMY TEN YEARS AGO POST OP PATIENT MILD INFECTION RESOLVED ANTIBIOTICS PATIENT RECENTLY DIAGNOSED SUPRACLAVICULAR AXILLARY LYMPHADENOPATHY RECENT PET SHOWED ENLARGED RIGHT EPITROCHLEAR LYMPH NODE BIOPSY SHOWED HODGKIN LYMPHOMA NODULAR SCLEROSIS BONE MARROW BIOPSY NEGATIVE LYMPHOMA PATIENT TREATED ABVD SUBSEQUENT SPECIMENS REVIEW PERI-PROSTHETIC FLUID RIGHT CHEST REPORTED ATYPICAL LYMPHOID CELLS CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA PERIPROSTHETIC FLUID SUBSEQUENT EXCISIONAL BIOPSY RIGHT BREAST CAPSULE IMMUNOHISTOCHEMICAL STAINS SHOW ATYPICAL LYMPHOID CELLS POSITIVE CD15 CD30 FINDINGS RAISE POSSIBILITY HODGKINS LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL EVENT CAPTURED LYMPHOMA DEVICE REMOVED PATIENT PARTIAL CAPSULECTOMY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/07/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3165371|10785195|N|1||MEDWATCH SUBMITTED B4 2013 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/07/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3165371|62391233|D|1||HEALTH PROFESSIONAL REPORTED  Â¿A SUBPECTORAL SALINE IMPLANT IDENTIFIED RIGHT CAPSULAR INFOLDING Â¿ CAPSULAR CONTRACTURES IDENTIFIED SMALL-MODERATE VOLUME FLUID SEEN AROUND IMPLANTÂ¿ ADDITIONALLY PATIENT REPORTS HEALTH PROFESSIONAL Â¿ITCHING RIGHT BREASTÂ¿PATIENT MASTECTOMY TEN YEARS AGOÂ¿POST OP PATIENT MILD INFECTION RESOLVED ANTIBIOTICSÂ¿ PATIENT RECENTLY DIAGNOSED SUPRACLAVICULAR AXILLARY LYMPHADENOPATHY Â¿RECENT PET SHOWED Â¿ENLARGED RIGHT EPITROCHLEAR LYMPH NODEÂ¿ BIOPSY SHOWED Â¿HODGKIN LYMPHOMA NODULAR SCLEROSIS BONE MARROW BIOPSY NEGATIVE LYMPHOMA PATIENT TREATED ABVD SUBSEQUENT SPECIMENS REVIEW PERI-PROSTHETIC FLUID RIGHT CHEST REPORTED ATYPICAL LYMPHOID CELLS CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA PERIPROSTHETIC FLUID SUBSEQUENT EXCISIONAL BIOPSY RIGHT BREAST CAPSULE IMMUNOHISTOCHEMICAL STAINS SHOW ATYPICAL LYMPHOID CELLS POSITIVE CD15 CD30 FINDINGS RAISE POSSIBILITY HODGKINÂ¿S LYMPHOMAÂ¿ PATHOLOGICAL MARKERS CONFIRM ALCL EVENT CAPTURED LYMPHOMA DEVICE REMOVED PATIENT PARTIAL CAPSULECTOMY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/07/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3016526|3318828|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE ALCL SEROMA PT HISTORY LEFT SIDE BREAST CANCER PT PRESENTS B6 2012 LEFT SIDE BREAST SWELLING CT PERFORMED CONFIRMS SEROMA B6 2012 SEROMA ASPIRATED SENT CULTURE ALCL DIAGNOSED|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT||03/19/2013|||DA|N|R||0HP|FTR|1.0||nan||252664|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||153-360||True
3016526|10649467|N|1||MEDWATCH SUBMITTED B4 2013 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY LABELING SILICONE IMPLANTS DEVICE LABELING ADDRESS EVENT SEROMA BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT||03/19/2013|||DA|N|R||0HP|FTR|1.0||nan||252664|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||153-360||True
3108566|17000166|N|1||B4 DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|05/07/2013|||DA|N|R||0HP|FTR|1.0|02/22/2012|nan||1409894|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3108566|16911202|D|1||HEALTHCARE PROFESSIONAL REPORTED CASE SEROMA CAPSULAR CONTRACTURE BAKER GRADE IV LYMPHOMA PT PRIMARY BILATERAL RECONSTRUCTION RIGHT SIDE BREAST CANCER B6 2007 TWO SUBSEQUENT SURGERIES PRESENTED B6 2011 SEROMA RIGHT BREAST BIOPSY NEGATIVE CAPSULE BIOPSY POSITIVE ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|05/07/2013|||DA|N|R||0HP|FTR|1.0|02/22/2012|nan||1409894|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3487123|4026308|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA B-SYMPTOMS VIA MW B4 MW NOTES REPORTER CALLED BEHALF PT DIAGNOSED ALCL PT PRESENTED ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED 2013 HISTORY HODGKINS LYMPHOMA DIAGNOSED 2011 TWO EVENTS CAME PT UNDERWENT BREAST AUGMENTATION 1994 2010 PT PRESENTED ABNORMAL MAMMOGRAM PERFORMED 2010 BREAST PAIN SKIN COLOR CHANGE SKIN TEXTURE CHANGE INFLOWING DIFFUSION RIGHT BREAST RIGHT CHECK SHOULDER PT RUNNING FEVER THROUGHOUT ENTIRE PROCESS MRI SUBSEQUENT TESTS PT DIAGNOSED HODGKINS LYMPHOMA UNDERWENT MANTLE RADIATION 2012 PT UNDERWENT SURGERY ESSENTIALLY BREAST MASS PT ALSO DESIRED MASTECTOMY REMOVAL RIGHT LEFT IMPLANTS CAPSULES PATHOLOGY OPERATION SOON REPORTED PT ALSO ALCL MASS COME LYMPHOMA|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/07/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3487123|11295370|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS A95R95 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS FOLLOWING LIST POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY RISKS INCLUDE IMPLANT DEFLATIONLEAKAGE ADDITIONAL SURGERY CAPSULAR CONTRACTURE INFECTION TOXIC SHOCK SYNDROME NECROSIS HEMATOMA SEROMA EXTRUSION BREAST PAIN CHANGES NIPPLE SENSATION CHANGES BREAST SENSATION DISSATISFACTION COSMETIC RESULTS TWINKLING FOLDING DISPLACEMENT ASYMMETRY PALPABILITY VISIBILITY PTOSIS SLOSHING CALCIFIC DEPOSITS IRRITATIONINFLAMMATION DELAYED WOUND HEALING HYPERTROPHIC SCARRING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY DIFFICULTYINABILITY BREAST FEEDING INABILITY ADEQUATELY VISUALIZE BREAST LESIONS MAMMOGRAPHY ADDITION POTENTIAL ADVERSE EVENTS CONCERNS CERTAIN SYSTEMIC DISEASES|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/07/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3402995|11208865|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE BREAST IMPLANTS|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-492|10/07/2013|||DA|N|R||0HP|FTR|1.0|07/24/2012|nan||1475843|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3418292|3776961|D|1||SILICONE MENTOR BREAST IMPLANTS 2006 GOT DIAGNOSED RHEUMATOID ARTHRITIS 1 YEAR LATER ALSO HASHIMOTOS DISEASE CHRONIC FATIGUE BRAIN FOG POSSIBLE ALCL LYMPHOMA ACCORDING DOCTOR GETTING REMOVED NEXT MONTH GIVE UPDATE REMOVAL SILICONE IMPLANTS MARKET|SILICONE BREAST IMPLANT||10/15/2013|||||||0HP|FTR|1.0||SILICONE BREAST IMPLANT|||||||MENTOR|||||||True
3405834|62723956|D|1||ADDITIONAL INFORMATION REPORTED JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT CASE REPORT REVIEW LITERATURE DETORRES ET AL  REPORTS PRACTICAL ONCOLOGY RADIOTHERAPY 18 2013 DEVELOPED FOLLOW AXILLARY LYMPH NODE EXCISIONAL BIOPSY NODE SHOWED ALK NEGATIVE ALCL PET-TAC SHOWS FOCAL INCREASED FDG UPTAKE LEFT AXILLAR REGION BREAST PROSTHETIC FLUID AREA PATHOLOGICAL FINDINGS PATIENT RECEIVED 4 CYCLES CHOP CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE CHEMOTHERAPY PROSTHESES REMOVED PATIENT RECEIVED POSTOPERATIVE ADJUVANT RADIOTHERAPY CHEST WALL REGIONAL LYMPH NODES TOTAL DOSE 36 GY PATHOLOGY FOLLOW-UP CONFIRMING CD30+ THEREFORE EVENT REMAIN REPORTABLE LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|10/04/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3405834|62724174|D|1||RECEIVED ARTICLE PRODUCT WATCH ENTITLED ALCL ASSOCIATED BREAST IMPLANT CASE REPORT REVIEW LITERATURE WRITTEN DETORRES ET AL WITHIN ARTICLE NOTED PATIENT SEROMA LYMPHOMA MANUFACTURER DEVICE UNKNOWN ADDITIONAL INFORMATION REPORTED JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT CASE REPORT REVIEW LITERATURE DETORRES ET AL REPORTS PRACTICAL ONCOLOGY RADIOTHERAPY 18 2013 DEVELOPED FOLLOW AXILLARY LYMPH NODE EXCISIONAL BIOPSY NODE SHOWED ALK NEGATIVE ALCL PET-TAC SHOWS FOCAL INCREASED FDG UPTAKE LEFT AXILLAR REGION BREAST PROSTHETIC FLUID AREA PATHOLOGICAL FINDINGS PATIENT RECEIVED 4 CYCLES CHOP CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE CHEMOTHERAPY PROSTHESES REMOVED PATIENT RECEIVED POSTOPERATIVE ADJUVANT RADIOTHERAPY CHEST WALL REGIONAL LYMPH NODES TOTAL DOSE 36 GY PATHOLOGY FOLLOW-UP CONFIRMING CD30+ THEREFORE EVENT REMAIN REPORTABLE LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|10/04/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3405834|3912734|D|1||RECD ARTICLE PRODUCT WATCH ENTITLED ALCL ASSOCIATED BREAST IMPLANT CASE REPORT REVIEW LITERATURE WRITTEN DE TORRES ET AL WITHIN ARTICLE NOTED PT SEROMA LYMPHOMA MFR DEVICE UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|10/04/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3405834|11208949|N|1||DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS SEROMA RATE = 10  COMPLICATIONS BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY LABELING SILICONE IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|10/04/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3031007|10638503|N|1||MED WATCH SUBMITTED B4 2012 EVENT SUBMITTED INITIALLY VIA B6 2011 PT PLANNER ADDRESSES LUMP NODULE DISTINGUISHING IMPLANT BREAST TISSUE BREAST SELF-EXAMINATION PERFORM BREAST SELF-EXAMINATION MONTHLY IMPLANTED BREAST ORDER EFFECTIVELY ASK SURGEON HELP DISTINGUISH IMPLANT BREAST TISSUE NEW LUMPS ABNORMAL FINDING MAMMOGRAM EVALUATED BIOPSY BIOPSY PERFORMED CARE MUST TAKEN AVOID PUNCTURING IMPLANT DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY LABELING SILICONE IMPLANTS|STYLE 168 SALINE FILLED BREAST IMPLANT|UNK STYLE 168|11/29/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3428790|15948961|N|1||B4 DEVICE LABELING REVIEWED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|10/18/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|LA AURORA DE HEREDIA|||US|ALLERGAN||CA|||||True
3023802|10610793|N|1||B4 DEVICE LABELLING ADDRESSES SEROMA ALCL ANAPLASTIC LARGE CELL LYMPHOMA BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMENT PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFO FDAS ANALYSIS REVIEW ALCL PTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSAND PROSTHETICSBREASTIMPLANTSUCM239995HTM|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410360|03/26/2013|||DA|N|R||0HP|FTR|1.0|10/03/2012|nan||1507531|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3023802|3320091|D|1||ALLERGAN REP REPORTED PHYSICIAN REPORTS PT DIAGNOSED ALCL PT PRESENTED RIGHT SIDE SWOLLEN BREAST ASPIRATION PERFORMED FLUID BLOOD|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410360|03/26/2013|||DA|N|R||0HP|FTR|1.0|10/03/2012|nan||1507531|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3031016|10592270|N|1||MED WATCH SUBMITTED B4 2012 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS B4 STUDY 7 YEAR ADVERSE EVENT RATES PRIMARY AUGMENTATION PATIENTS SEROMA RATE = B4 PRIMARY RECONSTRUCTION PATIENTS SEROMA RATE = B4 SWELLING = B4 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY LABELING SILICONE IMPLANTS|STYLE 10 SILICONE GEL FILLED BREAST IMPLANT|10-390|11/15/2012|||DA|N|R||0HP|FTR|1.0|10/15/2011|nan||1361759|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3031016|3257906|D|1||HEALTH PROFESSIONAL REPORTED LEFT SIDE PAIN ACCUMULATION FLUID DIAGNOSIS ALCL EVENT REPORTED VIA EPSR Q2 B6 2010|STYLE 10 SILICONE GEL FILLED BREAST IMPLANT|10-390|11/15/2012|||DA|N|R||0HP|FTR|1.0|10/15/2011|nan||1361759|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3181456|19289444|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-450|06/14/2013|||DA|N|R||0HP|FTR|1.0|01/08/2015|nan||1808425|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3133486|18401533|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PT CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS REPORTED EVENTS LUMPNODULES LYMPHADENOPATHY PTS CORE STUDY LABELING SILICONE BREAST IMPLANTS REPORTED EVENTS LUMPNODULES LYMPHADENOPATHY PTS B4 STUDY LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/24/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3289293|11049115|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-500|08/07/2013|||DA|N|R||0HP|FTR|1.0|12/15/2011|nan||1381094|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2926371|3122338|D|1||POSSIBLE ALCL SYMPTOMS|GEL-FILLED MAMMARY PROSTHESIS|354-4007|01/15/2013|||DA|N|R||0HP|FTR|1.0||BREAST IMPLANT||5744550|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR|75038|TX|75038||||True
3378227|11220647|N|1||MEDWATCH SUBMITTED B4 2013 DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PATIENT SEROMA RATE = 16 PRIMARY RECONSTRUCTION PATIENTS = 10 COMPLICATIONS SWELLING = 71 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-480|09/17/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3378227|3752540|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE ALCL SEROMA VIA ALLERGAN LEGAL DEPARTMENT B4 PATIENT HISTORY BREAST CANCER DIAGNOSED B62004 TOTAL MASTECTOMY LYMPHNODE DISSECTION B6 2004 B6 2006 PATIENT UNDERWENT RECONSTRUCTION SURGERY LATISSISMUS DORSI FLAP USING ALLERGAN 110-480 TEXTURED DEVICES B6 2003 PATIENT SIX ROUNDS CHEMO REQUIRE RADIATION B6 2013 PATIENT PRESENTED SURGEON LEFT BREAST BREAST SWELLING REFERRAL PCP ULTRASOUND CARRIED B6 2013 EXPLANT SURGERY COMPLETE CAPSULECTOMY B6 2013 PERFORMED SEROMA SENT LAB ALONG IMPLANT CAPSULE SURGERY PATIENT ALSO NOTED NODULES LEFT BREAST IMPLANT HISTOLOGY REPORT NOTES ALCL ALK-MARKER CD30+|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-480|09/17/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3514500|11379692|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-400|11/19/2013|||DA|N|R||0HP|FTR|1.0|01/02/2015|nan||1805378|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3181455|10752736|N|1||MEDWATCH SUBMITTED B4 2013 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY LABELING SILICONE IMPLANTS|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-450|06/14/2013|||DA|N|R||0HP|FTR|1.0|01/08/2015|nan||1808425|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2933301|10421458|N|1||MEDWATCH SUBMITTED B4 2013 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY LABELING SILICONE IMPLANTS|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 120|01/23/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2933301|3225699|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED LETTER REPORTING PATIENT BILATERAL BREAST AUGMENTATION SILICONE BREAST IMPLANTS DIAGNOSED LYMPHOMA ANTERIOR MEDIASTINUM LIMITED INFORMATION AVAILABLE CASE INITIAL INVESTIGATION UNLIKELY CHANCE INFORMATION OBTAINED HOWEVER ADDITIONAL INFORMATION DEVICE INFORMATION IMPLANTINGEXPLANTING PHYSICIAN LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL FILE REVIEWED UPDATED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 120|01/23/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3134127|10793581|N|1||B4 B4 LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA ALCL ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANT CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM R CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFORMATION FDAS ANALYSIS REVIEW ALCL PTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSETHETICSBREASTIMPLANTSUCM239995HTM 410 LABELING ADDRESSES CAPSULAR CONTRACTURE CAPSULAR CONTRACTURE - PTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PTS PRIMARY AUGMENTATION RECONSTRUCTION PTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT RUPTURE ONE COMMON REASONS REOPERATION B4 LABELING ADDRESSES SEROMA ADDITIONAL COMPLICATIONS - BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME PAIN HEMATOMASEROMA CHANGES NIPPLE BREAST SENSATION IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3134127|3458905|D|1||ANAPLASTIC LARGE CELL LYMPHOMA BREAST ARISING AROUND MAMMARY IMPLANT CAPSULE B6 REPORT WRITTEN B4 REPORTS ALCL SEROMA CAPSULAR CONTRACTURE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3134127|61102727|N|1||MEDWATCH SUBMITTED FDA 07162015 ADVERSE EVENT ALCL REPORTED PREVIOUSLY PATHOLOGY FOLLOW-UP CONFIRMING CD30+ ALK- EVENT REMAIN REPORTABLE LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3134124|18173802|N|1||B4 410 DEVICE LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA ALCL ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANT CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM ER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFORMATION FDAS ANALYSIS REVIEW ALCL PTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICAL DEVICESPRODUCTSAND MEDICALPROCEDURESIMPLANTSANDPROSETHETICSBREASTIMPLANTSUCM239995HTM 410 LABELING ADDRESSES SEROMA PAIN ADDITIONAL COMPLICATIONS - BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME PAIN HEMATOMASEROMA CHANGES NIPPLE BREAST SENSATION IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3134124|17839593|D|1||ANAPLASTIC LARGE CELL LYMPHOMA BREAST ARISING AROUND MAMMARY IMPLANT CAPSULE B6 REPORT WRITTEN AESTHETIC PLASTIC SURGERY 2013 REPORTS ALCL SEROMA PAIN|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3030982|10638158|N|1||MED WATCH SUBMITTED B4 2012 EVENT SENT INITIALLY VIA B6 2009 Q1 B6 2010 Q2 B6 2010 Q4 B6 2011 DEVICE LABELLING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = B4 PRIMARY RECONSTRUCTION PTS = B4 COMPLICATIONS SWELLING = B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/20/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3031014|3257466|D|1||HEALTHCARE PROFESSIONAL REPORTS ARTICLE CASE SEROMA ALCL LANCET 2012 380 1530 WITHIN ARTICLE AUTHOR REPORTS B4 2010 PREVIOUSLY HEALTHY B6 WOMAN TEXTURED SALINE BREAST IMPLANTS PLACED SUBPECTORALLY 8 YEARS AGO AESTHETIC PURPOSES PRESENTED 2-MONTH HISTORY PAINLESS MASS UNDERNEATH LEFT ARM PHYSICAL EXAMINATION SHOWED SYMMETRICAL BREASTS OVERLYING SKIN NIPPLE CHANGES TWO LARGE MOBILE NODES PALPABLE LEFT AXILLA INITIAL BREAST MAMMOGRAPHY ULTRASONOGRAPHY CONFIRMED LEFT AXILLARY LYMPHADENOPATHY SHOW PERI-IMPLANT FLUID COLLECTION BIOPSY LEFT AXILLARY MASS SHOWED FINDINGS CONSISTENT CLASSIC HODGKINS LYMPHOMA NODULAR SCLEROSING TYPE LACKED TWO TYPICAL STAINS-CD15 PAX5 PET-CT SHOWED 5-CM AREA PET-AVID LEFT AXILLARY LYMPHADENOPATHY HODGKINS LYMPHOMA STAGE IA DIAGNOSED PT TWO CYCLES ADRIAMYCIN BLEOMYCIN VINBLASTINE DACARBAZINE ABVD 2000 GY FIELD RADIATION LEFT AXILLA INITIAL TREATMENT COMPLETED B6 2011 FU CT SCAN B6 2011 SHOWED DECREASE SIZE LEFT AXILLARY LYMPHADENOPATHY UNILATERAL FLUID COLLECTION HOWEVER NOTED AROUND LEFT BREAST IMPLANT FIGURE FLUID INCREASED SIZE PRESENTED 6 MONTHS ALTER LEAKAGE SEROUS FLUID LEFT BREAST CYTOLOGY PERI-IMPLANT FLUID SHOWED CD30+ LYMPHOMA CELLS INDETERMINATE LINEAGE DIFFERENT DIAGNOSIS INCLUDED RECURRENT HODGKINS LYMPHOMA IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMA REPEAT PET-CT SHOWED PET-AVID AREAS BILATERAL AXILLARY LYMPH NODES IMPLANTS REMOVED CAPSULECTOMIES B6 2011 REPEAT PET-CT SHOWED PET-AVID AREAS BILATERAL AXILLARY LYMPH NODES IMPLANTS REMOVED CAPSULECTOMIES B6 2011 TREATED FOUR CYCLES SALVAGE CHEMOTHERAPY GEMCITABINE CISPLATIN ASSUMED RECURRENT HODGKINS LYMPHOMA FU SONOGRAPHY LEFT BREAST 1 MONTH LATER SHOWED HYPOECHOIC MASS BIOPSY MASS SHOWED SIMILAR CELLS PERI-IMPLANT FLUID CD30+ LYMPHOMA CELLS INDETERMINATE ORIGIN MASS RESECTED B6 2012 PATHOLOGICAL TESTS SHOWED B6 SEROMA-ASSOCIATED LARGE-CELL LYMPHOMA ALK-NEGATIVE ALCL RETROSPECTIVE REVIEW SIDES SHOWED LARGE CELLS CHARACTERISTIC ALK-NEGATIVE ALCL SUBSTANTIAL OVERLAP MORPHOLOGY IMMUNOPHENOTYPE CELLS INITIAL AXILLARY LYMPH NODE BIOPSY PERI-IMPLANT FLUID FINAL LEFT BREAST MASS BIOPSY SUGGESTED MANIFESTATIONS ALCL PRESENTATION UNIQUE ALK-NEGATIVE ALCL PRESENTED PATHOLOGICAL AXILLARY LYMPH NODE INSTEAD TYPICAL PERI-IMPLANT SEROMA PT COMPLETED BRENTUXIMAB THERAPY TREATMENT ALK-NEGATIVE ALCL PT LAST SEEN B6 2012 STABLE CONDITION|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/15/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3030984|3326574|D|1||RESEARCH REVIEW RN PRODUCT SUPPORT SPECIALIST FOLLOWING ARTICLE CAME ATTENTION ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING BREAST ARCH PATHOLOGY LAB MEDICAL JOURNAL- VOL 133 SEP 2009 WITHIN ARTICLE AUTHOR NOTES SEROMA LYMPHOMA ADDL INFO ARTICLE ENTITLE BREAST IMPLANT CAPSULE-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIC-ALCL DIAGNOSTIC PATHOLOGY JOURNAL NEW EVENTS REPORT|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|11/29/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3030984|10610877|N|1||MEDWATCH SUBMITTED 29NOV2012 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS A95R95 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|11/29/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3030978|10610875|N|1||B4 EVENT SUBMITTED INITIALLY VIA B6 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS CORE STUDY 7 YEAR ADVERSE EVENT RATES PRIMARY AUGMENTATION PATIENTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PATIENTS = 10 COMPLICATIONS SWELLING = 71 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|11/20/2012|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNK||CA|||||True
3487125|4004895|D|1||HEALTHCARE PROFESSIONAL REPORTS VIA B4 CASE LATE SEROMA LYMPHOMA REPORT COMES UNIDENTIFIED HEALTHCARE PROFESSIONAL B4 NOTES MAY CONCERN PURSUANT PARTNERSHIP FDA CONCERNING BREAST IMPLANT-ASSOCIATED ALCL REPORTING CASE ALCL ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT PT FIRST PRESENTED BREAST AUGMENTATION SEVERAL YEARS PRIOR NOTICED SWELLING LEFT BREAST EVENTUALLY BECAME PAINFUL CAUSED SEEK TREATMENT WORKUP EVENTUALLY REVEALED SEROMA AROUND BREAST IMPLANT FLUID CAME BACK CD 30 POSITIVE ALK NEGATIVE CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA IMPLANTS REMOVED BILATERALLY FELT ADEQUATE TREATMENT PROBLEM CONTINUES UNDERGO SURVEILLANCE US ADDITION HEMATOLOGYONCOLOGY TEAM NOTE FOUND NONRUPTURED 410 CC TEXTURED SILICONE IMPLANT MAY CUI AVAILABLE UNITED STATES PTS CARE COORDINATED PLASTIC SURGERY HEMATOLOGYONCOLOGY TEAMS BREAST IMPLANTS REMOVED REPLACED PT UNDERGO SURVEILLANCE MRI ULTRASOUND|UNK CUI GEL|UNK CUI GEL|11/07/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3487125|11357748|N|1||DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PATIENTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PATIENTS = 10 COMPLICATIONS SWELLING = 71 CORE STUDY LABELING SILICONE IMPLANTS BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL CORE STUDY LABELING SILICONE IMPLANTS|UNK CUI GEL|UNK CUI GEL|11/07/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3011109|10629210|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|03/13/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3390404|3798157|D|1||BILATERAL SUBGLANDULAR TEXTURED SILICONE GEL BREAST IMPLANTS IMPLANTED 15 YEARS AGO RECENT DEVELOPMENT 700 CC OPAQUE PERI-IMPLANT SEROMA CAPSULAR THICKENING INF LEFT BREAST STATUS POST BILATERAL IMPLANT EXPLANTATION BILATERAL CAPSULECTOMY DIAGNOSIS LEFT BREAST IMPLANT- ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ALCL LEFT BREAST CAPSULECTOMY PATHOLOGICAL SPECIMEN L BREAST SEROMA FLUID POSITIVE ALCL CELLS FOLLOWING REPEAT BILATERAL CAPSULECTOMY DIAGNOSIS BILATERAL BREAST AUGMENTATIONCOSMESIS|TEXTURED SILICONE GEL IMPLANT 220CC||10/02/2013||||N|||000|FTR|1.0||BREAST IMPLANTS|||||||MCGHAN|||||||True
3167435|3551128|D|1||PT UNDERWENT BREAST RECONSTRUCTION MENTOR SILTEX GEL-FILLED DEVICES PT UNDERWENT SURGERY 5 YRS LATER CORRECT SYMMETRY ISSUE LARGE SEROMA FIBRINOUS GELANTINOUS TISSUE DISCOVERED IMPLANT TISSUE SENT CULTURE CAME BACK ALCL DEVICE DISCARDED B4|MEMORYGEL MAMMARY PROSTHESIS|354-4450|06/05/2013||||N|R||0HP|FTR|1.0||BREAST IMPLANT||5769207|||IRVING|US|MENTOR||TX|||||True
3208898|3579679|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE ALCL RIGHT BREAST ALONG SEROMA PT AUGMENTATION DATE SURGERY PROVIDED TIME PT PRESENTED PAIN SWELLING B6 2013 US CONFIRMED SEROMA B6 2013 CYTOLOGY TAKEN SENT PATHOLOGY PT BILATERAL REMOVAL CAPSULECTOMY WITHOUT REPLACEMENT B6 2013 PET SCAN PERFORMED NEGATIVE ONCOLOGY CONSULT TOOK PLACE HOWEVER NOTES AVAILABLE TIME INFO PROVIDED CONFIRMS FAMILY HISTORY BREAST CANCER HOWEVER POSITIVE HISTORY OVARIAN CANCER|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-507|07/02/2013|||DA|N|R||0HP|FTR|1.0|01/25/2013|nan||1559225|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3208898|11075171|N|1||B4 DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS - 10 COMPLICATIONS SWELLING = 71 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-507|07/02/2013|||DA|N|R||0HP|FTR|1.0|01/25/2013|nan||1559225|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3523594|11380524|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS PTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-397|12/02/2013|||DA|N|R||0HP|FTR|1.0|09/05/2012|nan||1495081|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3264883|3621903|D|1||ALCL SYMPTOMS|SILTEX CONTOUR PROFILE ROUND SPECTRUM|354-2515|07/26/2013|||||R||0HP|FWM|1.0||BREAST IMPLANT|||||IRVING|US|MENTOR||TX|||||True
3428755|21496558|D|1||ALCL CASE REPORT PT B6 PRESENTED LATE SEROMA CAPSULAR CONTRACTURE PAIN RIGHT BREAST B6 2013 PT DELAYED SURGICAL INTERVENTION SEROMA TEMPORARILY BETTER PHYSICIAN INSISTED INTERVENTION DEVICE REMOVED B6 2013 DIAGNOSIS B6 2013 RIGHT BREAST SEROMA FLUID - MALIGNANT CELLS PRESENT FLUID CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA LARGE CELLS NOTED OUTSIDE FIBROUS CAPSULE CAPSULAR INVASION EXTRACAPSULAR EXTENSION NOTED|SILICONE GEL - FILLED TEXTURED BREAST IMPLANT|20621-525U|10/18/2013|||DA|N|R||0HP|FTR|1.0|04/01/2008|nan|||11220 GRADER ST|STE 100|DALLAS|US|SILIMED|75238|TX|75238||20621||True
3170177|21675522|D|1||REPORTER CALLED BEHALF PT DIAGNOSED ALCL PT PRESENTED ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED B6 2013 HISTORY HODGKINS LYMPHOMA DIAGNOSED B6 2011 TWO EVENTS CAME PT UNDERWENT BREAST AUGMENTATION 1994 REPORT FILED RESPONSE FOLLOWING REPORT WWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTUCM239995HTM 2010 PT PRESENTED ABNORMAL MAMMOGRAM DONE B6 2010 BREAST PAIN SKIN COLOR CHANGE SKIN TEXTURE CHANGE INFLOWING DIFFUSION RIGHT BREAST RIGHT NECK SHOULDER PT RUNNING FEVER THROUGHOUT ENTIRE PROCESS MRI SUBSEQUENT TESTS PT DIAGNOSED HODGKINS LYMPHOMA UNDERWENT MANTLE RADIATION B6 2012 PT UNDERWENT SURGERY ESSENTIALLY BREAST MASS PT ALSO DESIRED MASTECTOMY REMOVAL RIGHT LEFT IMPLANTS CAPSULES PATHOLOGY OPERATION SOON REPORTED PT ALSO ALCL MASS COME LYMPHOMA|MCGHAN 420 CC BREAST IMPLANTS (RIGHT & LEFT)||06/13/2013|||||||0|FWM|1.0||SALINE BREAST IMPLANT|||||||MCGHAN|||||||True
3269181|3756340|D|1||SUDDEN ONSET SWELLING LATE SEROMA LEFT BREAST IMPLANT RECONSTRUCTION PREVIOUSLY 2-STAGE BREAST RECONSTRUCTION PLACEMENT BILATERAL TISSUE EXPANDERS B6 2005 MCGHAN REF 67-133LV13 EXPANDERS LEFT SN B4 LOT 623514 RIGHT SN B4 LOT 1030255 IMPLANTS PLACED B6 2005 INAMED REF 27-FF125-375 LEFT SN B4 LOT 335112 RIGHT SN B4 LOT 380839 PRESENTATION LATE SEROMA ALMOST 8 YRS IMPLANT PLACEMENT SEROMA FLUID ASPIRATED ULTRASOUND GUIDANCE POSITIVE MALIGNANT CELL ANAPLASTIC LARGE CELL LYMPHOMA ALCL INPATIENT SURGERY REMOVAL BILATERAL BREAST IMPLANTS TOTAL CAPSULECTOMIES PERFORMED PATHOLOGY REVEALED ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING EXTENDING BEYOND LEFT CAPSULE CONTRALATERAL RIGHT SIDE SEROMA FLUID AROUND TIME SURGERY FLUID SENT CYTOLOGY ALSO FOUND POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA EVIDENCE DISTANT DISEASE TISSUE EXPANDERS USED 1ST STAGE BREAST RECONSTRUCTION PRIOR PLACEMENT IMPLANT EXPANDERS PLACED B6 2005 REMOVED B6 2005 FINAL IMPLANTS PLACED EXPANDERS MCGHAN 133LV INAMED EXPANDERS REFERENCECATALOG 76-133LV13 SERIAL NUMBERS LOT NUMBERS DESCRIBED INITIAL NARRATIVE EVENT REASON USE 1 - POSTMASTECTOMY BREAST RECONSTRUCTION 2 - POSTMASTECTOMY BREAST RECONSTRUCTION EVENT ABATED USE STOPPED DOSE REDUCED 1 - YES 2 - YES|410FF BREAST IMPLANT LEFT|27-FF125-375|08/01/2013||||Y|||0LP|FWM|1.0||BREAST IMPLANT, HIGHLY-TEXTURED FORM-STABLE||335112|||||INAMED|||||||True
3269181|3756340|D|1||SUDDEN ONSET SWELLING LATE SEROMA LEFT BREAST IMPLANT RECONSTRUCTION PREVIOUSLY 2-STAGE BREAST RECONSTRUCTION PLACEMENT BILATERAL TISSUE EXPANDERS B6 2005 MCGHAN REF 67-133LV13 EXPANDERS LEFT SN B4 LOT 623514 RIGHT SN B4 LOT 1030255 IMPLANTS PLACED B6 2005 INAMED REF 27-FF125-375 LEFT SN B4 LOT 335112 RIGHT SN B4 LOT 380839 PRESENTATION LATE SEROMA ALMOST 8 YRS IMPLANT PLACEMENT SEROMA FLUID ASPIRATED ULTRASOUND GUIDANCE POSITIVE MALIGNANT CELL ANAPLASTIC LARGE CELL LYMPHOMA ALCL INPATIENT SURGERY REMOVAL BILATERAL BREAST IMPLANTS TOTAL CAPSULECTOMIES PERFORMED PATHOLOGY REVEALED ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING EXTENDING BEYOND LEFT CAPSULE CONTRALATERAL RIGHT SIDE SEROMA FLUID AROUND TIME SURGERY FLUID SENT CYTOLOGY ALSO FOUND POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA EVIDENCE DISTANT DISEASE TISSUE EXPANDERS USED 1ST STAGE BREAST RECONSTRUCTION PRIOR PLACEMENT IMPLANT EXPANDERS PLACED B6 2005 REMOVED B6 2005 FINAL IMPLANTS PLACED EXPANDERS MCGHAN 133LV INAMED EXPANDERS REFERENCECATALOG 76-133LV13 SERIAL NUMBERS LOT NUMBERS DESCRIBED INITIAL NARRATIVE EVENT REASON USE 1 - POSTMASTECTOMY BREAST RECONSTRUCTION 2 - POSTMASTECTOMY BREAST RECONSTRUCTION EVENT ABATED USE STOPPED DOSE REDUCED 1 - YES 2 - YES|410FF BREAST IMPLANT RIGHT|27-FF125-375|08/01/2013||||Y|||0LP|FWM|2.0||BREAST IMPLANT, HIGHLY-TEXTURED FORM-STABLE||380839|||||INAMED|||||||True
3269181|3756340|D|1||SUDDEN ONSET SWELLING LATE SEROMA LEFT BREAST IMPLANT RECONSTRUCTION PREVIOUSLY 2-STAGE BREAST RECONSTRUCTION PLACEMENT BILATERAL TISSUE EXPANDERS B6 2005 MCGHAN REF 67-133LV13 EXPANDERS LEFT SN B4 LOT 623514 RIGHT SN B4 LOT 1030255 IMPLANTS PLACED B6 2005 INAMED REF 27-FF125-375 LEFT SN B4 LOT 335112 RIGHT SN B4 LOT 380839 PRESENTATION LATE SEROMA ALMOST 8 YRS IMPLANT PLACEMENT SEROMA FLUID ASPIRATED ULTRASOUND GUIDANCE POSITIVE MALIGNANT CELL ANAPLASTIC LARGE CELL LYMPHOMA ALCL INPATIENT SURGERY REMOVAL BILATERAL BREAST IMPLANTS TOTAL CAPSULECTOMIES PERFORMED PATHOLOGY REVEALED ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING EXTENDING BEYOND LEFT CAPSULE CONTRALATERAL RIGHT SIDE SEROMA FLUID AROUND TIME SURGERY FLUID SENT CYTOLOGY ALSO FOUND POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA EVIDENCE DISTANT DISEASE TISSUE EXPANDERS USED 1ST STAGE BREAST RECONSTRUCTION PRIOR PLACEMENT IMPLANT EXPANDERS PLACED B6 2005 REMOVED B6 2005 FINAL IMPLANTS PLACED EXPANDERS MCGHAN 133LV INAMED EXPANDERS REFERENCECATALOG 76-133LV13 SERIAL NUMBERS LOT NUMBERS DESCRIBED INITIAL NARRATIVE EVENT REASON USE 1 - POSTMASTECTOMY BREAST RECONSTRUCTION 2 - POSTMASTECTOMY BREAST RECONSTRUCTION EVENT ABATED USE STOPPED DOSE REDUCED 1 - YES 2 - YES|MCGHAN BREAST IMPLANT RIGHT|67-133LV13|08/01/2013||||Y|||0LP|FWM|4.0||BREAST IMPLANT||1030255|||||MCGHAN|||||||True
3269181|3756340|D|1||SUDDEN ONSET SWELLING LATE SEROMA LEFT BREAST IMPLANT RECONSTRUCTION PREVIOUSLY 2-STAGE BREAST RECONSTRUCTION PLACEMENT BILATERAL TISSUE EXPANDERS B6 2005 MCGHAN REF 67-133LV13 EXPANDERS LEFT SN B4 LOT 623514 RIGHT SN B4 LOT 1030255 IMPLANTS PLACED B6 2005 INAMED REF 27-FF125-375 LEFT SN B4 LOT 335112 RIGHT SN B4 LOT 380839 PRESENTATION LATE SEROMA ALMOST 8 YRS IMPLANT PLACEMENT SEROMA FLUID ASPIRATED ULTRASOUND GUIDANCE POSITIVE MALIGNANT CELL ANAPLASTIC LARGE CELL LYMPHOMA ALCL INPATIENT SURGERY REMOVAL BILATERAL BREAST IMPLANTS TOTAL CAPSULECTOMIES PERFORMED PATHOLOGY REVEALED ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING EXTENDING BEYOND LEFT CAPSULE CONTRALATERAL RIGHT SIDE SEROMA FLUID AROUND TIME SURGERY FLUID SENT CYTOLOGY ALSO FOUND POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA EVIDENCE DISTANT DISEASE TISSUE EXPANDERS USED 1ST STAGE BREAST RECONSTRUCTION PRIOR PLACEMENT IMPLANT EXPANDERS PLACED B6 2005 REMOVED B6 2005 FINAL IMPLANTS PLACED EXPANDERS MCGHAN 133LV INAMED EXPANDERS REFERENCECATALOG 76-133LV13 SERIAL NUMBERS LOT NUMBERS DESCRIBED INITIAL NARRATIVE EVENT REASON USE 1 - POSTMASTECTOMY BREAST RECONSTRUCTION 2 - POSTMASTECTOMY BREAST RECONSTRUCTION EVENT ABATED USE STOPPED DOSE REDUCED 1 - YES 2 - YES|MCGHAN BREAST IMPLANT LEFT|67-133LV13|08/01/2013||||Y|||0LP|FWM|3.0||BREAST IMPLANT||623514|||||MCGHAN|||||||True
3530632|3971653|D|1||ALCL CASE REPORT RIGHT BREAST SEROMA ASSOCIATED ALCL HISTORY BILATERAL BREAST AUGMENTATION RIGHT BREAST POLYURETHANE COVERED PROSTHESIS POLYTECH SILIMED 30645 290L DA 295ML|POLY-SILIMED BREAST IMPLANT 30645 290L DA 295ML||12/17/2013|||||||0|FTR|1.0||POLY-SILIMED BREAST IMPLANT||||||US|SILIMED|||||||True
3032437|10643171|N|1||MEDWATCH SUBMITTED 03282013 DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 DEVICE LABELING ADDRESSES REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-330|03/29/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3530618|20699147|D|1||ALCL CASE REPORT PATIENT PERSONAL HISTORY LEFT BREAST CANCER 2005 UNDERWENT RADICAL MASTECTOMY RECONSTRUCTION TISSUE EXPANDER 2006 SUBSTITUTION TISSUE EXPANDER DEFINITIVE BREAST PROSTHESIS INAMED 410LX 625GR BREAST AUGMENTATION LEFT BREAST INAMED 410LX 625GR B6 2012 POSITIVE LYMPH NODE RIGHT AXILLARY SITE ALCL B6 2012 SEROMA ASSOCIATED ALCL LEFT BREAST|410LX 625GR BREAST IMPLANT||12/17/2013|||||||0|FTR|1.0||BREAST PROSTHESIS|||||||INAMED|||||||True
3530645|4116958|D|1||ALCL CASE REPORT SEROMA ASSOCIATED PRIMARY ALCL RIGHT BREAST PATIENT PERSONAL HISTORY RIGHT BREAST CANCER RIGHT MASTECTOMY IMMEDIATE RECONSTRUCTION LATISSIMUS DORSI FLAP TEXTURED SILICONE PROSTHESIS MCGHAN ST-MX410 DA 445GR|TEXTURED 445GR SILICONE PROSTHESIS||12/17/2013|||||||0|FTR|1.0||BREAST IMPLANT|||||||MCGHAN|||||||True
3199749|3477268|D|1||COMPANY REP REPORTED RIGHT SIDE ANAPLASTIC LARGE-CELL LYMPHOMA SUBCUTANEOUS NODULES LYMPH NODES PT BILATERAL RECONSTRUCTION SEVEN YEARS AGO STYLE 410 BREAST IMPLANT PLACED LEFT SIDE STYLE 115 PLACED RIGHT SIDE PT DONE WELL PRESENTED LAST WEEK PATHOLOGY REPORT ONCOLOGIST STATING ALCL PT STATED NODULES RIGHT AXILLA PET SCAN CARRIED SHOWED METASTASIS LUNG BONE MARROW INVOLVEMENT SEROMA NOTED ONCOLOGIST DECIDED TREATMENT PLAN EXCLUDE RADIATION EXPLANT SURGERY TAKE PLACE B6 2013|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-378|05/20/2013|||DA|N|R||0HP|FTR|1.0|04/24/2011|nan||1267625|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3199749|10822419|N|1||MEDWATCH SUBMITTED 05202013 ALLERGAN LABELING ADDRESSES EVENT BREAST LUMPS FOLLOWS BREAST SELF-EXAMINATIONS FOLLOWING BREAST AUGMENTATION CONTINUE PERFORM BREAST SELF-EXAMINATION MONTHLY MAY DIFFICULT BREAST IMPLANT PLACE CONTINUE PERFORM MONTHLY BREAST SELF EXAMINATION EFFICIENTLY ASK SURGEON HELP IDENTIFY DIFFERENCE IMPLANT BREAST TISSUE ABLE IDENTIFY IMPLANT BREAST TISSUE DECREASE NECESSITY EXCESSIVE SQUEEZING IMPLANT EXAMINATION NEW LUMPS EVALUATED BIOPSY APPROPRIATE BIOPSY PERFORMED SURE INFORM MEDICAL PROFESSIONAL PERFORMING BIOPSY BREAST IMPLANTS CARE TAKEN AVOID INJURING IMPLANT 410 DEVICE LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA ALCL BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFO FDAS ANALYSIS REVIEW ALCL PTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-378|05/20/2013|||DA|N|R||0HP|FTR|1.0|04/24/2011|nan||1267625|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2933318|10421850|N|1||MEDWATCH SUBMITTED B4 2013 DEVICE LABELING REVIEWED REPORTED EVENT LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|CUI TEXTURED SALINE FILLED BREAST IMPLANT|UNK STYLE RTV|01/25/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2933318|3225696|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED LETTER REPORTING PT BILATERAL BREAST AUGMENTATION MCGHAN SALINE IMPLANTS DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA LIMITED INFO AVAILABLE CASE INITIAL INVESTIGATION UNLIKELY CHANCE INFO OBTAINED HOWEVER ADDL INFO DEVICE INFO IMPLANTINGEXPLANTING PHYSICIAN LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL FILE REVIEWED UPDATED|CUI TEXTURED SALINE FILLED BREAST IMPLANT|UNK STYLE RTV|01/25/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2933317|17460937|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED LETTER REPORTING PATIENT UNDERWENT BREAST AUGMENTATION SURGERY ALLERGAN SALINE FILLED BREAST IMPLANTS DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA LIMITED INFORMATION AVAILABLE CASE INITIAL INVESTIGATION UNLIKELY CHANCE INFORMATION OBTAINED HOWEVER ADDITIONAL INFORMATION DEVICE INFORMATION IMPLANTINGEXPLANTING PHYSICIAN LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL FILE REVIEWED UPDATED|STYLE 168 SALINE FILLED BREAST IMPLANT|UNK STYLE 168|01/23/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2933317|17754366|N|1||MEDWATCH SUBMITTED B4 2013 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 168 SALINE FILLED BREAST IMPLANT|UNK STYLE 168|01/23/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2973798|3169696|D|1||ALCL RIGHT BREAST PRESENTED PERSISTENT SEROMAS REQUIRED MULTIPLE ASPIRATIONS TEXTURED IMPLANT PLACED SUBFASCIAL PECTORAL PLANE SALT BASED TEXTURE FULL CAPSULECTOMY REMOVAL IMPLANT DONE B6 2012 INTERCONSULTATION MED  ONCOLOGY RECOMMENDED CHEMOTHERAPY CURRENT RECEIVED|NATRELLE STYLE 110 REF #110-300|#110-300|02/13/2013||||N|||0HP|FWM|1.0||NONE||110-300|||||ALLERGAN|||||NATRELLE STYLE 110||True
3199735|10822749|N|1||MEDWATCH SUBMITTED 05172013 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS REPORTED EVENTS LUMPNODULES PTS CORE STUDY LABELING SILICONE IMPLANTS EVENTS LUMPNODULES PTS B4 STUDY LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/17/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2987556|3127805|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA SEROMA LIMITED INFORMATION AVAILABLE CASE INITIAL INVESTIGATION UNLIKELY CHANCE INFORMATION OBTAINED HOWEVER ADDITIONAL INFORMATION DEVICE INFORMATION IMPLANTINGEXPLANTING PHYSICIAN LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL FILE REVIEWED UPDATED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/26/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2987556|10550391|N|1||B4 DEVICE LABELING REVIEWED B4 STUDY SEROMA PRIMARY AUGMENTATION PATIENTS SEROMA RATE= 16 PRIMARY RECONSTRUCTION PATIENTS= 10 COMPLICATIONS SWELLING = 71 REPORTED EVENTS LYMPHOMAALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/26/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3523590|17924822|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA SEROMA VIA B4 ALCL RIGHT BREAST PRESENTED PERSISTENT SEROMAS REQUIRED MULTIPLE ASPIRATIONS TEXTURED IMPLANT PLACED SUBFASCIAL PECTORAL PLANE SALT BASED TEXTURE FULL CAPSULECTOMY REMOVAL IMPLANT DONE INTERCONSULTATION MEDONCOLOGY RECOMMENDED CHEMOTHERAPY CURRENT RECEIVED INVESTIGATION OFFICE ABLE PROVIDE MEDICAL RECORDS CLINICAL PATHOLOGY PROVIDED CAPSULE SEROMA RIGHT BREAST CAPSULE CONSISTENT ALCL SEROMA NOTES ATYPICAL CELLS CONSISTENT ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-330|11/15/2013|||DA|N|R||0HP|FTR|1.0|09/17/2011|nan||1338908|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3523590|18099523|N|1||DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PATIENTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PATIENTS = 10 COMPLICATIONS SWELLING = 71 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-330|11/15/2013|||DA|N|R||0HP|FTR|1.0|09/17/2011|nan||1338908|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3523596|17094739|N|1||DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PATIENTS SEROMA RATE = 16PRIMARY RECONSTRUCTION PATIENTS = 10 COMPLICATIONS SWELLING = 71 ALLERGEN CORE STUDY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGEN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/05/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3523596|16780284|D|1||HEALTHCARE PROFESSIONAL REPORTS VIA B4 CASE LYMPHOMA SEROMA REPORT STATES BILATERAL SUBGLANDULAR TEXTURED SILICONE BREAST IMPLANTS IMPLANTED 15 YEARS AGO RECENT DEVELOPMENT 700 CC OPAQUE PERI-IMPLANT SEROMA CAPSULAR THICKENING INF LEFT BREAST STATUS POST BILATERAL IMPLANT EXPLANTATION BILATERAL CAPSULECTOMY DIAGNOSIS LEFT BREAST IMPLANT ASSOCIATED ALCL LEFT BREAST CAPSULECTOMY PATHOLOGICAL SPECIMEN LEFT BREAST SEROMA FLUID POSITIVE ALCL CELLS FOLLOWING REPEAT BILATERAL CAPSULECTOMY DIAGNOSIS BILATERAL BREAST AUGMENTATIONCOSMESIS DEVICE INFORMATION PROVIDED CONTACT INFORMATION HEALTH PROFESSIONAL OBTAIN INFORMATION TIME|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/05/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3520860|11504286|N|1||DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PATIENTS SEROMA RATE = B4 PRIMARY RECONSTRUCTION PATIENTS = B4 COMPLICATIONS SWELLING = B4 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING PERFORM BREAST SELF-EXAMINATION MONTHLY IMPLANTED BREAST ORDER EFFECTIVELY ASK SURGEON HELP DISTINGUISH IMPLANT BREAST TISSUE NEW LUMPS ABNORMAL FINDING MAMMOGRAM EVALUATED BIOPSY SALINE PATIENT BROCHURE DEVICE LABELING REVIEWED FOLLOWING COMPLICATIONS REPORTED RATE LESS 0 CAPSULE CALCIFICATION GEL MIGRATION IRRIGATION CORE STUDY SILICONE DFU FOLLOWING COMPLICATIONS NOTED A95R95 3 YEAR 5 YEAR STUDY IRRITATIONINFLAMMATION 32 AUGMENTATION PATIENTS 66 RECONSTRUCTION PATIENTS SALINE DFU DY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PATIENTS A95R95 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|11/20/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3523577|19399809|N|1||DEVICE LABELING REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|12/02/2013|||DA|N|R||0HP|FWM|1.0|03/29/2008|nan||620705|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3523577|19486817|D|1||HEALTH PROFESSIONAL REPORTED CASE ALCL APPROX B6 2013 PT COMPLAINED LEFT SIDE DEFLATION EXAMINED NOTED RIGHT BREAST ENLARGING REVIEWING MAMMOGRAM PERFORMED B6 2013 FLUID SEEN BEHIND CAPSULE PT SENT MRI SHOWED UPTAKE CAPSULE PT ADMITTED ELEVATED WHITE COUNT ABDOMINAL PAIN CT ABDOMEN NEGATIVE WELL CXR DIAGNOSIS TIME ADMISSION RIGHT BREAST MASS ASPIRATION PERFORMED RESULTS 5 ATYPICAL CELLS PATHOLOGIST PERFORMED FLOWCYTOMETRY DIAGNOSIS ALCL MADE CAPSULE ALK- RESULTS SENT NIH CONFIRM DIAGNOSIS PET SCAN PERFORMED REVEALING LYMPH NODE POSITIVE SURGEON FEELS DUE DYE MRI PT UNDERGO ANOTHER WEEKS PT SEEN ONCOLOGIST RADIATION ONCOLOGIST DISCUSSING POSSIBLE TREATMENT RADIATION SURGEON STATES FEELS UNNECESSARY ADDL INFO SENT IFWHEN BECOMES AVAILABLE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|12/02/2013|||DA|N|R||0HP|FWM|1.0|03/29/2008|nan||620705|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3001322|19290071|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/08/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3001322|18848109|D|1||COMPANY REP REPORTS CASE ALCL INVESTIGATION SURGEON REPORTS PT MRI COMPLETE CAPSULECTOMY CYTOLOGY TAKEN CYTOLOGY REPORT NEGATIVE TIME HOWEVER TWO MONTHS LATER CAPSULE REPORTED POSITIVE ALCL PATHOLOGY RECEIVED ALLERGAN TIME INVESTIGATION STILL ONGOING NEW INFO FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/08/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3516781|15280203|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B6 STUDY LABELING SALINE BREAST IMPLANTS|STYLE 468 SALINE FILLED BREAST IMPLANT|468-495|11/22/2013|||DA|N|R||0HP|FWM|0.0||nan||NI|||GOLETA, NE||ALLERGAN||CA|||||True
3516781|15024064|D|1||LEGAL DOCUMENTS RECEIVED ALLERGAN NOTE CASE LYMPHOMA DOCUMENTS STATE B6 2002 PATIENT IMPLANTED MCGHAN 468 IMPLANTS B62011 PATIENT DIAGNOSED ABNORMAL T-CELL LARGE SIZE CONSISTENT T-CELL LYMPHOMA PARTICULARLY ALCL RADIOLOGY SCHEDULING FORM PREPARED EMORY HEALTHCARE B6 2011 DESCRIBES DIAGNOSIS T-CELL LYMPHOMA BREAST IMPLANTS TIME INVESTIGATION CANNOT TAKE PLACE DUE LACK INFORMATION PROVIDED ADDITIONAL INFORMATION OBTAINED REVIEWED REPORTED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-495|11/22/2013|||DA|N|R||0HP|FWM|0.0||nan||NI|||GOLETA, NE||ALLERGAN||CA|||||True
3402996|11151144|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY LABELING SILICONE BREAST IMPLANTS|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-492|10/07/2013|||DA|N|R||0HP|FTR|1.0|07/30/2012|nan||1478533|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3349460|3862832|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE POSSIBLE ALCL DISCOVERED PT PRESENTED COMPLAINT SEROMA LABS PRESENTED CASE DATE|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|09/04/2013|||DA|N|R||0HP|FTR|1.0|11/15/2008|nan||249662|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3349460|11291351|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|09/04/2013|||DA|N|R||0HP|FTR|1.0|11/15/2008|nan||249662|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3165348|10785196|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B6 STUDY LABELING SILICONE IMPLANTS|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-800|06/07/2013|||DA|N|R||0HP|FTR|1.0|04/16/2013|nan||1599614|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2926387|15858134|D|1||POSSIBLE ALCL SYMPTOMS|GEL-FILLED MAMMARY PROSTHESIS|354-4007|01/15/2013||||N|R||0HP|FTR|1.0||BREAST IMPLANT||5627854|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR|75038|TX|75038||||True
3142943|20557559|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/30/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2979718|10510771|N|1||MEDWATCH SUBMITTED B4 2013 DEVICE LABELING ADDRESSES IRRITATIONINFLAMMATION SIGNS ACUTE INFECTION INCLUDE ERYTHEMA TENDERNESS FLUID ACCUMULATION PAIN FEVER PTS ADVISED CONTACT PHYSICIAN IMMEDIATELY DIAGNOSIS TREATMENT SYMPTOMS DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 363 SALINE FILLED BREAST IMPLANT|27-363311|02/22/2013|||DA|N|R||0HP|FWM|1.0|01/15/2006|nan||85285R|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN||AA|||||True
2903656|3063201|D|1||ALCL CASE REPORT DIAGNOSIS ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA CD30+ SP LEFT AXILLARY LN BIOPSY 52110 PT B6 FEMALE STAGE IV ALK NEGATIVE ANAPLASTIC LARGE-CELL LYMPHOMA DIAGNOSED B6 2010 CURRENTLY UNDERGOING CHEMOTHERAPY FOLLOWED ONCOLOGY BILATERAL BREAST AUGMENTATION SILICONE IMPLANTS 30 YEARS AGO RUPTURE RIGHT SIDE IMPLANTS REMOVED REPLACED 2005 LOCAL PLASTIC SURGEON STATES SUBPECTORAL INFRAMAMMARY FOLD INCISION BELIEVES RIGHT IMPLANT 325 CC LEFT 350 CC ONE RECENT CT SCANS PERFORMED LYMPHOMA STAGING APPEARED EVIDENCE RUPTURE RIGHT BREAST IMPLANT REMOVED IMPLANTS B6 2012 REPLACED DUE POSSIBLE LINK BREAST IMPLANTS ALCL|INAMED||12/28/2012|||||||0HP|FTR|2.0||SILICONE BREAST IMPLANT||NONE|||IRVINE|US|ALLERGAN||CA|||STYLE 110|REF# 110-390|True
2903656|3063201|D|1||ALCL CASE REPORT DIAGNOSIS ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA CD30+ SP LEFT AXILLARY LN BIOPSY 52110 PT B6 FEMALE STAGE IV ALK NEGATIVE ANAPLASTIC LARGE-CELL LYMPHOMA DIAGNOSED B6 2010 CURRENTLY UNDERGOING CHEMOTHERAPY FOLLOWED ONCOLOGY BILATERAL BREAST AUGMENTATION SILICONE IMPLANTS 30 YEARS AGO RUPTURE RIGHT SIDE IMPLANTS REMOVED REPLACED 2005 LOCAL PLASTIC SURGEON STATES SUBPECTORAL INFRAMAMMARY FOLD INCISION BELIEVES RIGHT IMPLANT 325 CC LEFT 350 CC ONE RECENT CT SCANS PERFORMED LYMPHOMA STAGING APPEARED EVIDENCE RUPTURE RIGHT BREAST IMPLANT REMOVED IMPLANTS B6 2012 REPLACED DUE POSSIBLE LINK BREAST IMPLANTS ALCL|INAMED||12/28/2012||10/01/2012||R|||0HP|FTR|1.0||SILICONE BREAST IMPLANT||NONE|||IRVINE|US|ALLERGAN||CA|||STYLE 110|REF# 110-420|True
2930345|17450111|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED LETTER REPORTING PATIENT BILATERAL BREAST AUGMENTATION MCGHAN SILICONE GEL FILLED BREAST IMPLANTS DIAGNOSED CB-30 POSITIVE ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA LIMITED INFORMATION AVAILABLE CASE INITIAL INVESTIGATION UNLIKELY CHANCE INFORMATION OBTAINED HOWEVER ADDITIONAL INFORMATION DEVICE INFORMATION IMPLANTINGEXPLANTING PHYSICIAN LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL FILE REVIEWED UPDATED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|01/22/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA||||NI|True
2930345|17758765|N|1||MEDWATCH SUBMITTED B4 2013 ALLERGAN PRODUCT LABELING SALINE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY WELL B4 STUDY B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|01/22/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA||||NI|True
3030996|20232348|D|1||HEALTH PROFESSIONAL REPORTED CAPSULAR CONTRACTURE BAKER GRADE IV POTENTIALLY ALCL EVENT SUBMITTED B6 B6 2010|STYLE 168 SALINE FILLED BREAST IMPLANT|168-240|11/15/2012||05/27/2010|DA|Y|Y||0HP|FWM|1.0|04/10/2003|nan||542534|||GOLETA|US|ALLERGAN||CA|||||True
3030996|20584028|N|1||MED WATCH SUBMITTED B4 2012 LAB ANALYSIS YELLOW PARTICLES INNER OUTER SURFACE IMPLANT BROWN PARTICLES NOTED FILL CHANNEL DEVICE NOTED BIOLOGICAL TISSUE 243 GMS FLUID DRAINED DEVICE DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS B4 STUDY 3 YEAR 5 YEAR CUMULATIVE FIRST OCCURRENCE KAPLAN-MEIER ADVERSE EVENT RATES 95 CONFIDENCE INTERVAL PATIENT SEROMA 26 3 YEARS 26 5 YEARS BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING ADDRESS CAPSULAR CONTRACTURE AUGMENTATION CAPSULAR CONTRACTURE 725 RECONSTRUCTION NA CAPSULAR CONTRACTURE 125 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 168 SALINE FILLED BREAST IMPLANT|168-240|11/15/2012||05/27/2010|DA|Y|Y||0HP|FWM|1.0|04/10/2003|nan||542534|||GOLETA|US|ALLERGAN||CA|||||True
3070387|3264818|D|1||MAY CONCERN PURSUANT PARTNERSHIP FDA B4 CONCERNING BREAST IMPLANT-ASSOCIATED ALCL REPORTING CASE ALCL ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT PT B6 FEMALE FIRST PRESENTED LAST B6 BREAST AUGMENTATION B6 SEVERAL YEARS PRIOR NOTICED SWELLING LEFT BREAST EVENTUALLY BECAME PAINFUL CAUSED SEEK TREATMENT WORKUP EVENTUALLY REVEALED SEROMA AROUND BREAST IMPLANT FLUID CAME BACK CD 30 POSITIVE ALK NEGATIVE CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA IMPLANTS REMOVED BILATERALLY FELT ADEQUATE TREATMENT PROBLEM CONTINUES UNDERGO SURVEILLANCE US ADDITION HEMATOLOGYONCOLOGY TEAM NOTE FOUND NONRUPTURED 410 CC TEXTURED SILICONE IMPLANTS MADE CUI AVAILABLE UNITED STATES PTS CARE COORDINATED PLASTIC SURGERY HEMATOLOGYONCOLOGY TEAMS B6 BREAST IMPLANTS REMOVED REPLACED PT UNDERGO SURVEILLANCE MRI ULTRASOUND|TEXTURED SILICONE BREAST IMPLANT||04/16/2013|||DA|N|||0HP|FTR|1.0||TESTURED SILICONE BREAST IMPLANT, 410 CC||UNK|||||COX-UPHOFF INTERNATIONAL|||||||True
3530889|15985736|N|1||B4 DEVICE LABELING ADDRESSES EVENTS FOLLOWING LIST POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY IMPLANT DEFLATIONLEAKAGE ADDL SURGERY CAPSULAR CONTRACTURE INFECTION TOXIC SHOCK SYNDROME NECROSIS HEMATOMA SEROMA EXTRUSION BREAST PAIN CHANGES NIPPLE SENSATION CHANGES BREAST SENSATION DISSATISFACTION COSMETIC RESULTS WRINKLING FOLDING DISPLACEMENT ASYMMETRY PALPABILITY VISIBILITY PTOSIS SLOSHING CALCIFIC DEPOSITS IRRITATIONINFLAMMATION DELAYED WOUND HEALING HYPERTROPHIC SCARRING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY DIFFICULTYINABILITY BREAST FEEDING INABILITY ADEQUATELY VISUALIZE BREAST LESIONS MAMMOGRAPHY PRIMARY AUGMENTATION PATIENTS SEROMA RATE= 26 PRIMARY RECONSTRUCTION PATIENTS SEROMA RATE = 39 DEFLATION RATE = 68 75 REPORTED EVENTS LYMPHOMAALCL PATIENTS A95R95 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 468 SALINE FILLED BREAST IMPLANT|468-495|12/17/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|71 SOUTH LOS CARNEROS ROAD||GOLETA|US|ALLERGAN|93117|CA|93117||||True
3530889|15813592|D|1||ALLERGAN LEGAL REPORTS CASE LYMPHOMA ALCL MAMMOGRAM ULTRASOUND SHOWED DIFFUSE EXTRAVASATED FLUID NOTED AROUND RIGHT BREAST IMPLANT CONSISTENT LEAK SPECIFIC FINDINGS MALIGNANCY SURGICAL CONSULTATION RECOMMENDED LEAKAGE DEVICE CYTOLOGY REPORT RIGHT SIDE ASPIRATES TAKEN NOTED POSITIVE MALIGNANT CELLS ALCL PATHOLOGY REPORT RIGHT SIDE CAPSULE SHOWED CHRONIC INFLAMMATION MALIGNANCY|STYLE 468 SALINE FILLED BREAST IMPLANT|468-495|12/17/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|71 SOUTH LOS CARNEROS ROAD||GOLETA|US|ALLERGAN|93117|CA|93117||||True
3519392|3961243|D|1||RECEIVED REPORT ALCL VIA B4 LIMITED INFORMATION NOTED FORM STATES ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED LEFT BREAST PATIENT STYLE 468 TEXTURED SALINE BREAST IMPLANT B6 CONTACT INFORMATION PROVIDED THEREFORE INVESTIGATION ABLE PERFORMED TIME|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|12/03/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3519392|11323356|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|12/03/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3474013|15266478|D|1||2010 EXPERIENCED HEMATOMA LOWER INSIDE LEFT BREAST ACCOMPANIED GREAT PAIN GRADUALLY BREAST DEVELOPED PAINFUL CAPSULAR CONTRACTURE MASS LEFT ARMPIT LYMPH NODES TREATED B6 ASTHMA MEDICATION WORK RECEIVED LETTER ALCL ALARMED EVEN SAW SEVERAL DOCTORS NONE KNEW TEST ALCL BEGAN EXPERIENCING SENSATION CHEST FELT LIKE ABSCESS SPREADING RIBCAGE LUNG MAKES INCREDIBLY HARD SLEEP NIGHT CONSTANT PAIN RECENTLY OFFICE B4WAS CLOSED FORCED GO FIELD TECHNICIAN LINEMAN POSITION PROGRESSED TRAINING LAST 6 MONTHS EXPERIENCED UNBELIEVABLE AMOUNT PAIN LACK SLEEP UBER FATIGUE WENT B6 AUTOMATICALLY PROVIDE INSURANCE LAST YEAR ASKED MRI FINALLY GOT MRI RADIOLOGIST STATED IMPLANT POSSIBLY RUPTURED EVIDENCE 2 LEAKS EXACT WORDING SUBJECT INTERPRETATION SINCE RECEIVED INFORMATION 2 WEEKS AGO RESEARCHED INTERNET FOUND B4 PROVIDING EXPLANT MONEY CERTAIN CONDITIONS UNFORTUNATELY CONDITIONS STIPULATIONS EXTREMELY SUBJECTIVE EXAMPLE EXPLANT MONEY ALLOTTED IMPLANT SUBJECT EXPOSED SORT STRESS ACCIDENT ALSO LIFETIME WARRANTY CASES APPLICABLE BRINGS QUESTION DETERMINATION MADE CASE IMPLANTS WARRANTY WOULD CHOOSE REPLACED DYNAMICS EXPLANT SURGERY B4 PROVIDE BREAST IMPLANTS CASE EXPLANT FITS PERFECT LITTLE BOX CREATED SURGEON COMPELLED GO CHECKLIST MIDDLE SURGERY DET|SILIMED BREAST IMPLANT|UNK|11/13/2013|||||||0|FTR|1.0|11/25/2014|BREAST IMPLANT||UNK|||||SIENTRA|||||SILIMED|UNK|True
2933302|3232091|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED LETTER REPORTING PATIENT UNDERWENT BREAST AUGMENTATION SURGERY IMPLANTATION GEL FILLED IMPLANT DIAGNOSED SEROMA ASSOCIATED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA ADJACENT IMPLANT LIMITED INFORMATION AVAILABLE CASE INITIAL INVESTIGATION UNLIKELY CHANCE INFORMATION OBTAINED HOWEVER ADDITIONAL INFORMATION DEVICE INFORMATION IMPLANTINGEXPLANTING PHYSICIAN LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL FILE REVIEWED UPDATED|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|01/23/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2933302|10417526|N|1||MEDWATCH SUBMITTED B4 2013 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY LABELING SILICONE IMPLANTS EVENT SEROMA PER B4 STUDY AUGMENTATION PATIENTS B4 REPORTED|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|01/23/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3031018|15417883|N|1||MED WATCH SUBMITTED B4 2012 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS B4 STUDY 7 YEAR ADVERSE EVENT RATES PRIMARY AUGMENTATION PATIENTS SEROMA RATE = B4 PRIMARY RECONSTRUCTION PATIENTS = B4 COMPLICATIONS SWELLING = B4 REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY LABELING SILICONE IMPLANTS|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-390|11/15/2012|||DA|N|R||0HP|FTR|1.0|12/01/1995|nan||2-143391|||GOLETA, NE|US|ALLERGAN||CA|||||True
3031018|15024796|D|1||HEALTHCARE PROFESSIONAL REPORTED ALLERGAN EMPLOYEE ALCL SEROMA ALLERGAN ABLE GATHER INFORMATION REGARDING DEVICE ALONG PATIENT NOTES MEDWATCH SUBMITTED VIA B6 2011|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-390|11/15/2012|||DA|N|R||0HP|FTR|1.0|12/01/1995|nan||2-143391|||GOLETA, NE|US|ALLERGAN||CA|||||True
3031001|10651277|N|1||MEDWATCH SUBMITTED B4 2012 EVENTS INITIALLY SUBMITTED VIA B6 Q4 B6 2011 DEVICE LABELING ADDRESSES CAPSULAR CONTRACTURE FOLLOWING INFORMATION PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME SEVEN YEAR CORE STUDY NOTES PRIMARY AUGMENTATION CAPSULAR CONTRACTURE IIIIV B4 SEVEN YEAR CORE STUDY NOTES PRIMARY RECONSTRUCTION B4 SILICONE DFU LABELING NOTES PATIENTS B4 STUDY INCLUDED CAPSULAR CONTRACTURE RATE B4 AUGMENTATION B4 RECONSTRUCTION SALINE DFU DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B6 STUDY LABELING SILICONE IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|11/29/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA, NE|US|ALLERGAN||CA|||||True
3378228|3720626|D|1||HEALTHCARE PROFESSIONAL REPORTS COMPANY REP CASE SEROMA POSSIBLE ALCL PT AUGMENTATION SURGERY 1998 SILICONE BREAST IMPLANTS PT PRESENTS LEFT BREAST SWELLING EXPLANT SURGERY TOOK PLACE B6 2013 SEROMA SENT CYTOLOGY POSITIVE ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/17/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3378228|11263716|N|1||MEDWATCH SUBMITTED B4 2013 DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMA SEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/17/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3370062|19556679|D|1||ALCL DOCTOR RETIRED COMPLAINT INFORMATION PROVIDED MEDWATCH|nan||09/13/2013|||DA|N|R||0HP|FWM|1.0||BREAST IMPLANT|||||IRVING|US|MENTOR||TX|||||True
3533089|19299131|D|1||ALCL CASE REPORT PT BILATERAL BREAST AUGMENTATION PERFORMED 2005 RECENTLY DEVELOPED SEROMA ASPIRATED FOUND ATYPICAL CELLS PERFORMED BILATERAL IMPLANT REMOVAL TOTAL CAPSULECTOMY FINAL PATHOLOGY REVEALED ALCL LEFT BREAST|INAMED SALINE BREAST IMPLANT||10/22/2013||||N|||0HP|FWM|1.0||SALINE BREAST IMPLANT|||||||INAMED|||||||True
3896045|12024305|N|1||DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4  INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|06/12/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3896045|4542003|D|1||RECEIVED NOTIFICATION MEDICAL AFFAIRS CASE ALCL HEALTHCARE PROFESSIONAL REPORTS B6 PT RECEIVED COSMETIC AUGMENTATION 1969 PERMANENT SILICONE IMPLANTS DUE CAPSULAR CONTRACTURE EXCHANGED PERMANENT SALINE IMPLANTS 1997 B6 2013 DEVELOPED DELAYED SEROMA LEFT BREAST FNA DEMONSTRATED BIA-ALCL UNDERWENT BILATERAL EXPLANTATION CAPSULECTOMIES B6 2013 PT NOTED MASS MEDIAL ASPECT LEFT CAPSULE POSTOPERATIVE PATHOLOGY CONFIRMED BIA-ALCL MARGINS POSITIVE RETURNED OPERATING ROOM B6 2014 BILATERAL COMPLETION CAPSULECTOMY RESIDUAL BIA-ALCL PATHOLOGY REMAINS DISEASE FREE PT ALSO HISTORY RIGHT BREAST CANCER TREATED MASTECTOMY NODAL DISSECTION PLACEMENT TISSUE EXPANDER IMMEDIATELY 2003 GET CHEMOTHERAPY RADIATION SUBSEQUENTLY PLACED ENDOCRINE TREATMENT 5 YEARS NOTIFICATION ALSO PROVIDED DATE EXPLANTATION CAPSULECTOMY TOOK PLACE B6 2014 NOTES 168-330 FILLED 325CC PLACED SUB-MUSCULARLY DATE DIAGNOSIS B6 2014 PROVIDES LYMPHOMA CELLS POSITIVE CD30 DIFFUSE STRONG CD43 WEAK NEGATIVE CD3 CD20 CD45 ALK-1 CD68 E-CADHERIN MOC31 GATA3 ER PR AE1AE3 PAN-CK CK7 CAM52 MELANOMA COCKTAIL S-100 CD3 CD20 STAINS HIGHLIGHT BACKGROUND RARE SCATTERED SMALL T-CELLS B-CELLS RESPECTIVELY CD45 STAIN HIGHLIGHTS SCATTERED HEMATOPOIETIC CELLS CD68 INFO PROVIDED T25 ALSO NEGATIVE PATHOLOGY REPORT REQUESTED PROVIDED IFTHEN INFO PROVIDED FORWARDED MEDICAL SAFETY TEAM DETERMINED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL HOWEVER ADDL INFO LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL FILE REVIEWED UPDATED|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|06/12/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3738245|11860603|N|1||DEVICE LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA ALCL BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMAWHEN TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF155-740|03/31/2014|||DA|N|R||0HP|FTR|1.0|02/15/2004|nan||47173|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3642248|4203744|D|1||LITERATURE REVIEW CHEMOTHERAPY-RESISTANT BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA MURALIDHARAN PARTHASARATHY ET AL BMJ CASE REP 2013 ARTICLE REPORTS PT PRESENTING SYMPTOMS DISCOMFORT HARDENING LEFT BREAST EXAM REVEALED VAGUE MASS MEASURING 5 CM UPPER OUTER QUADRANT LEFT BREAST TOGETHER PALPABLE AXILLARY LYMPH NODES THREE YEARS PRIOR PT TREATED SEROMA DRAINED SEROMA NOTED TIME BILATERAL CAPSULAR CONTRACTURE NOTED LEFT RIGHT DIAGNOSTICS CONFIRMED ALCL LEFT BREAST CHEMOTHERAPY TREATMENT CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE PT REASSESSED LEFT BREAST MASS UNCHANGED SECOND LINE CHEMOTHERAPY GIVEN CISPLATIN GEMCITABINE REPEAT CORE BIOPSY CONFIRMED PERSISTENT ALK NEGATIVE ALCL PT LEFT MASTECTOMY REMOVAL LEFT BREAST IMPLANT FOLLOWED RADIATION THERAPY PT SINCE RECOVERED SIGNS RECURRENCE ALTHOUGH MFR DEVICE UNK ALLERGANS APPROACH COMPLIANCE RESOLVE DOUBT FAVOR REPORTING|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/31/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNK||CA|||||True
3642248|11681289|N|1||ALLERGAN REQUESTED INFO AUTHOR ARTICLE RECEIVED DATE DEVICE LABELING ADDRESSES EVENT SEROMA LYMPHADENOPATHY CAPSULAR CONTRACTURE PRIMARY AUGMENTATION PTS ALLERGAN CORE STUDY SEROMA RATE = 16 LYMPHADENOPATHY = 0 CAPSULAR CONTRACTURE = 155 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA PTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENT LYMPHOMAALCL PT CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS NOTED LUMPNODULES MASSES PTS B4 STUDY LABELING SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/31/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNK||CA|||||True
3642248|55007799|D|1||LITERATURE REVIEW CHEMOTHERAPY-RESISTANT BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA MURALIDHARAN PARTHASARATHY ET AL BMJ CASE REP 2013 ARTICLE REPORTS PATIENT PRESENTING SYMPTOMS DISCOMFORT HARDENING LEFT BREAST EXAM REVEALED VAGUE MASS MEASURING 5 CM UPPER OUTER QUADRANT LEFT BREAST TOGETHER PALPABLE AXILLARY LYMPH NODES THREE YEARS PRIOR PATIENT TREATED SEROMA DRAINED SEROMA NOTED TIME BILATERAL CAPSULAR CONTRACTURE NOTED LEFT RIGHT DIAGNOSTICS CONFIRMED ALCL LEFT BREAST CHEMOTHERAPY TREATMENT CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE PATIENT REASSESSED LEFT BREAST MASS UNCHANGED SECOND LINE CHEMOTHERAPY GIVEN CISPLATIN GEMCITABINE REPEAT CORE BIOPSY CONFIRMED PERSISTENT ALK NEGATIVE ALCL PATIENT LEFT MASTECTOMY REMOVAL LEFT BREAST IMPLANT FOLLOWED RADIATION THERAPY PATIENT SINCE RECOVERED SIGNS RECURRENCE ALTHOUGH MANUFACTURER DEVICE UNKNOWN ALLERGANS APPROACH COMPLIANCE RESOLVE DOUBT FAVOR REPORTING|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/31/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNK||CA|||||True
4370907|20979164|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE DRAINAGE REDNESS TISSUE BREAK INCISION INFECTION HEALTHCARE PROFESSIONAL ALSO REPORTED DEVICE REMOVED INSIDE CAPSULE BLACK GRANULES SPECIFIED BLOOD CLOTS ADDITIONAL REPORT INCLUDES PT MAY ALCL CAPTURED LYMPHOMA CONFIRMED VIA DIAGNOSTICS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410640|12/23/2014|||DA|N|R||0HP|FTR|1.0||nan||2586316|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4370907|21377261|N|1||B4 DEVICE LABELING ADDRESSES LYMPHOMA REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS DEVICE LABELING ADDRESSES INFECTION ERYTHEMA DRAINAGE WOUND DEHISCENCE POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIGNS ACUTE INFECTION INCLUDE ERYTHEMA TENDERNESS FLUID ACCUMULATION PAIN FEVER DEVICE LABELING ADDRESSES THROMBUS PRECAUTION CONDITIONS MEDICATIONS INTERFERE WOULD HEALING|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410640|12/23/2014|||DA|N|R||0HP|FTR|1.0||nan||2586316|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3896044|4422726|D|1||PT REPORTED RIGHT SIDE LUMP ANAPLASTIC LARGE CELL LYMPHOMA MEDICAL SAFETY TEAM DETERMINED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CRITERIA DIAGNOSE ALCL LIMITED INFO AVAILABLE CASE INITIAL INVESTIGATION UNLIKELY CHANCE INFO OBTAINED HOWEVER ADDL INFO DEVICE INFO IMPLANTINGEXPLANTING PHYSICIAN LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSED ALCL FILE REVIEWED UPDATED|STYLE 168 SALINE FILLED BREAST IMPLANT|168-210|06/12/2014|||DA|N|R||0HP|FWM|1.0|07/27/2012|nan||1643163|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3896044|11927538|N|1||DEVICE LABELINGPT BROCHURE SILICONE PT BROCHURE BREAST SELF EXAMINATIONS FOLLOWING BREAST AUGMENTATION CONTINUE PERFORM BREAST SELF-EXAMINATION MONTHLY MAY DIFFICULT BREAST IMPLANT PLACE CONTINUE PERFORM MONTHLY BREAST SELF EXAMINATION EFFICIENTLY ASK SURGEON HELP IDENTIFY DIFFERENCE IMPLANT BREAST TISSUE ABLE IDENTIFY IMPLANT BREAST TISSUE DECREASE NECESSITY EXCESSIVE SQUEEZING IMPLANT EXAMINATION NEW LUMPS EVALUATED BIOPSY APPROPRIATE BIOPSY PERFORMED SURE INFORM MEDICAL PROFESSIONAL PERFORMING BIOPSY BREAST IMPLANTS CARE TAKEN AVOID INJURING IMPLANT DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 168 SALINE FILLED BREAST IMPLANT|168-210|06/12/2014|||DA|N|R||0HP|FWM|1.0|07/27/2012|nan||1643163|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3946570|54659173|D|1||HEALTHCARE PROFESSIONAL REPORTS INCIDENCE ANAPLASTIC LARGE CELL LYMPHOMA ALCL APPEARS ASSOCIATED USE TEXTURED BREAST IMPLANTS ENCOUNTERED 3 CASES WITHIN PAST 3 YEARS 130 CASES REPORTED WORLDWIDE TWO PATIENTS MCGHAN IMPLANTS IE TEXTURING PROCESS ALLERGAN CURRENTLY USE MEDICAL SAFETY TEAM DETERMINED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL MULTIPLE ATTEMPTS MADE OBTAIN INFORMATION INCLUDING CYTOLOGYPATHOLOGY REPORTS DEVICE INFORMATION ETC IFWHEN ADDITIONAL INFORMATION BECOME AVAILABLE FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3946570|12158512|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B6 STUDY LABELING SILICONE IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3946570|4604105|D|1||HEALTHCARE PROFESSIONAL REPORTS INCIDENCE ANAPLASTIC LARGE CELL LYMPHOMA ALCL APPEARS ASSOCIATED USE TEXTURED BREAST IMPLANTS ENCOUNTERED 3 CASES WITHIN PAST 3 YEARS 130 CASES REPORTED WORLDWIDE TWO PTS MCGHAN IMPLANTS IE TEXTURING PROCESS ALLERGAN CURRENTLY USE MEDICAL SAFETY TEAM DETERMINED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL MULTIPLE ATTEMPTS MADE OBTAIN INFO INCLUDING CYTOLOGYPATHOLOGY REPORTS DEVICE INFO ETC IFWHEN ADDL INFO BECOME AVAILABLE FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3827677|11796221|N|1||DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 DEVICE LABELING REVIEW REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY LABELING SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/08/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
4027347|11946404|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY LABELING SILICONE IMPLANTS|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-150|08/05/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3827707|22310609|N|1||DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS DEVICE LABELING REVIEWED EVENTS LYMPHOMAALCL NOTED SILICONE DEVICE LABELING B4 STUDY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/08/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNK||CA|||||True
4020375|11988433|N|1||DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PT = 10 COMPLICATIONS SWELLING = 71 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL PTS A95R95 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS SILICONE PT BROCHURE BREAST SELF-EXAMINATIONS FOLLOWING BREAST AUGMENTATION CONTINUE PERFORM BREAST SELF-EXAMINATION MONTHLY MAY DIFFICULT BREAST IMPLANT PLACE CONTINUE PERFORM MONTHLY BREAST SELF EXAMINATION EFFICIENTLY ASK SURGEON HELP IDENTIFY DIFFERENCE IMPLANT BREAST TISSUE ABLE IDENTIFY IMPLANT BREAST TISSUE DECREASE NECESSITY EXCESSIVE ANT EXAMINATION NEW LUMPS EVALUATED BIOPSY APPROPRIATE BIOPSY PERFORMED SURE INFORM MEDICAL PROFESSIONAL PERFORMING BIOPSY BREAST IMPLANTS CARE TAKEN AVOID INJURING IMPLANT SALINE PT BROCHURE DISTINGUISHING IMPLANT BREAST TISSUE BREAST SELF-EXAMINATION PERFORM BREAST SELF-EXAMINATION MONTHLY IMPLANTED BREAST ORDER EFFECTIVELY ASK SURGEON HELP DISTINGUISH IMPLANT BREAST TISSUE NEW LUMPS ABNORMAL FINDING MAMMOGRAM EVALUATED BIOPSY BIOPSY PERFORMED CARE MUST TAKEN AVOID PUNCTURING IMPLANT|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/31/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
4020375|4878205|D|1||B6 2014 RECEIVED ARTICLE PRODUCT WATCH ENTITLED FLOW CYTOMETRY ALK- NEGATIVE ALCL BREAST IMPLANT ASSOCIATED EFFUSION CAPSULAR TISSUE WITHIN ARTICLE NOTES CASE B6 YEAR OLD PT BREAST PROSTHETIC IMPLANT 65 YEARS PRIOR CLINICAL PRESENTATION UPON PRESENTATION PT REPORTED SWELLING AREA WITHOUT PAIN ERYTHEMA BILATERAL MAMMOGRAM BREAST ULTRA-SOUND REPORTED NEGATIVE MASS LESIONS NEVERTHELESS LARGE AMOUNT FLUID IDENTIFIED AROUND RIGHT IMPLANT INVOLVING ADJACENT CAPSULAR TISSUE ASPIRATION FLUID 380 CC DEMONSTRATED HIGHLY ATYPICAL CELLS CT SCAN CHEST ABDOMEN PELVIS SHOWED EVIDENCE DISEASE RESULT IMMUNOHISTOCHEMICAL STAINING POSITIVE CD15 CD30 45 NEGATIVE ALK-1 PAX-5 CD3 CD20 PAN-CYTOKERATIN EMA MENTION DEVICES USED PT THEREFORE EMAIL SENT AUTHOR TRY OBTAIN MISSING INFO|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/31/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3895999|16446469|D|1||L BREAST IMPLANTED LARGE CELL LYMPHOMA SP L BREAST IMPLANT PLACEMENT 2003 1998- B6 DIAGNOSED L BREAST CA L LUMPECTOMY RADIATION DONE 2002-L LATISSIMUS DORSI MYOCUTANEOUS FLAP RECONSTRUCTION TISSUE EXPANDER MENTOR REFB4 LOT 248391 R SUBQ MASTECTOMY IMMEDIATE RECONSTRUCTION SALINE IMPLANT MENTOR REFB4 SILTEX CONTOUR PROFILE MAMM PROSTH LOT 251827 SN B4 ADDED 450ML IMPLANT PATH REPORT B6 2002 NEGATIVE CARCINOMA EITHER BREAST B62013 SECOND STAGE RECONSTRUCTION L BREAST EXPANDER REMOVED MCGHAN 163 SALINE IMPLANT PLACED REF B4 SN B4 LOT 582791 380CC PRESENTED DR B6 B6 2014 PAIN SWELLING L BREAST-GRADE IV CAPSULE CONTRACTURE NOTED WISH SCHEDULE SURGERY TIME SECOND CONSULTATION B6 2014 NEW LUMP L BREAST ULTRASOUND MRI L BREAST BIOPSY DONE B6 2014 REMOVED INTACT IMPLANT L BREAST MCGHAN STYLE 163 SALINE TEXTURED IMPLANT L TOTAL CAPSULECTOMY L BREAST PATH REPORT SHOWS ALCL ANAPLASTIC LARGE CELL LYMPHOMA|MCGHAN|27-163361|06/20/2014|||||||0HP|FWM|1.0||SALINE IMPLANT||582791|||SANTA BARBARA||INAMED|93111||93111||STYLE 163||True
3883642|12109135|N|1||B4 DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS CORE STUDY 7 YEAR ADVERSE EVENT RATES PRIMARY AUGMENTATION PTS SEROMA RATE= 16 PRIMARY RECONSTRUCTION PTS =10 COMPLICATIONS SWELLING = 71 BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN SILICONE LABELING DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS SILICONE PT BROCHURE BREAST SELF-EXAMINATIONS FOLLOWING BREAST AUGMENTATION CONTINUE PERFORM BREAST SELF-EXAMINATION MONTHLY MAY DIFFICULT BREAST IMPLANT PLACE CONTINUE PERFORM MONTHLY BREAST SELF EXAMINATION EFFICIENTLY ASK SURGEON HELP IDENTIFY DIFFERENCE IMPLANT BREAST TISSUE ABLE IDENTIFY IMPLANT BREAST TISSUE DECREASE NECESSITY EXCESSIVE SQUEEZING IMPLANT EXAMINATION NEW LUMPS PSY APPROPRIATE BIOPSY PERFORMED SURE INFORM MEDICAL PROFESSIONAL PERFORMING BIOPSY BREAST IMPLANTS CARE TAKEN AVOID INJURING IMPLANT|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110361|06/18/2014|||DA|N|R||0HP|FTR|1.0|09/30/2010|nan||1148082|||ARKLOW, COUNTY, WICKLOW|EI|ALLERGAN|||||||True
3883642|4565748|D|1||ADDITIONAL INFO RECEIVED LITERATURE ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS FIVE AUSTRALIAN CASES PUBLISHED PLASTIC RECONSTRUCTIVE SURGERY B6 2012 PG 610E-617E WITHIN ARTICLE AUTHOR DESCRIBES B6 UNDERWENT BILATERAL AUGMENTATION 110-360 INAMED TEXTURED ROUND DEVICES VIA INFRAMAMMARY SUB GLANDULAR POCKET B6 2008 PT PRESENTED SPONTANEOUS LEFT BREAST SWELLING ALTHOUGH FEVER MILD DISCOMFORT LEFT BREAST DIFFUSELY SWOLLEN PT NORMAL MAMMO 2008 2009 ULTRASOUND REVEALED SEROMA CT SCAN SHOWED INFOLDING IMPLANT 7 9 OCLOCK APPARENT MASS SLIGHTLY INCREASED DENSITY B6 2009 SURGERY PLANNED REMOVE PRESUMED RUPTURED IMPLANT TIME SURGERY STRAW COLORED SEROMA 200CC FOUND IMPLANT INTACT WITHIN CAPSULE TWO AREAS GRANULOMATOUS TISSUE THICK MASS INFEROMEDIALLY CAPSULE MASS SENT MICROBIOLOGY CULTURE HISTOPATHOLOGY LYMPHOID CELLS HIGHLY ATYPICAL SHOWING ENLARGED IRREGULARLY CONFIGURED NUCLEI IMMUNOHISTOCHEMICAL ANALYSIS SHOWED CD30 + ALK- B-CELL MARKER NEGATIVE T-CELL MARKER PARTIAL PATCHILY-POSITIVE CD3 CD43 CD45RO CD5 TISSUE FINDINGS CONSISTENT LOCALIZED FORM SYSTEMIC ALCL LARGE T-CELL LYMPHOMA BREAST HEALED RECURRENT MASS APPEARED WEEKS LATER STAGING CT CHEST ABD PELVIS PET SCAN SHOWED EVIDENCE DISEASE OUTSIDE BREAST UNDERWENT CHEMO CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE B6 2009 MASS FAILED RESPOND PROGRESSED WOUND LYMPHOMA METASTASIZED THORACOLUMBAR REGION RIGHT LUNG SEEN B6 2009 PET SCAN TREATED RADIATION SECOND ROUND CHEMO USING GEMCITABINE IFOSFAMIDE VINORELBINE RESPONDED WELL UNDERWENT BONE MARROW TRANSPLANT 122009 TWO YEARS DIAGNOSIS REMAINS REMISSION EVENT ORIGINALLY SUBMITTED VIA B4 B4 2011|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110361|06/18/2014|||DA|N|R||0HP|FTR|1.0|09/30/2010|nan||1148082|||ARKLOW, COUNTY, WICKLOW|EI|ALLERGAN|||||||True
3676747|18765997|N|1||DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS FOLLOWING LIST POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY RISKS INCLUDE IMPLANT DEFLATIONLEAKAGE ADDL SURGERY CAPSULAR CONTRACTURE DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY LABELING SILICONE IMPLANTS|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|02/25/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3676747|18791128|D|1||HEALTHCARE PROFESSIONAL REPORTS CAPSULAR CONTRACTURE SEROMA ALCL LEFT SIDE DEVICE RECEIVED CALL HEALTHCARE PROFESSIONAL INDICATING INFO REGARDING CASE WAITING SURGEON SIGN OP REPORT ALSO INFORMED ORIGINAL IMPLANTING SURGEON LONGER PTS MEDICAL RECORDS PT PART B6 STUDY DOESNT REMEMBER ONE INFO OBTAINED EXPLANTING PHYSICIAN SUBMITTED DIRECTOR MEDICAL SAFETY DETERMINED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|02/25/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3993362|11951948|N|1||DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTIONS PTS = 10 COMPLICATIONS SWELLING = 71 REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS EXACT DEVICE INFO UNK HOWEVER SPEAK 168-330 ONGOING INVESTIGATION CARRIED CASE MEDICAL SAFETY TEAM DETERMINED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL LIMITED INFO AVAILABLE CASE INITIAL INVESTIGATION UNLIKELY CHANCE INFO OBTAINED HOWEVER ADDITIONAL INFO DEVICE INFO IMPLANTING PHYSICIAN LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL FILE REVIEWED UPDATED|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|07/24/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3827676|11739817|N|1||DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 B4 STUDY DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL LABELING SALINE IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|05/08/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA, NE|US|UNK||CA|||||True
4012140|18368421|D|1||B6 2014 RECEIVED ARTICLE ENTITLED BREAST IMPLANT-ASSOCIATED ALCL REPORT 2 CASES REVIEW LITERATURE AESTHETIC SURGERY JOURNAL 06172014 WITHIN ARTICLE NOTES CASE B6 PT PRESENTED ACUTE ENLARGEMENT RIGHT BREAST SWELLING SIXTEEN YEARS EARLIER PT BILATERAL AUGMENTATION SURGERY 425CC TEXTURED ROUND IMPLANTS PLACED SUBGLANDULARLY MFR IMPLANTS KNOWN PT UNDERGO ADDITIONAL BREAST SURGERY PRESENTING OFFICE CLINICAL EXAM SHOWED SWELLING RIGHT BREAST MASSES US SHOWED FLUID COLLECTION AROUND RIGHT IMPLANT INTACT MRI CONFIRMED PRESENCE FLUID REVEAL MASSES US GUIDED ASPIRATION SHOWED CD30+ ALK-ALCL CELLS ALSO POSITIVE CD45 CD5 CD4 FAILED EXPRESS CD34 CD20 CD68 CD10 PT UNDERWENT BILATERALLY CAPSULECTOMIES IMPLANT REMOVAL WITHOUT REPLACEMENT B6 2012 SILICONE FOUND CAPSULE PT SENT ONCOLOGY PT RECEIVE ADDITIONAL TREATMENT DISEASE FREE SINCE 15 MONTH FOLLOW-UP PT CONTINUES PAIN AFFECTED BREAST REPRESENTS CASE 2|UNK SALINE IMPLANT|UNK SALINE IMPLANT|07/16/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA||||NI|True
4012140|18669174|N|1||DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 FOLLOWING LIST POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY RISKS INCLUDE IMPLANT DEFLATIONLEAKAGE ADDITIONAL SURGERY CAPSULAR CONTRACTURE  INFECTION TOXIC SHOCK SYNDROME NECROSIS HEMATOMA SEROMA EXTRUSION BREAST PAIN CHANGES NIPPLE SENSATION CHANGES BREAST SENSATION DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|07/16/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA||||NI|True
4012140|55598047|D|1||25JUN2014 RECEIVED ARTICLE ENTITLED BREAST IMPLANT-ASSOCIATED ALCL REPORT 2 CASES REVIEW LITERATURE AESTHETIC SURGERY JOURNAL 17JUN2014  WITHIN ARTICLE NOTES CASE B6 PATIENT PRESENTED ACUTE ENLARGEMENT RIGHT BREAST SWELLING SIXTEEN YEARS EARLIER PATIENT BILATERAL AUGMENTATION SURGERY 425CC TEXTURED ROUND IMPLANTS PLACED SUBGLANDULARLY MANUFACTURER IMPLANTS KNOWN PATIENT UNDERGO ADDITIONAL BREAST SURGERY PRESENTING OFFICE CLINICAL EXAM SHOWED SWELLING RIGHT BREAST MASSES US SHOWED FLUID COLLECTION AROUND RIGHT IMPLANT INTACT MRI CONFIRMED PRESENCE FLUID REVEAL MASSES US GUIDED ASPIRATION SHOWED CD30+ ALK-ALCL CELLS ALSO POSITIVE CD45 CD5 CD4 FAILED EXPRESS CD34 CD20 CD68 CD10 PATIENT UNDERWENT BILATERALLY CAPSULECTOMIES IMPLANT REMOVAL WITHOUT REPLACEMENT B6 2012 SILICONE FOUND CAPSULE PATIENT SENT ONCOLOGY PATIENT RECEIVE ADDITIONAL TREATMENT DISEASE FREE SINCE 15 MONTH FOLLOW PATIENT CONTINUES PAIN AFFECTED BREAST REPRESENTS CASE 2|UNK SALINE IMPLANT|UNK SALINE IMPLANT|07/16/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA||||NI|True
3611913|4170417|D|1||REPORTED EVENTS CUTANEOUS ALCL CASE 2 BREAST PRESENTATION MASS EFFECT FLUID AROUND IMPLANT STATED JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING BREAST ARCH PATHOLOGY LAB MEDICAL JOURNAL- VOLUME 133 SEPTEMBER 2009 ALTHOUGH MANUFACTURER DEVICE UNKNOWN ALLERGANS APPROACH COMPLIANCE RESOLVE DOUBT FAVOR REPORTING|UNK SALINE IMPLANT|UNK SALINE IMPLANT|01/30/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA, NE||ALLERGAN||CA|||||True
3611913|11526026|N|1||EVENT INITIALLY SUBMITTED VIA B4 TERM CODES SEROMA CANCER NON BREAST TERM CODE CANCER NON BREAST RETIRED USE LYMPHOMA CASES RESULT INCREASED SPECIFICITY SAFETY DATE BASE TERM CODE CANCER NON BREAST CHANGED LYMPHOMA DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PATIENTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PATIENTS = 10 COMPLICATIONS SWELLING = 71 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|01/30/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA, NE||ALLERGAN||CA|||||True
3693307|11615224|N|1||EVENT INITIALLY SUBMITTED VIA EASR B6 2010 ADVERSE EVENT TERM CODE CANCER NON BREAST UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED CANCER NONBREAST LYMPHOMA - ALCL DUE INCREASED SPECIFICITY DEVICE LABELING ADDRESSES FOLLOWING ADVERSE EVENTS PER FOUR STUDY TRIALS SALINE IMPLANTS IRRITATION FOLLOWING LIST POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY RISKS INCLUDE ADDITIONAL SURGERY IRRITATIONINFLAMMATION PER CORE STUDY SILICONE IMPLANT IRRITATION REPORTED RATE 0 DEVICE LABELING REVIEWED EVENTS LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMA LISTED CORE STUDY SILICONE STUDY TRIALS LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/14/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3946569|4537478|D|1||HEALTHCARE PROFESSIONAL REPORTS INCIDENCE ANAPLASTIC LARGE CELL LYMPHOMA ALCL APPEARS ASSOCIATED USE TEXTURED BREAST IMPLANTS ENCOUNTERED 3 CASES WITHIN PAST 3 YEARS 130 CASES REPORTED WORLDWIDE TWO PTS MCGHAN IMPLANTS IE TEXTURING PROCESS ALLERGAN CURRENTLY USE MEDICAL SAFETY TEAM DETERMINED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL MULTIPLE ATTEMPTS MADE OBTAIN INFO INCLUDING CYTOLOGYPATHOLOGY REPORTS DEVICE INFO ETC IFWHEN ADDL INFO BECOME AVAILABLE FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3887949|22205446|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS COR STUDY LABELING SILICONE IMPLANTS|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-304|06/03/2014|||DA|N|R||0HP|FTR|1.0|11/11/2012|nan||1528157|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3883653|12100665|N|1||MEDWATCH SUBMITTED B4 2012 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 LABELING SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|06/18/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3883653|4596671|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE ALCL PAIN SEROMA LEFT SIDE DEVICE VOLUNTARY MW REPORT B4 HEALTH PROFESSIONAL REPORTS PT UNDERWENT BILATERAL BREAST IMPLANTS 1989 STARTING 2011 DEVELOPED DISCOMFORT LEFT CHEST WALL LARGE FLUID COLLECTION SURROUNDING LEFT IMPLANT FOUND 2012 FLUID DRAINAGE SHOWED ALK NEGATIVE ALCL CELLS WITHOUT MASS UNDERWENT REMOVAL BILATERAL BREAST IMPLANTS B6 2012 EVENT ABATED USE STOPPED DOSE REDUCED EXPLANTING SURGEON PROVIDED INFO INCLUDING PATHOLOGY CYTOLOGY REPORTS INFO BECOMES AVAILABLE FORWARDED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|06/18/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3679657|17568717|D|1||HEALTHCARE PROFESSIONAL REPORTS VIA B6 CASE SEROMA LYMPHOMA WITHIN REPORT STATES ALCL CASE REPORT PT BILATERAL BREAST AUGMENTATION PERFORMED 2005 RECENTLY DEVELOPED SEROMA ASPIRATED FOUND ATYPICAL CELLS PERFORMED BILATERAL IMPLANT REMOVAL TOTAL CAPSULECTOMY FINAL PATHOLOGY REVEALED ALCL LEFT BREAST SEVERAL ATTEMPTS MADE GATHER INFO REGARDING CASE EVENT NEW INFO FORWARDED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/07/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3679657|17783100|N|1||MEDWATCH SUBMITTED 03072014 DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/07/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
4081199|4894070|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE RIGHT SIDE LYMPHOMA ALCL|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|09/08/2014|||DA|N|R||0HP|FTR|1.0|10/15/2006|nan||120755|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4081199|12433772|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|09/08/2014|||DA|N|R||0HP|FTR|1.0|10/15/2006|nan||120755|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3761522|62721912|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LATE SEROMA DIAGNOSED ALCL  PATHOLOGY REPORT CONFIRMED MARKERS CD30 POSITIVE ALK NEG ANTIGEN MARKERS CD3 POS CD4 POS CD43 POS HIGH PROLIFERATIVE INDEX KI-67 100|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-600|04/07/2014||07/24/2014|DA|Y|Y||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN|93117|CA|93117||||True
3761522|11717501|N|1||B4 DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTION PTS = 10 COMPLICATIONS SWELLING = 71 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-600|04/07/2014||07/24/2014|DA|Y|Y||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN|93117|CA|93117||||True
4296519|18889780|D|1||ALCL CASE REPORT - B6 FEMALE CAUCASIAN HISTORY BILATERAL BREAST AUGMENTATION 1996 OUTSIDE FACILITY PT 4 YEAR HX PAINFUL SWELLING LEFT BREAST MAMMOGRAM 2 YR HISTORY INDURATION ERYTHEMA INFERIOR PORTION LEFT BREAST 2012 PT UNDERWENT MRI SKIN BIOPSY INDURATED PORTION LEFT BREAST REPORT BIOPSY SHOWED INFLAMMATORY TISSUE MALIGNANCY PT PRESENTED INCREASED PAIN SWELLING LEFT BREAST LEFT BREAST FIRM LARGER VOLUME RIGHT BREAST AREA 5 X 8 CM ERYTHEMA ALONG INFERIOR ASPECT LEFT BREAST PT TAKEN OPERATING ROOM B6 2014 DENSE FIBROSIS INDURATION SKIN UNDERLYING BREAST TISSUE LEFT FROZEN SECTION PATHOLOGY CONSISTENT PROBABLE INFLAMMATORY CARCINOMA ENTIRE CAPSULECTOMY PERFORMED BILATERALLY RIGHT CAPSULE THIN IMPLANT INTACT LEFT CAPSULE THICK FIRM IMPLANT COMPLETELY DEFLATED IMPLANT SURROUNDED 250-300 CC CREAM MONOGENEOUS YELLOW FLUID SENT CYTOLOGY PROCEDURE BILATERAL CAPSULECTOMY REMOVAL IMPLANTS CLOSURE DRAINS IMPLANTS MCGHAN TEXTURED SALINE IMPLANTS 270 CC APPEARED SHAPED IMPLANTS IDENTIFYING MARKS IMPLANTS PROCEDURE 1996 ADDL PROCEDURES BREASTS SINCE INITIAL IMPLANTATION|MCGHAN TEXTURED SALINE IMPLANT, 270CC||11/28/2014||||N|||0|FWM|1.0||SALINE IMPLANT|||||||MCGHAN|||||||True
4296519|18889780|D|1||ALCL CASE REPORT - B6 FEMALE CAUCASIAN HISTORY BILATERAL BREAST AUGMENTATION 1996 OUTSIDE FACILITY PT 4 YEAR HX PAINFUL SWELLING LEFT BREAST MAMMOGRAM 2 YR HISTORY INDURATION ERYTHEMA INFERIOR PORTION LEFT BREAST 2012 PT UNDERWENT MRI SKIN BIOPSY INDURATED PORTION LEFT BREAST REPORT BIOPSY SHOWED INFLAMMATORY TISSUE MALIGNANCY PT PRESENTED INCREASED PAIN SWELLING LEFT BREAST LEFT BREAST FIRM LARGER VOLUME RIGHT BREAST AREA 5 X 8 CM ERYTHEMA ALONG INFERIOR ASPECT LEFT BREAST PT TAKEN OPERATING ROOM B6 2014 DENSE FIBROSIS INDURATION SKIN UNDERLYING BREAST TISSUE LEFT FROZEN SECTION PATHOLOGY CONSISTENT PROBABLE INFLAMMATORY CARCINOMA ENTIRE CAPSULECTOMY PERFORMED BILATERALLY RIGHT CAPSULE THIN IMPLANT INTACT LEFT CAPSULE THICK FIRM IMPLANT COMPLETELY DEFLATED IMPLANT SURROUNDED 250-300 CC CREAM MONOGENEOUS YELLOW FLUID SENT CYTOLOGY PROCEDURE BILATERAL CAPSULECTOMY REMOVAL IMPLANTS CLOSURE DRAINS IMPLANTS MCGHAN TEXTURED SALINE IMPLANTS 270 CC APPEARED SHAPED IMPLANTS IDENTIFYING MARKS IMPLANTS PROCEDURE 1996 ADDL PROCEDURES BREASTS SINCE INITIAL IMPLANTATION|MCGHAN TEXTURED SALINE IMPLANT, 270CC||11/28/2014||||N|||0|FWM|2.0||SALINE IMPLANT|||||||MCGHAN|||||||True
3962610|11940107|N|1||REPORTED EVENTS LYMPHOMAALCL PATIENTS B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|STYLE 163 SALINE FILLED BREAST IMPLANT|UNK STYLE 163|07/15/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA,|US|ALLERGAN||CA|||||True
3962610|4605458|D|1||HEALTHCARE PROFESSIONAL CALLS REPORT LEFT SIDE ALCL PAIN CAPSULAR CONTRACTURE BAKER GRADE IV EXPLANT SURGERY TOOK PLACE B6 2014 DEVICE RETURNED TIME CALL EXACT DEVICE INFORMATION UNKNOWN HOWEVER ALLERGAN SALINE STYLE 163 IMPLANT REGARDING CAPSULAR CONTRACTURE PATIENT INFECTION HEMATOMA PATIENT UNDERWENT RADIATION TREATMENT 1998 CALL PLACED OFFICE NURSE INFORMS ALLERGAN PATIENT PRESENTED CAPS GRADE IV PAIN LUMP LOCATED LEFT SIDE SURGERY TOOK PLACE B6 2014 COMPLETE CAPSULECTOMY IMPLANT REMOVAL WITHOUT REPLACEMENT TOOK PLACE FLUID NOTED TIME SURGERY FLUID ASPIRATED SUBMITTED PATIENT HISTORY BREAST CANCER RECONSTRUCTION LATISSIMUS FLAP IMPLANT AFFECTED SIDE NOTED LEFT PER OFFICE PATH REPORT NOTES POSITIVE CD30 CD2 CD4 CD43 CD45 TUMOR CELLS NEGATIVE CD20 CD3 CD5 CD7 CD8 TIA-1 ALKX2 CK-OSCAR|STYLE 163 SALINE FILLED BREAST IMPLANT|UNK STYLE 163|07/15/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA,|US|ALLERGAN||CA|||||True
4296470|15126609|D|1||ALCL CASE REPORT ASSOCIATED BREAST CANCER RECONSTRUCTION IMPLANT|MCGHAN ALLERGAN||11/25/2014|||||||0HP|FWM|1.0||SALINE TEXTURED BREAST IMPLANT||1059645|||IRVINE||MCGHAN|92623||92623||27-363150LF||True
3913154|12138316|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20/650|06/11/2014|||DA|N|R||0HP|FTR|1.0|01/09/2013|nan||1551301|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3876028|4461510|D|1||SALES REP REPORTED CASE POSSIBLE ALCL OCCURENCE DEVICE MFR UNK ONGOING INVESTIGATION CARRIED MULTIPLE ATTEMPTS MADE OBTAIN ADDL INFO ALLERGAN RECEIVED DETAILS REGARDING REPORTED EVENT|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/30/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA, NE|US|ALLERGAN||CA|||||True
3876028|12022295|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL OBSERVED CARE STUDY LABELING SILICONE IMPLANTS REPORTED EVENTS LYMPHOMAALCL OBSERVED B4 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/30/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA, NE|US|ALLERGAN||CA|||||True
3883660|12100667|N|1||B4 EVENT INITIALLY SUBMITTED EASR Q4 B4 2010 Q1 B4 2010 Q2 B4 2010 Q4 B4 2011 ALLERGAN SILICONE DEVICE LABELING ADDRESSES FOLLOWING EVENTS PER CORE STUDY 7 YEARS PRIMARY RECONSTRUCTION PTS SEROMA RATE = 0 SWELLING RATE = 71 CAPSULAR CONTRACTURE RATE = 171 PTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA ALLERGAN LABELING SILICONE IMPLANT DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-630|06/18/2014|||DA|N|R||0HP|FTR|1.0||nan||569899|||GOLETA|US|ALLERGAN||CA|||||True
3883660|4593228|D|1||HEALTHCARE PROFESSIONAL REPORTED CASE ALCL VIA ADJUNCT STUDY FORM PT DIAGNOSED LEFT BREAST CANCER 1995 RECONSTRUCTION SURGERY OCCURRED B6 2002 STYLE 153 IMPLANT SYMPTOMS ENLARGED LEFT BREAST CAPSULAR CONTRACTURE OCCURRED LEFT SIDE SEROMA TREATED DRAINAGE SEROMA RECURRED EXPLANTED B6 2005 REPLACED MENTOR DEVICE STYLE UNK BIOPSY SEROMA FLUID LEFT BREAST CAPSULE PERFORMED B6 2005 TIME DIAGNOSED ANAPLASTIC LARGE CELL CELL LYMPHOMA RADIATION THERAPY BEGAN B6 2005 FINE FOLLOW PHYSICIAN 2007|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-630|06/18/2014|||DA|N|R||0HP|FTR|1.0||nan||569899|||GOLETA|US|ALLERGAN||CA|||||True
3874163|4506744|D|1||ANAPLASTIC LARGE CELL LYMPHOMA ALCL BREAST IMPLANT RELATED DISCOVERED UPON REMOVING BREAST IMPLANT CAPSULE SEROMA FLUID RIGHT BREAST PT TEXTURED SALINE-FILLED ALLERGAN IMPLANTS PLACED COSMETIC BREAST ENLARGEMENT B6 2009 PT NOTICED BREAST ASYMMETRY SUMMER 2013 PROGRESSED RIGHT BREAST NOTICEABLY LARGER LEFT SIDE ULTRASOUND STUDY DONE B6 2014 SHOWING APPEARED FLUID AROUND RIGHT IMPLANT - POSSIBLE DEFLATION IMPLANT INTACT UPON REMOVAL LARGE SURROUNDING SEROMA SUSPICION ALCL RIGHT BREAST IMPLANT TOTAL CAPSULECTOMY IMPLANT REMOVAL DONE CAPSULE SEROMA FLUID SPECIMENS SENT HISTOLOGYPATHOLOGY EVALUATION|NATRELLE SALINE IMPLANT|168-330|06/11/2014|||||||0HP|FWM|1.0||SALINE IMPLANT|||||||ALLERGAN|||||168 NATRELLE SALINE- FILLED||True
3946563|19797996|D|1||HEALTHCARE PROFESSIONAL REPORTS INCIDENCE ANAPLASTIC LARGE CELL LYMPHOMA ALCL APPEARS ASSOCIATED USE TEXTURED BREAST IMPLANTS ENCOUNTERED 3 CASES WITHIN PAST 3 YEARS 130 CASES REPORTED WORLDWIDE TWO PATIENTS MCGHAN IMPLANTS IE TEXTURING PROCESS ALLERGAN CURRENTLY USE MEDICAL SAFETY TEAM DETERMINED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL MULTIPLE ATTEMPTS MADE OBTAIN INFO INCLUDING CYTOLOGYPATHOLOGY REPORTS DEVICE INFO ETC IFWHEN ADDITIONAL INFO BECOME AVAILABLE FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3946563|19859922|N|1||B4 DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3642249|18155221|N|1||ADVERSE EVENT TERM CODES CANCER CANCER NONBREAST RETIRED USE LYMPHOMA LYMPHOMA - ALCL CASES RESULT INCREASED SPECIFICITY SAFETY DATABASE TERM CODES LYMPHOMA LYMPHOMA - ALCL USED RATHER CANCER CANCER NONBREAST EVENT SUBMITTED VIA B4 B4 2011 TERM CODES MFR UNK CANCER DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|02/05/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3636464|18588666|N|1||EVENT INITIALLY SUBMITTED VIA EASR B4 TERM CODES SEROMA CANCER NON BREAST CORRECTED DATA TERM CODE CANCER NON BREAST RETIRED USE LYMPHOMA CASES RESULT INCREASED SPECIFICITY SAFETY DATA BASE TERM CODE CANCER NON BREAST CHANGED LYMPHOMA DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PERCENT PRIMARY RECONSTRUCTION PTS = 10 PERCENT COMPLICATIONS SWELLING = 71 PERCENT DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS B6  STUDY LABELING SILICONE IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/29/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3827678|11739818|N|1||DEVICE LABELING ADDRESS EVENT SEROMA PRIMARY AUGMENTATION PTS SEROMA RATE = 16 REVIEW LABELING CASES LYMPHOMAALCL LABELING SILICONE IMPLANTS B4 STUDY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/08/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNK||CA|||||True
3986857|4822318|D|1||ALCL CASE REPORT LOCATION ALCL R BREASTAXILLA CLINICAL PRESENTATION RECURRENT FLUID COLLECTIONS MULTIPLE NEGATIVE BIOPSIES DATES USE 7 YEARS DIAGNOSIS REASON USE BREAST AUGMENTATION|SILICONE BREAST IMPLANT||08/04/2014|||||||0|FTR|1.0||SILICONE BREAST IMPLANT|||||||nan|||||||True
3671970|19393472|N|1||EVENT INITIALLY SUBMITTED VIA B6 TERM CODES SEROMA CANCER RUPTURE ADVERSE EVENT TERM CODE SEROMA REMOVED MEDICAL RECORDS PROVIDED DIAGNOSIS SEROMA UPDATE SAFETY DATA BASE NOTES REPORTED EVENT CANCER TERM CODE CHANGED CANCER LYMPHOMA DUE INCREASED SPECIFICITY DEVICE LABELING SILICONE BREAST IMPLANTS ADDRESSES FOLLOWS POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMA ALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|02/12/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN|93117|CA|93117||||True
4055803|4860628|D|1||SILICONE BREAST IMPLANTS REPLICON SURGITEK 1990 FDA APPROVED PROCEDURE DOCTOR TOLD WOULD LAST LIFETIME HEALTH RISKS TOLD NEGATIVE ISSUE 1 PATIENTS IMPLANTS BECOME HARD DUE ENCAPSULATION PROBLEMS PROBLEM 2 YEARS LEAK CONTAINED WITHIN ENCAPSULATED AREA 5 YEARS LATER B6 2014 MAMMOGRAM SHOWS PROGRESSIVE LEAK OUTSIDE ENCAPSULATION TEST RECENT UNEXPLAINED HEALTH ISSUES PAIN WEIGHT LOSS 20 YEARS EXPERIENCED NUMEROUS AUTOIMMUNE DISORDERS HEALTH ISSUES DIAGNOSIS UNKNOWN ORIGIN ALWAYS ASK DOCTORS COULD CAUSED SILICONE IMPLANTS ALWAYS SAID POSSIBLE DISABILITY FIBROMYALGIA SEVERAL YEARS SCHEDULED TOXIC IMPLANTS REMOVED COST ALMOSTB6 INSURANCE HELP ORIGINALLY MADE DECISION IMPLANTS FDA DOCTORS SAID TOTALLY SAFE NEVER SMOKED EVEN ONE PUFF EAT GARDEN RAISED WHOLE FOODS B6 TAKE MEDS NEVER DONE DRUGS PEOPLE SMOKE EAT KNOWING RISK HEART DISEASE DIABETES CANCER ETC INSURANCE STILL PAYS TREATMENT USE MONEY SAVED SELLING FAMILY HEIRLOOMS PAY TREATMENT MUST TRUSTED FDA DONT UNDERSTAND FDA RECOMMENDS REMOVING LEAKING SILICONE IMPLANTS HEALTH PROBLEMS SILICONE IMPLANTS ALWAYS STRONGLY SUPPORTED WONDERFUL GOVERNMENT HEART BROKEN WRONG RESEARCH OTHERS DONE LIMITED FLAWED CONVINCED DOCTORS IMPLANT RELATED HEALTH ISSUES PROBLEM THEREFORE WOMEN LIKE TRY GET DOCTORS INVESTIGATE POSSIBILITY DISMISSED TOLD SYMPTOMS EITHER HEADS CAUSED VIRUS STRESS GO HOME RELAX LOSS CONFIDENCE TRUST GOVERNMENT ACTUALLY ONE WORST PROBLEM ISSUE SAD DEPRESSED UNDERSTAND HIGH DEGREE SUICIDE WOMEN IMPLANT PROBLEMS QUALITY LIFE ROCK BOTTOM 30 YEARS TEACHING SECONDARY EDUCATION PUBLIC SCHOOL SYSTEM LOOKING FORWARD RETIREMENT YEARS RESOURCES USED PAY DOCTORS PRAY FIND ALCL READ INSURANCE PAY CANCER TREATMENT EITHER ABLE GET TREATMENT WRONG GOVERNMENT ALLOWS HAPPEN WOMEN IMPLANTS TIME TOLD TOTALLY SAFE 1990 RESEARCH BELIEVED FDA MAKING SAFE DECISION WANTED HUSBAND PROUD SAD HEART BROKEN TEST EVEN THOUGH PAY MONTHLY INSURANCE PREMIUMS WOULDNT PAY EITHER|REPLICON SILICONE BREAST IMPLANT||08/28/2014|||||||0|FTR|2.0||SILICONE BREAST IMPLANT|||||||MEDICAL ENGINEERING CORPRATION|||||NOT KNOWN||True
4055803|4860628|D|1||SILICONE BREAST IMPLANTS REPLICON SURGITEK 1990 FDA APPROVED PROCEDURE DOCTOR TOLD WOULD LAST LIFETIME HEALTH RISKS TOLD NEGATIVE ISSUE 1 PATIENTS IMPLANTS BECOME HARD DUE ENCAPSULATION PROBLEMS PROBLEM 2 YEARS LEAK CONTAINED WITHIN ENCAPSULATED AREA 5 YEARS LATER B6 2014 MAMMOGRAM SHOWS PROGRESSIVE LEAK OUTSIDE ENCAPSULATION TEST RECENT UNEXPLAINED HEALTH ISSUES PAIN WEIGHT LOSS 20 YEARS EXPERIENCED NUMEROUS AUTOIMMUNE DISORDERS HEALTH ISSUES DIAGNOSIS UNKNOWN ORIGIN ALWAYS ASK DOCTORS COULD CAUSED SILICONE IMPLANTS ALWAYS SAID POSSIBLE DISABILITY FIBROMYALGIA SEVERAL YEARS SCHEDULED TOXIC IMPLANTS REMOVED COST ALMOSTB6 INSURANCE HELP ORIGINALLY MADE DECISION IMPLANTS FDA DOCTORS SAID TOTALLY SAFE NEVER SMOKED EVEN ONE PUFF EAT GARDEN RAISED WHOLE FOODS B6 TAKE MEDS NEVER DONE DRUGS PEOPLE SMOKE EAT KNOWING RISK HEART DISEASE DIABETES CANCER ETC INSURANCE STILL PAYS TREATMENT USE MONEY SAVED SELLING FAMILY HEIRLOOMS PAY TREATMENT MUST TRUSTED FDA DONT UNDERSTAND FDA RECOMMENDS REMOVING LEAKING SILICONE IMPLANTS HEALTH PROBLEMS SILICONE IMPLANTS ALWAYS STRONGLY SUPPORTED WONDERFUL GOVERNMENT HEART BROKEN WRONG RESEARCH OTHERS DONE LIMITED FLAWED CONVINCED DOCTORS IMPLANT RELATED HEALTH ISSUES PROBLEM THEREFORE WOMEN LIKE TRY GET DOCTORS INVESTIGATE POSSIBILITY DISMISSED TOLD SYMPTOMS EITHER HEADS CAUSED VIRUS STRESS GO HOME RELAX LOSS CONFIDENCE TRUST GOVERNMENT ACTUALLY ONE WORST PROBLEM ISSUE SAD DEPRESSED UNDERSTAND HIGH DEGREE SUICIDE WOMEN IMPLANT PROBLEMS QUALITY LIFE ROCK BOTTOM 30 YEARS TEACHING SECONDARY EDUCATION PUBLIC SCHOOL SYSTEM LOOKING FORWARD RETIREMENT YEARS RESOURCES USED PAY DOCTORS PRAY FIND ALCL READ INSURANCE PAY CANCER TREATMENT EITHER ABLE GET TREATMENT WRONG GOVERNMENT ALLOWS HAPPEN WOMEN IMPLANTS TIME TOLD TOTALLY SAFE 1990 RESEARCH BELIEVED FDA MAKING SAFE DECISION WANTED HUSBAND PROUD SAD HEART BROKEN TEST EVEN THOUGH PAY MONTHLY INSURANCE PREMIUMS WOULDNT PAY EITHER|REPLICON SILICONE BREAST IMPLANT||08/28/2014|||||||0|FTR|1.0||SILICONE BREAST IMPLANT|||||||MEDICAL ENGINEERING CORPRATION|||||NOT KNOWN||True
3913157|17551292|N|1||DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-750|06/11/2014|||DA|N|R||0HP|FTR|1.0|02/14/2013|nan||1571059|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3671971|18584358|N|1||EVENT INITIALLY SUBMITTED VIA B6 TERM CODES RUPTURE SEROMA CANCER NON BREAST ADVERSE EVENT TERM CODES RUPTURE SEROMA REMOVED MEDICAL REPORTS PROVIDED DIAGNOSIS SEROMA NEGATIVE LEFT SIDE RUPTURE UPDATED SAFETY DATA BASE NOTES REPORTED EVENT CANCER TERM CODE CHANGED CANCER LYMPHOMA DUE INCREASED SPECIFICITY DEVICE LABELING SILICONE BREAST IMPLANTS ADDRESSES EVENTS FOLLOWS POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE CAPSULAR CONTRACTURE REOPERATION DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMA ALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST|02/12/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
4317244|5130090|D|1||B6 FEMALE PRESENTED RIGHT LATERAL CHEST MELANOMA EXCISION FOUND AXILLARY LYMPHADENOPATHY ULTRASOUND NORMAL PT ALSO APPEARED RIGHT BREAST FIRM GRADE IV CAPSULAR CONTRACTURE PT INITIALLY DECLINED TREATMENT RETURNED DIAGNOSED ALCL B6 2013|MCGHAN 240CC||12/10/2014|||DA||*||0HP|FWM|1.0||BREAST IMPLANT TYPE UNCLEAR|||||||MCGHAN|||||||True
3739115|16914969|D|1||FILE ORIGINALLY SENT MARCH MFR REPORT 1645337-2014-00019 DUPLICATEALCL SYMPTOMS ALCL SYMPTOMS CONFIRMED RHEUMATOID PHYSICIAN|CONTOUR PROFILE HIGH GEL - LUMERA|354-1401|04/10/2014|||DA||R||0HP|FTR|1.0||BREAST IMPLANT||5591688|||IRVING|US|MENTOR||TX|||||True
3739116|4275183|D|1||FILE ORIGINALLY SENT MARCH MFR REPORT 1645337-2014-00019 DUPLICATE ALCL SYMPTOMS CONFIRMED RHEUMATOID PHYSICIAN|COUNTOUR PROFILE HIGH GEL - LUMERA|354-1401|04/10/2014|||DA||R||0HP|FTR|1.0||BREAST IMPLANT||5591688|||IRVING|US|MENTOR||TX|||||True
3693305|4292884|D|1||RESEARCH ARTICLE PUBLISHED 2008 AMERICAN JOURNAL SURGICAL PATHOLOGY ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT CAPSULE CASE REPORT REVIEW LITERATURE REPORTED B6 PT HISTORY RIGHT SIDE BREAST CANCER RECONSTRUCTION ALLERGAN SALINE TEXTURED BREAST IMPLANT B6 2005 PT PRESENTED SEROMA SUBSEQUENTLY DIAGNOSED ALCL CELL TYPE CASE STUDY REPORTED ORIGINALLY ANOTHER DOCTOR ET AL ANNALS PLASTIC SURGERY B6 2007|STYLE 363 SALINE FILLED BREAST IMPLANT|27-363651|03/14/2014|||DA|N|R||0HP|FWM|1.0||nan||532328|||GOLETA|US|ALLERGAN||CA|||||True
3693305|11615223|N|1||EVENT INITIALLY REPORTED VIA EASR B6 2010 ADVERSE EVENT TERM CODE CANCER NON BREAST UPDATE SAFETY DATA BASE REPORTED EVENT NOTES TERM CODE CHANGED CANCER NONBREAST LYMPHOMA - ALCL DUE INCREASED SPECIFICITY DEVICE LABELING REVIEWED EVENTS LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMA STUDY TRIALS LABELING SALINE IMPLANTS|STYLE 363 SALINE FILLED BREAST IMPLANT|27-363651|03/14/2014|||DA|N|R||0HP|FWM|1.0||nan||532328|||GOLETA|US|ALLERGAN||CA|||||True
4012158|4705786|D|1||B6 2014 RECEIVED ARTICLE ENTITLED BREAST IMPLANT-ASSOCIATED ALCL REPORT 2 CASES REVIEW LITERATURE AESTHETIC SURGERY JOURNAL 17 JUNE 2014 WITHIN ARTICLE NOTES CASE B6 PATIENT PRESENTED SIX WEEK HISTORY RIGHT BREAST SWELLING NINE YEARS EARLIER PATIENT BILATERAL SUBMUSCULAR AUGMENTATION 510CC ALLERGAN TEXTURED IMPLANT POST OP COMPLICATIONS PATIENT FAMILY HISTORY BREAST CANCER PERSONAL HISTORY CELIAC DISEASE UPON PRESENTATION MASSES FOUND RIGHT BREAST ERYTHEMA SWELLING MAMMOGRAM REVEALED FLUID SURROUNDING IMPLANT INTACT US ALSO SHOWS INTACT IMPLANT FLUID ADJACENT IMPLANT INDICATIVE INFLAMMATORY PROCESS SEROMA PERCUTANEOUS FLUID COLLECTION 200CC CLEAR FLUID DEMONSTRATED POPULATION LARGE CELLS EXPRESSION CD2 CD5 CD4 CD30 FAILED EXPRESS CD3 CD7 RESULTS IMMUNHISTOCHEMICAL STAINING NEGATIVE ALK-1 PATIENT ALSO MRI BREAST CONFIRMING INTACT IMPLANTS SENT ONCOLOGY STAGING TREATMENT PET SCAN NEGATIVE TREATMENT INCLUDED CAPSULECTOMY IMPLANT REMOVAL BILATERALLY WITHOUT REPLACEMENT B6 2011 EVIDENCE SILICONE WITHIN CAPSULE PATIENT DISEASE FREE SINCE B6 2013 REPRESENTS CASE 1 WITHIN ARTICLE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|07/16/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
4012158|11950283|N|1||DEVICE LABELING ADDRESSES EVENT SEROMA PRIMARY AUGMENTATION PATIENTS SEROMA RATE= 16 PRIMARY RECONSTRUCTION PATIENTS= 10 COMPLICATIONS SWELLING= 71 SIGNS ACUTE INFECTION INCLUDE ERYTHEMA TENDERNESS FLUID ACCUMULATION PAIN FEVER PATIENTS ADVISED CONTACT PHYSICIAN IMMEDIATELY DIAGNOSIS TREATMENT SYMPTOMS DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PATIENTS B6 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|07/16/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3611928|11525621|N|1||EVENT INITIALLY SUBMITTED VIA B4 B4 2010 TERM CODES CANCER LUMPNODULE MANUFACTURER UNK UPDATE SAFETY DATA BASE NOTES TERM CODE CHANGED LYMPHPOMA LYMPHOMA ALCL DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS DEVICE LABELING ADDRESS EVENT SWELLING PRIMARY AUGMENTATION PTS SWELLING RATE = 92 PERCENT PRIMARY RECONSTRUCTION PTS = 84 PERCENT SILICONE PT BROCHURE FOLLOWING BREAST AUGMENTATION CONTINUE PERFORM BREAST SELF-EXAMINATION MONTHLY MAY DIFFICULT BREAST IMPLANT PLACE CONTINUE PERFORM MONTHLY BREAST SELF EXAMINATION EFFICIENTLY ASK SURGEON HELP IDENTIFY DIFFERENCE IMPLANT BREAST TISSUE ABLE IDENTIFY IMPLANT BREAST TISSUE DECREASE NECESSITY EXCESSIVE SQUEEZING IMPLANT EXAMINATION NEW LUMPS EVALUATED BIOPSY APPROPRIATE BIOPSY PERFORMED SURE INFORM MEDICAL PROFESSIONAL PERFORMING BIOPSY BREAST IMPLANTS CARE TAKEN AVOID INJURING IMPLANT|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/30/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3611928|4157112|D|1||REPORTED EVENTS ALK- ALCL CASE 3 BREAST PRESENTATION PAIN SWELLING SCAR FLUID STATED JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING BREAST ARCH PATHOLOGY LAB MEDICAL JOURNAL-VOL 133 SEP 2009 ALTHOUGH MFR DEVICE UNK ALLERGANS APPROACH COMPLIANCE RESOLVE DOUBT FAVOR REPORTING|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/30/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3642247|11651516|N|1||EVENT INITIALLY SUBMITTED VIA B4 B4 2010 TERM CODES SEROMA CANCER CORRECTED  UPDATE SAFETY DATA BASE REPORTED EVENT NOTES TERM CODE CHANGED CANCER LYMPHOMA - ALCL DUE INCREASED SPECIFICITY DEVICE LABELING REVIEWED REPORTED EVENTS LYMPHOMAALCL PTS A95R95 STUDY INCLUDED LABELING SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|02/07/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
5186386|29786531|D|1||HEALTH PROFESSIONAL REPORTED APPEARANCE PERI PROSTHETIC RECIDIVIST LIQUID HISTOLOGICAL EXAMINATION RESULTED COMPATIBLE ANAPLASTIC LARGE CELL LYMPHOMA DEVICE EXPLANTED TOTAL CAPSULECTOMY PERFORMED SIDE UNSPECIFIED EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED CONFIRM ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX150-620|10/29/2015||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1325729|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5186386|29786530|N|1||DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX150-620|10/29/2015||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1325729|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5108565|26936205|D|1||HEALTH PROFESSIONAL REPORTED SPONTANEOUS RECURRENT SEROMA RIGHT BREAST POSITIVE CYTOLOGY ANAPLASTIC LYMPHOMA DEVICE REMOVED CAPSULE ANALYZED RESULT ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE DIAGNOSED CAPSULE SPECIFIED ALCL CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED SEE MFR  9617229-2015-00372 LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1509947|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5108565|26936204|N|1|| DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1509947|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4377497|17379665|N|1||UNIQUE IDENTIFIER UDI  NA MEDWATCH SUBMITTED 12242014 ALLERGAN RECEIVED PRODUCT TIME THEREFORE ANALYSIS TESTING DONE UNLIKELY RHE PRODUCT RETURNED DEATH SURGICALPHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ADDRESSES REPORTED EVENT DEATH FOLLOWS SURGICAL PROCEDURE BREAST IMPLANTATION WITHOUT RISKS BREAST IMPLANTATION ELECTIVE PROCEDURE PT MUST WELL COUNSELED UNDERSTAND RISKBENEFIT RELATIONSHIP DEVICE LABELING ADDRESSES ALCL REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS DEVICE LABELING ADDRESSES LUMPS PTS PERFORM BREAST SELF-EXAMINATIONS MONTHLY SHOWN DISTINGUISH IMPLANT BREAST TISSUE PT MANIPULATE SQUEEZE IMPLANT EXCESSIVELY PT TOLD PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGE IMPLANT SHAPE MAY SIGNS SYMPTOMATIC RUPTURE IMPLANT PT SIGNS TOLD REPORT POSSIBLY MRI EVALUATION SCREEN RUPTURE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4377497|17294303|D|1||HEALTH PROFESSIONAL REPORTED PT FELT LUMP LEFT BREAST UNDERWENT FNA MASS DIAGNOSED ALCL STAGE IE MASS 4X3CM SIZE CUTANEOUS INVOLVEMENT SYSTEMIC DISEASE POINT UNDERWENT CHOP CHEMOTHERAPY FOLLOWED REGIONAL RADIATION HOWEVER RECURRENCE DISEASE WITHIN FOUR MONTHS ADJUNCTIVE TREATMENT DISEASE PROGRESSED CNS INVOLVEMENT MENINGEAL DISEASE EXPIRED B6 1997|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4377497|55005828|D|1||HEALTH PROFESSIONAL REPORTED PATIENT FELT LUMP LEFT BREAST UNDERWENT FNA MASS DIAGNOSED ALCL STAGE IE MASS 4X3CM SIZE CUTANEOUS INVOLVEMENT SYSTEMIC DISEASE POINT UNDERWENT CHOP CHEMOTHERAPY FOLLOWED REGIONAL RADIATION HOWEVER RECURRENCE DISEASE WITHIN FOUR MONTHS ADJUNCTIVE TREATMENT DISEASE PROGRESSED CNS INVOLVEMENT MENINGEAL DISEASE EXPIRED B6 1997|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
5067426|25380332|N|1||B4 DEVICE LABELING ADDRESSES ADDITIONAL COMPLICATIONS - BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME PAIN HEMATOMASEROMA CHANGES NIPPLE BREAST SENSATION IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS LYMPHOMAS INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL Â¿ INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE 20 CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED IDENTIFY ALCL CANCERS BREAST IMPORTANT NOTE FINDINGS CONSIDERED PRELIMINARY MAJORITY CASES REPORTED PATIENTS BREAST IMPLANTS PRESENT LATE OCCURRING SEROMAS INDOLENT CLINICAL COURSE INCLUDING INVOLVING SPONTANEOUS REMISSION WITHOUT ADJUVANT THERAPY STUDY CONCLUDED CAUSE EFFECT RELATIONSHIP ALCL BREAST IMPLANTS PERTINENT FINDINGS RESPECTING CASES ASSOCIATED ALLERGAN DEVICES REPORTED ALLERGAN EG TIME CLINICAL PRESENTATION SIGNS SYMPTOMS IMMUNOHISTOLOGICAL ANALYSIS TYPE IMPLANT TEXTURE PATIENT HISTORY IMPLANTS PHYSICIANS KEEP ABREAST ALCL LITERATURE PROVIDE APPROPRIATE THERAPY PATIENTS NEEDED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM120-280|09/10/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4385771|12654428|N|1||UNIQUE IDENTIFIER UDI  APPLICABLE DEVICE LABELING ADDRESSES REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4385771|55591134|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED RAPID LATE SEROMA DIAGNOSED BIA-ALCL RIGHT BREAST STAGE IE UNDERWENT BILATERAL CAPSULECTOMIES IMPLANT REMOVAL RECEIVED CHOP ICE CHEMOTHERAPY RADIATION THERAPY FOLLOWED STEM CELL TRANSPLANT POSTOPERATIVELY FOLLOW IMAGING PET RECURRENCE DISEASE REMAINS HEALTHY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4385771|5287622|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED RAPID LATE SEROMA DIAGNOSED BIA-ALCL RIGHT BREAST STAGE IE UNDERWENT BILATERAL CAPSULECTOMIES IMPLANT REMOVAL RECEIVED CHOP ICE CHEMOTHERAPY RADIATION THERAPY FOLLOWED STEM CELL TRANSPLANT POSTOPERATIVELY FOLLOW IMAGING PET RECURRENCE DISEASE REMAINS HEALTHY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4791712|50521769|D|1||FU CONFIRMED PHYSICIAN PT LYMPHOMA ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084366|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4791712|22282406|N|1||B4 DEVICE LABELING ADDRESSES POSSIBILITY ADVERSE EVENTS POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY DISCUSS PT WARNINGS PRECAUTIONS IMPORTANT FACTORS CONSIDER POSSIBLE ADVERSE EVENTS ALLERGANS CORE CLINICAL STUDY RESULTS BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084366|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4791712|22243235|D|1||PT REPORTED RIGHT SIDE RUPTURE PT ADDITIONALLY REPORTED NAUSEA ALCL UNSPECIFIED SIDE EFFECTS ALCL CAPTURED LYMPHOMA EVENT CANNOT CONFIRMED PHYSICIAN SEE MFR 9617229-2015-00086|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084366|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4791712|50912363|D|1||PATIENT REPORTED RIGHT SIDE RUPTURE PATIENT ADDITIONALLY REPORTED NAUSEA ALCL UNSPECIFIED SIDE EFFECTS ALCL CAPTURED LYMPHOMA EVENT CANNOT CONFIRMED PHYSICIAN SEE MFR  9617229-2015-00086 LEFT SIDE FOLLOW-UP CONFIRMED PHYSICIAN PATIENT LYMPHOMA ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084366|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5048951|24795080|N|1||DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-270|09/02/2015||||N|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||540807|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5048951|24795081|D|1||HEALTH PROFESSIONAL REPORTED VIA VOLUNTARY MEDWATCH 5042321 PATIENT NOTED INCREASED SIZE LEFT BREAST FIRM MASS MEDIALLY ALSO LEFT BREAST ULTRASONIC-GUIDED NEEDLE BIOPSY BREAST MASS PROVIDED RETRO-PECTORAL LEFT AXILLARY LYMPH NODES DONE SHOWED ANAPLASTIC LARGE CELL LYMPHOMA ALK NEG BREAST NODES PETCT SHOWED BREAST MASS HIGHLY HYPERMETABOLIC ENLARGED HYPERMETABOLIC LEFT AXILLARY NODES PATIENT RECEIVED CHEMOTHERAPY CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE ETOPOSIDE GOOD RESPONSE BREAST IMPLANT REMOVAL RECOMMENDED PER FOLLOW-UP HEALTH PROFESSIONAL ADDITIONALLY REPORTED PATIENT LEFT SIDE CAPSULAR CONTRACTURE NOTED BULGING LEFT SIDE BAKER GRADE PROVIDED HEALTH PROFESSIONAL CONFIRMED LEFT SIDE DEVICE REMAINS IMPLANTED PATIENT DECLINED REMOVED EVENT CAPTURED LYMPHOMA CONFIRMATION ALCL RECEIVED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-270|09/02/2015||||N|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||540807|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4385755|16883770|D|1||HEALTH PROFESSIONAL REPORTED PT DEVELOPED AXILLARY PERICAPSULAR SUPRACLAVICULAR MASSES DIAGNOSED CD30+ ALK-ALCL SYNCHRONOUS HODGKINS LYMPHOMA TREATED BILATERAL IMPLANT REMOVAL CAPSULECTOMIES CHEMOTHERAPY CHOP X 3 ROUNDS RADIATION AXILLA FOLLOW IMAGING CT SCAN RECURRENCE DISEASE REMAINS HEALTHY ALCL AFFECTED BREAST REPORTED UNILATERAL -LEFT HEALTH PROFESSIONAL ADDITIONALLY REPORTED CAPSULAR CONTRACTURE BAKER GRADE III|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4385755|54780897|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED AXILLARY PERICAPSULAR SUPRACLAVICULAR MASSES DIAGNOSED CD30+ ALK- ALCL SYNCHRONOUS HODGKINS LYMPHOMA TREATED BILATERAL IMPLANT REMOVAL CAPSULECTOMIES CHEMOTHERAPY CHOP X 3 ROUNDS RADIATION AXILLA FOLLOW IMAGING CT SCAN RECURRENCE DISEASE REMAINS HEALTHY ALCL AFFECTED BREAST REPORTED UNILATERAL - LEFT HEALTH PROFESSIONAL ADDITIONALLY REPORTED CAPSULAR CONTRACTURE BAKER GRADE III|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4385755|17004785|N|1||REPORTED EVENTS LYMPHOMA ALCL PTS B6 STUDY LABELING SILICONE IMPLANTS DEVICE LABELING ADDRESSES LUMPS PTS PERFORM BREAST SELF-EXAMINATIONS MONTHLY SHOWN DISTINGUISH IMPLANT BREAST TISSUE PT MANIPULATE SQUEEZE IMPLANT EXCESSIVELY PT TOLD PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGE IMPLANT SHAPE MAY SIGNS SYMPTOMATIC RUPTURE IMPLANT PT SIGNS TOLD REPORT POSSIBLY MRI EVAL SCREEN RUPTURE DEVICE LABELING ADDRESSES CAPSULAR CONTRACTURE PTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PTS PRIMARY AUGMENTATION RECONSTRUCTION PTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
5286885|33230445|D|1||PHYSICIAN REPORTED RIGHT SIDE DEVICE REMOVAL REPLACEMENT DIAGNOSIS ANAPLASTIC LARGE CELL LYMPHOMA ALCL PATHOLOGICAL MARKERS PROVIDED CASE CAPTURED LYMPHOMA CONFIRMATION RECEIVED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|12/10/2015|||DA|N|R||0HP|FTR|1.0|10/21/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1157331|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5286885|36621596|D|1||ADDITIONAL INFORMATION RECEIVED REVEALS PATIENT EXPERIENCED VOLUME INCREASE RIGHT SIDE APPROXIMATELY EIGHT YEARS IMPLANTATION SUBSEQUENT MRI SHOWED PERIPROSTHETIC SEROMA RIGHT SIDE SUBSEQUENT FINE-NEEDLE ASPIRATION CYTOLOGY SHOWS INFLAMMATION PATIENT TREATED ANTI-INFLAMMATORY ANTIBIOTICS PATIENT EXPERIENCED RIGHT BREAST VOLUME INCREASE APPROXIMATELY THREE MONTHS PRIOR DEVICE REMOVAL TOTAL CAPSULECTOMY PERFORMED EXPLANT ALCL DIAGNOSED CAPSULE PATHOLOGICAL ANALYSIS PATHOLOGICAL MARKERS STILL PROVIDED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|12/10/2015|||DA|N|R||0HP|FTR|1.0|10/21/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1157331|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5286885|33230384|N|1||DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS  CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|12/10/2015|||DA|N|R||0HP|FTR|1.0|10/21/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1157331|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5270622|32776697|D|1||COMPANY REPRESENTATIVE REPORTED BEHALF HEALTH PROFESSIONAL DELAYED SEROMA ALCL SWELLING SIDE UNKNOWN EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED CONFIRM ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|12/07/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||565193|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5270622|36726551|D|1||COMPANY REPRESENTATIVE REPORTED BEHALF HEALTH PROFESSIONAL DELAYED SEROMA ALCL SWELLING SIDE UNKNOWN EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED CONFIRM ALCL HEALTH PROFESSIONAL ADDITIONALLY REPORTED ALCL CASE REPORT PATIENT UNDERWENT UNCOMPLICATED BILATERAL BREAST AUGMENTATION MCGHAN STYLE 468 SALINE-FILLED BREAST IMPLANTS PATIENT WELL PATIENT NOTED INTERMITTENT SWELLING LEFT BREAST MAMMOGRAM ULTRASOUND LEFT BREAST ORDERED PCP CONFIRMED PERI-PROSTHETIC SEROMA WITHOUT ABNORMAL BREAST TISSUE FINDINGS SWELLING BECAME PERSISTENT PATIENT SEEN OFFICE EVAL TAKEN EXPEDIENTLY OPERATING ROOM SEROMA ASPIRATION CULTURES CAPSULE BIOPSY CONFIRMED ALCL CULTURES NEGATIVE ONE WEEK LATER PATIENT UNDERWENT COMPLETE CAPSULECTOMY IMPLANT REMOVAL WITHOUT REPLACEMENT|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|12/07/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||565193|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5270622|33982741|D|1||COMPANY REPRESENTATIVE REPORTED BEHALF HEALTH PROFESSIONAL DELAYED SEROMA ALCL SWELLING SIDE UNKNOWN EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED CONFIRM ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|12/07/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||565193|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5270622|32776696|N|1||MEDWATCH SUBMITTED 12072015 DEVICE LABELING ADDRESSES PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|12/07/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||565193|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5088633|26204676|N|1||MEDWATCH SUBMITTED 09182015 DEVICE LABELING PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/18/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNK|||||||True
5088633|54646607|D|1||PHYSICIAN REPORTED CASE BREAST IMPLANT ALCL ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY CONFIRMED EFFUSION SIDE UNKNOWN TREATMENT YET OCCURRED DEVICE REMAINS IMPLANTED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/18/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNK|||||||True
5088633|26204677|D|1||PHYSICIAN REPORTED CASE BREAST IMPLANT ALCL ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY CONFIRMED EFFUSION SIDE UNKNOWN TREATMENT YET OCCURRED DEVICE REMAINS IMPLANTED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/18/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNK|||||||True
4407133|12734109|N|1||UNIQUE IDENTIFIER UDI  B4 DEVICE LABELING ADDRESSES LYMPHOMA REPORTED EVENTS LYMPHOMAALCL PTS CORE STUDY LABELING SILICONE IMPLANTS DEVICE LABELING ADDRESSES SEROMA POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY DEVICE LABELING ADDRESSES CREASEFOLDING IMPLANT FOLLOWING THINGS MAY CAUSE IMPLANTS RUPTURE DAMAGE SURGICAL INSTRUMENTS STRESSING IMPLANT IMPLANTATION WEAKENING FOLDING WRINKLING IMPLANT SHELL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-390|01/08/2015||07/30/2015|DA|R|Y||0HP|FTR|1.0|02/04/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1708168|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4407133|25949126|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE IMPLANT FOLDS LIQUID  AROUND IMPLANT REMOTE POSSIBILITY ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-390|01/08/2015||07/30/2015|DA|R|Y||0HP|FTR|1.0|02/04/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1708168|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4407133|5301992|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE IMPLANT FOLDS LIQUID AROUND IMPLANT REMOTE POSSIBILITY ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-390|01/08/2015||07/30/2015|DA|R|Y||0HP|FTR|1.0|02/04/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1708168|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5331748|39806228|D|1||COMPANY REPRESENTATIVE REPORTED CASE ALCL FOLLOW-UP HEALTH PROFESSIONAL FINDS PATIENT PRESENTED EXPANDING SEROMA SPECIFIED LEFT BREAST SEROMA DRAINED SENT CYTOLOGY SEVERE CAPSULAR CONTRACTURE LATER IDENTIFIED BAKER GRADE IV BIOPSIED DEVICE EXPLANTED CAPSULECTOMY PERFORMED PATIENT CURRENTLY Â¿SEEING HAEMATOLOGYONCOLOGYÂ¿ IMMUNOCHEMISTRY REPORTED RECEIVED NOTES POSITIVE CD30Â¿NEGATIVE ALK-1Â¿ DIAGNOSIS LYMPHOMA ALCL CONFIRMED PATHOLOGY ADDITIONALLY STATES Â¿CHRONICALLY INFLAMED DENSE FIBROUS CONNECTIVE TISSUEÂ¿ Â¿CHRONIC INFLAMMATORY CELLSÂ¿|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FF130-425|12/29/2015|||DA|N|R||0HP|FTR|1.0|04/19/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1832218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5331748|34569574|N|1||MEDWATCH SUBMITTED 12292015 B4 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FF130-425|12/29/2015|||DA|N|R||0HP|FTR|1.0|04/19/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1832218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5331748|34569575|D|1||COMPANY REPRESENTATIVE REPORTED CASE ALCL FOLLOW-UP HEALTH PROFESSIONAL FINDS PATIENT PRESENTED EXPANDING SEROMA SPECIFIED LEFT BREAST SEROMA DRAINED SENT CYTOLOGY SEVERE CAPSULAR CONTRACTURE LATER IDENTIFIED BAKER GRADE IV BIOPSIED DEVICE EXPLANTED CAPSULECTOMY PERFORMED PATIENT CURRENTLY SEEING HAEMOTOLOGYONCOLOGYIMMUNOCHEMISTRY REPORTED RECEIVED NOTES POSITIVE CD30NEGATIVE ALK-1 DIAGNOSIS LYMPHOMA ALCL CONFIRMED PATHOLOGY ADDITIONALLY STATES CHRONICALLY INFLAMED DENSE FIBROUS CONNECTIVE TISSUE CHRONIC INFLAMMATORY CELLS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FF130-425|12/29/2015|||DA|N|R||0HP|FTR|1.0|04/19/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1832218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4553413|59981182|D|1||PHYSICIAN REPORTS TUMEFACTION PAIN REDNESS LEFT PERI-PROSTHETIC EXTRAVASATION LEFT SIDE LEFT SIDE DEVICE REMOVED REPLACED REPORT STATES REDNESS PERIPROSTHETIC EFFUSION PAIN PECTORAL SIDE TUMEFACTION PERIPROSTHETIC CAPSULE TEAR PROSTHETIC SIDE PERIPROSTHETIC CAPSULE TREATMENT REPORTED EXCISION TUMEFACTION CAPSULECTOMY RE-IMPLANTATION STRICT MONITORING MARKERS ALCL DIAGNOSIS B6 2015 INCLUDE CD30+ALK-|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|02/25/2015|||DA|N|R||0HP|FTR|1.0|11/01/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1159047|900 PARKWAY GLOBAL PARK|ZONA FRANCA|ARKLOW, COUNTY WICKLOW|CS|ALLERGAN|||||||True
4680690|13211132|N|1||B4 DEVICE LABELING UNDERGOING TYPE SURGICAL PROCEDURE INVOLVES RISKS EFFECTS ANESTHESIA INFECTION SWELLING REDNESS BLEEDING PAIN EVEN DEATH RISKS SERIOUS RISKS NEED BALANCED BENEFITS SURGERY WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ANAPLASTIC LARGE CELL LYMPHOMA ALCL SCAR TISSUE FLUID ADJACENT IMPLANT ALCL BREAST CANCER - RARE TYPE NON-HODGKINS LYMPHOMA CANCER IMMUNE SYSTEM ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS PTS DIAGNOSED SOUGH MEDICAL TREATMENT IMPLANT-RELATED SYMPTOMS PAIN LUMPS SWELLING ASYMMETRY DEVELOPED INITIAL SURGICAL SITES FULLY HEALED CASES REPORTED ALCL TYPICALLY DIAGNOSED YEARS IMPLANT SURGERY ONE RECONSTRUCTION PT PIVOTAL STUDY REPORTED ALCL 10 YEARS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF140-440|04/09/2015|||DA|N|R||0HP|FTR|1.0|03/20/2012|nan||1408999|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4742777|16612615|N|1||UNIQUE IDENTIFIER UDI  APPLICABLE EVENT ANAPLASTIC LARGE CELL LYMPHOMA INITIALLY REPORTED B6 2011 ADVERSE EVENT TERM CODE CANCER UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED CANCER LYMPHOMA-ALCL DUE INCREASED SPECIFICITY PATIENT IDENTIFIER B6 RELATES PATIENTS RECORD PREVIOUSLY EXISTING EASY TRACK DATABASE CURRENT DATABASE PATIENT IDENTIFIER B6 DEVICE LABELING PATIENTS ADVISED IMPLANTS CONSIDERED LIFETIME DEVICES POTENTIALLY UNDERGO IMPLANT REMOVAL WITHOUT REPLACEMENT COURSE LIFE PATIENTS ALSO ADVISED CHANGES BREAST FOLLOWING EXPLANTATION IRREVERSIBLE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/30/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|LA AURORA DE HEREDIA||NE|CS|ALLERGAN|||||||True
5285719|38372148|D|1||COMPANY REPRESENTATIVE REPORTED PHYSICIAN STATED POSSIBLE ALCLNO SPECIFICS GIVEN FOLLOW-UP HEALTH PROFESSIONAL CONFIRMS MANUFACTURER ALLERGAN PATIENT PRESENTED RIGHT BREAST SWOLLEN RED FINE NEEDLE ASPIRATION REPORTS APPARENT TINY CALCIFICATIONSÂ¿ Â¿APPROXIMATELY ONE LITER YELLOW SLIGHTLY TURBID FLUID OBTAINEDÂ¿ IMPRESSION STATES Â¿THERE AREAS SOFT TISSUE NODULARITY ALONG MARGINS FLUID COLLECTION SUSPICIOUS LYMPHOMA CYTOLOGY SHOWS MALIGNANCY CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ PATHOLOGY REPORT NOTES CD30 POSITIVE ALK-1 NEGATIVE CAPSULECTOMY EXPLANTATION OCCURRED ADDITIONALLY HEALTH PROFESSIONAL REPORTED INCREASED TENDERNESS SMALL AREAS SKIN BREAKDOWN ANTERIOR CAPSULE WHITE NECROTIC APPEARING TISSUE SEVERAL SPOTS EXTENDED WAY DEEP DERMIS PAIN DEEMED SECONDARY EVENT NECROSIS|STYLE 468 SALINE FILLED BREAST IMPLANT|468-350|12/10/2015||01/08/2016|DA|R|Y||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5285719|33288642|N|1||MEDWATCH SUBMITTED 12102015 DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-350|12/10/2015||01/08/2016|DA|R|Y||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5285719|35139726|D|1||COMPANY REPRESENTATIVE REPORTED PHYSICIAN STATED POSSIBLE ALCL SPECIFICS GIVEN FOLLOW-UP HEALTH PROFESSIONAL CONFIRMS MANUFACTURER ALLERGAN PATIENT PRESENTED RIGHT BREAST SWOLLEN RED FINE NEEDLE ASPIRATION REPORTS APPARENT TINY CALCIFICATIONS APPROXIMATELY ONE LITER YELLOW SLIGHTLY TURBID FLUID OBTAINED IMPRESSION STATES AREAS SOFT TISSUE NODULARITY ALONG MARGINS FLUID COLLECTION SUSPICIOUS LYMPHOMA CYTOLOGY SHOWS MALIGNANCY CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY REPORT NOTES B4 POSITIVE ALK-1 NEGATIVE CAPSULECTOMY EXPLANTATION OCCURRED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-350|12/10/2015||01/08/2016|DA|R|Y||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5285719|39855319|D|1||COMPANY REPRESENTATIVE REPORTED PHYSICIAN STATED POSSIBLE ALCLNO SPECIFICS GIVEN FOLLOW-UP HEALTH PROFESSIONAL CONFIRMS MANUFACTURER ALLERGAN PATIENT PRESENTED RIGHT BREAST SWOLLEN RED FINE NEEDLE ASPIRATION REPORTS APPARENT TINY CALCIFICATIONSÂ¿ Â¿APPROXIMATELY ONE LITER YELLOW SLIGHTLY TURBID FLUID OBTAINEDÂ¿ IMPRESSION STATES Â¿THERE AREAS SOFT TISSUE NODULARITY ALONG MARGINS FLUID COLLECTION SUSPICIOUS LYMPHOMA CYTOLOGY SHOWS MALIGNANCY CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ PATHOLOGY REPORT NOTES CD30 POSITIVE ALK-1 NEGATIVE CAPSULECTOMY EXPLANTATION OCCURRED ADDITIONALLY HEALTH PROFESSIONAL REPORTED INCREASED TENDERNESS SMALL AREAS SKIN BREAKDOWN ANTERIOR CAPSULE WHITE NECROTIC APPEARING TISSUE SEVERAL SPOTS EXTENDED WAY DEEP DERMIS PAIN DEEMED SECONDARY EVENT NECROSIS|STYLE 468 SALINE FILLED BREAST IMPLANT|468-350|12/10/2015||01/08/2016|DA|R|Y||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5285719|33288643|D|1||COMPANY REPRESENTATIVE REPORTED PHYSICIAN STATED POSSIBLE ALCLNO SPECIFICS GIVEN SIDE SPECIFIED MANUFACTURER DEVICE UNKNOWN PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-350|12/10/2015||01/08/2016|DA|R|Y||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5054360|24980550|D|1||PATIENT REPORTED LEFT SIDE SEROMA ANAPLASTIC LYMPHOMA DEVICE REMOVED PATIENT ADDITIONALLY REPORTED SAMPLE CAPSULE TAKEN LEFT SIDE CAME BACK POSITIVE ANAPLASTIC LYMPHOMA DIAGNOSTIC MARKERS CONFIRM ALCL RECEIVED EVENT CAPTURED LYMPHOMA EVENTS CONFIRMED HEALTH PROFESSIONAL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410580|09/03/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2429863|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5054360|24980549|N|1||DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT PLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY CASE-CONTROL STUDIES EVALUATE ASSOCIATION NATRELLEÂ® 410 BREAST IMPLANTS 5 RARE DISEASE OUTCOMES RARE CONNECTIVE TISSUE DISEASES NEUROLOGICAL DISEASES BRAIN CANCER CERVICALVULVAR CANCER LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410580|09/03/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2429863|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4385729|54697092|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED DELAYED SEROMA LEFT BREAST FNA DEMONSTRATED BIA-ALCL UNDERWENT BILATERAL EXPLANTATION CAPSULECTOMIES NOTED MASS MEDIAL ASPECT LEFT CAPSULE POSTOPERATIVE PATHOLOGY CONFIRMED BIA-ALCL MARGINS POSITIVE RETURNED OPERATING ROOM BILATERAL COMPLETION CAPSULECTOMY RESIDUAL BIA-ALCL PATHOLOGY REMAINS DISEASE FREE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4385729|5263406|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED DELAYED SEROMA LEFT BREAST FNA DEMONSTRATED BIA-ALCL UNDERWENT BILATERAL EXPLANTATION CAPSULECTOMIES NOTED MASS MEDIAL ASPECT LEFT CAPSULE POSTOPERATIVE PATHOLOGY CONFIRMED BIA-ALCL MARGINS POSITIVE RETURNED OPERATING ROOM BILATERAL COMPLETION CAPSULECTOMY RESIDUAL BIA-ALCL PATHOLOGY REMAINS DISEASE FREE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4385729|12634624|N|1||DEVICE LABELING ADDRESSES REPORTED EVENT ALCL FOLLOWS BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REP PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSISTWITH VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS DEVICE LABELING ADDRESSES REPORTED EVENT JUMPMASSCYST FOLLOWS B6 STUDY LEAST 1 REOPERATION PERFORMED 315 PATIENTS 365 10 YEARS TOTAL 424 REOPERATIONS PERFORMED PRIMARY REASON REOPERATION 10 YEARS AUGMENTATION PATIENTS IMPLANT DEFLATION 217 PERCENTAGE REOPERATIONS DUE LUMPMASSCYST INCREASED 85 293 REOPERATIONS 5 YEARS 139 424 REOPERATIONS 10 YEARS OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PTS AGE COULD EXPLANATION INCREASE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4385750|20562037|N|1||DEVICE LABELING ADDRESSES REPORTED EVENT ALCL FOLLOWS BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REP PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4385750|20374001|D|1||HEALTH PROFESSIONAL REPORTED PT DEVELOPED RAPID DELAYED SEROMA DIAGNOSED CD30+ ALK- ALCL MALIGNANT EFFUSION TREATED BILATERAL IMPLANT REMOVAL CAPSULECTOMIES CHEMOTHERAPY CHOP FU IMAGING CT SCAN RECURRENCE DISEASE ALCL AFFECTED BREAST REPORTED UNILATERAL - RIGHT STAGE IE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4385750|55048878|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED RAPID DELAYED SEROMA DIAGNOSED CD30+ ALK- ALCL MALIGNANT EFFUSION TREATED BILATERAL IMPLANT REMOVAL CAPSULECTOMIES CHEMOTHERAPY CHOP FOLLOW IMAGING CT SCAN RECURRENCE DISEASE ALCL AFFECTED BREAST REPORTED UNILATERAL - RIGHT STAGE IE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4791713|50656531|D|1||FU CONFIRMED PHYSICIAN PT LYMPHOMA ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084729|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4791713|21083118|D|1||PATIENT REPORTED LEFT SIDE DISCOMFORT PATIENT ADDITIONALLY REPORTED STOMACH PAINS NAUSEA ALCL SIDE EFFECTS ALCL CAPTURED LYMPHOMA EVENT CANNOT CONFIRMED PHYSICIAN SEE MFR 9617229-2015-00085 RIGHT SIDE|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084729|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4791713|50913116|D|1||PATIENT REPORTED LEFT SIDE DISCOMFORT PATIENT ADDITIONALLY REPORTED STOMACH PAINS NAUSEA ALCL SIDE EFFECTS ALCL CAPTURED LYMPHOMA EVENT CANNOT CONFIRMED PHYSICIAN SEE MFR  9617229-2015-00085 RIGHT SIDE FOLLOW-UP CONFIRMED PHYSICIAN PATIENT LYMPHOMA ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084729|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4385811|5262304|D|1||HEALTH PROFESSIONAL REPORTED PT RECEIVED BILATERAL MASTECTOMIES NOTE PTS PATHOLOGY CD30+ ALK-ALCL STAGE IE  FOUND CONTRALATERAL RIGHT BREAST TIME MASTECTOMY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNK|NE||NE||||True
4385811|55591407|D|1||HEALTH PROFESSIONAL REPORTED PATIENT RECEIVED BILATERAL MASTECTOMIES NOTE PATIENTS PATHOLOGY CD30+ ALK- ALCL STAGE IE FOUND CONTRALATERAL RIGHT BREAST TIME MASTECTOMY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNK|NE||NE||||True
4385811|12655352|N|1||DEVICE LABELING ADDRESSES REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNK|NE||NE||||True
4627437|5593685|D|1||HEALTH PROFESSIONAL REPORTED VIA VOLUNTARY MW5039349 ALCL CASE REPORT HISTORY BILATERAL BREAST AUGMENTATION PT HX PAINFUL SWELLING LEFT BREAST MAMMOGRAM INDURATION ERYTHEMA INFERIOR PORTION LEFT BREAST PT UNDERWENT MRI SKIN BIOPSY INDURATED PORTION LEFT BREAST REPORT BIOPSY SHOWED INFLAMMATORY TISSUE MALIGNANCY PT PRESENTED INCREASED PAIN SWELLING LEFT BREAST LEFT BREAST FIRM LARGER VOLUME RIGHT BREAST PATIENT AREA 5 X 8 CM ERYTHEMA ALONG INFERIOR ASPECT LEFT BREAST UPON REMOVAL PATIENT DENSE FIBROSIS INDURATION SKIN UNDERLYING BREAST TISSUE LEFT FROZEN SECTION PATHOLOGY CONSISTENT PROBABLE INFLAMMATORY CARCINOMA ENTIRE CAPSULECTOMY PERFORMED BILATERALLY LEFT CAPSULE THICK FIRM IMPLANT COMPLETELY DEFLATED IMPLANT SURROUNDED 250-300CC CREAM MONOGENOUS YELLOW FLUID SENT CYTOLOGY PROCEDURE BILATERAL CAPSULECTOMY REMOVAL IMPLANTS CLOSURE DRAINS IMPLANTS MCGHAN TEXTURED SALINE IMPLANTS 270CC APPEARED SHAPED IMPLANTS IDENTIFYING MARKS IMPLANTS LYMPHOMA CAPTURED CONFIRMATION ALCL CD30+ ALK- RECEIVED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/23/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5108543|32666145|D|1||HEALTH PROFESSIONAL REPORTED SEVERAL SPONTANEOUS SEROMA LEFT BREAST NEGATIVE CYTOLOGY SPONTANEOUSLY RESOLVED DEVICE REMOVED CAPSULE ANALYZED RESULT ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE DIAGNOSED CAPSULE SPECIFIED ALCL CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED SEE MFR  9617229-2015-00373 RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5108543|26936807|N|1||DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5108543|32280916|D|1||HEALTH PROFESSIONAL REPORTED SEVERAL SPONTANEOUS SEROMA LEFT BREAST NEGATIVE CYTOLOGY SPONTANEOUSLY RESOLVED DEVICE REMOVED CAPSULE ANALYZED RESULT ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE DIAGNOSED CAPSULE SPECIFIED ALCL CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED SEE MFR  9617229-2015-00373 RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5108543|49682505|D|1||HEALTH PROFESSIONAL REPORTED SEVERAL SPONTANEOUS SEROMA LEFT BREAST NEGATIVE CYTOLOGY SPONTANEOUSLY RESOLVED DEVICE REMOVED CAPSULE ANALYZED RESULT ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE DIAGNOSED CAPSULE SPECIFIED ALCL CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED SEE MFR  9617229-2015-00373 RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5108543|26936808|D|1||HEALTH PROFESSIONAL REPORTED SEVERAL SPONTANEOUS SEROMA LEFT BREAST NEGATIVE CYTOLOGY SPONTANEOUSLY RESOLVED DEVICE REMOVED CAPSULE ANALYZED RESULT ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE DIAGNOSED CAPSULE SPECIFIED ALCL CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED SEE MFR  9617229-2015-00373 RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4859987|5847605|D|1||HEALTH PROFESSIONAL REPORTED PT DEVELOPED LARGE VOLUME LATE SEROMA AROUND RIGHT RECONSTRUCTIVE BREAST IMPLANT FLUID ASPIRATED SENT CYTOLOGY CONFIRMED ANAPLASTIC LARGE CELL LYMPHOMA ALK-1 NEGATIVE SUBSEQUENT PET SCAN - MILD ACTIVITY INTERNAL MAMMARY LYMPH NODES AWAITING FINAL HAEMATOLOGY REVIEW DEVICE REMOVED FOLLOW-UP REPORTED FINE NEEDLE ASPIRATION SEROMA FLUID AROUND RIGHT IMPLANT CONFIRMED DIAGNOSIS ALK-1 NEGATIVE ALCL ALCL CONTAINED WITHIN CAPSULE PERIPROSTHETIC FLUID PATHOLOGY REPORT CONFIRMED  CD30 LARGE CELL POSITIVE  ALK-1 NEGATIVE OVERALL FINDINGS SUGGESTIVE ALK-1 NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA STAGE 1AE PET-CT SCAN REPORTS BILATERAL BORDERLINE ENLARGED INTERNAL MAMMARY LYMPH NODES SHOW MILDLY INCREASED METABOLIC ACTIVITY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FM-410500|06/19/2015|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4874726|31122635|D|1||PHYSICIAN REPORTED SUSPICION ALCL LYMPHOMA SIDE UNSPECIFIED MANUFACTURER DEVICE UNKNOWN PATHOLOGICAL MARKERS RECEIVED CONFIRM ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/26/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4874726|22249899|D|1||PHYSICIAN REPORTED SUSPICION ALCL LYMPHOMA SIDE UNSPECIFIED MFR DEVICE UNK PATHOLOGICAL MARKERS RECEIVED CONFIRM ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/26/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4874726|54538473|D|1||PHYSICIAN REPORTED SUSPICION ALCL LYMPHOMA SIDE UNSPECIFIED MANUFACTURER DEVICE UNKNOWN PATHOLOGICAL MARKERS RECEIVED CONFIRM ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/26/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4385762|5263418|D|1||MEDICAL STAFF REPORTED EXPLANTATION PERIPROSTHETIC RIGHT SIDE ANAPLASTIC LARGE CELL LYMPHOMA T-CELL FORMED EXUDATE WITHOUT INFILTRATION TUMOR CAPSULE ALCL YET CONFIRMED VIA DIAGNOSTICS THEREFORE EVENT LYMPHOMA REPORTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MF120-295|12/31/2014|||DA||R||0HP|FTR|1.0|02/08/2013|nan||1553196|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5078001|40431380|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE DEFLATION HEALTH PROFESSIONAL ADDITIONALLY REPORTED ENLARGED RIGHT BREAST SEROMA RIGHT BREAST IMPLANT POCKET PATIENT GIVEN ANTIBIOTICS IMPROVEMENT RECURRENT SUDDENLY ENLARGING RIGHT BREASTÂ¿ TIME SURGERY CLEAR STRAW COLORED FLUID APPROXIMATELY 450CC REMOVED PROTEINACEOUS EXUDATE FOUND AROUND POCKET IMPLANTÂ¿ PATHOLOGY REPORT STATES DIAGNOSIS Â¿CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK-NEGATIVE ALCL ASSOCIATED BREAST IMPLANT NEOPLASTIC CELLS CD30 CD4 CD43 POSITIVEÂ¿ PER ADDITIONAL INFORMATION HEALTH PROFESSIONAL NOTED SWELLING INVOLVING RIGHT BREAST BELIEVED INFECTION TREATED ANTIBIOTICS|STYLE 168 SALINE FILLED BREAST IMPLANT|168-420|09/15/2015||08/21/2015|DA|R|Y||0HP|FWM|1.0|05/01/2005|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||564274|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4385745|18292591|D|1||HEALTH PROFESSIONAL REPORTED PT DEVELOPED RAPID LATE SEROMA DIAGNOSED BIA-ALCL RIGHT BREAST CAPSULE PATHOLOGY EXPLANTATION UNDERWENT BILATERAL CAPSULECTOMIES IMPLANT REMOVAL RECEIVED CHOP CHEMOTHERAPY REFUSED RADIATION THERAPY FOLLOW IMAGING PET RECURRENCE DISEASE REMAINS HEALTHY ALCL AFFECTED BREAST SPECIFIED UNILATERAL - LEFT STAGE IE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE DEREDIA|CS|UNK|||||||True
4385745|18428752|N|1||DEVICE LABELING ADDRESSES REPORTED EVENT ALCL FOLLOWS BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE DEREDIA|CS|UNK|||||||True
4385745|75875876|D|1||HEALTH PROFESSIONAL REPORTED PATIENT RECEIVED ALCL DIAGNOSIS B6 2012 ALCL STAGE TIME DIAGNOSIS PROVIDED Â¿STAGE II II NEGATIVE FISH ALK NEGATIVEÂ¿ PATIENT EXPERIENCED Â¿DISCOMFORT LEFT BREAST 78 CM MASS ADJACENT IMPLANTÂ¿ HEALTH PROFESSIONAL CONFIRMED PERI-IMPLANT SEROMA PRESENT Â¿MASS 78 CM CAUSING PAINÂ¿|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE DEREDIA|CS|UNK|||||||True
4385745|55222307|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED RAPID LATE SEROMA DIAGNOSED BIA-ALCL RIGHT BREAST CAPSULE PATHOLOGY EXPLANTATION UNDERWENT BILATERAL CAPSULECTOMIES IMPLANT REMOVAL RECEIVED CHOP CHEMOTHERAPY REFUSED RADIATION THERAPY FOLLOW IMAGING PET RECURRENCE DISEASE REMAINS HEALTHY ALCL AFFECTED BREAST SPECIFIED UNILATERAL - LEFT STAGE IE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE DEREDIA|CS|UNK|||||||True
4648716|13098279|N|1||EVENT ANAPLASTIC LARGE CELL LYMPHOMA INITIALLY REPORTED VIA B4 B4 2010 ADVERSE EVENT TERM CODE CANCER EVENT REPORTED VIA B4 B4 2012 ADVERSE EVENT TERM CODE LYMPHOMA UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED LYMPHOMA ALCL DUE INCREASED SPECIFICITY B6 DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS POSTOPERATIVE HEMATOMA SEROMA MAY MINIMIZED METICULOUS ATTENTION HEMOSTASIS SURGERY POSSIBLY ALSO POSTOPERATIVE USE CLOSED DRAINAGE SYSTEM PERSISTENT EXCESSIVE BLEEDING MUST CONTROLLED IMPLANTATION POSTOPERATIVE EVACUATION HEMATOMA SEROMA MUST CONDUCTED CARE AVOID BREAST IMPLANT CONTAMINATION DAMAGE SHARP INSTRUMENTS USE CARE SUBSEQUENT PROCEDURES OPEN CAPSULOTOMY BREAST POCKET REVISION HEMATOMASEROMA ASPIRATION BIOPSYLUMPECTOMY AVOID DAMAGE IMPLANT B4 STUDY CONTINUE EVALUATE LONG-TERM B4 SAFETY EFFECTIVENESS PRODUCTS ADDITION ALLERGAN INITIATED SEPARATE B4 POST-APPROVAL STUDY B4 ADDRESS SPECIFIC ISSUES ALLERGANS CORE STUDY DESIGNED FULLY ANSWER WELL PROVIDE REAL-WORLD ASSESSMENT ENDPOINTS B4 ALLERGAN UPDATE LABELING REGULAR BASIS RESULTS TWO STUDIES B4 REPORTS CANCERS BRAIN RESPIRATORY CERVICALVULVAR PRIMARY RECONSTRUCTION REVISION-RECONSTRUCTION PATIENTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|03/31/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5105218|26823377|N|1||DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|09/25/2015||||N|R||0HP|FTR|1.0|11/04/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1671333|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5105218|26823378|D|1||MEDICAL STAFF REPORTED SUSPECTED RUPTURED RIGHT SIDE ADDITIONAL REPORT REGULATORY BODY VIA EXPLANTING PHYSICIAN INDICATES PATIENT PRESENTED INCREASE VOLUME RIGHT BREAST TESTING REVEALED MAJOR RIGHT PERIPROSTHETIC FLUID EFFUSION DEVICE REMOVED FOUND INTACT LIQUID AROUND RIGHT IMPLANT FOUND HEMORRHAGIC LIQUID WITHOUT MALIGNANT CELLS RIGHT CAPSULECTOMY TESTING YIELDED PATHOLOGICAL RESULTS ALCL CD3+ ALK1- SEROMA ONSEQUENCES LISTED ASALCL CD30+ALK1- CONFIRMED LYMPHOPATH|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|09/25/2015||||N|R||0HP|FTR|1.0|11/04/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1671333|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4922480|6025362|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE DEVICE REMOVAL DUE SWELLING SUBCUTANEOUS MASSES ALCL EVENT LYMPHOMA-ALCL CONFIRMED PATHOLOGY INDICATED CD30 ATYPICAL LYMPHOCYTE ALK1 NON REACTIVE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-500|07/16/2015|||DA|N|R||0HP|FTR|1.0|09/26/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE PEL-FILLED||2031914|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5285827|34095038|D|1||ALLERGAN SALES REPRESENTATIVE REPORTED REVISION CASE PATIENT ALLERGAN IMPLANTSTHERE FLUID AROUND DEVICE OFFICE SENT FLUID CULTURED CULTURED FLUID CAME BACK POSITIVE BREAST IMPLANT ASSOCIATED ALCL SIDE UNSPECIFIED FOLLOW-UP HEALTH PROFESSIONAL CONFIRMED REASON SURGERY LEFT BREAST KEPT GETTING LARGER LARGER SWELLING PATHOLOGY NOTED OPAQUE ORANGE FLUID CONFIRMED PRESENCE CD30+ ALK- PATHOLOGY ALSO NOTED CLINICAL HISTORY LEFT BREAST IMPLANT MALPOSITION ALCL CONFIRMED|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|12/10/2015|||DA|N|R||0HP|FWM|1.0|12/04/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1375592|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5285827|33170547|D|1||ALLERGAN SALES REPRESENTATIVE REPORTED REVISION CASE PATIENT ALLERGAN IMPLANTSTHERE FLUID AROUND DEVICE OFFICE SENT FLUID CULTURED CULTURED FLUID CAME BACK POSITIVE BREAST IMPLANT ASSOCIATED ALCL SIDE UNSPECIFIED FOLLOW-UP HEALTH PROFESSIONAL CONFIRMED REASON SURGERY LEFT BREAST KEPT GETTING LARGER LARGER SWELLING PATHOLOGY NOTED OPAQUE ORANGE FLUID CONFIRMED PRESENCE CD30+ ALK- PATHOLOGY ALSO NOTED CLINICAL HISTORY LEFT BREAST IMPLANT MALPOSITION ALCL CONFIRMED|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|12/10/2015|||DA|N|R||0HP|FWM|1.0|12/04/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1375592|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5285827|33170546|N|1||MEDWATCH SUBMITTED 12102015 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|12/10/2015|||DA|N|R||0HP|FWM|1.0|12/04/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1375592|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5061707|25188102|D|1||HEALTH PROFESSIONAL REPORTED HISTORY L BREAST SIZE INCREASE RO SEROMA - ATYPICAL LEUKOCYTES CD30+ ALK- TREATMENT REPORTED TOTAL CAPSULECTOMY  EXPLANTATION FOLLOW DIAGNOSTIC TESTS RECEIVED CONFIRMED PRESENCE SEROMA ALCL BREAST ULTRASOUND STATES 375ML MINIMALLY TURBID STRAW COLOURED FLUID ASPIRATED CYTOPATHOLOGY FLUID REPORTS SPECIMEN RECEIVED L BREAST 20 ML CLEAR YELLOW FLUID CONCLUSION RARE ATYPICAL LARGE CD30+ CELLS PRESENT HISTOPATHOLOGY REPORT STATES  MICROSCOPIC DESCRIPTION ATYPICAL CELLS STRONGLY CD30 MEMBRANE EXPRESSING ALK-1 NEGATIVE DIAGNOSES STATES BREAST IMPLANT-ASSOCIATED LARGE CELL LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX125-370|09/08/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1331894|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5061707|25188101|N|1||MEDWATCH SUBMITTED 09082015 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT PLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX125-370|09/08/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1331894|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4702227|13234344|N|1||B4 DEVICE LABELING BASED INFORMATION FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL 9 PRIMARY AUGMENTATION PATIENTS 19 NEW DIAGNOSIS BREAST CANCER 10 YEARS ALLERGAN PIVOTAL STUDY PRIMARY AUGMENTATION PATIENTS 1 REPORT SKIN CANCER 1 REPORT RENAL CELL CANCER 1 PRIMARY AUGMENTATION PATIENT PREGNANT TIME IMPLANTATION GAVE BIRTH CHILD LATER DEVELOPED HISTIOCYTOSIS 1 REVISION-AUGMENTATION PATIENT 08 NEW DIAGNOSIS BREAST CANCER 10 YEARS 1 PATIENT REPORT BLADDER CANCER 1 PATIENT REPORT MULTIPLE MYELOMA 17 RECONSTRUCTION PATIENTS 76 RECURRENCE BREAST CANCER 10 YEARS 1 REPORT NON-HODGKINS LYMPHOMA 1 REPORT UTERINE CANCER REVISION-RECONSTRUCTION PATIENTS REPORTED RECURRENCE BREAST CANCER 10 YEARS REPORTS CANCERS REVISION-RECONSTRUCTION PATIENTS ONE RECONSTRUCTION PATIENT PIVOTAL STUDY REPORTED ALCL 10 YEARS SOMETIMES SYMPTOMS ASSOCIATED GEL IMPLANT RUPTURE SYMPTOMS INCLUDE HARD KNOTS LUMPS SURROUNDING IMPLANT ARMPIT CHANGE LOSS SIZE SHAPE BREAST IMPLANT PAIN TINGLING SWELLING NUMBNESS BURNING HARDENING BREAST LITERATURE REPORTS ALSO MADE ASSOCIATING SILICONE BREAST IMPLANTS VARIOUS RHEUMATOLOGICAL SIGNS SYMPTOMS FATIGUE EXHAUSTION JOINT PAIN SWELLING MUSCLE PAIN CRAMPING TINGLING NUMBNESS WEAKNESS SKIN RASHES|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410335|04/16/2015||02/25/2013|DA|Y|Y||0HP|FTR|1.0|02/02/2011|nan||1223847|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4702227|5724962|D|1||HEALTH PROFESSIONAL REPORTED ANAPLASTIC LARGE CELL LYMPHOMA PATIENT PRESENTED RIGHT BREAST SWELLING EVENT ANAPLASTIC LARGE CELL LYMPHOMA CAPTURED LYMPHOMA DIAGNOSTIC TESTING CONFIRM DIAGNOSIS ALCL DEVICE REMOVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410335|04/16/2015||02/25/2013|DA|Y|Y||0HP|FTR|1.0|02/02/2011|nan||1223847|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5039249|24514426|D|1||BREAST AUGMENTATION 2007 IMPLANTS GUMMY BEAR SILICONE MUSCLE REALLY HADNT PAYING ATTENTION CERTAIN SYMPTOM EARLY B6 2014 EXERCISING NOTICED SEVERE PAIN RIGHT CALF MUSCLE THOUGHT TORN CALF WEEK WENT AWAY CONTINUED EXERCISE NOTICED EXTREME FATIGUE MUSCLES REALIZED COULD LIFT RIGHT FOOT SEARCHING INTERNET REALIZED FOOT DROP TIME STARTED NOTICING MUSCLES TWITCHING INTERNET RESEARCHER FINDING INCREDIBLY SCARY ADDITION RIGHT BREAST EPISODE SWELLING PAIN SCHEDULED APPOINTMENT BREAST ULTRASOUND MAMMO MRI FINDING FLUID IMPLANT SCHEDULED BIOPSY MENTIONED ALCL APPOINTMENT BIOPSY DOC COULD FIND ENOUGH FLUID BIOPSY PAIN GONE ABORTED PROCEDURE FAST FORWARD B6 2014 SAW GP MUSCLE CRAMPS FOOT DROP REFERRED NEUROLOGIST ASKED DOCTORS IMPLANTS COULD RADIOLOGIST FOUND EVIDENCE RUPTURE RELATED - SAID OH IM EXPERT NEUROLOGIST 1 COUPLE TESTS BLOOD COPPER EMG SAID DEFINITELY WEAKNESS UNEXPLAINED FOOT DROP PROBABLY ALS WORLD COME CRASHING GOT SECOND OPINION NEUROLOGIST SPECIALIZES ALS UPON FIRST MEETING SAID COULD MANY THINGS ORDERED ANOTHER EMG DOC SAID TEST RESULTS SEEM CONSISTENT ALS TEST ALS WOULD WAIT SEE SITUATION B6 BLOOD TESTS LATER ALS MARKERS ANYTHING ELSE CONCLUSION ANOTHER EMG DONE SPECIALISTS OFFICE ONE TECH SAID PARTS TESTED BETTER LAST TIME AREAS LOOKED MAYBE SLIGHTLY WORSE POINT STOPPED FOCUSING BREAST RIGHT SIDE STILL DOESNT FEEL RIGHT SLIGHTLY RIGID FEEL RIPPLES IMPLANT NECK APPEARS SLIGHTLY SWOLLEN RIGHT SEARCHING BACK LAST 8 YEARS STARTED REALIZING MUSCLE WEAKNESSES PROBABLY BEGAN 3-4 YEARS AGO CRAMPS LEAST 3-4 YEARS IVE STRUGGLED MILD FACIAL BREAK OUTS SMELLING URINE EXTREME SYMPTOMS CERTAIN DAYS MONTH TONGUE SWELLING ANXIETY FATIGUE ETC WILLING SIT AROUND NOTHING SEEING NATUROPATH SAYS LYME TEST CAME BACK 5050 CHANCE LYME B12 LOW TESTOSTERONE LEVELS BARELY EXISTENT ONE MICRONUTRIENT LOW IVE SHARED NEUROLOGIST SAYS NONE MEANS ANYTHING GETTING SLIGHTLY WEAKER WALK LIMP DUE FOOT DROP JOINT PAIN BACK PAIN COME GO FOOT DROP MUSCLE TWITCHES REMAIN GUT SAYS IMPLANTS KNOW TEST DEFINITIVE ANSWER B6 2015 WENT EXPLANT FOUND RIGHT IMPLANT RUPTURED SILICONE SPILLED TISSUES DOCTOR PERFORMED EN BLOC CAPSULECTOMY REPLACED IMPLANTS MENTOR SALINE IMPLANTS 15 POST EXPLANT NOTICE MILD CHANGES IMPROVEMENTS HOWEVER MUSCLE TWITCHES FOOT DROP REMAIN FOUND B6 GROUP 300 WOMEN EXTREMELY ILL IMPLANTS TRYING GET HELP GET HEALTHY BELIEVE SOFT SILICONE POISONING DETECTED MEDICAL TESTS PROCESS TRYING SMALL THINGS DETOX EAT HEALTHY INFRARED SAUNA ETC WAITING PRAYING IMPROVEMENT|NATRELLE SILICONE|20-300|08/25/2015||||*|*||0LP|FTR|0.0||BREAST IMPLANT|||||||ALLERGAN|||||STYLE 20||True
4616833|54647640|D|1||REPORTED EVENTS 24 UNPUBLISHED CASES BI-ALCL FOUND JOURNAL ABSTRACT Â¿1435 BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIALCL COMPREHENSIVE HISTOPATHOLOGICAL EVALUATION 40 CASES PROPOSAL PATHOLOGIC STAGING SYSTEMÂ¿ ANNUAL ABSTRACT MEETINGS DIAGNOSTIC TESTING PROVIDED EVENT CAPTURED LYMPHOMA SIDE UNKNOWN MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/18/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|LA AURORA DE HEREDIA||NE|CS|UNK|||||||True
4616833|5653848|D|1||REPORTED EVENTS 24 UNPUBLISHED CASES BI-ALCL FOUND JOURNAL ABSTRACT 1435 BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIALCL COMPREHENSIVE HISTOPATHOLOGICAL EVALUATION 40 CASES PROPOSAL PATHOLOGIC STAGING SYSTEM ANNUAL ABSTRACT MEETINGS DIAGNOSTIC TESTING PROVIDED EVENT CAPTURED LYMPHOMA SIDE UNKNOWN MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/18/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|LA AURORA DE HEREDIA||NE|CS|UNK|||||||True
4922479|6435381|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE DEVICE REMOVED DUE SEROMA SUDDENLY APPEARED SWELLING MAMMARY SEVERAL WEEKS REMOVAL RIGHT SIDE IMPLANT DOUBLE CAPSULE FOUND PATHOLOGICAL TESTING SEROMA CAPSULE REVEALED PATHOLOGICAL MARKERS CD30+ ALK- FOCAL INFLAMMATORY CHRONIC REARRANGEMENTS CONFIRMS DIAGNOSIS RIGHT SIDE ANAPLASTIC LARGE CELL LYMPHOMA ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF120-270|07/16/2015|||DA|N|R||0HP|FTR|1.0|08/25/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE, GEL-FILLED||1126779|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4385726|12614082|N|1||UNIQUE IDENTIFIER UDI NA DEVICE LABELING ADDRESSES ALCL REPORTED EVENTS LYMPHOMAALCL PATIENTS CORE STUDY LABELING SILICONE IMPLANTS DEVICE LABELING ADDRESSES SEROMA POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENUMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS DEVICE LABELING ADDRESSES LUMPS PATIENTS PERFORM BREAST SELF-EXAMINATIONS MONTHLY SHOWN DISTINGUISH IMPLANT BREAST TISSUE PATIENT MANIPULATE SQUEEZE IMPLANT EXCESSIVELY PATIENT TOLD PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGE IMPLANT SHAPE MAY SIGNS SYMPTOMATIC RUPTURE IMPLANT PATIENT SIGNS TOLD REPORT POSSIBLY MRI EVAL SCREEN RUPTURE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|LA AURORA DE HEREDIA|||CS|UNK|||||||True
4385726|5263405|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED DELAYED SEROMA LEFT BREAST UNDERWENT BILATERAL EXCHANGE IMPLANTS NOTED MASS MEDIAL ASPECT LEFT CAPSULE BIOPSIED EXCHANGE ABORTED IMPLANTS REPLACED POSTOPERATIVELY NOTED BIA-ALCL PATHOLOGY MASS RETURNED OPERATING ROOM BILATERAL COMPLETION CAPSULECTOMY NOTED RESIDUAL BIA-ALCL STAGE IE PATHOLOGY WELL SEROMA ASPIRATE REMAINS DISEASE FREE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|LA AURORA DE HEREDIA|||CS|UNK|||||||True
4385726|55049256|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED DELAYED SEROMA LEFT BREAST UNDERWENT BILATERAL EXCHANGE IMPLANTS NOTED MASS MEDIAL ASPECT LEFT CAPSULE BIOPSIED EXCHANGE ABORTED IMPLANTS REPLACED POSTOPERATIVELY NOTED BIA-ALCL PATHOLOGY MASS RETURNED OPERATING ROOM BILATERAL COMPLETION CAPSULECTOMY NOTED RESIDUAL BIA-ALCL STAGE IE PATHOLOGY WELL SEROMA ASPIRATE REMAINS DISEASE FREE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|LA AURORA DE HEREDIA|||CS|UNK|||||||True
4702206|17934685|D|1||HEALTHCARE PROFESSIONAL REPORTED DIAGNOSIS ALCL SEROMA FLUID ASPIRATED AROUND IMPLANTS SPECIMEN SENT B6 DX MADE EVENT ALCL CAPTURED LYMPHOMA CONFIRMATION PATHOLOGY RESULTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/16/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA, NE|CS|UNK|||||||True
4702206|55589065|D|1||HEALTHCARE PROFESSIONAL REPORTED DIAGNOSIS ALCL SEROMA FLUID ASPIRATED AROUND IMPLANTS SPECIMEN SENT UNIV VA PATH DX MADE EVENT ALCL CAPTURED LYMPHOMA CONFIRMATION PATHOLOGY RESULTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/16/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA, NE|CS|UNK|||||||True
4849890|5944021|D|1||HEALTH PROFESSIONAL REPORTED PATIENT SMALL AMOUNT SEROMA OPERATING ROOM FOUND ALCL CELLS CYTOLOGY FLUID PATHOLOGY RESULTS AVAILABLE ALCL CONFIRMED THEREFORE REPORTED LYMPHOMA DEVICE REMOVED|STYLE 410 OCHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF125-375|06/15/2015|||DA|N|R||0HP|FTR|1.0|02/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICON GEL-FILLED||380839|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4645849|5618617|D|1||REGULATORY AGENCY REPORTED FOLLOWING EVENTS VOLUNTARY REPORT NUMBER MW5039416 PATIENT PRESENTED RIGHT LATERAL CHEST MELANOMA EXCISION FOUND AXILLARY LYMPHADENOPATHY ULTRASOUND NORMAL PT ALSO APPEARED RIGHT BREAST FIRM GRADE IV CAPSULAR CONTRACTURE PT INITIALLY DECLINED TREATMENT RETURNED DIAGNOSED ALCL PATHOLOGY RESULTS PROVIDED REPORT ALCL CAPTURED LYMPHOMA UNLESS PATHOLOGY RESULTS RECEIVED TREATMENT UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/30/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4432002|20460339|D|1||PHYSICIAN REPORTED ANAPLASTIC LYMPHOMA CLINICAL SIGNS EXTRAVASATION EXTRAVASATION CODED RUPTURE SIDE SPECIFIED ALLERGAN NURSE SPECIALIST CONFIRMED EVENT LYMPHOMA REPORTED EVENT ALCL CONFIRMED CYTOLOGYIMMUNOCHEMISTRY MARKERS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/15/2015|||DA|N|R||0HP|FTR|1.0||FTR||NI|||LA AURORA DE HEREDIA, NE|CS|ALLERGAN|||||||True
4702228|13160829|N|1||EVENT ANAPLASTIC LARGE CELL LYMPHOMA INITIALLY REPORTED VIA B4 B4 2010 ADVERSE EVENT TERM CODE CANCER UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED CANCER LYMPHOMA-ALCL DUE INCREASED SPECIFICITY PT IDENTIFIER B6 RELATES PTS RECORD PREVIOUSLY EXISTING B4 DATABASE CURRENT DATABASE PT IDENTIFIER B6 DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDED IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO BEN REPORTED WOMEN IMPLANTS USE CARE SUBSEQUENT PROCEDURES OPEN CAPSULOTOMY BREAST POCKET REVISION HEMATOMASEROMA ASPIRATION BIOPSYLUMPECTOMY AVOID DAMAGE IMPLANT PT PERFORM BREAST SELF-EXAMINATIONS MONTHLY SHOWN DISTINGUISH IMPLANT BREAST TISSUE PT MANIPULATE SQUEEZE EXCESSIVELY PT TOLD PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGE IMPLANT SHAPE MAY SIGNS SYMPTOMATIC RUPTURE IMPLANT PT SIGNS TOLD REPORT POSSIBLY MRI EVAL SCREEN RUPTURE NATRELLE CORE STUDY CONTINUE EVALUATE LONG-TERM 10 YEARS SAFETY EFFECTIVENESS PROD ADDITION ALLERGAN INITIATED SEPARATE LARGE 10-YEAR POSTAPPROVAL STUDY BREAST IMPLANT FU STUDIES BIFS ADDRESS SPECIFIC ISSUES ALLERGANS CORE STUDY DESIGNED FULLY ANSWER WELL PROVIDE REAL-WORLD ASSESSMENT ENDPOINTS ENDPOINTS BIFS LARGE POSTAPPROVAL STUDY INCLUDE LONG-TERM LOCAL COMPLICATIONS CONNECTIVE TISSUE DISEASE CTD CTD SIGNS SYMPTOMS NEUROLOGICAL DISEASE NEUROLOGICAL SIGNS SYMPTOMS OFFSPRING ISSUES REPRODUCTIVE ISSUES CANCER SUICIDE MAMMOGRAPHY ISSUES MRI COMPLIANCE RESULTS ALLERGAN UPDATE LABELING REGULAR BASIS RESULTS TWO STUDIES 1 PRIMARY AUGMENTATION PT NEW DIAGNOSIS BREAST CANCER 7 YEARS CORE STUDY 13 BENIGN BREAST DISEASE RATE 1 MALIGNANT BREAST DISEASE RATE REVISION-AUGMENTATION PTS 1 PT NEW DIAGNOSIS BREAST CANCER THER 15 BENIGN BREAST DISEASE RATE 1 MALIGNANT BREAST DISEASE RATE 7 YEARS PRIMARY AUGMENTATION PTS 1 REPORT THYROID CANCER 1 REPORT BRAIN CANCER REPORTS CANCERS RESPIRATORY CERVICALVULVAR REVISION-AUGMENTATION PTS 8 PRIMARY RECONSTRUCTION PTS 8 NEW REPORTS BREAST CANCER 7 YEARS CORE STUDY 17 BENIGN BREAST DISEASE RATE 10 MALIGNANT BREAST DISEASE RATE 7 YEARS REVISION RECONSTRUCTION PTS REPORTS NEW DIAGNOSES REOCCURRENCE BREAST CANCER 7 BENIGN BREAST DISEASE RATE 7 YEARS REPORTS CANCERS BRAIN RESPIRATORY CERVICALVULVAR PRIMARY RECONSTRUCTION REVISION-RECONSTRUCTION PTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/16/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|NE||NE||||True
5155756|28464643|N|0||DEVICE LABELING PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY DEFLATION Â¿ BREAST IMPLANTS LIFETIME DEVICES SALINE BREAST IMPLANTS DEFLATE SHELL DEVELOPS TEAR HOLE DEFLATION OCCUR TIME IMPLANTATION LIKELY OCCUR LONGER IMPLANT IMPLANTED FOLLOWING THINGS MAY CAUSE IMPLANTS DEFLATE DAMAGE SURGICAL INSTRUMENTS FOLDING WRINKLING IMPLANT SHELL EXCESSIVE FORCE CHEST EG CLOSED CAPSULOTOMY CONTRAINDICATED TRAUMA COMPRESSION MAMMOGRAPHIC IMAGING SEVERE CAPSULAR CONTRACTURE BREAST IMPLANTS MAY ALSO SIMPLY WEAR TIME LABORATORY STUDIES IDENTIFIED CAUSES DEFLATION ALLERGANÂ¿S PRODUCT HOWEVER CONCLUSIVELY KNOWN WHETHER TESTS IDENTIFIED CAUSES DEFLATION|STYLE 168 SALINE FILLED BREAST IMPLANT|168-420|10/16/2015||||N|R||0HP|FWM|1.0|05/01/1996|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2-163072|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5155756|28464644|D|0||LAW FIRM REPORTED POSSIBLE LUMP BEHIND PATIENTS LEFT BREAST LEFT IMPLANT RUPTURE ADDITIONAL INFORMATION PROVIDED REVEALS PATIENT PRESENTED SMALL MASS LEFT CHEST WALL MEDIAL RECONSTRUCTION MASS RAPIDLY GROWN SIZE PUSHING IMPLANT LATERALLY GOTTEN QUITE UNCOMFORTABLE PATIENT SAW PHYSICIAN OBTAINED CT DEMONSTRATING LARGE MASS DEFORMING IMPLANT LOCATED SUB-PECTORALLY PATIENT ULTIMATELY DIAGNOSED LEFT SUB-PECTORAL MASS IDENTIFIED LYMPHOMA BIOPSY REVEALED PATIENT ALCL ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE CD30 RESULTS PATHOLOGY TESTS PROVIDED UNCONFIRMED REPORT ALCL CAPTURED LYMPHOMA TIME TREATMENT INCLUDED MULTIPLE HOSPITALIZATIONS LEFT SIDE DEVICE REMOVAL 16 ROUNDS CHEMOTHERAPY MULTIPLE SURGERIES ADDITIONAL NOTES INCLUDE BASAL CELL CARCINOMA MALIGNANT MELANOMA HERPES ZOSTER SIDE SPECIFIED MELANOMA RELATED DEVICE FIRST DIAGNOSED PRIOR IMPLANTATION RECORD LEFT SIDE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-420|10/16/2015||||N|R||0HP|FWM|1.0|05/01/1996|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2-163072|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4859975|54646975|D|1||HEALTH PROFESSIONAL REPORTED CASE ALCL SIDE UNSPECIFIED MANUFACTURER DEVICE UNKNOWN PATHOLOGICAL MARKERS CONFIRM ALCL PROVIDED THEREFORE EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/19/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|LA AURORA DE HEREDIA||NE|CS|UNK|||||||True
4859975|5810930|D|1||HEALTH PROFESSIONAL REPORTED CASE ALCL SIDE UNSPECIFIED MANUFACTURER DEVICE UNK PATHOLOGICAL MARKERS CONFIRM ALCL PROVIDED THEREFORE EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/19/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|LA AURORA DE HEREDIA||NE|CS|UNK|||||||True
5286834|33227133|N|1||DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/10/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5286834|33227134|D|1||HEALTH PROFESSIONAL REPORTED PERIPROSTHETIC OEDEMA LEADING PARTIAL CAPSULECTOMY CAPSULECTOMY LEFT SIDE PATIENT DIAGNOSED ALCL ANAPLASTIC LARGE CELL LYMPHOMA CD30+ ALK-|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/10/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4385769|18798721|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED RAPID LATER SEROMA DIAGNOSED BIA-ALCL RIGHT BREAST STAGE IE CAPSULE PATHOLOGY EXPLANTATION UNDERWENT BILATERAL CAPSULECTOMIES IMPLANT REMOVAL RECEIVED CHOP CHEMOTHERAPY RADIATION THERAPY FU IMAGING PET RECURRENCE DISEASE REMAINS HEALTHY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA, NE|CS|UNK|||||||True
4385769|55589830|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED RAPID LATE SEROMA DIAGNOSED BIA-ALCL RIGHT BREAST STAGE IE CAPSULE PATHOLOGY EXPLANTATION UNDERWENT BILATERAL CAPSULECTOMIES IMPLANT REMOVAL RECEIVED CHOP CHEMOTHERAPY RADIATION THERAPY FOLLOW IMAGING PET RECURRENCE DISEASE REMAINS HEALTHY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA, NE|CS|UNK|||||||True
4385769|19013900|N|1||UDI NA DEVICE LABELING ADDRESSES REPORTED EVENT ALCL FOLLOWS BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REP PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALLER NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA, NE|CS|UNK|||||||True
4957654|19502324|D|1||HEALTH PROFESSIONAL REPORTED CALCIFICATION CAPSULE ANAPLASTIC LARGE CELL LYMPHOMA ALCL PATHOLOGY REMOVED LEFT BREAST CAPSULECTOMY SPECIMEN EXCHANGE IMPLANT ALCL CONFIRMED PATHOLOGICAL MARKERS RECEIVED EVENT CAPTURED LYMPHOMA TIME|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4957654|55248981|D|1||ADDITIONAL INFORMATION PROVIDED HEALTHCARE PROFESSIONAL NOTES DIAGNOSTIC INFORMATION REPORTED CD30+ ALK- PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED PATIENT SINCE RECEIVED B4 ROUNDS CHOEP TREATMENT B6 2015-B6 2016 B4 ROUNDS GDP TREATMENT B6 2016-B6 2016 B4 ROUNDS BRENTUXIMAB STARTING B6 2016 PRESENT STEM CELL TRANSPLANT PLANNED B6 2016|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4957654|26958644|D|1||FOLLOW-UP PHYSICIAN REVEALS FOLLOWING LEFT SIDE EVENTS CAPSULAR CONTRACTURE BAKER IIIIV NOTED REACTIVE AXILLARY LYMPH NODES EDEMA SUSPECTED PAIN PATHOLOGICAL TESTING LEFT BREAST CAPSULE FEATURES CONSISTENT BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA DESCRIPTION CAPSULE INCLUDED THREE ADJACENT SEPARATE HARD WHITE NODULES MEASURING 50 CM 55 CM 60 CM MAXIMUM DIAMETER TESTING ALK RESULTS PERFORMED PROVIDED PATHOLOGY TESTS ALCL CANNOT CONFIRMED CONTINUE CAPTURED LYMPHOMA|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4957654|55248980|N|1||EVENT LYMPHOMA ALCL PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4943508|6632766|D|1||ALCL DIAGNOSIS|SILTEX CONTOUR PROFILE LUMERA MODERATE GEL|324-1307|07/17/2015|||DA||R||0HP|FTR|1.0||CONTOUR PROFILE GEL||5713687|||IRVING|US|MENTOR||TX|||||True
4702205|15310134|D|1||HEALTH PROFESSIONAL REPORTED REGULATORY AGENCY VIA VOLUNTARY MW5039346 ALCL CASE REPORT ASSOCIATED BREAST CANCER RECONSTRUCTION PATIENT FOLLOW-UP REVEALS PATIENT HISTORY LEFT BREAST DUCTAL CARCINOMA SITU PRIOR BREAST IMPLANTS PATIENT PRESENTED SWELLING PAIN PRIMARY DIAGNOSIS ALCL DIAGNOSED RIGHT SIDE PERI IMPLANT FLUID 1 X 23 CM MASS MEDIANINFERIOR EDGE IMPLANT SEROMA NOTED SEVERE PATIENT TREATED CHEMOTHERAPY RIGHT SIDE DEVICE EXPLANTED PATHOLOGY RESULTS CONFIRM DIAGNOSIS READ BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IMMUNOSTAINS SHOW TUMOR CELLS POSITIVE CD30 CD2 CD4 NEGATIVE ER PR HER2 CYTOKERATIN S100 CD45 MPO CD3 CD20 ALK1|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|04/16/2015|||DA|N|R||0HP|FWM|1.0|12/05/2008|nan||1059645|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4600131|5470590|D|1||PHYSICIAN REPORTED REGULATORY AGENCY 2 SUICIDE ATTEMPTS FIBROMYALGIA RUPTURE ROTATOR CUFF LEFT B6 TWO PHLEBITIS DYSTHYROIDEA IRON DEFICIENCY ANEMIA GASTRITIS ESOPHAGITIS ARTHRITIS REQUIRING IMPLANTATION KNEE PROSTHESIS CLINICAL CONSEQUENCE ANAPLASTIC LARGE CELL LYMPHOMA ALCL ALK1 - CD30 LAGC SIDE UNKNOWN TREATMENT UNKNOWN|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|03/11/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4600131|12978182|N|1||DEVICE LABELING ADDRESSES ALCL ANAPLASTIC LARGE CELL LYMPHOMA ALCL - WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ANAPLASTIC LARGE CELL LYMPHOMA ALCL SCAR TISSUE FLUID ADJACENT IMPLANT ALCL BREAST CANCER - RARE TYPE NON-HODGKINS LYMPHOMA CANCER IMMUNE SYSTEM ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS PATIENTS DIAGNOSED SOUGHT MEDICAL TREATMENT IMPLANT RELATED SYMPTOMS PAIN LUMPS SWELLING ASYMMETRY DEVELOPED INITIAL SURGICAL SITES FULLY HEALED CASES REPORTED ALCL TYPICALLY DIAGNOSED YEARS IMPLANT SURGERY DEVICE LABELING ADDRESSES ARTHRITIS FIBROMYALGIA CONNECTIVE TISSUE DISEASES INCLUDE DISEASES LUPUS SCLERODERMA RHEUMATOID ARTHRITIS FIBROMYALGIA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|03/11/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5098529|26591653|N|1||DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL PATIENT TOLD PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGE IMPLANT SHAPE MAY SIGNS SYMPTOMATIC RUPTURE IMPLANT PATIENT SIGNS TOLD REPORT POSSIBLY MRI EVALUATION SCREEN RUPTURE LITERATURE REPORTS ALSO MADE ASSOCIATING SILICONE BREAST IMPLANTS VARIOUS RHEUMATOLOGICAL SIGNS SYMPTOMS FATIGUE EXHAUSTION JOINT PAIN SWELLING MUSCLE PAIN CRAMPING TINGLING NUMBNESS WEAKNESS SKIN RASHES|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/23/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||nan|||||||True
4385749|15814629|D|1||HEALTH PROFESSIONAL REPORTED DIAGNOSIS ANAPLASTIC LYMPHOMA LINKED BREAST PROSTHESIS PLACED BREAST RECONSTRUCTION DIAGNOSTIC TESTS PROVIDED CONFIRM ALCL EVENT LYMPHOMA REPORTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX115-315|12/24/2014|||DA|N|R||0HP|FTR|1.0|08/25/2012|nan||1474756|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4943532|6632764|D|1||ALCL DIAGNOSIS|SILTEX CONTOUR PROFILE LUMERA MODERATE GEL|324-1257|07/17/2015|||DA||R||0HP|FTR|1.0||CONTOUR PROFILE GEL||5681120|||IRVING|US|MENTOR||TX|||||True
4819204|5927912|D|1||10 YEARS IMPLANTS DISCOVERED ALCL ALK-|BREAST IMPLANT|*|05/29/2015|||||||0HP|FWM|1.0||BREAST IMPLANT||*|*||*|*|UNK|||||*|*|True
4922455|6051210|D|1||PHYSICIAN REPORTED PT DEVELOPED FULMINANT ALCL DUE ALLERGAN IMPLANT SEVERE DISEASE PRIMARY TUMOR BREAST INGROWTH THORACIC MUSCLES RIBS ALCL CAPTURED LYMPHOMA REPORT PATHOLOGICAL TESTING PROVIDED SIDE UNK TREATMENT UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/16/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL SALINE||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4922455|14212221|N|1||BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/16/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL SALINE||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5230911|31447414|N|1||DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|11/17/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4553419|19634012|N|1||UNIQUE IDENTIFIER UDI  B4 DEVICE LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALAL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL YU PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410470|02/25/2015|||DA|N|R||0HP|FTR|1.0|01/15/2011|nan||1210806|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4553419|19316035|D|1||HEALTH PROFESSIONAL REPORTED LYMPHOMA ALCL DEVICE REMOVED PATHOLOGY REPORT DIAGNOSIS STATES ALK-NEGATIVE ANPLASTIC LARGE CELL LYMPHOMA INVOLVING CAPSULE IMMUNOSTAINS SHOW TUMOR CELLS POSITIVE CD30|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410470|02/25/2015|||DA|N|R||0HP|FTR|1.0|01/15/2011|nan||1210806|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5222818|31178939|N|1||B4 DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL PASS STUDY LEAST 1 REOPERATION PERFORMED 315 PATIENTS 365 10 YEARS TOTAL 424 REOPERATIONS PERFORMED PRIMARY REASON REOPERATION 10 YEARS AUGMENTATION PATIENTS IMPLANT DEFLATION 217 PERCENTAGE REOPERATIONS DUE LUMPMASSCYST INCREASED 85 293 REOPERATIONS 5 YEARS 139 424 REOPERATIONS 10 YEARS OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PATIENTS AGE COULD EXPLANATION INCREASE POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY CAPSULAR CONTRACTURE Â¿ PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT DEFLATION ONE COMMON REASONS REOPERATION 237 PATIENTS R95 STUDY LEAST 1 REOPERATION PERFORMED 99 PATIENTS 42 TOTAL 125 REOPERATIONS 5 YEARS PRIMARY REASON REOPERATION 5 YEARS CAPSULAR CONTRACTURE 256 237 RECONSTRUCTION PATIENTS R95 62 PATIENTS 262 70 IMPLANTS REMOVED 5 YEARS 70 RECONSTRUCTION IMPLANTS REMOVED 5 YEARS 70 REPLACED COMMON REASON IMPLANT REMOVAL CAPSULAR CONTRACTURE 314 10 YEARS 104 IMPLANTS REMOVED 85 PATIENTS COMMON REASON IMPLANT REMOVAL IMPLANT LEAKAGEDEFLATION 327|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-410|11/13/2015||||N|R||0HP|FWM|1.0|10/09/2005|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||569053|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5222818|31178940|D|1||PHYSICIAN REPORTED VIA VOLUNTARY MW5055722 PATIENT CAME SKIN LESION CHEST BIOPSY LESION CAME BACK ALCL ANAPLASTIC LARGE CELL LYMPHOMA PHYSICIAN ADDITIONALLY NOTED RIGHT SIDE DEVICE RIGHT SIDE CAPSULE REMOVED FLUID SENT CYTOLOGY PHYSICIAN SPECIFIED RIGHT BREAST FILLED THICK RED COLOREDBROWN COLORED FLUID REPORT RIGHT SIDE FOLLOW-UP REVEALS PATHOLOGY INITIALLY ASSESSED ABDOMINAL LESION BIOPSY RESULTS LESION UPPER ABDOMEN - CD30 POSITIVE LYMPHOMA CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA LARGE CELLS ALSO NEGATIVE EBER ALK-1 IMPLANTS REMOVED PATHOLOGY INDICATED RIGHT BREAST CAPSULE DIAGNOSED ALCL ALK NEGATIVE PATHOLOGY REPORT ADDITIONALLY INDICATES SINGLE 15 CM NODULE IDENTIFIED LOCATED NEAR IDENTICAL LESION RIGHT BREAST CAPSULE NODULE TESTED POSITIVE CD30 NEGATIVE ALK ALSO NOTED IMPLANT RECEIVED MINIMAL AMOUNTS ATTACHED BLOOD CLOT TISSUE PHYSICIAN ADDITIONALLY REPORTED RIGHT SIDE GRADE IV CAPSULAR CONTRACTURE PHYSICIAN NOTED PATIENT REFUSED CHEMOTHERAPY RADIOTHERAPY|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-410|11/13/2015||||N|R||0HP|FWM|1.0|10/09/2005|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||569053|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4902572|55597680|D|1||REPORT NULL-TYPE ANAPLASTIC LARGE CELL LYMPHOMA ARISING SILICONE BREAST IMPLANT CAPSULE WRITTEN PLASTIC RECONSTRUCTIVE SURGERY JUNE 2011 VOL 127 NUMBER 6 REPORTS PATIENT PRESENTED PAINFUL RIGHT BREAST BAKER GRADE III CAPSULAR CONTRACTUREIMPLANT REMOVED SUBMUSCULAR POUCH EXPLORED DRAINAGE SEROUS-HEMATIC FLUID SURROUNDING RIGHT PROSTHESIS CAPSULECTOMY PERFORMED REMOVED FIBROUS TISSUE ANALYZED ALTERED ASPECT PATHOLOGY FINDINGS CONSISTENT DIAGNOSIS NULL-TYPE ANAPLASTIC LYMPHOMA KINASE-NEGATIVE NON-HODGKINS ANAPLASTIC LARGE CELL LYMPHOMA ALCL DEVICE REMOVED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/08/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4902572|14225628|N|1||UNIQUE IDENTIFIER UDI  NA MEDWATCH SUBMITTED FDA 07082015 DEVICE LABELING POTENTIAL ADVERSE EVENT MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANTS CONSIDER POSSIBLY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REP PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS PTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PTS PRIMARY AUGMENTATION RECONSTRUCTION PTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT DEFLATION ONE COMMON REASONS REOPERATION PTS ALSO ADVISED ADDL SURGERY MAY NEEDED CASES PAIN ANDOR FIRMNESS SEVERE SURGERY RANGES REMOVAL IMPLANT CAPSULE TISSUE REMOVAL POSSIBLE REPLACEMENT IMPLANT SURGERY MAY RESULT LOSS BREAST TISSUE CAPSULAR CONTRACTURE MAY HAPPEN ADDL SURGERIES CAPSULAR CONTRACTURE MAY INCREASE RISK DEFLATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/08/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4902572|6067684|D|1||REPORT NULL-TYPE ANAPLASTIC LARGE CELL LYMPHOMA ARISING SILICONE BREAST IMPLANT CAPSULE WRITTEN PLASTIC RECONSTRUCTIVE SURGERY JUNE 2011 VOL 127 NUMBER 6 REPORTS PT PRESENTED PAINFUL RIGHT BREAST BAKER GRADE III CAPSULAR CONTRACTUREIMPLANT REMOVED SUBMUSCULAR POUCH EXPLORED DRAINAGE SEROUS-HEMATIC FLUID SURROUNDING RIGHT PROSTHESIS CAPSULECTOMY PERFORMED REMOVED FIBROUS TISSUE ANALYZED ALTERED ASPECT PATHOLOGY FINDINGS CONSISTENT DIAGNOSIS NULL-TYPE ANAPLASTIC LYMPHOMA KINASE-NEGATIVE NON-HODGKINS ANAPLASTIC LARGE CELL LYMPHOMA ALCL DEVICE REMOVED MFR DEVICE UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/08/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
5138318|27896968|D|1||ALLERGAN REPRESENTATIVE REPORTED CASE ALCL RECEIVED PHYSICIAN PATIENT PRESENTED SEROMA DRAINED SEROMA PROCEEDED SURGERY COMPLETE CAPSULECTOMY SEND CAPSULE PATHOLOGY PATHOLOGY CONFERRED CD30+ SIDE UNSPECIFIED FOLLOW-UP HEALTH PROFESSIONAL FOUND EXPANDING RIGHT BREAST CATEGORIZED SIGNIFICANT SEROMA CAPSULAR CONTRACTURE BAKER GRADE DIFFICULT DETERMINE DUE TENSION CAUSED SEROMA DEVICE REMOVED INTRAOPERATIVELY NOTED MATERIAL INTRACAPSULE APPEARED OLD HEMATOMA PATIENT YET CHEMOTHERAPY RADIOTHERAPY IMMUNOHISTOCHEMISTRY MALIGNANT APPEARING TUMOR CELLS REVEALS CELLS NEGATIVE CK7 AE1AE3 CD68 CK19 CK20 ER CD20 EMA TUMOR CELLS POSITIVE CD3 CD30 CD45 IMMUNOHISTOCHEMISTRY SUPPORTS DIAGNOSIS ANAPLASTIC LARGE CELL LYMPHOMA CELL LYMPHOMA ALK- MARKER CONFIRMED EVENT CAPTURED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX155-685|10/08/2015||||N|R||0HP|FTR|1.0|11/28/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1172190|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5138318|27896967|N|1||B4 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX155-685|10/08/2015||||N|R||0HP|FTR|1.0|11/28/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1172190|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5286954|40348295|N|1||MEDWATCH SENT FDA 3142016 PHYSICIAN CONFIRM WHETHER DEVICE EXPLANTED CONFIRM DEVICE WOULD RETURNED THEREFORE ANALYSIS TESTING DONE EVENTS REPORTED MEDICAL INTERVENTION REQUIRED ALTHOUGH DEVICE-RELATEDNESS ESTABLISHED EVENTS SEROMA GRANULOMATOUS REACTION LIPOPHAGIC NECROSIS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL -- INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION INFLAMMATORY REACTION STUDIES EVALUATING CAPSULES AROUND TEXTURED IMPLANTS REPORTED POSSIBLE SILICONE PARTICLES WITHIN GIANT CELLS INDICATIVE LOCAL NONSPECIFIC FOREIGN BODY REACTION SILICONE GRANULOMA FORMATION CASE INFLAMMATORY REACTION SURGEON ADVISED REMOVE DEVICE PATIENTS BODY SECURE EVIDENCE POSSIBLE CAUSE INFLAMMATORY REACTION TREAT PATIENT CORRESPONDINGLY ADVISED REPLACE IMPLANT INFLAMMATORY REACTION PASSED COMPLETELY CAUSE ELIMINATED NECROSIS NECROSIS MAY INHIBIT WOUND HEALING REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION PERMANENT SCAR DEFORMITY MAY OCCUR RESULT NECROSIS USE MICROWAVE DIATHERMY PATIENTS BEAST IMPLANTS MICROWAVE DIATHERMY REPORTED CAUSE TISSUE NECROSIS SKIN EROSION IMPLANT EXTRUSION|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM240|12/10/2015|||DA|N|R||0HP|FTR|1.0|06/17/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2131883|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5286954|33227537|D|1||PHYSICIAN REPORTS PATIENT BREAST IMPLANT DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL RIGHT BREAST PATHOLOGICAL MARKERS PROVIDED CASE CAPTURED LYMPHOMA DIAGNOSTIC CONFIRMATION RECEIVED TREATMENT UNKNOWN|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM240|12/10/2015|||DA|N|R||0HP|FTR|1.0|06/17/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2131883|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5286954|33227536|N|1||DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM240|12/10/2015|||DA|N|R||0HP|FTR|1.0|06/17/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2131883|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5286954|40348296|D|1||FOLLOW-UP REVEALS PATIENT EXPERIENCED SEVERE RIGHT SIDE PERIPROSTHETIC SEROMA APPROXIMATELY TWO HALF YEARS REVISION AUGMENTATION PATHOLOGY TESTS PERFORMED RIGHT BREAST CAPSULECTOMY APPROXIMATELY 30 ML RELATIVELY THICK LIQUID YELLOWISH OPAQUE 10 ML FRESH SAMPLE TAKEN CAPSULE REVEALS GRANULOMATOUS REACTION LIPHOPHAGIC NECROSIS RIGHT SIDE SEROMA CELLS POSITIVE CD30 ALK MARKERS TESTED REMAINS SUSPECTED CASE ALCL TOTAL CAPSULECTOMY PERFORMED TREATMENT UNCLEAR EXPLANT OCCURRED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM240|12/10/2015|||DA|N|R||0HP|FTR|1.0|06/17/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2131883|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4374378|5118989|D|1||PT UNDERWENT BREAST AUGMENTATION MENTOR SILTEX GEL FILLED MAMMARY PROSTHESES B6 2007 UB B6 2014 PT DIAGNOSED ALCL DEVICES REMOVED B6 2014|MEMORYGEL SILTEX ROUND MODERATE PLUS PROFILE|354-4001|12/18/2014||||N|R||0HP|FTR|1.0||BREAST IMPLANT||5703499|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR|75038|TX|75038||||True
4623194|18636183|D|1||HEALTH PROFESSIONAL REPORTED NEW CASE ALCL NATRELLE IMPLANT SIDE UNSPECIFIED EVENT CAPTURED LYMPHOMA ALCL CONFIRMED VIA PATHOLOGY|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/20/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5098467|26589688|N|1||B4 BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL PATIENT TOLD PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGE IMPLANT SHAPE MAY SIGNS SYMPTOMATIC RUPTURE IMPLANT PATIENT SIGNS TOLD REPORT POSSIBLY MRI EVALUATION SCREEN RUPTURE LITERATURE REPORTS ALSO MADE ASSOCIATING SILICONE BREAST IMPLANTS VARIOUS RHEUMATOLOGICAL SIGNS SYMPTOMS FATIGUE EXHAUSTION JOINT PAIN SWELLING MUSCLE PAIN CRAMPING TINGLING NUMBNESS WEAKNESS SKIN RASHES|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/23/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4974939|14087432|N|1||DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTEDLY GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/04/2015|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4623212|5575786|D|1||HEALTH PROFESSIONAL REPORTED NEW CASE ALCL NATRELLE IMPLANT SIDE UNSPECIFIED EVENT CAPTURED LYMPHOMA ALCL CONFIRMED VIA PATHOLOGY|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/20/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4626734|5586914|D|1||ALCL SYMPTOMS REF FDA REPORT MW5040065|BREAST IMPLANT|NI|03/17/2015|||DA|R|R||0HP|FTR|1.0||MENTOR MOULDED TEARDROP BREAST IMPLANT||NI|||IRVING|US|MENTOR||TX|||NI||True
4739846|5823824|D|1||HEALTH PROFESSIONAL REPORTED RECURRENT PERI PROSTHETIC LYMPHOCELE ERYTHEMATOUS SKIN TOTAL CAPSULECTOMY PERFORMED LEFT PROSTHESIS REMOVED ROTATION PROSTHESIS DOUBLE CAPSULE FOUND SEROMA SEVERAL NODES TISSUE FOUND UPPER BANK MASTECTOMY ALCL LYMPHOMA DIAGNOSED ADDITIONAL REPORT STATES RELAPSING PERIPROSTHETIC LYMPHOCELE ERYTHEMA NODULES AROUND BORDERS MASTECTOMY DOUBLE CAPSULE REARRANGEMENT TCRG TCRB LOCI TREATMENT INCLUDED IMPLANT ABLATION TOTAL CAPSULECTOMY CHANGE PROSTHESIS POLYTECH ADJUVANT TREATMENT ALCL DIAGNOSED VIA MARKERS CD30+ALK-|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410375|04/29/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4665224|5729407|D|1||REPORTED LYMPHADENOPATHYEXTRAVASATION ADDITIONAL REPORT STATES LEVY MICROBIOLOGY LEFT BREAST ANAPATH EXERESE LEFT DEVICE BREAST CAPSULE PERIPROSTHETIC BREAST CAPSULE SIDE INTRACAPSULAR INFILTRATION CD30 + ALCL EMA + PATHOLOGY RECEIVED CONFIRM ALCL EVENT REMAIN REPORTABLE LYMPHOMA|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120341|04/06/2015||07/14/2014|DA|Y|Y||0HP|FTR|1.0|12/09/2010|NONE||1178535|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4665224|13168503|N|1||DEVICE LABELING ADDRESSES LYMPHOMA LYMPHOMAS INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - DOCUMENTATION MEDICAL SUGGESTS POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSALITY BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXTREMELY RARE OCCURS WOMEN WITHOUT BREAST IMPLANTS DEVICE LABELING ADDRESSES RUPTURE RUPTURE - PTS INFORMED FILLED BREAST IMPLANTS SILICONE GEL LAST LIFETIME IMPLANT RUPTURE POSSIBILITY CONSIDER DECISION REMOVE RUPTURED IMPLANT SUSPECTED TAKEN REVIEWING CLINICAL DATA AVAILABLE CAREFUL THOUGHT PT HOWEVER IMPLANT RUPTURE DIAGNOSED RECOMMENDED REMOVE IMPLANT DEVICE LABELING ADDRESSES LYMPHADENOPATHY ADDITIONAL COMPLICATIONS - BREAST IMPLANT SURGERY FOLLOWING SITUATIONS MAY ARISE PERSIST VARY INTENSITY DURATION PAIN HEMATOMASEROMA CHANGES SENSATION NIPPLE BREAST EXTRUSION NECROSIS DELAYED WOUND HEALING TISSUE ATROPHY BREAST DEFORMITIES CHEST CALCIUM DEPOSITS FORM SOMETIMES CAPSULE TISSUE SURROUNDING IMPLANT MANIFESTED SYMPTOMS PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120341|04/06/2015||07/14/2014|DA|Y|Y||0HP|FTR|1.0|12/09/2010|NONE||1178535|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5303162|33710388|D|1||ALCL CASE REPORT B6 OTHERWISE HEALTHY WHITE FEMALE UNDERWENT UNCOMPLICATED BILATERAL BREAST AUGMENTATION MCGHAN STYLE 468 SALINE-FILLED BREAST IMPLANTS B6 2002 WELL B6 2015 NOTED INTERMITTENT SWELLING LEFT BREAST CHANGE RIGHT BREAST DENIES SYMPTOMS MILD PRESSURE SENSATION LEFT BREAST MAMMOGRAM ULTRASOUND LEFT BREAST ORDERED PCP B6 2015 CONFIRMED PERI-PROSTHETIC SEROMA WITHOUT ABNORMAL BREAST TISSUE FINDINGS SWELLING BECAME PERSISTENT SEEN OFFICE EVAL TAKEN EXPEDIENTLY OPERATING ROOM SEROMA ASPIRATION CULTURES CAPSULE BIOPSY CONFIRMED ALCL CULTURES NEGATIVE ONE WEEK LATER UNDERWENT BILATERAL COMPLETE CAPSULECTOMY BILATERAL IMPLANT REMOVAL WITHOUT REPLACEMENT|STYLE 468 SALINE IMPLANT|27-468301|12/11/2015||||*|*||I|FWM|2.0||SALINE BREAST IMPALNT||565193||||US|MCGHAN|||||468||True
5303162|33710388|D|1||ALCL CASE REPORT B6 OTHERWISE HEALTHY WHITE FEMALE UNDERWENT UNCOMPLICATED BILATERAL BREAST AUGMENTATION MCGHAN STYLE 468 SALINE-FILLED BREAST IMPLANTS B6 2002 WELL B6 2015 NOTED INTERMITTENT SWELLING LEFT BREAST CHANGE RIGHT BREAST DENIES SYMPTOMS MILD PRESSURE SENSATION LEFT BREAST MAMMOGRAM ULTRASOUND LEFT BREAST ORDERED PCP B6 2015 CONFIRMED PERI-PROSTHETIC SEROMA WITHOUT ABNORMAL BREAST TISSUE FINDINGS SWELLING BECAME PERSISTENT SEEN OFFICE EVAL TAKEN EXPEDIENTLY OPERATING ROOM SEROMA ASPIRATION CULTURES CAPSULE BIOPSY CONFIRMED ALCL CULTURES NEGATIVE ONE WEEK LATER UNDERWENT BILATERAL COMPLETE CAPSULECTOMY BILATERAL IMPLANT REMOVAL WITHOUT REPLACEMENT|STYLE 468 SALINE IMPLANT|27-468301|12/11/2015||||*|*||I|FWM|1.0||SALINE BREAST IMPLANT||565193||||US|MCGHAN|||||468||True
4399502|19805106|D|1||ONE RARE CASES ANAPLASTIC LARGE CELL LYMPHOMA ALCL CAUSED BREAST IMPLANTS CAPSULECTOMY BREASTS SINCE RECONSTRUCTION USING DIFFERENT MAKETYPE PROSTHESIS SINCE FIRST DIAGNOSED 2009 ABLE OBTAIN INFORMATION DETERMINED CASES LIKE MINE RECOMMENDATIONS GIVEN PATIENTS TIME DISCOVERED FIRST COUSIN ALSO SUFFERED CONDITION ALSO CAUSED IMPLANTS ALSO TOLD CAUGHT EARLY ENOUGH REQUIRE TREATMENT REMOVAL HAPPENED BIRTH COUNTRY B6 PLASTIC SURGEON B6 B6 PERFORMED ORIGINAL BREAST AUGMENTATION 2006 RECENTLY STARTED RESEARCHING PREVIOUS CONDITION CANNOT FIND DETAILS CONTACT INFORMATION COUNTRY HOPING AMERICAN FDA MAY CURRENT INFORMATION GIVE|MOULDED TEARDROP BREAST IMPLANT||01/05/2015|||DA||*||0|FTR|1.0||MOULDED TEARDROP BREAST IMPLANT|||||||MENTOR|||||||True
4399502|19805106|D|1||ONE RARE CASES ANAPLASTIC LARGE CELL LYMPHOMA ALCL CAUSED BREAST IMPLANTS CAPSULECTOMY BREASTS SINCE RECONSTRUCTION USING DIFFERENT MAKETYPE PROSTHESIS SINCE FIRST DIAGNOSED 2009 ABLE OBTAIN INFORMATION DETERMINED CASES LIKE MINE RECOMMENDATIONS GIVEN PATIENTS TIME DISCOVERED FIRST COUSIN ALSO SUFFERED CONDITION ALSO CAUSED IMPLANTS ALSO TOLD CAUGHT EARLY ENOUGH REQUIRE TREATMENT REMOVAL HAPPENED BIRTH COUNTRY B6 PLASTIC SURGEON B6 B6 PERFORMED ORIGINAL BREAST AUGMENTATION 2006 RECENTLY STARTED RESEARCHING PREVIOUS CONDITION CANNOT FIND DETAILS CONTACT INFORMATION COUNTRY HOPING AMERICAN FDA MAY CURRENT INFORMATION GIVE|MOULDED TEARDROP BREAST IMPLANT||01/05/2015|||||*||0|FTR|2.0||MOULDED TEARDROP BREAST IMPLANT|||||||MENTOR|||||||True
4794812|17626734|D|1||HEALTHCARE PROFESSIONAL REPORTS ALCL CASE REPORT SEROMA ASSOCIATED PRIMARY ALCL RIGHT BREAST PATIENT PERSONAL HISTORY RIGHT BREAST CANCER RIGHT MASTECTOMY IMMEDIATE RECONSTRUCTION LATISSIMUS DORSI FLAP TEXTURED SILICONE PROSTHESIS VIA MW 5033512 ALCL CONFIRMED VIA PATHOLOGY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MX-410445|05/22/2015|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4672656|13207851|N|1||B4 EVENT ANAPLASTIC LARGE CELL LYMPHOMA INITIALLY REPORTED VIA EASR B6 2010 ADVERSE EVENT TERM CODE CANCER UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED CANCER LYMPHOMA-ALCL DUE INCREASED SPECIFICITY SEROMA REPORTED TIME ALSO DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MUFTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL USE CARE SUBSEQUENT PROCEDURES OPEN CAPSULOTOMY BREAST POCKET REVISION HEMATOMASEROMA ASPIRATION BIOPSYLUMPECTOMY AVOID DAMAGE IMPLANT SHELL VALVE POSTOPERATIVE EVACUATION HEMATOMA SEROMA MUST CONDUCTED CARE AVOID BREAST IMPLANT CONTAMINATION DAMAGE SHARP INSTRUMENTS USE MICROWAVE DIATHERMY PATIENTS BREAST IMPLANTS RECOMMENDED REPORTED CAUSE TISSUE NECROSIS SKIN EROSION EXTRUSION IMPLANT ALLERGAN TESTED VIVO EFFECTS RADIATION THERAPY PATIENTS BREAST IMPLANTS LITERATURE SUGGESTS RADIATION THERAPY MAY INCREASE LIKELIHOOD CAPSULAR CONTRACTURE NECROSIS IMPLANT EXTRUSION PATIENTS INFORMED DISSATISFACTION COSMETIC RESULTS RELATED THINGS SCAR DEFORMITY HYPERTROPHIC SCARRING CAPSULAR CONTRACTURE ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION INCORRECT SIZE IMPLANT PALPABILITYVISIBILITY MAY OCCUR CAREFUL SURGICAL PLANNING TECHNIQUE MINIMIZE PRECLUDE RISK RESULTS PRE-EXISTING ASYMMETRY MAY ENTIRELY CORRECTABLE REVISION SURGERY MAY INDICATED MAINTAIN PATIENT SATISFACTION CARRIES ADDITIONAL CONSIDERATIONS RISKS RECONSTRUCTION MAIN REASONS REOPERATION 5 10 YEARS IMPLANT MALPOSITION YEAR 5 RATE= 32 IMPLANT MALPOSITION YEAR 10 RATE= 38|STYLE 163 SALINE FILLED BREAST IMPLANT|163-530|04/08/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4720409|16988108|D|1||HEALTH PROFESSIONAL REPORTED LATE SEROMA - ASPIRATION POSITIVE ALCL SPECIFIED RIGHT SIDE CYTOLOGY CONFIRMS TUMOUR CELLS EXPRESS PAN LYMPHOID MARKER CD45 CD3 CD30 B CELLS EXPRESSING CD20 STAINING ALK1CONCLUSION MALIGNANT BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX130-450|04/21/2015|||DA|N|R||0HP|FTR|1.0|06/14/2015|nan||1850087|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4688919|5687161|D|1||REPORT AGGRESSIVE PRESENTATION BREAST IMPLANT ASSOCIATED ALK-1 NEGATIVE ALCL BILATERAL AXILLARY LYMPH NODE INVOLVEMENT ARTICLE DR GOVIND BHAGAT REPRINTED INFORMA HEALTHCARE 2009 JOURNAL STATES FOLLOWING RECONSTRUCTION PT DEVELOPED RIGHT AXILLARY LYMPHADENOPATHY  RIGHT AXILLARY LN BIOPSY SHOWED LARGE CELL NEOPLASM INFILTRATING EXPANDING SINUSES EXHAUSTIVE STAINING PANEL LED DIAGNOSIS ALK-1 NEGATIVE ALCL GROSSLY INTACT IMPLANT REMOVED CAPSULECTOMY RESULTS SHOW CD30+|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/13/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4688919|13145475|N|1||EVENT ANAPLASTIC LARGE CELL LYMPHOMA INITIALLY REPORTED VIA EASR B6 2011 ADVERSE EVENT TERM CODE CANCER UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED LYMPHOMA - ALCL DUE INCREASED SPECIFICITY PATIENT IDENTIFIER B6 RELATES PATIENTS RECORD PREVIOUSLY EXISTING B6 DATABASE CURRENT DATABASE PATIENT IDENTIFIER PR B6 DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS NATRELLE CORE STUDY CONTINUE EVALUATE LONG-TERM 10 YEARS SAFETY EFFECTIVENESS PRODUCTS ADDITION ALLERGAN INITIATED SEPARATE LARGE 10-YEAR POST-APPROVAL STUDY BREAST IMPLANT FOLLOW-UP STUDIES BIFS ADDRESS SPECIFIC ISSUES ALLERGANS CORE STUDY DESIGNED FULLY ANSWER WELL PROVIDE REAL-WORLD ASSESSMENT ENDPOINTS ENDPOINTS BIFS LARGE POST-APPROVAL STUDY INCLUDE LONG-TERM LOCAL COMPLICATIONS CONNECTIVE TISSUE DISEASE CTD CTD SIGNS SYMPTOMS NEUROLOGICAL DISEASE NEUROLOGICAL SIGNS SYMPTOMS OFFSPRING ISSUES REPRODUCTIVE ISSUES LACTATION ISSUES CANCER SUICIDE MAMMOGRAPHY ISSUES MRI COMPLIANCE RESULTS ALLERGAN UPDATE LABELING REGULAR BASIS RESULTS TWO STUDIES 1 PRIMARY AUGMENTATION PATIENT NEW DIAGNOSIS BREAST CANCER 7 YEARS CORE STUDY 13 BENIGN BREAST DISEASE RATE 1 MALIGNANT BREAST DISEASE RATE REVISION-AUGMENTATION PATIENTS 1 PATIENT NEW DIAGNOSIS BREAST CANCER 15 BENIGN BREAST DISEASE RATE 1 MALIGNANT BREAST DISEASE RATE 7 YEARS PRIMARY AUGMENTATION PATIENTS 1 REPORT THYROID CANCER 1 REPORT BRAIN CANCER REPORTS CANCERS RESPIRATORY CERVICALVULVAR REVISION-AUGMENTATION PATIENTS 8 PRIMARY RECONSTRUCTION PATIENTS 8 NEW REPORTS BREAST CANCER 7 YEARS CORE STUDY 17 BENIGN BREAST DISEASE RATE 10 MALIGNANT BREAST DISEASE RATE 7 YEARS REVISION RECONSTRUCTION PATIENTS REPORTS NEW DIAGNOSES REOCCURRENCE BREAST CANCER 7 BENIGN BREAST DISEASE RATE 7 YEARS REPORTS CANCERS BRAIN RESPIRATORY CERVICALVULVAR PRIMARY RECONSTRUCTION REVISION-RECONSTRUCTION PATIENTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/13/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4730396|17824636|N|1||EVENT ANAPLASTIC LARGE CELL LYMPHOMA INITIALLY REPORTED VIA EASR JULY 28 2010 ADVERSE EVENT TERM CODE CANCER UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED CANCER LYMPHOMA - ALCL DUE INCREASED SPECIFICITY B6|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/24/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|LA AURORA DE HEREDIA|||CS|ALLERGAN|||||||True
5092043|26351217|N|1||DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/21/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5092043|26351218|D|1||EXPLANTING PHYSICIAN REPORTED CAPSULE CONFINED ALCL SPECIFIED RIGHT SIDE DEVICE EXPLANTED POSTOPERATIVE COMPLICATIONS EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/21/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5029322|24060408|D|1||PATIENT CAME SKIN LESION CHEST BILATERAL BREAST RECONSTRUCTION MASTECTOMY IMPLANTS 13 YEARS AGO BIOPSY LESION CAME BACK ALCL REMOVED IMPLANTS CAPSULES SENT FLUID CYTOLOGY R BREAST FILLED THICK RED COLOREDBROWN COLORED FLUID IMPLANTS ALLERGAN 410 SHAPED SILICONE IMPLANTS BIOPSY PROVEN ALCL SKIN LESION BREAST CANCER TISSUE EXPANDERIMPLANT RECONSTRUCTION DATES USE 13 YEARS REASON USE BREAST RECONSTRUCTION|410 SHAPED SILICONE IMPLANT||08/19/2015||||Y|*||0HP|FTR|1.0||ALLERGAN 410 SHAPED SILICONE IMPLANT|||||IRVINE|US|ALLERGAN|92623|CA|92623||410 SHAPED IMPLANT||True
4739847|20018445|D|1||PHYSICIAN REPORTS LEFT SIDE DEVICE REMOVAL REPLACEMENT PT HISTORY BREAST CANCER DUE SEROMA CONFIRMED HISTOLOGY ALCL ANAPLASTIC LARGE CELL LYMPHOMA ALCL CONFIRMED TEST RESULTS NEITHER PROVIDED REPORTED EVENT CAPTURED LYMPHOMA TEST RESULTS RECEIVED|UK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/29/2015|||DA|N|R||0HP|FWM|1.0||nan|||||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4541872|16628904|D|1||PT B6 FEMALE HISTORY DCIS LEFT BREAST DIAGNOSED 1989 UNDERWENT LUMPECTOMY RADIATION THERAPY FOUND RECURRENCE 2006 TIME UNDERWENT LEFT MASTECTOMY SENTINEL LYMPH NODE BIOPSY 2006 RECONSTRUCTION B6 2007 UNDERWENT DELAYED PLACEMENT MENTOR TEXTURED SILTEXT MEDIUM HEIGHT TISSUE EXPANDER REFERENCE 3584-6215 LOT 5725412 SERIAL NUMBER B4 650CC VOLUME INTRAOPERATIVE FILL 180CC SALINE LATISSIMUS DORSI FLAP LEFT SIDE UNDERWENT TISSUE EXPANSION SUBSEQUENTLY B6 2007 UNDERWENT EXCHANGE TISSUE EXPANDER PERMANENT SILICONE TEXTURED MENTOR CPG IMPLANT CONCURRENTLY UNDERWENT RIGHT MASTOPEXY AUGMENTATION SYMMETRY PTS RECORDS DR B6 REVIEWED PT MENTOR CPG 323 SILICONE GEL IMPLANT 685 CC LEFT REF 334-1452G MENTOR CPG 323 GEL IMPLANT SIZE 350CC RIGHT REF 350-3501BC B6 2014 NOTICED LEFT BREAST SUDDENLY 1-2 WEEKS LARGER RIGHT FLUID COLLECTION FOUND PHYSICAL EXAM UNDERWENT ASPIRATION FLUID COLLECTION TOTALED 400 CUBIC CENTIMETERS CLEAR YELLOW OUTPUT SENT PATHOLOGY DEMONSTRATED CD30 POSITIVE ALK NEGATIVE ANAPLASTIC LARGE-CELL LYMPHOMA ALCL CONSISTENT BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 2014 UNDERWENT BILATERAL BREAST EXPLANTATION WELL BILATERAL TOTAL CAPSULECTOMIES EXTENSIVE CAPSULECTOMY LEFT SIDE MARGINS NEGATIVE PER PTS REPORT SUSPICIOUS LYMPHADENOPATHY DONE B6 ALSO PTS BREAST RECONSTRUCTION MASS ALCL LOCATED WITHIN IMPLANT CAPSULE PTS SURGICAL ONCOLOGIST DR B6 PT SEEN LYMPHOMA SERVICE PLASTIC SURGERY B4 SURVEILLANCE RECONSTRUCTION|CPG MEMORY SHAPE GEL BREAST IMPLANT|334-1452G|02/19/2015|||DA|N|R||0HP|FTR|1.0||BREAST IMPLANT||5719721|||IRVING|US|MENTOR||TX|||||True
6177062|62452555|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL SEROMA BREAST LUMPS ERYTHEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6177062|62452556|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 OLD PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED MASS SEROMA ERYTHEMATOUS SKIN ERUPTION  TREATMENT REPORTED IMPLANT REMOVAL CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5445101|38528419|D|1||MCGHAN STYLE 120 TEXTURED IMPLANTS MCGHAN - ALLERGAN INSERTED BILATERALLY B6 2004 B6 EXCESS FLUID RIGHT BREAST DRAINED TESTED CANCEROUS BECAME SICK B6 2015 MANY BLOOD TESTS B6 2015 RIGHT BREAST SWOLLEN B6 2015 TOLD ALCL RIGHT BREAST FLUID B6 IMPLANTS REMOVED CAPSULES SCAR TISSUE REMOVED HOPE REMOVAL LYMPHOMA CLEAR TESTING B  CELLS CONFIRMED CELL LYMPHOPROLIFERATIVE DISORDER CONTINUE MONITORED NEXT YEARS|MCGHAN STYLE 120 GEL, HIGH ROUND TEXTURED||02/12/2016||||*|*||0LP|FTR|1.0||MCGHAN STYLE 120 GEL, HIGH ROUND TEXTURED|||||||ALLERGAN|||||STYLE 120|27-120301|True
6145451|61448261|D|1||PHYSICIAN REPORTED PATIENT LATE SEROMA RIGHT SIDE CYTOLOGICAL EXAMINATION RESULTED ALCL DIAGNOSIS EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM120-280|12/05/2016||||N|R||0HP|FTR|1.0|06/13/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1287540|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6145451|61448260|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED DEVICE RETURN DEVICE RETURNED ANALYSIS PERFORMED RESULTS REPORTED SUPPLEMENTAL REPORT EVENTS LATE SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY RECORD DHR PERFORMED IDENTIFY DEVIATIONS ERRORS OMISSIONS MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM120-280|12/05/2016||||N|R||0HP|FTR|1.0|06/13/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1287540|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6145512|63919661|D|1||RECEIVED ADDITIONAL INFORMATION PHYSICIAN REPORTING IMMUNOHISTOCHEMISTRY TUMOR CELLS STRICTLY LIMITED FIBRIN COATING CD30+ ALK- EVENT CONFIRMED ALCL DIAGNOSIS ALCL OCCURRED B6 2016 PHYSICIAN ADDITIONALLY REPORTED INFLAMMATORY DERMAL CONNECTIVE TISSUE RIGHT SIDE RIGHT SIDE PAIN CAPSULAR CONTRACTURE BAKER GRADE II MEDWATCH RIGHT SIDE DEVICE SEE MANUFACTURER REPORT  9617229-2016-00173 LEFT SIDE REPORT|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/03/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013309|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6145512|63919660|N|1||B4 DEVICE ANALYZED ALLERGAN B4 VISUAL ANALYSIS RETURNED DEVICE IDENTIFIED BROWN PARTICLES DELAMINATION PLUG STRAP LEAK TEST PERFORMED FOUND LEAKAGE MICROSCOPIC ANALYSIS PERFORMED IDENTIFY DELAMINATION PLUG STRAP DISK SHELL FILL TEST INSPECTION PERFORMED RESULT BLOCKAGE BASED DEVICE ANALYSIS FINAL ASSESSMENT DELAMINATION PLUG STRAP DISK SHELL ASSESSED ADHESIVE FAILURE DEVICE HISTORY RECORD DHR IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS EVENTS LYMPHOMA-ALCL CAPSULAR CONTRACTURE INFLAMMATION PAIN PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST FORMATION FIBROUS TISSUE AROUND IMPLANTED DEVICE NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY ONE COMMON REASONS REOPERATION CAUSE CAPSULAR CONTRACTURE UNKNOWN HOWEVER LIKELY MULTIFACTORIAL MAY COMMON FOLLOWING INFECTION HAEMATOMA SEROMA CONTRACTURE DEVELOPS VARYING DEGREES UNILATERALLY BILATERALLY MAY OCCUR WITHIN WEEKS YEARS SURGERY CONTRACTURE FIBROUS CAPSULAR TISSUE SURROUNDING IMPLANT MAY CAUSE RANGE SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES CONSIDERED CLINICALLY SIGNIFICANT MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT CORRECTIVE SURGICAL PROCEDURES TREAT CAPSULAR CONTRACTURE EXTERNAL COMPRESSION MASSAGE MAY RESULT IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA Â¿AS EXPECTED FOLLOWING INVASIVE SURGICAL PROCEDURE PAIN VARYING INTENSITY DURATION MAY OCCUR FOLLOWING IMPLANTATION ADDITION IMPROPER PLACEMENT SURGICAL TECHNIQUE CAPSULAR CONTRACTURE MAY RESULT PAIN ASSOCIATED NERVE ENTRAPMENT INTERFERENCE MUSCLE MOTION UNEXPLAINED PAIN MUST PROMPTLY INVESTIGATEDÂ¿|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/03/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013309|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6145512|61450145|N|1||DEVICE CURRENTLY RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/03/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013309|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5691027|51422386|D|1||PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410215|06/01/2016|||DA|N|R||0HP|FTR|1.0|06/02/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1620541|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5691027|46273891|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE REMOVAL REPLACEMENT DUE LATE SEROMA COMPANY REPRESENTATIVE REPORTED BEHALF PHYSICIAN SENT SEROMA FLUID CAPSULE TISSUE PATHOLOGY TEST ALCL DOCTOR REPORTED TEST CAME BACK POSITIVE COMPANY REPRESENTATIVE ADDITIONALLY REPORTED BEHALF PHYSICIAN DISEASE SHOWED PATHOLOGY SEROMA FLUID CAPSULE PARTIAL CAPSULECTOMY DONE INTRAOP IMPLANT REPLACED PATHOLOGICAL MARKERS CONFIRM ALCL YET RECEIVED EVENT CAPTURED LYMPHOMA TIME|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410215|06/01/2016|||DA|N|R||0HP|FTR|1.0|06/02/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1620541|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5691027|46273890|N|1||MEDWATCH SENT FDA 06012016 EVENTS SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE RETURNED THEREFORE UNAVAILABLE ANALYSIS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410215|06/01/2016|||DA|N|R||0HP|FTR|1.0|06/02/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1620541|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5644586|48310176|D|1||HEALTH PROFESSIONAL REPORTED ONE ALCL PATIENTS SURGERY REMOVE REPLACEMENT IMPLANT NEW CAPSULE THUS COME BACK POSITIVE ALCL SPECIFIED RIGHT SIDE EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSF365|05/10/2016||04/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2740658|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5644586|44853450|D|1||HEALTH PROFESSIONAL REPORTED ONE ALCL PATIENTS SURGERY REMOVE REPLACEMENT IMPLANT NEW CAPSULE THUS COME BACK POSITIVE ALCL SPECIFIED RIGHT SIDE EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSF365|05/10/2016||04/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2740658|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5644586|47903123|D|1||HEALTH PROFESSIONAL REPORTED ONE ALCL PATIENTS SURGERY REMOVE REPLACEMENT IMPLANT NEW CAPSULE THUS COME BACK POSITIVE ALCL SPECIFIED RIGHT SIDE EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSF365|05/10/2016||04/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2740658|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5644586|44853449|N|1||MEDWATCH SENT FDA 05102016 EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE YET RECEIVED DEVICE HISTORY RECORD REVIEWED RESULTS STATE REVIEW DHR B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUN NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL Â¿ INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSF365|05/10/2016||04/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2740658|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6177002|62447627|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA Â¿DISRUPTED IMPLANTÂ¿ TREATMENT REPORTED IMPLANT REMOVAL CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP FOUND Â¿NO EVIDENCE DISEASEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6177002|62447626|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5415036|38228122|N|1||IDEAL IMPLANT SUBMIT WITHIN 30 DAYS BECOMING AWARE INCIDENT FOLLOWING REASONS PER FDA REGULATIONS REPORTABLE EVENTS SERIOUS INJURY ONE 1 LIFE THREATENING 2 RESULTS PERMANENT IMPAIRMENT BODY FUNCTION PERMANENT DAMAGE BODY STRUCTURE 3 NECESSITATES MEDICAL SURGICAL INTERVENTION PRECLUDE PERMANENT IMPAIRMENT BODY FUNCTION PERMANENT DAMAGE BODY STRUCTURE PER DEFINITION NOTED IDEAL IMPLANT INCORPORATED UNDERSTOOD COMMON SALINE BREAST IMPLANT DEFLATION WOULD FALL WITHIN DEFINITION SERIOUS INJURY WOULD THEREFORE CONSIDERED REPORTABLE ALTHOUGH SURGICAL INTERVENTION MAY PERFORMED REMOVE ANDOR REPLACE BREAST IMPLANT MEDICALLY REQUIRED PRECLUDE PERMANENT IMPAIRMENT BODY FUNCTION PERMANENT DAMAGE BODY STRUCTURE IMPLANTS FILLED NORMAL SALINE HARMLESSLY ABSORBED BODY DEFLATION POSES MINIMAL RISK PATIENT CONSIDERED SERIOUS ABSENCE ADDITIONAL SERIOUS CONDITION EXTRUSION TISSUE NECROSIS SEPSIS LYMPHOMA ALCL NEUROLOGIC PROBLEM BREAST MASS POSSIBLE AFFECT FETUS ETC DEFLATION ABSENT ADDITIONAL SERIOUS PATIENT CONDITION POSE RISK PATIENT DEATH SERIOUS INJURY IDEAL IMPLANT CONSIDER DEFLATION SURGERY REMOVE DEFLATED IMPLANT SURGICAL INTERVENTION PRECLUDE PERMANENT IMPAIRMENT BODY FUNCTION PERMANENT DAMAGE BODY STRUCTURE DEFLATION TYPE DEVICE MALFUNCTION SERIOUS INJURY SERIOUS CONDITION DEATH REPORTED CONSEQUENCE WOULD CONSIDERED REPORTABLE HOWEVER RECENT FDA INSPECTION PERFORMED B6 2016 OBSERVATION MADE DEFLATION REPORTED FDA UPON LEARNING FDA CONSIDERS DEFLATION EXPLANTED REPORTABLE IDEAL IMPLANT BEGAN SUBMITTING REPORTS PAST DEFLATIONS CONTINUE REPORT INSTANCES EXPLANTED DEFLATIONS FUTURE|IDEAL IMPLANT STRUCTURED BREAST IMPLANT|370|02/06/2016||11/30/2015||R|Y||0HP|FWM|1.0||SALINE-FILLED BREAST IMPLANT||61048|5005 LYNDON B JOHNSON FREEWAY|SUITE 900|DALLAS|US|IDEAL IMPLANT INCORPORATED|75244|TX|75244||37001||True
5488699|39950189|D|1||COMPANY REPRESENTATIVE REPORTED REMOVAL ALLERGAN TEXTURED ROUND IMPLANT SIDE UNKNOWN DUE ALCL FOLLOW-UP HEALTH PROFESSIONAL CONFIRMED RIGHT SIDE ALCL DIAGNOSIS STAINS CD30 STRONGLY POSITIVE WITHIN ABNORMAL CELLS STAIN ALK NEGATIVE ADDITIONAL INFORMATION NOTED PATIENT RECENTLY CHANGES APPEARANCE CONTOUR BREAST AREAIS PLANNING MRI EVALUATION PATIENTS RATHER CYSTIC BREAST DISEASE PATIENT ENCAPSULATED IMPLANT RIGHT SIDE HIGHER CONTRALATERAL LEFT SIDE APPEARS BIT ANTERIOR OPERATIVE REPORT STATED SIGNIFICANT ADHESION CHEST WALL PRESENCE CAPSULAR CONTRACTURE BAKER GRADE SPECIFIED TREATMENT INCLUDED REMOVAL IMPLANT CAPSULE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|03/09/2016|||DA|N|R||0HP|FWM|1.0|04/12/2008|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||621428|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5488699|39950188|N|1||MEDWATCH SUBMITTED 03092016 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION BEN IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|03/09/2016|||DA|N|R||0HP|FWM|1.0|04/12/2008|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||621428|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5488699|41343378|D|1||COMPANY REPRESENTATIVE REPORTED REMOVAL ALLERGAN TEXTURED ROUND IMPLANT SIDE UNKNOWN DUE ALCL FOLLOW-UP HEALTH PROFESSIONAL CONFIRMED RIGHT SIDE ALCL DIAGNOSIS STAINS CD30 STRONGLY POSITIVE WITHIN ABNORMAL CELLS STAIN ALK NEGATIVE ADDITIONAL INFORMATION NOTED PATIENT RECENTLY CHANGES APPEARANCE CONTOUR BREAST AREA PLANNING MRI EVALUATION PATIENTS RATHER CYSTIC BREAST DISEASE PATIENT ENCAPSULATED IMPLANT RIGHT SIDE HIGHER CONTRALATERAL LEFT SIDE APPEARS BIT ANTERIOR OPERATIVE REPORT STATED SIGNIFICANT ADHESION CHEST WALL PRESENCE CAPSULAR CONTRACTURE BAKER GRADE SPECIFIED TREATMENT INCLUDED REMOVAL IMPLANT CAPSULE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|03/09/2016|||DA|N|R||0HP|FWM|1.0|04/12/2008|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||621428|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5597717|43315362|N|1||MEDWATCH SUBMITTED FDA 04222016 B4  DEVICE RETURNED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLY CAUSE EVENT DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|07/12/2001|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||530498|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5597717|49979645|D|1||COMPANY REPRESENTATIVE REPORTED BEHALF HEALTH PROFESSIONAL CASE ALCL PATIENT INITIALLY PRESENTED SEROMA SIGNIFICANTLY SWOLLEN HEALTH PROFESSIONAL SUGGESTED REMOVAL CAPSULECTOMY HOWEVER PATIENT CHOSE MOVE FORWARD SURGERY PATIENT PASSED AWAY FOLLOW-UP HEALTH PROFESSIONAL REPORTED RIGHT SIDE CAPSULAR CONTRACTURE BAKER GRADE III THICKENING CAPSULE CAPSULITIS PATHOLOGY NOTES SPECIMENS LEFT AXILLARY LYMPH NODES BIOPSY RIGHT PECTORALIS MUSCLE BIOPSY PATIENT ENLARGED LEFT AXILLARY LYMPH NODES PATHOLOGY NOTES SPECIMENS ALK NEGATIVE WEAKLY POSITIVE CD30 MICROSCOPIC DESCRIPTION NOTES NECROTIC DEBRIS REGARD LYMPH NODE BIOPSY MUSCLE BIOPSY ADDITIONAL PATHOLOGY RESULTS PROVIDED RIGHT AXILLA SKIN BIOPSY RIGHT THORACENTESIS 50 ML CLEAR YELLOW FLUID FINDINGS INDICATE LYMPHOMA ALCL DIAGNOSIS CONFIRMED VIA PATHOLOGY PATIENT TREATED CHEMOTHERAPY MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00033 LEFT SIDE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|07/12/2001|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||530498|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5597717|43315363|D|1||COMPANY REPRESENTATIVE REPORTED BEHALF HEALTH PROFESSIONAL CASE ALCL PATIENT INITIALLY PRESENTED SEROMA SIGNIFICANTLY SWOLLEN HEALTH PROFESSIONAL SUGGESTED REMOVAL CAPSULECTOMY HOWEVER PATIENT CHOSE MOVE FORWARD SURGERY PATIENT PASSED AWAY FOLLOW-UP HEALTH PROFESSIONAL REPORTED RIGHT SIDE CAPSULAR CONTRACTURE BAKER GRADE III THICKENING CAPSULE CAPSULITIS PATHOLOGY NOTES SPECIMENS Â¿LEFT AXILLARY LYMPH NODES BIOPSYÂ¿ Â¿RIGHT PECTORALIS MUSCLE BIOPSYÂ¿ PATIENT Â¿ENLARGED LEFT AXILLARY LYMPH NODESÂ¿ PATHOLOGY NOTES SPECIMENS Â¿ALK NEGATIVEÂ¿ Â¿WEAKLY POSITIVE CD30Â¿ MICROSCOPIC DESCRIPTION NOTES Â¿NECROTIC DEBRISÂ¿ REGARD LYMPH NODE BIOPSY MUSCLE BIOPSY ADDITIONAL PATHOLOGY RESULTS PROVIDED Â¿RIGHT AXILLA SKIN BIOPSYÂ¿ Â¿RIGHT THORACENTESIS 50 ML CLEAR YELLOW FLUIDÂ¿ FINDINGS INDICATE LYMPHOMA ALCL DIAGNOSIS CONFIRMED VIA PATHOLOGY PATIENT TREATED CHEMOTHERAPY MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00033 LEFT SIDE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|07/12/2001|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||530498|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5597737|43319693|N|1||MEDWATCH SUBMITTED FDA 04222016 B4 DEVICE RETURNED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLY CAUSE EVENT DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|01/20/2002|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||533743|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5597737|49978503|D|1||COMPANY REPRESENTATIVE REPORTED BEHALF HEALTH PROFESSIONAL PATIENT PASSED AWAY FOLLOW-UP HEALTH PROFESSIONAL REPORTED LEFT SIDE CAPSULAR CONTRACTURE BAKER GRADE IV PATHOLOGY NOTES SPECIMENS LEFT AXILLARY LYMPH NODES BIOPSY RIGHT PECTORALIS MUSCLE BIOPSY PATIENT ENLARGED LEFT AXILLARY LYMPH NODES PATHOLOGY NOTES SPECIMENS ALK NEGATIVE WEAKLY POSITIVE CD30 MICROSCOPIC DESCRIPTION NOTES NECROTIC DEBRIS REGARD LYMPH NODE BIOPSY MUSCLE BIOPSY ADDITIONAL PATHOLOGY RESULTS PROVIDED RIGHT AXILLA SKIN BIOPSY RIGHT THORACENTESIS 50 ML CLEAR YELLOW FLUID FINDINGS INDICATE LYMPHOMA ALCL DIAGNOSIS CONFIRMED VIA PATHOLOGY ALCL CAPTURED BILATERALLY CASE APPEARS SYSTEMIC PATIENT TREATED CHEMOTHERAPY MEDWATCH REPRESENTS LEFT SIDE SEE MFR  9617229-2016-00031 RIGHT SIDE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|01/20/2002|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||533743|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5597737|43319694|D|1||COMPANY REPRESENTATIVE REPORTED BEHALF HEALTH PROFESSIONAL PATIENT PASSED AWAY FOLLOW-UP HEALTH PROFESSIONAL REPORTED LEFT SIDE CAPSULAR CONTRACTURE BAKER GRADE IV PATHOLOGY NOTES SPECIMENS Â¿LEFT AXILLARY LYMPH NODES BIOPSYÂ¿ Â¿RIGHT PECTORALIS MUSCLE BIOPSYÂ¿ PATIENT Â¿ENLARGED LEFT AXILLARY LYMPH NODESÂ¿ PATHOLOGY NOTES SPECIMENS Â¿ALK NEGATIVEÂ¿ Â¿WEAKLY POSITIVE CD30Â¿ MICROSCOPIC DESCRIPTION NOTES Â¿NECROTIC DEBRISÂ¿ REGARD LYMPH NODE BIOPSY MUSCLE BIOPSY ADDITIONAL PATHOLOGY RESULTS PROVIDED Â¿RIGHT AXILLA SKIN BIOPSYÂ¿ Â¿RIGHT THORACENTESIS 50 ML CLEAR YELLOW FLUIDÂ¿ FINDINGS INDICATE LYMPHOMA ALCL DIAGNOSIS CONFIRMED VIA PATHOLOGY ALCL CAPTURED BILATERALLY CASE APPEARS SYSTEMIC PATIENT TREATED CHEMOTHERAPY MEDWATCH REPRESENTS LEFT SIDE SEE MFR  9617229-2016-00031 RIGHT SIDE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|01/20/2002|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||533743|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6037732|57779754|D|1||ALLERGAN PRODUCT SURVEILLANCE RECEIVED REPORT THERAPEUTIC GOODS ADMINISTRATION TGA TGA REPORTED SWELLING BREAST LYMPHOMA ALCL SIDE UNKNOWN DEVICE EXPLANTED CAPSULECTOMY PERFORMED PATIENT CURRENTLY RECEIVING CHEMOTHERAPY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/18/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6037732|57779753|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/18/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5922918|58726651|D|1||ADDITIONAL INFORMATION HEALTHCARE PROFESSIONAL REPORTED PATIENT IMPLANTED LEFT SIDE 1998 SALINE TEXTURED MCGHAN DEVICE SERIAL NUMBER AVAILABLE B6 2016 PATIENT PRESENTED Â¿RAPID SWELLING LEFT BREASTÂ¿ Â¿PERI-IMPLANT SEROMAÂ¿ SEVERE CAPSULAR CONTRACTURE BAKER GRADE III PATHOLOGY REPORT NOTES Â¿CHRONIC INFLAMMATIONÂ¿ Â¿NECROTIC TISSUE FRAGMENTSÂ¿ Â¿RED-BROWN MURKY FLUIDÂ¿ PATIENT RECEIVED ALCL DIAGNOSIS B6 2016 PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL RECEIVED DEVICE EXPLANTED CAPSULECTOMY PERFORMED PETMRI PERFORMED DUE PATIENT ANXIETY EXPLANTED DEVICE RETURNED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|09/01/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5922918|53782148|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING PATIENT INFORMATION DEVICE INFORMATION SIDE EXPERIENCING POSSIBLE ALCL PATHOLOGY REPORT DEVICE RETURN REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|09/01/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5922918|53782149|D|1||HEALTHCARE PROFESSIONAL REPORTED PATIENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL EXPLANT SURGERY OCCURRED 3 WEEKS AGO PATHOLOGICAL MARKERS RECEIVED CONFIRMING ALCL EVENT CAPTURED LYMPHOMA MARKERS RECEIVED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|09/01/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5896408|52758840|N|1||MEDWATCH SENT FDA 08232016 DEVICE RETURNED DEVICE ANALYSIS COMPLETE FINDINGS SENT FOLLOW-UP REPORT EVENTS INFLAMMATION LYMPHOMA SWELLING PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING PRODUCT INFORMATION REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES REPORTED EVENTS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|08/23/2016||08/23/2016|DA|R|Y||0HP|FTR|1.0|02/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||384466|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6106201|65086177|D|1||PHYSICIAN REPORTS PATIENT SWELLING LEFT BREAST LEFT SIDE SEROMA FLUID CD30+ LYMPHOMA TREATED BIA-ALCL TOTAL CAPSULECTOMY EXPLANT REPORTED TIME ALCL CONFIRMED PATHOLOGICAL MARKER ALK- ALLERGAN RECEIVES CONFIRMATION MARKERS TERM CODED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|11/16/2016||12/14/2016|DA|R|Y||0HP|FTR|1.0|07/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||225212|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6106201|60020511|D|1||PHYSICIAN REPORTS PATIENT SWELLING LEFT BREAST LEFT SIDE SEROMA FLUID CD30+ LYMPHOMA TREATED BIA-ALCL TOTAL CAPSULECTOMY EXPLANT REPORTED TIME ALCL CONFIRMED PATHOLOGICAL MARKER ALK- ALLERGAN RECEIVES CONFIRMATION MARKERS TERM CODED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|11/16/2016||12/14/2016|DA|R|Y||0HP|FTR|1.0|07/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||225212|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6106201|60020510|N|1||FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RECEIVED LAB ANALYSIS PERFORMED RESULTS REPORTED SUPPLEMENTAL REPORT EVENTS SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES REPORTED EVENTS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION DEVICE HISTORY RECORD DHR REVIEW SUMMARY REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS ADDITION DHR SHELL RUN NUMBER 8070302 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|11/16/2016||12/14/2016|DA|R|Y||0HP|FTR|1.0|07/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||225212|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
5708570|46882993|N|1||MEDWATCH SENT FDA 06092016 RESPONSE FDA REPORT NUMBER MW5061580 B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE SERIALLOT NUMBER PATIENT INFORMATION PROVIDED DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-400|06/09/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5708570|46882994|D|1||HEALTH PROFESSIONAL REPORTED ALCL ASSOCIATED SILICONE BREAST IMPLANT SIDE UNSPECIFIED FOLLOW-UP REPORTED PATIENT DEVELOPED MASS SEROMA LEFT SIDE INITIAL BIOPSY TAKEN MASS DIAGNOSED FAT NECROSIS MASS SEROMA CONFIRMED SEPARATE EVENTS DEVICE YET REMOVED PROCEEDING CHEMOTHERAPY CURRENTLY PATIENT IMPLANT REMOVAL CAPSULECTOMY PENDING SUCCESS CHEMOTHERAPY HEALTH PROFESSIONAL CONFIRMED VERBALLY PATHOLOGY REPORTS STATED MARKERS CD30+  ATYPICAL LYMPHOID INFILTRATE ALK-1|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-400|06/09/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5596175|43273717|N|1||B4 DEVICE RETURNED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLY CAUSE EVENT DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NONHODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-500|04/21/2016|||DA|N|R||0HP|FTR|1.0|01/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1204889|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6011867|56822654|D|1||ALLERGANÂ¿S LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ ARTICLEÂ¿S PURPOSE CAPTURE REPORTED BIA-ALCL AUSTRALIA NEW ZEALAND STUDY ASSOCIATION RISK DIFFERENT IMPLANT SURFACES INCIDENCE BIA-ALCL TOTAL 46 PATIENTS IDENTIFIED 2007 AUGUST 2016 FIVE WOMEN MULTIPLE IMPLANTS REMAINING 41 SINGLE IMPLANT HISTORY TOTAL 56 IMPLANT PAIRS ARTICLE STATES Â¿ALL PATIENTS EXPOSED TEXTURED IMPLANTS POINT IMPLANT HISTORYÂ¿ ARTICLE CLARIFIES Â¿THERE TOTAL 46 IMPLANTS PLACED AUSTRALIA 8 IMPLANTS PLACED NEW ZEALAND TWO PATIENTS IMPLANT PLACED OUTSIDE AUSTRALIA NEW ZEALAND 1 MEXICO 1 THAILANDÂ¿ MANUFACTURER COULD SPECIFIED ARTICLE STATES Â¿BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED 571 IMPLANTS SERIESÂ¿ ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011867|56822653|N|1||MEDWATCH SENT FDA 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENT LYMPHOMA ALCL PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5670826|58278251|D|1||PHYSICIAN REPORTED TUMOUR CELLS EXPRESS CD3 CD30 CD15 P63 FOCAL WEAK NEGATIVE PAX5 CD20 ALK EBV EBER DIAGNOSIS ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANTS EVENT ALCL CONFIRMED TIME PHYSICIAN ADDITIONALLY REPORTED SMALL POST-BIOPSY HEMATOMA OBSERVED PROBABLE THROMBOSIS ADJACENT VESSEL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MM125-320|05/20/2016|||DA|N|R||0HP|FTR|1.0|02/03/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2073435|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5670826|45647377|D|1||PHYSICIAN REPORTED APPROXIMATELY FIVE YEARS IMPLANTATION PATIENT CONSULTED DOCTOR DISCOVERING SELF-EXAM TEN DAYS EARLIER INFRACLAVICULAR C11 LUMPS PATIENTS LEFT BREAST LEFT AXILLARY ADENOPATHY ULTRASOUND-GUIDED BAG ACCORDING BI-RADS ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA ALCL CD30 RESULTS PROVIDED REPORT ALCL YET CONFIRMED CURRENTLY CAPTURED LYMPHOMA DEVICE EXPLANTED PATIENT STUDIED CHEMOTHERAPY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MM125-320|05/20/2016|||DA|N|R||0HP|FTR|1.0|02/03/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2073435|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5670826|45647376|N|1||REPORTER EVENT ASKED RETURN PRODUCT ANALYSIS ALLERGAN RECEIVED PRODUCT TIME THEREFORE ANALYSIS TESTING DONE EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY REVIEW REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR WORK ORDER B4 INDICATES REPROCESS PRIMARY PACKAGING OPERATION HOWEVER COMPLETED DIFFERENT SERIAL NUMBER UNIT RELATION NEITHER CAUSE REPORTED EVENT DHR ASSEMBLY REPORT VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUNS NUMBER 10009114 10009114 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURANCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MM125-320|05/20/2016|||DA|N|R||0HP|FTR|1.0|02/03/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2073435|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6146400|61491852|N|1||B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA NECROSIS PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA ARTICLE CITATION Â¿CLASSICAL HODGKIN LYMPHOMA ARISING ADJACENT BREAST IMPLANTÂ¿ CIARA RYAN MB MRCSI FRCPATH1 YASSER GED MB1 FIONA QUINN PHD1 JAN WALKER BSC1 JOHN KENNEDY MB FRCPI1 CHARLES GILLHAM MB MRCP FRCR1 STEFANIA PITTALUGA MD PHD2 RONAN MCDERMOTT MB MRCPI FRCR FFRRCSI1 ELISABETH VANDENBERGHE MB PHD MRCPI MRCPATH1 CLIONA GRANT MB MRCPI1 RICHARD FLAVIN MD PHD FRCPATH1 INTERNATIONAL JOURNAL SURGICAL PATHOLOGY 2016 VOL 245 448Â¿455|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/05/2016|||DA|*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5880065|52274646|N|1||MEDWATCH SENT FDA 08162016 EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT FOLLOW PERFORMED DETERMINE DEVICE MANUFACTURER SERIAL NUMBER LOT NUMBER IMPLANT DATE PATIENT NAME PATIENT DATE BIRTH PATHOLOGICAL TESTING RESULTS EXPLANT DATE DEVICE RELATIONSHIP REPORTED EVENT DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/16/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNK|||||||True
5880065|52274647|D|1||ALLERGAN REPRESENTATIVE REPORTED VIA EMAIL RECEIVED POSTER LEFT SIDE ALCL COMPLAINT DEVICE MANUFACTURER UNKNOWN EMAIL STATES 61524 HOSPITAL  POSTER RECENTLY PRESENTED HEALTHCARE PROFESSIONAL POSTER ALCL COMPLAINT SPECIFY DEVICE MANUFACTURE COMPANY HEALTHCARE PROFESSIONAL REFUSES PROVIDE INFORMATION HOSPITAL AUTHORIZE PROVIDE WITHOUT SUBJECT CONSENT|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/16/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNK|||||||True
5936530|54204593|D|1||HEALTHCARE PROFESSIONAL REPORTED UNKNOWN SIDE LYMPHOMA ALCL PATHOLOGICAL MARKERS RECEIVED THEREFORE EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/08/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5936530|54204592|N|1||MEDWATCH SENT FDA 09082016 EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING SERIAL NUMBER DATE IMPLANTEXPLANT IMPLANTING PHYSICIAN PATIENT INFORMATION RETURN PATHOLOGICAL MARKERS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/08/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176674|62457390|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA MASS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176674|62457391|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED MASS SEROMA TREATMENT REPORTED IMPLANT REMOVAL CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6142978|61395222|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL DEATH PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6142978|61395223|D|1||LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTED Â¿19 I-ALCLSÂ¿ CASES ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ ARTICLE REPORTED CASES Â¿INFILTRATIVE I-ALCLÂ¿ SURVIVAL RATE 525 ARTICLE REPORTS CASES RESULTED DEATH TWO LYMPHOMA PROGRESSION RECORD REPRESENTS CASES INFILTRATIVE I-ALCL RESULTED DEATH LYMPHOMA PROGRESSION ARTICLE REPORTS HISTOPATHOLOGY REPORTS MALIGNANT CELLS CD30-POSITIVE ALK NEGATIVE REGARDS TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL PERFORMED 17 19 PATIENTS ADDITIONAL TREATMENT BASED MOSTLY CHOP CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 IRRADIATION N = 119 CHOP ALONE ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL GIVEN TWO PATIENTSÂ¿ WAY KNOWING TREATMENT USED TWO CASES MANUFACTURER DEVICES UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6153182|61700300|N|1||B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHADENOPATHY LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5940718|69962842|N|1||EVENTS INFLAMMATION LUMPNODULE LYMPHOMA ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CASES PATIENTS PRESENTED MASSES ADJACENT BREAST IMPLANT PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/09/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5940718|69962843|D|1||HEALTHCARE PROFESSIONAL ADDITIONALLY REPORTED LEFT SIDE MASS INFLAMMATION PATHOLOGICAL MARKERS CD30+ ALK- RECEIVED THEREFORE LYMPHOMA ALCL CONFIRMED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/09/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5940718|54394902|N|1||MEDWATCH SENT FDA 09092016 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/09/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5940718|54394903|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE PATIENT PRESENTED LARGE SEROMA RECEIVED ALCL DIAGNOSIS B6 2014 TOTAL CAPSULECTOMY PERFORMED B6 2014 IMPLANT REMOVAL REPLACEMENT PATIENT REMAINS DISEASE FREE B6 2016 PATIENT TREATED SURGERY CHEMO THERAPY CHOP RADIATION PATHOLOGICAL MARKERS RECEIVED EVENT CAPTURED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/09/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5644581|44885546|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT KNOWN DEVICE RETURNED MISSING INFORMATION INCLUDES DEVICE SERIAL NUMBER IMPLANT DATE DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL  INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/10/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||nan|||||||True
5644581|44885547|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE DEVICE REMOVAL TOTAL CAPSULECTOMY FOLLOWING SEROMA DIAGNOSIS ALCL MANUFACTURER DEVICE UNKNOWN EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/10/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||nan|||||||True
6199283|63133499|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM130-360|12/22/2016|||DA|N|R||0HP|FTR|1.0|11/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||352966|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6023404|72695628|D|1||PHYSICIAN REPORTS PATIENT SUDDEN ONSET SEROMA RIGHT SIDE PHYSICIAN REPORTED IMPLANT REMOVED PART TOTAL CAPSULECTOMY DIAGNOSIS IA LCAL MADE CYTOLOGY ASPIRATED SEROMA FLUID EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FX155-775|10/12/2016||03/02/2017|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2379964|900 PARKWAY GLOBAL PARK|ZONA FRANCA|ARKLOW, COUNTY WICKLOW|CS|ALLERGAN|||||||True
6023404|57191543|D|1||PHYSICIAN REPORTS PATIENT SUDDEN ONSET SEROMA RIGHT SIDE PHYSICIAN REPORTED IMPLANT REMOVED PART TOTAL CAPSULECTOMY DIAGNOSIS IA LCAL MADE CYTOLOGY ASPIRATED SEROMA FLUID EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FX155-775|10/12/2016||03/02/2017|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2379964|900 PARKWAY GLOBAL PARK|ZONA FRANCA|ARKLOW, COUNTY WICKLOW|CS|ALLERGAN|||||||True
6023404|57191542|N|1||FOLLOW-UP PERFORMED DEVICE RETURN EVENTS LYMPHOMA SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES REPORTED EVENTS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FX155-775|10/12/2016||03/02/2017|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2379964|900 PARKWAY GLOBAL PARK|ZONA FRANCA|ARKLOW, COUNTY WICKLOW|CS|ALLERGAN|||||||True
5415044|38160022|N|1||IDEAL IMPLANT SUBMIT MDR WITHIN 30 DAYS BECOMING AWARE INCIDENT FOLLOWING REASONS PER FDA REGULATIONS REPORTABLE EVENTS SERIOUS INJURY ONE LIFE THREATENING RESULTS PERMANENT IMPAIRMENT BODY FUNCTION PERMANENT DAMAGE BODY STRUCTURE NECESSITATES MEDICAL SURGICAL INTERVENTION PRECLUDE PERMANENT IMPAIRMENT BODY FUNCTION PERMANENT DAMAGE BODY STRUCTURE PER DEFINITION NOTED IDEAL IMPLANT INCORPORATED UNDERSTOOD COMMON SALINE BREAST IMPLANT DEFLATION WOULD FALL WITHIN DEFINITION SERIOUS INJURY WOULD THEREFORE CONSIDERED REPORTABLE ALTHOUGH SURGICAL INTERVENTION MAY PERFORMED REMOVE ANDOR REPLACE BREAST IMPLANT MEDICALLY REQUIRED PRECLUDE PERMANENT IMPAIREMENT BODY FUNCTION PERMANENT DAMAGE BODY STRUCTURE IMPLANTS FILLED NORMAL SALINE HARMLESSLY ABSORBED BODY DEFLATION POSES MINIMAL RISK PATIENT CONSIDERED SERIOUS ABSENCE ADDITIONAL SERIOUS CONDITION EXTRUSION TISSUE NECROSIS SEPSIS LYMPHOMA ALCL NEUROLOGIC PROBLEM BREAST MASS POSSIBLE AFFECT FETUS ETC DEFLATION ABSENT ADDITIONAL SERIOUS PATIENT CONDITION POSE RISK PATIENT DEATH SERIOUS INJURY IDEAL IMPLANT CONSIDER DEFLATION SURGERY REMOVE DEFLATED IMPLANT SURGICAL INTERVENTION PRECLUDE PERMANENT IMPAIRMENT BODY FUNCTION PERMANENT DAMAGE BODY STRUCTURE DEFLATION TYPE DEVICE MALFUNCTION SERIOUS INJURY SERIOUS CONDITION DEATH REPORTED CONSEQUENCE WOULD CONSIDERED REPORTABLE HOWEVER RECENT FDA INSPECTION PERFORMED 2116-2316 OBSERVATION MADE DEFLATION REPORTED FDA UPON LEARNING FDA CONSIDERS DEFLATION EXPLANTED REPORTABLE IDEAL IMPLANT BEGAN SUBMITTING REPORTS PAST DEFLATIONS CONTINUE REPORT INSTANCES EXPLANTED DEFLATIONS FUTURE|IDEAL IMPLANT STRUCTURED BREAST IMPLANT|405|02/06/2016||10/28/2015|DA|R|Y||0HP|FWM|1.0||SALINE-FILLED BREAST IMPLANT||61030|5005 LYNDON B JOHNSON FREEWAY|SUITE 900|DALLAS|US|IDEAL IMPLANT INCORPORATED|75244|TX|75244||40501||True
6153188|61710211|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ 137 6 1659-1669 HONGHUA HU PHD KHALID JOHANI AHMAD ALMATROUDI KAREN VICKERY PHD BVSC BRUCE VAN NATTA MD MARSHALL E KADIN MD GARRY BRODY MD MARK CLEMENS MD CHAN YOON CHEAH MD STEPHEN LADE MD PREETI AVINASH JOSHI MDPHD H MILES PRINCE MDPHD ANAND K DEVA BSCMED MBBS MS PUBLISHED JUNE 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6153188|61710212|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES GATHERED FOUR CENTERS INTERNATIONAL COLLABORATIVE STUDY TOTAL 22 PATIENTS TABLE 1Â¿ ARTICLE GOES STATE Â¿BOTH BREAST IMPLANTÂ¿ASSOCIATED ALCL NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG TISSUE CAPSULE 49 Ã 106 CELLSMG TISSUE ANALYSIS MICROBIOME BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES SPECIES IDENTIFIED NONTUMOR CAPSULE SPECIMENS SIGNIFICANTLY GREATER PROPORTION RALSTONIA SPP PRESENT ALCL SPECIMENS COMPARED NONTUMOR CAPSULE SPECIMENS P  005 CONTRAST SIGNIFICANTLY STAPHYLOCOCCUS SPP FOUND ASSOCIATED NONTUMOR CAPSULE SPECIMENS COMPARED BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM VISUALIZED SCANNING ELECTRON MICROSCOPY FLUORESCENT SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- CD30+ REPORTED ACCORDING TABLE 1 Â¿CLINICAL SUMMARY BREAST IMPLANTÂ¿ASSOCIATED ALCL PATIENTSÂ¿ 3 CASES ALCL PRESENTATION Â¿NOT KNOWNÂ¿ CURRENTLY WAY DETERMINE CASES DEVICE TYPE TESTED NEGATIVE BACTERIAL INFECTION REPORT CAPTURE 3 CASES ALCL PRESENTATION Â¿NOT KNOWNÂ¿|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5659740|45309562|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE SWELLING WOULD COME GO VARYING TIMES ADDITION FIRMNESS SIGNIFICANT SUPERIOR POLE FULLNESS CAPSULAR CONTRACTURE BAKER GRADE IV CONFIRMED UPON EXPLANT CAPSULECTOMY PATHOLOGY NOTED RIGHT BREAST CAPSULE CAPSULECTOMY BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA SEE COMMENT COMMENT NOTES LYMPHOMA CELLS APPEAR PRIMARILY CONFINED INNER SURFACE RIGHT BREAST CAPSULE DESCRIBED EFFUSION-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ALCLÂ¿ GROSS EXAMINATION NOTES Â¿PREVIOUSLY OPENED BREAST CAPSULE CONTAINS 45 CC TURBID TAN-YELLOW FLUIDÂ¿ MICROSCOPIC EXAMINATION NOTES Â¿THE LARGE ATYPICAL CELLS STAIN POSITIVELY CD30Â¿THESE CELLS NEGATIVE ALKÂ¿|STYLE 168 SALINE FILLED BREAST IMPLANT|UNK STYLE 168|05/17/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5659740|45309561|N|1||MEDWATCH SENT FDA 05172016 B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE RETURNED SERIAL NUMBER AVAILABLE DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|UNK STYLE 168|05/17/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5894468|52721867|D|1||COMPANY REPRESENTATIVE REPORTED BEHALF HEALTH PROFESSIONAL LATE SEROMA TESTED POSITIVE CD30 OPERATIVE REPORT REFERENCES SURGERY B6 2008 PATIENT BILATERAL NEOSUBMUSCULAR POCKET REPOSITIONING EXISTING BREAST IMPLANTS OPERATIVE REPORT ADDITIONALLY NOTES BOTTOMING BREAST IMPLANT BREAST ASYMMETRY CHEST WALL DEFORMITY CONSTRICTED BREASTÂ¿ ADDITION Â¿THE BREAST IMPLANT WIPED ANTIBIOTIC LAP PAD REINSERTED POCKETÂ¿ B6 2015 PATIENT NOTICED BREAST IMPLANTS ASYMMETRIC EVALUATED PLASTIC SURGEON SUSPECTED CAPSULAR CONTRACTION PHYSICIAN NOTES CLARIFY Â¿ON PHYSICAL EXAMINATION LEFT BREAST ALMOST TWICE SIZE RIGHT BREAST EDEMA LEFT BREAST SKIN ULTRASOUND LATER CONFIRMED LEFT SIDE RUPTURE FLUID SURROUNDING IMPLANT LEFT BREAST LATER BECAME ENGORGED DEVELOPED SEROMA ASPIRATED B6 2016 FOUND POSITIVE CD30 ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY DATED B6 2016 STATES Â¿LYMPHOID CELLS POSITIVE CD3 CD30Â¿THE FINDINGS SUGGEST POSSIBLE BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ EXAM DATED B6 2016 STATES Â¿DIAGNOSIS ALCL BREAST PALPABLE LEFT BREAST MASSÂ¿ PATIENT SURGERY B6 2016 REPLACEMENT TIME DEVICE AVAILABLE RETURN ALLERGAN B6 2016 PATIENT EVIDENCE ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-354|08/22/2016|||DA|N|R||0HP|FTR|1.0|01/13/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1393696|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5894468|52721866|N|1||B4 EVENTS LYMPHOMA ALCL SEROMA LATE EDEMA VISIBILITYPALPABILITY PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE REOPERATION IMPLANT REMOVAL ASYMMETRY IMPLANT MISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY HEMATOMASEROMA BREAST TISSUE ATROPHYCHEST WALL DEFORMITY|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-354|08/22/2016|||DA|N|R||0HP|FTR|1.0|01/13/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1393696|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5894468|54359677|D|1||COMPANY REPRESENTATIVE REPORTED BEHALF HEALTH PROFESSIONAL LATE SEROMA TESTED POSITIVE CD30 OPERATIVE REPORT REFERENCES SURGERY B6 2008 PATIENT BILATERAL NEOSUBMUSCULAR POCKET REPOSITIONING EXISTING BREAST IMPLANTS OPERATIVE REPORT ADDITIONALLY NOTES BOTTOMING BREAST IMPLANT BREAST ASYMMETRY CHEST WALL DEFORMITY CONSTRICTED BREASTÂ¿ ADDITION Â¿THE BREAST IMPLANT WIPED ANTIBIOTIC LAP PAD REINSERTED POCKETÂ¿ B6 2015 PATIENT NOTICED BREAST IMPLANTS ASYMMETRIC EVALUATED PLASTIC SURGEON SUSPECTED CAPSULAR CONTRACTION PHYSICIAN NOTES CLARIFY Â¿ON PHYSICAL EXAMINATION LEFT BREAST ALMOST TWICE SIZE RIGHT BREAST EDEMA LEFT BREAST SKIN ULTRASOUND LATER CONFIRMED LEFT SIDE RUPTURE FLUID SURROUNDING IMPLANT LEFT BREAST LATER BECAME ENGORGED DEVELOPED SEROMA ASPIRATED B6 2016 FOUND POSITIVE CD30 ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY DATED B6 2016 STATES Â¿LYMPHOID CELLS POSITIVE CD3 CD30Â¿THE FINDINGS SUGGEST POSSIBLE BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ EXAM DATED B6 2016 STATES Â¿DIAGNOSIS ALCL BREAST PALPABLE LEFT BREAST MASSÂ¿ PATIENT SURGERY 06132016 REPLACEMENT TIME DEVICE AVAILABLE RETURN ALLERGAN B6 2016 PATIENT EVIDENCE ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-354|08/22/2016|||DA|N|R||0HP|FTR|1.0|01/13/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1393696|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5935521|56208704|D|1||HEALTHCARE PROFESSIONAL REPORTED PATIENT PRESENTED RIGHT SIDE LARGE SEROMA LARGE PALPABLE MASS TOTAL CAPSULECTOMY PERFORMED B6 2016 IMPLANT REMOVAL REPLACEMENT PATIENT DIAGNOSED RIGHT SIDE ALCL B6 2016 COMPLETE PATHOLOGICAL MARKERS RECEIVED EVENT REPORTED LYMPHOMA PATIENT CURRENTLY RECEIVING CHEMOTHERAPY CHOP THERAPY|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|09/08/2016|||DA|N|R||0HP|FWM|1.0|05/05/2011|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1440846|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5935521|54162317|N|1||MEDWATCH SENT FDA 09082016 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|09/08/2016|||DA|N|R||0HP|FWM|1.0|05/05/2011|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1440846|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5935521|54162318|D|1||HEALTHCARE PROFESSIONAL REPORTED PATIENT PRESENTED RIGHT SIDE LARGE SEROMA LARGE PALPABLE MASS TOTAL CAPSULECTOMY PERFORMED B6 2016 IMPLANT REMOVAL REPLACEMENT PATIENT DIAGNOSED RIGHT SIDE ALCL B6 2016 COMPLETE PATHOLOGICAL MARKERS RECEIVED EVENT REPORTED LYMPHOMA PATIENT CURRENTLY RECEIVING CHEMOTHERAPY CHOP THERAPY|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|09/08/2016|||DA|N|R||0HP|FWM|1.0|05/05/2011|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1440846|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5904549|53036936|N|1||MEDWATCH SENT FDA 08252016 RESPONSE FDA REPORT NUMBER MW5063635 B4 DEVICE CONFIRMED AVAILABLE RETURN YET RECEIVED EVENTS LYMPHOMA EDEMA VISIBILITYPALPABILITY SENSATION INCREASE SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES REPORTED EVENTS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION SENSATION NIPPLE BREAST INCREASE DECREASE IMPLANT SURGERY TYPICALLY LOST COMPLETE MASTECTOMY NIPPLE REMOVED SEVERELY LESSENED PARTIAL MASTECTOMY|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
5904549|58060034|D|1||PHYSICIAN REPORTED RIGHT BREAST SWOLLEN FIRM SENSITIVE DEEP PALPATION PHYSICIAN ALSO STATED ANAPLASTIC LARGE CELL LYMPHOMA FOUND PERI PROSTHETIC FLUID FIBRINOID DEPOSITS WITHIN PERIPROSTHETIC CAPSULE RIGHT BREAST PHYSICIAN ALSO STATED PT UNDERWENT BILATERAL TOTAL CAPSULECTOMY IMPLANT REMOVAL YEAR PT DISEASE FREE CT PET SCANS INCLUDING RECENT SCAN SHOW SIGNS LYMPHOMA EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
5904549|53036937|D|1||PHYSICIAN REPORTED RIGHT BREAST SWOLLEN FIRM SENSITIVE DEEP PALPATION PHYSICIAN ALSO STATED ANAPLASTIC LARGE CELL LYMPHOMA FOUND PERI PROSTHETIC FLUID FIBRINOID DEPOSITS WITHIN PERIPROSTHETIC CAPSULE RIGHT BREAST PHYSICIAN ALSO STATED PT UNDERWENT BILATERAL TOTAL CAPSULECTOMY IMPLANT REMOVAL YEAR PT DISEASE FREE CT PET SCANS INCLUDING RECENT SCAN SHOW SIGNS LYMPHOMA EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
5904549|59237866|D|1||ADDITIONAL INFORMATION PATHOLOGY REPORTS SPECIFIES FIBRINOID MATERIAL NEXT PROSTHESIS TESTED CD30+ ALK- CONFIRMED CASE ALCL CAPTURED LYMPHOMA-ALCL|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
5884313|52381107|D|1||REPORTED EVENTS FOUND WITHIN FOLLOWING ARTICLE CANCER RISK BREAST IMPLANTS 10 TIMES HIGHER FIRST FEARED SHOCK WARNING SURGEONS  ONE BRITISH SURVIVOR RELIVES ORDEAL PATIENT REPORTED DISCOVERED LUMP SIZE 5P PIECE TOP RIGHT BREAST NEAR CLEAVAGE PATIENT REPORTED DIAGNOSIS ALCL VIA ULTRASOUND SCAN NEEDLE BIOPSY PATIENT RECEIVED CHEMOTHERAPY TREATMENT PATIENT ALSO REPORTED RIGHT BREAST SWOLLEN FELT BURNING HOT DEVELOPED RED ITCHY RASH BECAME UNABLE RAISE RIGHT ARM BRUSH HAIR TEETH COULD LONGER COOK DRIVE PATIENT RECEIVED SEVEN CYCLES BRENTUXIMAB DEVICE REMOVED PATIENT TOLD REMAINING CANCER EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/17/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5884313|52381106|N|1||FOLLOW-UP POSSIBLE CASE DEVICE HISTORY RECORD REQUESTED DEVICE INFORMATION UNKNOWN DEVICE LABELING ADDRESSES REPORTED EVENTS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/17/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5991152|58278327|D|1||GOVERNING BODY REPORTED RIGHT SIDE Â¿CLINICAL SIGNS SIGNS MRI ULTRASOUND ENLARGEMENT LYMPH NODES ANAPLASTIC LARGE CELL LYMPHOMA ALK- SPECIFIED DISCOVERING ANAPLASTIC LYMPHOMA AXILLARY LYMPHADENOPATHY ALCL DIAGNOSIS RECEIVED MAY 2016 TREATMENT INCLUDES EXPLANTATION BREAST PROSTHESIS CAPSULECTOMY PERFORMED ANATOMOPATHOLOGIC RESULT MATERIAL KEPT PATIENT RECEIVE SPECIFIC TREATMENT CHEMOTHERAPY APPROVAL COLLEGIAL DECISION MULTIDISCIPLINARY MEETING|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF135-420|09/30/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2334015|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5991152|56059751|N|1||MEDWATCH SENT FDA 09302016 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY REVIEW DHR SUMMARY REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED THREE DEVICES SCRAPPED ASSEMBLY PROCESS RELATED REPORTED EVENT  ADDITION DHR SHELL RUNS NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF135-420|09/30/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2334015|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5991152|56059752|D|1||GOVERNING BODY REPORTED RIGHT SIDE CLINICAL SIGNS SIGNS MRI ULTRASOUND ENLARGEMENT LYMPH NODES ANAPLASTIC LARGE CELL LYMPHOMA ALK- SPECIFIED DISCOVERING ANAPLASTIC LYMPHOMA AXILLARY LYMPHADENOPATHY ALCL DIAGNOSIS RECEIVED B6 2016 TREATMENT INCLUDES EXPLANTATION BREAST PROSTHESIS CAPSULECTOMY PERFORMED ANATOMOPATHOLOGIC RESULT MATERIAL KEPT PATIENT RECEIVE SPECIFIC TREATMENT CHEMOTHERAPY APPROVAL COLLEGIAL DECISION MULTIDISCIPLINARY MEETING|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF135-420|09/30/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2334015|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5595588|43273265|D|1||HEALTH PROFESSIONAL REPORTED PATIENT PRESENTED LATE ONSET SEROMA TESTED POSITIVE ALCL PATIENT IMPLANT REMOVED TOTAL CAPSULECTOMY RIGHT SIDE IMPLANT CAPSULE SENT HISTOLOGY PATHOLOGICAL MARKERS CONFIRM ALCL YET RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF140-535|04/21/2016||||N|R||0HP|FTR|1.0|09/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||165721|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5595588|43273124|N|1||EVENTS SEROMA-LATE LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLY CAUSE EVENT DEVICE RETURNED DEVICE LABELING ADDRESSES LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF140-535|04/21/2016||||N|R||0HP|FTR|1.0|09/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||165721|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6191866|64757804|N|1||EVENTS ALCL LYMPHOMA CAPSULAR CONTRACTURE SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVALHEMATOMASEROMA BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWINGSEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT RUPTURE ONE COMMON REASONS REOPERATION|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6191866|64757845|D|1||ADDITIONAL INFORMATION RECEIVED HEALTHCARE PROFESSIONAL STATED PATIENT Â¿PRESENTED LATE ONSET SEROMA LEFT BREAST ASPIRATE CONFIRMED ATYPICAL CELLS STRONGLY POSITIVE CD30 CELLS ALK NEGATIVE EMA POSITIVE DEVICE EXPLANTED CAPSULECTOMY PERFORMED LEFT SIDE SHOWED SMALL CLUSTERS ATYPICAL CELLS SURFACE MATERIAL CAPSULE POSITIVE CD30 EMA CD4 INVASION EFFUSION ASSOCIATED ALCLÂ¿ PATHOLOGICAL MARKERS RECEIVED CONFIRMING ALCL PATIENT ADDITIONALLY EXPERIENCED CAPSULAR CONTRACTURE BAKER GRADE III MEDWATCH REPRESENTS LEFT SIDE SEE MFR  9617229-2016-00248 RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6191866|67358310|N|1||DEVIATION B6 ALLERGAN INITIATED INVESTIGATION LATE REPORT ADDITIONAL DATA MODEL LOT  DEVICE AVAILABLE EVALUATION DEVICE EVALUATED BT MFR DEVICE MANUFACTURE DATE EVALUATION CODES EVALUATION DEVICE FOUND DEVICE RELATED EVENTS SEROMA CAPSULAR CONTRACTURE LYMPHOMA RECEIVED JANUARY 06 2017 LOT NUMBER 2029824 VISUAL ANALYSIS RETURNED DEVICE IDENTIFIED BROWN PARTICLES SHELL DEVICE DEFORMATION WEIGHT SPEC MICROSCOPIC ANALYSIS PERFORMED IDENTIFIED TWO OPENINGS RADIUS DISPLAYING STRIATED EDGE OPENINGS CONSISTENT USE SURGICAL TOOL NON-PENETRATED NICKS ADDITIONALLY PRESENT BASED DEVICE ANALYSIS FINAL ASSESSMENT TWO OPENINGS DUE SURGICAL DAMAGE SURGICAL TOOL LIKE SCRATCH DEVICE HISTORY RECORD DHR SUMMARY BASED RISK ANALYSIS PERFORMED AE TERM CODE LYMPHOMA-ALCL SELECTED ANALYSIS REPRESENTS HIGHEST RISK REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6191866|62906213|D|1||HEALTHCARE PROFESSIONAL REPORTED BREAST IMPLANTS REMOVED TODAY DUE ALCL SIDE SPECIFIED MEDWATCH REPRESENTS LEFT SIDE SEE MFR  9617229-2016-00248 RIGHT SIDE PATHOLOGICAL MARKERS CONFIRMING ALK- CD30+ RECEIVED EVENT Â¿DUE ALCLÂ¿ REPORTED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6191866|62906212|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6191866|67358311|D|1||HEALTHCARE PROFESSIONAL REPORTED BREAST IMPLANTS REMOVED TODAY DUE ALCL SIDE SPECIFIED PATHOLOGICAL MARKERS CONFIRMING ALK- CD30+ RECEIVED EVENT Â¿DUE ALCLÂ¿ REPORTED LYMPHOMA ADDITIONAL INFORMATION RECEIVED HEALTHCARE PROFESSIONAL STATED PATIENT Â¿PRESENTED LATE ONSET SEROMA LEFT BREAST ASPIRATE CONFIRMED ATYPICAL CELLS STRONGLY POSITIVE CD30 CELLS ALK NEGATIVE EMA POSITIVE DEVICE EXPLANTED CAPSULECTOMY PERFORMED LEFT SIDE SHOWED SMALL CLUSTERS ATYPICAL CELLS SURFACE MATERIAL CAPSULE POSITIVE CD30 EMA CD4 INVASION EFFUSION ASSOCIATED ALCLÂ¿ PATHOLOGICAL MARKERS RECEIVED CONFIRMING ALCL PATIENT ADDITIONALLY EXPERIENCED CAPSULAR CONTRACTURE BAKER GRADE III MEDWATCH REPRESENTS LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6191882|62905365|D|1||HEALTHCARE PROFESSIONAL REPORTED BREAST IMPLANTS REMOVED TODAY DUE ALCL SIDE SPECIFIED MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00212 LEFT SIDE PATHOLOGICAL MARKERS CONFIRMING ALK- CD30+ RECEIVED EVENT Â¿DUE ALCLÂ¿ REPORTED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF145-490|12/20/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6191882|65043306|N|1||CLARIFICATION REPORTED EVENT COMPLAINT RIGHT SIDE DEVICE INITIAL REPORT ALCL AFFECTED SIDE PROVIDED HEALTHCARE PROFESSIONAL CLARIFIED RIGHT SIDE UNAFFECTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF145-490|12/20/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6191882|65043307|D|1||ADDITIONAL INFORMATION RECEIVED HEALTHCARE PROFESSIONAL Â¿THE CONTRALATERAL IMPLANT ALSO REMOVED LINE PATIENTÂ¿S WISHES PER GUIDANCE MANAGEMENT ALCL CIRCUMSTANCE SIDE RIGHT SIDE HOWEVER UNAFFECTED DEVICE DISPOSEDÂ¿ COMPLAINT RIGHT SIDE DEVICE MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00212 LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF145-490|12/20/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6191882|62905244|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF145-490|12/20/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5896385|52760206|N|1||MEDWATCH SENT FDA 08232016 DEVICE RETURNED DEVICE ANALYSIS COMPLETE FINDINGS SENT FOLLOW-UP REPORT EVENTS INFLAMMATION LYMPHOMA SWELLING PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING PRODUCT INFORMATION REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES REPORTED EVENTS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|08/23/2016||08/23/2016|DA|R|Y||0HP|FTR|1.0|02/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||384466|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5719833|47208525|D|1||PATIENT REPORTED SEROMA RIGHT BREAST PARTIAL CAPSULECTOMY  CAPSULOTOMY EXCHANGE PERFORMED SURGICAL LOG REPORTS 600 CC SEROUS FLUID PRESENT RIGHT SEROLOGY PENDING PATHOLOGY + ALCL PETCT SCAN STATES FAINT ACTIVITY AFFILIATED RIGHT AXILLARY NODES RELATIVELY LESS CONCERN POTENTIALLY INFLAMMATORYREACTIVE CYTOLOGY REPORT STATES RIGHT BREAST FLUID HIGHLY ATYPICAL LYMPHOCYTES PRESENT CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE COMMENT HIGHLY ATYPICAL LYMPHOCYTES DEMONSTRATES STAINING CD30 NEGATIVE ALK-1 IMMUNOHISTOCHEMISTRY PROFILE CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/13/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2594775|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5719833|47208524|N|1||MEDWATCH SENT FDA 06132016 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS KNOWN DEVICE RETURNED PATIENT DECLINED PERMISSION CONTACT HEALTH PROFESSIONAL TIME DEVICE HISTORY RECORD REPORTS REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUNS NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/13/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2594775|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6145514|64146442|N|1||B4 DEVICE ANALYZED ALLERGAN B4 VISUAL ANALYSIS RETURNED DEVICE IDENTIFIED FLAT CREASES WHITE PARTICLES DEVICE OUTER SURFACE ONE CURVED OPENING POSTERIOR LEAK TEST PERFORMED IDENTIFIED OPENING MICROSCOPIC ANALYSIS PERFORMED IDENTIFY ONE OPENING STRIATED CURVED ASSESSED SURGICAL DAMAGE PARTIAL DELAMINATION PLUG STRAP DISK SHELL DUE ADHESIVE FAILURE FILL INSPECTION PERFORMED IDENTIFIED BLOCKAGE VALVE BASED DEVICE ANALYSIS FINAL ASSESSMENT ONE OPENING STRIATED CURVED ASSESSED SURGICAL DAMAGE PARTIAL DELAMINATION PLUG STRAP DISK SHELL DUE ADHESIVE FAILURE DEVICE HISTORY RECORD DHR IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS EVENTS LYMPHOMA-ALCL CAPSULAR CONTRACTURE INFLAMMATION PAIN PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST FORMATION FIBROUS TISSUE AROUND IMPLANTED DEVICE NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY ONE COMMON REASONS REOPERATION CAUSE CAPSULAR CONTRACTURE UNKNOWN HOWEVER LIKELY MULTIFACTORIAL MAY COMMON FOLLOWING INFECTION HAEMATOMA SEROMA CONTRACTURE DEVELOPS VARYING DEGREES UNILATERALLY BILATERALLY MAY OCCUR WITHIN WEEKS YEARS SURGERY CONTRACTURE FIBROUS CAPSULAR TISSUE SURROUNDING IMPLANT MAY CAUSE RANGE SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES CONSIDERED CLINICALLY SIGNIFICANT MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT CORRECTIVE SURGICAL PROCEDURES TREAT CAPSULAR CONTRACTURE EXTERNAL COMPRESSION MASSAGE MAY RESULT IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA Â¿AS EXPECTED FOLLOWING INVASIVE SURGICAL PROCEDURE PAIN VARYING INTENSITY DURATION MAY OCCUR FOLLOWING IMPLANTATION ADDITION IMPROPER PLACEMENT SURGICAL TECHNIQUE CAPSULAR CONTRACTURE MAY RESULT PAIN ASSOCIATED NERVE ENTRAPMENT INTERFERENCE MUSCLE MOTION UNEXPLAINED PAIN MUST PROMPTLY INVESTIGATEDÂ¿|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/09/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013310|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6145514|64146443|D|1||PHYSICIAN REPORTED FIRST LEFT BREAST SEROMA OCCURRING B6 2014 SECOND LEFT BREAST SEROMA OCCURRING B6 2016 RECEIVED ADDITIONAL INFORMATION PHYSICIAN REPORTING ANALYSIS SLIGHTLY CLOUDY ORANGE FLUID RESULTED LARGE CELLS TESTING CD30+ ALK- PHYSICIAN ADDITIONALLY REPORTED IMMUNOHISTOCHEMISTRY TUMOR CELLS STRICTLY LIMITED FIBRIN COATING CD30+ ALK- EVENT CONFIRMED ALCL DIAGNOSIS ALCL OCCURRED B6 2016 PHYSICIAN ADDITIONALLY REPORTED INFLAMMATORY COMPONENTS LEFT SIDE LEFT SIDE PAIN CAPSULAR CONTRACTURE BAKER GRADE II MEDWATCH LEFT SIDE DEVICE SEE MANUFACTURER REPORT  9617229-2016-00174 RIGHT SIDE REPORT|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/09/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013310|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6145514|61451047|N|1||DEVICE CURRENTLY RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/09/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013310|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5531532|41335749|N|1||DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-550|03/29/2016||04/13/2016|DA|R|Y||0HP|FTR|1.0|02/20/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1235003|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5690994|49507692|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DIAGNOSED ALCL DISEASE ASSOCIATED BREAST DEVICE SIDE UNSPECIFIED EXPLANT CAPSULECTOMY PERFORMED EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110391|06/01/2016|||DA|N|R||0HP|FTR|1.0|03/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||201218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5690994|46271112|N|1||MEDWATCH SENT FDA 06012016 EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT KNOWN DEVICE RETURNED PATIENT INFORMATION PROVIDED DEVICE LABELING ADDRESSES LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110391|06/01/2016|||DA|N|R||0HP|FTR|1.0|03/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||201218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5690994|46271113|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DIAGNOSED ALCL DISEASE ASSOCIATED BREAST DEVICE SIDE UNSPECIFIED EXPLANT CAPSULECTOMY PERFORMED EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110391|06/01/2016|||DA|N|R||0HP|FTR|1.0|03/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||201218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5956972|54992703|D|1||PHYSICIAN REPORTS PATIENT UNDERWENT DELAYED RECONSTRUCTION PROBLEMS 2015 PATIENT DEVELOPED SPONTANEOUS HEAMO-SEROUS FLUID COLLECTION AROUND IMPLANT FILE LEFT SIDE DEVICE REMOVED REPLACED REPORT STATES IMPLANT APPEARED PREDOMINANTLY INTACT TINY IRREGULARITY IDENTIFIED IMPLANT THEREFORE REPLACED LARGE BLOOD STAINED FLUID COLLECTION RECURRED 2016 LEADING EXPLORATION FIBRINOUS TISSUE REMOVED SENT HISTOLOGY DIAGNOSIS ALCL CONFIRMED EXPERT HAEMATOLOGY PANEL PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED THEREFORE EVENT CAPTURED LYMPHOMA|STYLE 150 EXPANDABLE BREAST IMPLANT|27-150496|09/16/2016|||DA|N|R||0HP|FTR|1.0|02/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1205583|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5956972|61427645|D|1||COMPLAINT DEVICE EVENTS SEROMA ALCL REPORTED SUBSEQUENT DEVICE MANUFACTURER REPORT  9617229-2016-00170|STYLE 150 EXPANDABLE BREAST IMPLANT|27-150496|09/16/2016|||DA|N|R||0HP|FTR|1.0|02/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1205583|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5956972|54992702|N|1||EVENTS LYMPHOMA SEROMA-LATE PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE RETURNED DISCARDED DEVICE LABELING ADDRESSES LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST DEVICE HISTORY RECORD STATES REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS  BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT ORACLE VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUNS NUMBER B4 IDENTIFY ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ERIR NUMBER B4 REFERENCED DHR RECORD SHELL RUN NUMBER B4 ER RELATED TAPERING PROCESS HOWEVER IMPACT DEVICES BASED REGULATORY REQUIREMENTS ERIR NUMBER B4 REFERENCED DHR RECORD SHELL RUN NUMBER B4 ER RELATED TAPERING PROCESS HOWEVER IMPACT DEVICES BASED REGULATORY REQUIREMENTS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS|STYLE 150 EXPANDABLE BREAST IMPLANT|27-150496|09/16/2016|||DA|N|R||0HP|FTR|1.0|02/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1205583|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6180550|62543961|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/16/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6180550|62543962|D|1||PHYSICIAN REPORTED PATIENT EXPERIENCED COMPLICATIONS 11 YEARS BREAST IMPLANTATION PHYSICIAN EXPLANTED DEVICE SENT SAMPLE TESTING SAMPLE TESTED POSITIVE ALCL SIDE UNKNOWN TIME ALCL CONFIRMED PATHOLOGICAL MARKERS CD30+ ALK- ALLERGAN RECEIVES CONFIRMATION MARKERS REPRESENTED TERM CODE LYMPHOMA|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/16/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6177211|62456167|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL SEROMA LUMP ERYTHEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6177211|62456168|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 OLD PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN CHART ADDITIONALLY PROVIDES PATIENT EXPERIENCED LEFT MASS SEROMA Â¿DISRUPTED IMPLANTÂ¿ ARTICLE ADDITIONALLY REPORTS ERYTHEMATOUS SKIN ERUPTION CASE TREATMENT REPORTED CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE EXPLANT REPORTED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5708519|46870798|D|1||AUTHORS REPORTED CASE ONE PATIENT FOLLOWING JOURNAL ARTICLE BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA CASE REPORT LITERATURE REVIEW AUTHORS REPORTED  PATIENT PRESENTED PAIN FIRMNESS PATIENTS RIGHT BREAST SEVERAL WEEKS PATIENT UNDERGONE BREAST AUGMENTATION SALINE IMPLANTS 16 YEARS PRIOR PRESENTATION ROUTINE LABORATORY WORK REVEALED ABNORMALITIES PATIENT REFERRED PATIENTS PRIMARY CARE PHYSICIAN MRI RIGHT BREAST MRI DEMONSTRATED LARGE FLUID COLLECTION SURROUNDING RIGHT BREAST IMPLANT ASSOCIATED SIGNIFICANT ENHANCEMENT SUSPICIOUS MASS LESION AXILLARY ADENOPATHY IMPLANT INTACT ULTRASOUND PERFORMED DEMONSTRATED SIMPLE FLUID COLLECTION SURROUNDING IMPLANT MASS IDENTIFIED ULTRASOUND-GUIDED FLUID ASPIRATION PERFORMED YIELDED APPROXIMATELY 20 CUBIC CENTIMETERS YELLOW SEROUS FLUID PATHOLOGY DEMONSTRATED SEROMA-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA RIGHT BREAST ANAPLASTIC LYMPHOMA KINASE ALK GENE TESTING NEGATIVE PATIENT UNDERWENT PETCT REVEALED METASTATIC DISEASE PATIENT TAKEN SURGERY IMPLANTS REMOVED PATIENT RECEIVE NEOADJUVANT ADJUVANT CHEMOTHERAPY RADIATION THERAPY PATIENT DISEASE-FREE EVIDENCE DISEASE RECURRENCE THREE YEARS CD30 RESULTS PROVIDED THEREFORE REPORTED CASE ALCL CONSIDERED SUSPECTED CASE CAPTURED LYMPHOMA MANUFACTURER DEVICE UNKNOWN|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5708519|46870797|N|1||MEDWATCH SENT FDA 06092016 FULL CITATION ARTICLE LETTER H ROP B EDISON N ET AL MARCH 26 2016 BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA CASE REPORT LITERATURE REVIEW  CUREUS 83 E546 DOI 107759CUREUS546 REQUEST INFORMATION REGARDING EVENT DATES PRODUCT INFORMATION PRODUCT RETURN PATIENT DETAILS MADE ALLERGAN RECEIVED RESPONSE CORRESPONDING AUTHOR ADDITIONAL ATTEMPTS MADE B4 EVENTS SEROMA FIRMNESS ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTER EVENT ASKED RETURN PRODUCT ANALYSIS ALLERGAN RECEIVED PRODUCT TIME THEREFORE ANALYSIS TESTING DONE DEVICE QUESTION MANUFACTURED ALLERGAN FOLLOWING DEVICE LABELING WOULD APPLY PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5788476|49361321|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT IMPLANT DATE DEVICE RETURN STATUS KNOWN TIME FOLLOW-UP CONDUCTED DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5788476|53800763|D|1||HEALTH PROFESSIONAL REPORTED BREAST VOLUME INCREASE 5 YEARS REPLACEMENT PART MAMMARY MASTECTOMY PERIPROSTHETIC EXTRAVASATION REMOVAL PROSTHESIS + TOTAL CAPSULECTOMY ANAPATH RESULTS ALCL CONFIRMED SIDE SPECIFIED INFORMATION RECEIVED REPORTS INCREASE VOLUME LEFT BREAST EFFUSION DISCOVERED VIA MRI WITHOUT PROSTHETIC LEAK WITHOUT REDNESS PAIN FEVER IMPLANT REMOVAL TOTAL CAPSULECTOMY IMPLANT FOUND INTACT SAMPLE TAKEN DIAGNOSIS ALCL AIM CD30+ ALK- DONE HISTOLOGICAL ANALYSIS CONFIRMED NETWORK LYMPHOPATH PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5788476|51513752|D|1||INFORMATION RECEIVED REPORTS INCREASE VOLUME LEFT BREAST EFFUSION DISCOVERED VIA MRI WITHOUT PROSTHETIC LEAK WITHOUT REDNESS PAIN FEVER IMPLANT REMOVAL TOTAL CAPSULECTOMIE IMPLANT FOUND INTACT SAMPLE TAKEN DIAGNOSIS ALCL AIM CD30+ ALK- DONE HISTOLOGICAL ANALYSIS CONFIRMED NETWORK LYMPHOPATH PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5788476|49361322|D|1||HEALTH PROFESSIONAL REPORTED BREAST VOLUME INCREASE 5 YEARS REPLACEMENT PART MAMMARY MASTECTOMY PERIPROSTHETIC EXTRAVASATION REMOVAL PROSTHESIS + TOTAL CAPSULECTOMY ANAPATH RESULTS ALCL CONFIRMED SIDE SPECIFIED PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5620649|49979256|D|1||EXPLANTING PHYSICIAN REPORTED PATIENT TREATED LATE SEROMA ANAPLASTIC LARGE CELL LYMPHOMA ALCL CONTRALATERAL SIDE FINE NEEDLE ASPIRATION BIOPSY CONTRALATERAL SIDE REVEALED FOLLOWING ADDITIONAL DIAGNOSIS CYTOLOGIC FINDINGS COMPATIBLE LYMPH NODE INVOLVEMENT LYMPHOPROLIFERATIVE PROCESS B4-B6 PROBABLY HODGKINS LYMPHOMA HODGKINS LYMPHOMA SYSTEMIC DISEASE SIDE-SPECIFIC EVENT DIAGNOSTIC TESTING REVEALED NON SIDE-SPECIFIC EVENTS GOITER LUNG PARENCHYMA MODERATE PARASEPTAL CENTRILOBULAR EMPHYSEMA MIDDLE UPPER FIELDS LAMINAR ATELECTASIS APPROXIMATELY ONE MONTH LEFT SIDE ALCL DIAGNOSIS PATIENTS RIGHT SIDE DEVICE REMOVED PHYSICIAN NOTED SURGERY OBSERVED CLINICAL WORSENING PATIENT RESPIRATORY FAILURE SECONDARY LEFT PLEURAL EFFUSION RESULTING ADMISSION ICU THORACIC DRAINAGE RECURRENT CHEST TUBE DRAINAGE REQUIRED 3 OCCASIONS PATIENTS FIRST STAY ICU PATIENT GOES FIRST FLOOR RECEIVES FIRST CYCLE CHEMOTHERAPY SHOWING GRADE IV NEUTROPENIA DIARRHOEA SECOND CHEMOTHERAPY PATIENT SHOWS MARKED CLINICAL DETERIORATION SUSPICIOUS TUMOUR LYSIS SYNDROME METABOLIC ACIDOSIS RENAL FAILURE RESULTS SECOND ADMISSION ICU PATIENT DIED APPROXIMATELY FIVE WEEKS IMPLANT REMOVAL MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00035 LEFT SIDE|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|04/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||396184|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5620649|44064473|D|1||EXPLANTING PHYSICIAN REPORTED PATIENT TREATED LATE SEROMA ANAPLASTIC LARGE CELL LYMPHOMA ALCL CONTRALATERAL SIDE FINE NEEDLE ASPIRATION BIOPSY CONTRALATERAL SIDE REVEALED FOLLOWING ADDITIONAL DIAGNOSIS CYTOLOGIC FINDINGS COMPATIBLE LYMPH NODE INVOLVEMENT LYMPHOPROLIFERATIVE PROCESS CD30-POSITIVE PROBABLY HODGKINS LYMPHOMA HODGKINS LYMPHOMA SYSTEMIC DISEASE SIDE-SPECIFIC EVENT DIAGNOSTIC TESTING REVEALED NON SIDE-SPECIFIC EVENTS GOITER Â¿LUNG PARENCHYMA MODERATE PARASEPTAL CENTRILOLOBULAR EMPHYSEMA MIDDLE UPPER FIELDSÂ¿ Â¿LAMINAR ATELECTASISÂ¿ APPROXIMATELY ONE MONTH LEFT SIDE ALCL DIAGNOSIS PATIENTS RIGHT SIDE DEVICE REMOVED PHYSICIAN NOTED SURGERY OBSERVED CLINICAL WORSENING PATIENT RESPIRATORY FAILURE SECONDARY LEFT PLEURAL EFFUSION RESULTING ADMISSION ICU THORACIC DRAINAGE RECURRENT CHEST TUBE DRAINAGE REQUIRED 3 OCCASIONS PATIENTS FIRST STAY ICU PATIENT GOES FIRST FLOOR RECEIVES FIRST CYCLE CHEMOTHERAPY SHOWING GRADE IV NEUTROPENIA DIARRHOEA SECOND CHEMOTHERAPY PATIENT SHOWS MARKED CLINICAL DETERIORATION SUSPICIOUS TUMOUR LYSIS SYNDROME METABOLIC ACIDOSIS RENAL FAILURE RESULTS SECOND ADMISSION ICU PATIENT DIED APPROXIMATELY FIVE WEEKS IMPLANT REMOVAL MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00035 LEFT SIDE|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|04/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||396184|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176804|62446183|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA TREATMENT REPORTED IMPLANT REMOVAL FOLLOW-UP FOUND EVIDENCE DISEASE MEDWATCH LEFT SIDE MFR 9617229-2016-00241 REPRESENTS RIGHT SIDE DEVICE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176804|62446182|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6064624|62738626|D|1||HEALTHCARE PROFESSIONAL REPORTED Â¿PATIENT CAME CLINIC B6 2016 RIGHT-SIDE SEROMA FINE NEEDLE ASPIRATION FNA B6 2016 FLOW CYTOMETRY RULE BIA-ALCL INADEQUATE SAMPLE B6 2016 FNA REPEATED B6 2016 CYTOLOGY FNA POSITIVE ALCLÂ¿ EVENTS INVOLVE NATRELLE IMPLANT PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL RECEIVED EVENT CYTOLOGY FNA POSITIVE ALCL CAPTURED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX140-520|10/28/2016|||DA|*|*||0HP|FTR|1.0|01/29/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1699897|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6064624|58710791|N|1||EVENTS LYMPHOMA SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX140-520|10/28/2016|||DA|*|*||0HP|FTR|1.0|01/29/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1699897|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6064624|58710792|D|1||HEALTHCARE PROFESSIONAL REPORTED PATIENT CAME CLINIC B6 2016 RIGHT-SIDE SEROMA FINE NEEDLE ASPIRATION FNA B6 2016 FLOW CYTOMETRY RULE BIA-ALCL INADEQUATE SAMPLE FNA REPEATED MONTH B6 2016 CYTOLOGY FNA POSITIVE ALCL EVENTS INVOLVE NATRELLE IMPLANT PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL RECEIVED EVENT CYTOLOGY FNA POSITIVE ALCL CAPTURED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX140-520|10/28/2016|||DA|*|*||0HP|FTR|1.0|01/29/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1699897|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6135580|61143723|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-700|11/30/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6135580|61143724|D|1||HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE METASTATIC BIA ALCL PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT REPORTED LYMPHOMA|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-700|11/30/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6148888|61547076|D|1||REVIEWED JOURNAL ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA PATIENT LI-FRAUMENI SYNDROMEÂ¿ Â¿WE REPORT UNIQUE CASE BIA-ALCL ARISING PATIENT LIÂ¿FRAUMENI SYNDROME GERMLINE MUTATIONS TP53 CASE NOTABLE SHORT INTERVAL 3 YEARS PLACEMENT IMPLANTS DEVELOPMENT ALCL CAPSULECTOMY IMPLANT REMOVAL PATIENT RECURRENCE BIA-ALCL CLINICAL FOLLOW-UP 7 YEARSÂ¿ ARTICLE STATES Â¿THE PATIENT NOTED ASYMMETRIC SWELLING RIGHT BREAST FINE NEEDLE ASPIRATION BREAST SEROMA PERFORMED LEADING DIAGNOSIS BIAALCLÂ¿ SAMPLE POSITIVE CD30 NEGATIVE ALK ARTICLE ALSO STATES SUBSEQUENT YEARS PATIENT DIAGNOSED ADRENOCORTICAL CARCINOMASUBSEQUENTLY DEVELOPED METASTATIC ADRENOCORTICAL CARCINOMA LIVER LUNG MANUFACTURER DEVICE UNKNOWN MEDWATCH RIGHT SIDE DEVICE SEE MANUFACTURER REPORT  9617229-2016-00207 LEFT SIDE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/06/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6148888|61547075|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA PATIENT LI-FRAUMENI SYNDROMEÂ¿ YI-SHAN LEE ARMANDO FILIE DIANE ARTHUR ANTONIO FOJO ELAINE JAFFE PUBLISHED HISTOPATHOLOGY 67 923Â¿935 2015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE SEROMA CANCER LYMPHOMA-ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/06/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5820703|50386638|N|1||MEDWATCH SENT FDA 07252016 B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT FOLLOW PERFORMED OBTAIN DEVICE MANUFACTURER SERIAL NUMBER LOT NUMBER IMPLANT EXPLANT DATE IMPLANTINGEXPLANTING PHYSICIAN PATIENT NAME PATIENT DATE BIRTH DEVICE RETURN STATUS DEVICE RELATIONSHIP REPORTED EVENTS DEVICE HISTORY RECORD UNAVAILABLE DEVICE INFORMATION UNKNOWN DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MX-410520|07/25/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5820703|50386639|D|1||FOLLOWING CASE RECEIVED ARTICLE TITLED SKIN INVOLVEMENT FIRST MANIFESTATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ARTICLE STATES PRESENT NEW CASE BREAST IMPLANT-ASSOCIATED ALCL CUTANEOUS LESIONS MIMICKING CUTANEOUS METASTASES POORLY DIFFERENTIATED BREAST ADENOCARCINOMA DETAILS INCLUDE SEVERAL CUTANEOUS NODULES 2 MONTHSÂ¿ DURATION RIGHT BREASTÂ¿RADIOGRAPHIC FOLLOW-UP REVEALED RIGHT SUPRACLAVICULAR MASS MULTIPLE ENLARGED LYMPH NODES PATIENT UNDERWENT CORE NEEDLE BIOPSY MASS REVEALED EXTENSIVE NECROSIS PATIENT TREATED CHEMOTHERAPY RADIATION THERAPY IMPROVEMENTS NOTED SECOND ROUND CHEMOTHERAPY PRESCRIBED DISEASE PROGRESSED Â¿WITH PROGRESSIVE HARDENING RIGHT BREAST APPEARANCE SEVERAL CUTANEOUS LESIONSTHERE ALSO SEVERAL POORLY CIRCUMSCRIBED ERYTHEMATOUS INDURATED PAPULESÂ¿THE PATIENT REPORTED MODERATE PAINÂ¿THE CT SCAN SHOWED LARGE AMOUNT PERI-IMPLANT FLUIDÂ¿ TESTED CELLS Â¿WERE CD15 CD30 POSITIVE ALK-1 NEGATIVEÂ¿ PATIENT DIAGNOSED ALCL ASSOCIATED BREAST IMPLANT CAPSULE Â¿PATIENT STARTED CHOP THERAPY BREAST IMPLANT REMOVED PATIENT PRESENTED FEBRILE NEUTROPENIA TREATMENT FINALLY PATIENT DIED SEPTIC SHOCKÂ¿ AUTOPSY REQUESTED FAMILY REFUSED MANUFACTURER DEVICE UNKNOWN MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00093 LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MX-410520|07/25/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5820703|55107988|D|1||FOLLOWING CASE RECEIVED ARTICLE TITLED SKIN INVOLVEMENT FIRST MANIFESTATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ARTICLE STATES PRESENT NEW CASE BREAST IMPLANT-ASSOCIATED ALCL CUTANEOUS LESIONS MIMICKING CUTANEOUS METASTASES POORLY DIFFERENTIATED BREAST ADENOCARCINOMA DETAILS INCLUDE SEVERAL CUTANEOUS NODULES 2 MONTHSÂ¿ DURATION RIGHT BREASTÂ¿RADIOGRAPHIC FOLLOW-UP REVEALED RIGHT SUPRACLAVICULAR MASS MULTIPLE ENLARGED LYMPH NODES PATIENT UNDERWENT CORE NEEDLE BIOPSY MASS REVEALED EXTENSIVE NECROSIS PATIENT TREATED CHEMOTHERAPY RADIATION THERAPY IMPROVEMENTS NOTED SECOND ROUND CHEMOTHERAPY PRESCRIBED DISEASE PROGRESSED Â¿WITH PROGRESSIVE HARDENING RIGHT BREAST APPEARANCE SEVERAL CUTANEOUS LESIONSTHERE ALSO SEVERAL POORLY CIRCUMSCRIBED ERYTHEMATOUS INDURATED PAPULESÂ¿THE PATIENT REPORTED MODERATE PAINÂ¿THE CT SCAN SHOWED LARGE AMOUNT PERI-IMPLANT FLUIDÂ¿  TESTED CELLS Â¿WERE CD15 CD30 POSITIVE ALK-1 NEGATIVEÂ¿ PATIENT DIAGNOSED ALCL ASSOCIATED BREAST IMPLANT CAPSULE Â¿PATIENT STARTED CHOP THERAPY BREAST IMPLANT REMOVED PATIENT PRESENTED FEBRILE NEUTROPENIA TREATMENT FINALLY PATIENT DIED SEPTIC SHOCKÂ¿ AUTOPSY REQUESTED FAMILY REFUSED MANUFACTURER DEVICE UNKNOWN MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00093 LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MX-410520|07/25/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5820703|57630105|D|1||ADDITIONAL INFORMATION B6 2003 PATIENT IMPLANTED NATRELLE BREAST IMPLANT 410MX 140-520 GEL TEXTURED SIZE UNKNOWN IMPLANTATION SITE UNKNOWN PATIENT EXPERIENCED ENLARGED RIGHT BREAST PATIENT DIAGNOSED RIGHT SIDE ALCL B6 2014 PATIENT RECEIVED FIRST CHOP CYCLE WITHOUT RESPONSE B6 2014 ASHAP CHEMOTHERAPY B6 2014 X 3 CYCLES DEVICE EXPLANTED B6 2014 IMPLANT PRESENT 10 YEARS 9 MONTHS ETOPOSIDE + CISPLATIN B6 2014 X 3 CYCLES TREATMENT SUSPENDED DUE NEUTROPENIA B6 2014 PATIENT RECEIVED 1 CYCLE BRENTUXIMAB PATIENT EXPERIENCED MULTI-ORGAN FAILURE DIED B6 2014 MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00093 LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MX-410520|07/25/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5761253|48540699|D|1||DIAGNOSED BREAST CANCER RIGHT BREAST B6 2010 CONTACTED BREAST CANCER SURGEON TOLD NEEDED MASTECTOMY SINCE 2 TUMORS DIFFERENT AREAS BREAST ALSO CONTACTED RECONSTRUCTIVEPLASTIC SURGEON AGREED IMPLANT PUT TIME SURGERY PLASTIC SURGEON PUT TISSUE EXPANDER THREE MONTHS B6 2011 ALLERGAN TEXTURED BREAST IMPLANT PUT STYLE IMPLANT APPROVED FDA YET SIGNED CONSENT FORM PART STUDY READ AGREEMENT THOROUGHLY TWO POSSIBLE RISKS INFECTION COMPARTMENT CONTRACTURE MENTION LYMPHOMA CANCER APPROXIMATELY 2 YEARS LATER FDA APPROVED STYLE IMPLANT STUDY ENDED B6 2016 RIGHT BREAST BECAME TIGHT HARD NEXT DAYS BECAME LARGER LARGER CONTACTED PLASTIC SURGEON ASKED TAKE PICTURE BREAST SEND SINCE TOWN TIME ORDERED ANTIBIOTIC MADE APPOINTMENT SEE FOLLOWING WEEK WENT SEE TOOK PICTURES TOLD PROBABLY INFECTION CONTINUE ANTIBIOTIC BREAST GOT BIGGER BIGGER SURGEON DECIDED REMOVE IMPLANT SURGERY TOOK TISSUE SAMPLE PUT NEW TEXTURED IMPLANT CLOSED INCISION B6 PATHOLOGY REPORT CAME BACK DIAGNOSIS ALCL CONFIRMED PET CT SCAN SURGEON SAID KNEW DOCTOR SPECIALIZED ALCL B6 HUSBAND FLEW B6 IMPLANT SURROUNDING SCAR TISSUE REMOVED SURGEONS AUTHORITY DISEASE ALSO RESEARCH DISEASE DONE TEAM SEEN DIAGNOSED CASES US TESTS DONE ULTRASOUND CHEST X-RAY SPOKE DOCTOR TOLD LYMPHOMA FLUID SURROUNDING IMPLANT SCAR TISSUE CAPSULE LYMPH NODES SURGERY B6 2016 INFORMED CANCER CELLS REMOVED CANCER FREE DECIDED SMOOTH SILICONE IMPLANT PUT SURGERY RATHER COME BACK LATER ADDITIONAL RECONSTRUCTION DOCTOR TOLD NONE ALCL CASES EVER INVOLVED SMOOTH IMPLANT ALSO AGREED PET CT SCAN EVERY 6 MONTHS SURE NEW CANCER CELLS|NATRELLE TEXTURED BREAST IMPLANT||06/27/2016||||N|*||I|FTR|1.0||BREAST IMPLANT|||||||ALLERGAN|||||||True
6176705|62451142|N|1||B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176705|62451143|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA DISRUPTED IMPLANT TREATMENT REPORTED IMPLANT REMOVAL RADIOTHERAPY B6 FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176730|62445769|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176730|62445770|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 YEAR-OLD PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA TREATMENT REPORTED IMPLANT REMOVAL FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176886|62453117|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 OLD PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED MASS SEROMA DISRUPTED IMPLANT TREATMENT REPORTED IMPLANT REMOVAL CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176886|62453116|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA SEROMA MASS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6146425|61492492|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA ARTICLE CITATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA CASE REPORT LITERATURE REVIEW LETTER HALEY ROP BAIYWO EDISON MICHELE N TURNER PATRICIA CUREUS 2016 VOL 8 3 PP E546 ELECTRONIC PUBLICATION DATE 26 MAR 2016 JOURNAL CODE 101596737 B4|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/05/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6146425|61492493|D|1||JOURNAL ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA CASE REPORT LITERATURE REVIEWÂ¿ ABSTRACT STATES Â¿PATIENT PRESENTED SEVERAL WEEKS PAIN FIRMNESS PATIENT RIGHT BREAST MRI ULTRASOUND DEMONSTRATED PERI-IMPLANT FLUID COLLECTION ULTRASOUND-GUIDED ASPIRATION REVEALED ANAPLASTIC LARGE CELL LYMPHOMA PATIENT TREATED IMPLANT REMOVAL ALONE REMISSION 3 YEARSÂ¿ PATHOLOGICAL MARKERS CONFIRM ALCL YET RECEIVED THEREFORE EVENT REPORTED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/05/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6176855|62446706|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6176855|62446707|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED LEFT SIDE TEXTURED SALINE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA TREATMENT REPORTED IMPLANT REMOVAL FOLLOW-UP FOUND EVIDENCE DISEASE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6176798|62453768|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176798|62453769|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA TREATMENT REPORTED IMPLANT REMOVAL FOLLOW-UP FOUND EVIDENCE DISEASE MEDWATCH RIGHT SIDE MFR 9617229-2016-00240 REPRESENTS LEFT SIDE DEVICE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6153200|61697779|D|1||LITERATURE ARTICLE Â¿COMPLETE SURGICAL EXCISION ESSENTIAL MANAGEMENT PATIENTS BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿87 PATIENTS BI-ALCL INCLUDING 50 PREVIOUSLY REPORTED LITERATURE 37 UNREPORTEDÂ¿ ARTICLE CONTINUES STATE Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMA BI-ALCL RARE TYPE T-CELL LYMPHOMA ARISES AROUND BREAST IMPLANTS OPTIMAL MANAGEMENT DISEASE ESTABLISHED GOAL STUDY EVALUATE EFFICACY DIFFERENT THERAPIES USED PATIENTS BI-ALCL DETERMINE OPTIMAL TREATMENT APPROACHÂ¿ Â¿THE MEDIAN MEAN FOLLOW-UP TIMESWERE 45 30 MONTHS RESPECTIVELY RANGE 3 217 MONTHS MEDIAN OVERALL SURVIVAL OS TIME DIAGNOSIS BI-ALCL 13 YEARS OS RATE 93AND 89AT 3 5 YEARS RESPECTIVELY PATIENTS LYMPHOMA CONFINED FIBROUS CAPSULE SURROUNDING IMPLANT BETTER EVENT-FREE SURVIVAL EFS OS PATIENTS LYMPHOMA SPREAD BEYOND CAPSULE P = 03 PATIENTS UNDERWENT COMPLETE SURGICAL EXCISION CONSISTED TOTAL CAPSULECTOMY BREAST IMPLANT REMOVAL BETTER OSP = 022 EFSP = 014 PATIENTS RECEIVED PARTIAL CAPSULECTOMY SYSTEMIC CHEMOTHERAPY RADIATION THERAPYÂ¿ CYTOLOGICAL MARKERS ALK- CD30+ REPORTED CURRENTLY WAY DETERMINE CASES THERAPIES DEVICE TYPE REPORT CAPTURE 37 UNREPORTED CASES ALCL  LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6153200|61697778|N|1||EVENT LYMPHOMA ALCL PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL Â¿COMPLETE SURGICAL EXCISION ESSENTIAL MANAGEMENT PATIENTS BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ MARK W CLEMENS L JEFFREY MEDEIROS CHARLES E BUTLER KELLY K HUNT MICHELLE FANALE STEVEN HORWITZ DENNIS WEISENBURGER JUN LIU ELIZABETH MORGAN RASHMI KANAGAL-SHAMANNA VINITA PARKASH JING NING ALIYAH R SOHANI JUDITH FERRY NEHA MEHTA-SHAH AHMED DOGAN HUI LIU NORA THORMANN ARIANNA DI NAPOLI STEPHEN LADE JORGE PICCOLINI RUBEN REYES TRAVIS WILLIAMS COLLEEN MCCARTHY SUMMER E HANSON LORETTA J NASTOUPIL RAKESH GAUR YASUHIRO OKI KEN H YOUNG ROBERTO N MIRANDA JOURNAL CLINICAL ONCOLOGY VOLUME 34 NUMBER 2 JANUARY 10 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6011951|56916914|D|1||ALLERGANS LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGY TABLE 4 PRESENTATION BIA-ALCL N=46 ARTICLE REPORTS FOLLOWING 2 CASES SEROMA CAPSULAR CONTRACTURE CONTRALATERAL RECORD CREATED CAPTURE 2 EVENTS CAPSULAR CONTRACTURE CONTRALATERAL EVENT SEROMA CAPTURED MDR  9617229-2016-00142 ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS MANUFACTURER COULD SPECIFIED ARTICLE STATES BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED 571 IMPLANTS SERIES ARTICLE STATES PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5864951|51736729|N|1||MEDWATCH SENT FDA 08102016 B4 CONCOMITANT MEDICAL PRODUCTS FOLIC ACID D3 VITAMIN CALCIUM CARBONATE OMEGA 3 PAST MEDICAL HISTORY HYDROXYCHLOROQUINE EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL CHANGES BREAST SENSATION HEMATOMASEROMA LYMPHADENOPATHY|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|N-27-120181|08/10/2016|||DA|N|R||0HP|FTR|1.0|02/20/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2243522|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5864951|51736730|D|1||ENGLISH PRODUCT FIELD NOTE PFN RECEIVED VIA EMAIL REPORTS LEFT SIDE PATIENT ALLERGAN PROSTHESIS DIAGNOSED ALCL ANAPLASTIC LARGE CELL LYMPHOMA ADENOPATHY AXILLARY ENCAPSULATION INFLAMMATORY PROCESS SUPERIOR INTERIOR INTRACAPSULAR LIQUID PATHOLOGIC DIAGNOSTIC NON-HODGKIN LYMPHOMA ALK NEGATIVE ANAPLASTIC LYMPHOMA ALK NEGATIVE CD 30+ ASSOCIATED BREAST PROSTHESIS CLINICAL STATUS II E  PATIENT MEDICAL HISTORY PRIMARY SJOGREN SYNDROME B6 2015 MRI FOUND BIGGER VOLUME LEFT BREAST EDEMA SUBCUTANEOUS LAYER PERIPROSTHETIC LIQUID ALSO NOTED PATIENT PRESENTED PAIN RELATED DEVICE ONE WEEK MRI B6 2015 NOTED CAPSULAR CONTRACTURE B6 2015 MRI DETECTED MASS SUPERIOR AREA LEFT BREAST BIOPSY INJURY CAME NEGATIVE B6 2016 PATIENT PALPATED LEFT AXILLARY ADENOPATHY B6 2016 CONSULTATION NOTED SIGNALS RUPTURE SMALL MASS SUPERIOR LEFT PROSTHESIS CONSULTATION HEALTHCARE PROFESSIONAL BIOPSY PERFORMED CONFIRMED LYMPHOMA ANAPLASTIC CELLS ALK - PERIPROSTHETIC LIQUID ALSO NOTED EXPLANT DATE PROVIDED B6 2016 IMPLANT REPLACED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|N-27-120181|08/10/2016|||DA|N|R||0HP|FTR|1.0|02/20/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2243522|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5864951|63818637|D|1||ENGLISH PRODUCT FIELD NOTE PFN RECEIVED VIA EMAIL REPORTS Â¿LEFT SIDE PATIENT ALLERGAN PROSTHESIS DIAGNOSED ALCL ANAPLASTIC LARGE CELL LYMPHOMA ADENOPATHY AXILLARY ENCAPSULATION INFLAMMATORY PROCESS SUPERIOR INTERIOR INTRACAPSULAR LIQUID PATHOLOGIC DIAGNOSTIC NON-HODGKIN LYMPHOMA ALK NEGATIVE ANAPLASTIC LYMPHOMA ALK NEGATIVE CD 30+ ASSOCIATED BREAST PROSTHESIS CLINICAL STATUS II EÂ¿ PATIENT MEDICAL HISTORY PRIMARY SJOGREN SYNDROME B6 2015 MRI FOUND BIGGER VOLUME LEFT BREAST EDEMA SUBCUTANEOUS LAYER PERIPROSTHETIC LIQUID ALSO NOTED PATIENT PRESENTED PAIN RELATED DEVICE ONE WEEK MRI B6 2015 NOTED CAPSULAR CONTRACTURE B6 2015 MRI DETECTED MASS SUPERIOR AREA LEFT BREAST BIOPSY INJURY CAME NEGATIVE B6 2016 PATIENT PALPATED LEFT AXILLARY ADENOPATHY B6 2016 CONSULTATION NOTED SIGNALS RUPTURE SMALL MASS SUPERIOR LEFT PROSTHESIS CONSULTATION HEALTHCARE PROFESSIONAL BIOPSY PERFORMED CONFIRMED LYMPHOMA ANAPLASTIC CELLS ALK - PERIPROSTHETIC LIQUID ALSO NOTED EXPLANT DATE PROVIDED B6 2016 IMPLANT REPLACED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|N-27-120181|08/10/2016|||DA|N|R||0HP|FTR|1.0|02/20/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2243522|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5864951|60014363|D|1||B4 PRODUCT FIELD NOTE PFN RECEIVED VIA EMAIL REPORTS LEFT SIDE PATIENT ALLERGAN PROSTHESIS DIAGNOSED ALCL ANAPLASTIC LARGE CELL LYMPHOMA ADENOPATHY AXILLARY ENCAPSULATION INFLAMMATORY PROCESS SUPERIOR INTERIOR INTRACAPSULAR LIQUID PATHOLOGIC DIAGNOSTIC NON-HODGKIN LYMPHOMA ALK NEGATIVE ANAPLASTIC LYMPHOMA ALK NEGATIVE CD 30+ ASSOCIATED BREAST PROSTHESIS CLINICAL STATUS II E  PATIENT MEDICAL HISTORY PRIMARY SJOGREN SYNDROME B6 2015 MRI FOUND BIGGER VOLUME LEFT BREAST EDEMA SUBCUTANEOUS LAYER PERIPROSTHESTIC LIQUID ALSO NOTED PATIENT PRESENTED PAIN RELATED DEVICE ONE WEEK MRI B6 2015 NOTED CAPSULAR CONTRACTURE B6 2015 MRI DETECTED MASS SUPERIOR AREA LEFT BREAST BIOPSY INJURY CAME NEGATIVE B6 2016 PATIENT PALPATED LEFT AXILLARY ADENOPATHY B6 2016 CONSULTATION NOTED SIGNALS RUPTURE SMALL MASS SUPERIOR LEFT PROSTHESIS CONSULTATION HEALTHCARE PROFESSIONAL BIOPSY PERFORMED CONFIRMED LYMPHOMA ANAPLASTIC CELLS ALK - PERIPROSTHESTIC LIQUID ALSO NOTED EXPLANT DATE PROVIDED B6 2016 IMPLANT REPLACED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|N-27-120181|08/10/2016|||DA|N|R||0HP|FTR|1.0|02/20/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2243522|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6037704|57781488|D|1||HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE SPONTANEOUS SEROMA LYMPHOMA ALCL B6 2016 COMPLETE CAPSULECTOMY EXPLANT OCCURRED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSX525|10/18/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2433989|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6037704|57781486|N|1||EVENTS SEROMA LYMPHOMA ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY REVIEW DHR SUMMARY REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR WORK ORDER B4 INDICATES REPROCESS PRIMARY PACKAGING OPERATION REPORTED DEVICE REPROCESSED HOWEVER REVIEW REPROCESS WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MAY ASSOCIATED REPORTED DEVICE EVENT DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUN NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSX525|10/18/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2433989|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6153112|61699206|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES GATHERED FOUR CENTERS INTERNATIONAL COLLABORATIVE STUDY TOTAL 22 PATIENTS TABLE 1Â¿ ARTICLE GOES STATE Â¿BOTH BREAST IMPLANTÂ¿ASSOCIATED ALCL NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG TISSUE CAPSULE 49 Ã 106 CELLSMG TISSUE ANALYSIS MICROBIOME BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES SPECIES IDENTIFIED NONTUMOR CAPSULE SPECIMENS SIGNIFICANTLY GREATER PROPORTION RALSTONIA SPP PRESENT ALCL SPECIMENS COMPARED NONTUMOR CAPSULE SPECIMENS P  005 CONTRAST SIGNIFICANTLY STAPHYLOCOCCUS SPP FOUND ASSOCIATED NONTUMOR CAPSULE SPECIMENS COMPARED BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM VISUALIZED SCANNING ELECTRON MICROSCOPY FLUORESCENT SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- CD30+ REPORTED ARTICLE STATES Â¿NONTUMOR CAPSULE SPECIMENS 62 PATIENTS UNDERGOING REVISION SURGERY HIGH-GRADE CAPSULAR CONTRACTUREÂ¿ CURRENTLY WAY DETERMINE CASES DEVICE TYPE REPORT CAPTURE 62 CASES NONTUMOR NON ALCL CAPSULAR CONTRACTURE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5343961|42390067|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE DEFLATION SILICONE DEVICE ADDITION ABSCESSAND PATHOLOGICAL TEST RESULT LYMPHOMA-ALCL PATIENT INITIALLY PRESENTED SWELLING LATER DIAGNOSED SEROMA PREOPERATIVE DIAGNOSES NOTED LEFT BREAST ABSCESS LEFT BREAST CANCER LEFT BREAST RUPTURED IMPLANT DEVICE REMOVED PARTIAL CAPSULECTOMY PERFORMED OPERATIVE NOTE REPORTS SEROMA ABSCESS FRIABLE BLEEDING TISSUEIT NOTED POSTERIOR CAPSULE ADHERENT ADDITIONAL SURGERY SCHEDULED REMOVE REMAINDER CAPSULE FINAL PATHOLOGIC DIAGNOSIS ALK NEGATIVE FOLLOWED CD30 4+ ADDITIONAL CYTOLOGY REPORT NOTES PARTIALLY DEGENERATED INFLAMMATORY CELLS ADDITIONALLY SURGICAL PATHOLOGY REPORT PROVIDED GROSS DESCRIPTION LEFT BREAST POSTERIOR CAPSULE LYMPHOMA CUT SURFACES YELLOW-TAN FOCAL BRIGHT YELLOW AREAS CONSISTENT PROBABLE FAT NECROSIS|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-630|01/05/2016||03/17/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||339918|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5343961|45289983|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE DEFLATION SILICONE DEVICE ADDITION ABSCESS PATHOLOGICAL TEST RESULT LYMPHOMA-ALCL PATIENT INITIALLY PRESENTED SWELLING LATER DIAGNOSED SEROMA PREOPERATIVE DIAGNOSES NOTED LEFT BREAST ABSCESS LEFT BREAST CANCER LEFT BREAST RUPTURED IMPLANT DEVICE REMOVED PARTIAL CAPSULECTOMY PERFORMED OPERATIVE NOTE REPORTS SEROMA ABSCESS FRIABLE BLEEDING TISSUEIT NOTED POSTERIOR CAPSULE ADHERENT ADDITIONAL SURGERY SCHEDULED REMOVE REMAINDER CAPSULE FINAL PATHOLOGIC DIAGNOSIS ALK NEGATIVE FOLLOWED CD30 4+ ADDITIONAL CYTOLOGY REPORT NOTES PARTIALLY DEGENERATED INFLAMMATORY CELLS|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-630|01/05/2016||03/17/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||339918|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5343961|35063342|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE DEFLATION SILICONE DEVICE ADDITION ABSCESSAND PATHOLOGICAL TEST RESULT LYMPHOMA-ALCL PATIENT INITIALLY PRESENTED SWELLING LATER DIAGNOSED SEROMA PREOPERATIVE DIAGNOSES NOTED LEFT BREAST ABSCESS LEFT BREAST CANCER LEFT BREAST RUPTURED IMPLANT DEVICE REMOVED PARTIAL CAPSULECTOMY PERFORMED OPERATIVE NOTE REPORTS SEROMA ABSCESS FRIABLE BLEEDING TISSUEIT NOTED POSTERIOR CAPSULE ADHERENTÂ¿ ADDITIONAL SURGERY SCHEDULED REMOVE REMAINDER CAPSULE FINAL PATHOLOGIC DIAGNOSIS Â¿ALK NEGATIVEÂ¿ FOLLOWED Â¿CD30 4+Â¿ ADDITIONAL CYTOLOGY REPORT NOTES Â¿PARTIALLY DEGENERATED INFLAMMATORY CELLSÂ¿|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-630|01/05/2016||03/17/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||339918|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5343961|40551738|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE DEFLATION SILICONE DEVICE ADDITION ABSCESSAND PATHOLOGICAL TEST RESULT LYMPHOMA-ALCL PATIENT INITIALLY PRESENTED SWELLING LATER DIAGNOSED SEROMA PREOPERATIVE DIAGNOSES NOTED LEFT BREAST ABSCESS LEFT BREAST CANCER LEFT BREAST RUPTURED IMPLANT DEVICE REMOVED PARTIAL CAPSULECTOMY PERFORMED OPERATIVE NOTE REPORTS SEROMA ABSCESS FRIABLE BLEEDING TISSUEIT NOTED POSTERIOR CAPSULE ADHERENT ADDITIONAL SURGERY SCHEDULED REMOVE REMAINDER CAPSULE FINAL PATHOLOGIC DIAGNOSIS ALK NEGATIVE FOLLOWED CD30 4+ ADDITIONAL CYTOLOGY REPORT NOTES PARTIALLY DEGENERATED INFLAMMATORY CELLS ADDITIONALLY SURGICAL PATHOLOGY REPORT PROVIDED GROSS DESCRIPTION LEFT BREAST POSTERIOR CAPSULE LYMPHOMA CUT SURFACES YELLOW-TAN FOCAL BRIGHT YELLOW AREAS CONSISTENT PROBABLE FAT NECROSIS|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-630|01/05/2016||03/17/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||339918|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5343961|36605829|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE DEFLATION SILICONE DEVICE ADDITION ABSCESS PATHOLOGICAL TEST RESULT LYMPHOMA-ALCL PATIENT INITIALLY PRESENTED SWELLING LATER DIAGNOSED SEROMA PREOPERATIVE DIAGNOSES NOTED LEFT BREAST ABSCESS LEFT BREAST CANCER LEFT BREAST RUPTURED IMPLANT DEVICE REMOVED PARTIAL CAPSULECTOMY PERFORMED OPERATIVE NOTE REPORTS SEROMA ABSCESS FRIABLE BLEEDING TISSUEIT NOTED POSTERIOR CAPSULE ADHERENT ADDITIONAL SURGERY SCHEDULED REMOVE REMAINDER CAPSULE FINAL PATHOLOGIC DIAGNOSIS ALK NEGATIVE FOLLOWED CD30 4+ ADDITIONAL CYTOLOGY REPORT NOTES PARTIALLY DEGENERATED INFLAMMATORY CELLS LEFT SIDE DEVICE REMOVED CAPSULECTOMY PERFORMED LYMPHOMA-ALCL CONFIRMED VIA PATHOLOGICAL MARKERS ADDITIONAL VOLUNTARY MEDWATCH 5058522 REPORTS LEFT BREAST SWELLING BECAME INFECTED PT PRESENTED PURULENT CHEESE CURLED FLUID MIXED SILICONE COMING OPEN AREA BREAST|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-630|01/05/2016||03/17/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||339918|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5343961|35063341|N|1||B4 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-630|01/05/2016||03/17/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||339918|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5343961|46279937|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE DEFLATION SILICONE DEVICE ADDITION ABSCESSAND PATHOLOGICAL TEST RESULT LYMPHOMA-ALCL PATIENT INITIALLY PRESENTED SWELLING LATER DIAGNOSED SEROMA PREOPERATIVE DIAGNOSES NOTED LEFT BREAST ABSCESS LEFT BREAST CANCER LEFT BREAST RUPTURED IMPLANT DEVICE REMOVED PARTIAL CAPSULECTOMY PERFORMED OPERATIVE NOTE REPORTS SEROMA ABSCESS FRIABLE BLEEDING TISSUE NOTED POSTERIOR CAPSULE ADHERENT ADDITIONAL SURGERY SCHEDULED REMOVE REMAINDER CAPSULE FINAL PATHOLOGIC DIAGNOSIS ALK NEGATIVE FOLLOWED CD30 4+ ADDITIONAL CYTOLOGY REPORT NOTES PARTIALLY DEGENERATED INFLAMMATORY CELLS|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-630|01/05/2016||03/17/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||339918|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5488680|39947737|N|1||DEVICE LABELING ADDRESSES LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST STUDIES EVALUATING CAPSULES AROUND TEXTURED EXPANDERS REPORTED POSSIBLE SILICONE PARTICLES GIANT CELLS INDICATIVE LOCAL NON SPECIFIC FOREIGN BODY REACTION SILICONE GRANULOMA FORMATION|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|03/09/2016|||DA|N|R||0HP|FTR|1.0|02/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||276452|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5488680|39947738|D|1||PATIENT REPORTED DIAGNOSED BREAST IMPLANT ASSOCIATED ALCL PATIENT SOUGHT CONSULT EXPERIENCING LOT SWELLING IMPLANT REMOVED PATHOLOGY RESULTS CONFIRMED ALCL FOLLOW-UP PROVIDED INDICATED RIGHT BREAST CYTOPATHOLOGY REPORT STATES FINE NEEDLE ASPIRATION RIGHT BREAST Â¿ 5 ML CLOUDY ORANGE FLUID Â¿ BREAST ASPIRATE IMPLANT CAPSULE FOLLOWED Â¿POSITIVE ANTIBODIES CD30 STRONGÂ¿ Â¿NEGATIVE ANTIBODIES ALK1 CONCLUSIONS REPORTED Â¿THIS IMMUNOPHENOTYPE TYPICAL SEEN BREAST-IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ ADDITIONALLY PHYSICIAN NOTES RECEIVED DOCUMENTED PRIOR 4 X 7 MM SIMPLE CYST 1100 OÂ¿CLOCK RIGHT BREAST HISTOPATHOLOGY REPORT NOTED CAPSULE FOREIGN BODY GRANULOMATOUS LYMPHOID REACTION|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|03/09/2016|||DA|N|R||0HP|FTR|1.0|02/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||276452|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5488680|41343420|D|1||PATIENT REPORTED DIAGNOSED BREAST IMPLANT ASSOCIATED ALCL PATIENT SOUGHT CONSULT EXPERIENCING LOT SWELLING IMPLANT REMOVED PATHOLOGY RESULTS CONFIRMED ALCL FOLLOW-UP PROVIDED INDICATED RIGHT BREAST CYTOPATHOLOGY REPORT STATES FINE NEEDLE ASPIRATION RIGHT BREAST - 5 ML CLOUDY ORANGE FLUID - BREAST ASPIRATE IMPLANT CAPSULE FOLLOWED - POSITIVE ANTIBODIES CD30 STRONG- - NEGATIVE ANTIBODIES ALK1 CONCLUSIONS REPORTED IMMUNOPHENOTYPE TYPICAL SEEN BREAST-IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ADDITIONALLY PHYSICIAN NOTES RECEIVED DOCUMENTED PRIOR 4 X 7 MM SIMPLE CYST 1100 OCLOCK RIGHT BREAST HISTOPATHOLOGY REPORT NOTED CAPSULE FOREIGN BODY GRANULOMATOUS LYMPHOID REACTION|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|03/09/2016|||DA|N|R||0HP|FTR|1.0|02/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||276452|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5844861|51109570|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE SUSPICION ALCL PATHOLOGICAL MARKERS RECEIVED EVENT Â¿SUSPICION ALCLÂ¿ REMAIN CAPTURED LYMPHOMA INTENTION PROSTHESIS REPLACEMENT HEALTHCARE PROFESSIONAL ADDITIONALLY REPORTED Â¿PATIENT ALSO PRESENTS SEROMAÂ¿ Â¿SLIGHTLY HARDENEDÂ¿ Â¿THICK CAPSULE AROUND DEVICEÂ¿|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/03/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5844861|51109569|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT FOLLOW CONDUCTED DETERMINE FOLLOWING INFORMATION SERIAL NUMBER LOT NUMBER IMPLANT DATE PATIENT NAME PATIENT DATE BIRTH PATHOLOGICAL TESTING RESULTS DETERMINATION SURGERY SCHEDULED DEVICE RELATIONSHIP REPORTED EVENTS DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/03/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5844861|55353371|D|1||MEDICAL PROFESSIONAL DETERMINED LATE SEROMA EVIDENCE ALCL LATE SEROMAS ALCL PATIENT DIAGNOSTIC PROCEDURE ULTRASOUND DIAGNOSIS PRESENCE FLUID THEREFORE EVENT LYMPHOMA USED TIME|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/03/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5607727|43625364|D|1||PHYSICIAN REPORTS PATIENT BIA-ALCL BREAST IMPLANT ASSOCIATED - ANAPLASTIC LARGE CELL LYMPHOMA DEVICE EXPLANTED PATHOLOGICAL MARKERS PROVIDED CASE CAPTURED LYMPHOMA SIDE UNKNOWN|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410420|04/26/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5607727|43625363|N|1||MEDWATCH SENT FDA 04262016 REPORTER EVENT ASKED RETURN PRODUCT ANALYSIS ALLERGAN RECEIVED PRODUCT TIME THEREFORE ANALYSIS TESTING DONE EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410420|04/26/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6158856|62125553|D|1||ALLERGAN PRODUCT SURVEILLANCE RECEIVED LITERATURE ARTICLE Â¿COMPREHENSIVE IMMUNOPHENOTYPIC ANALYSIS 64 CASES BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA SHOWS ACTIVATED CYTOTOXIC SILENT T-CELL RECEPTOR PATTERNÂ¿ 13NOV2016 ARTICLE REPORTS Â¿64 CASESÂ¿ ARTICLE CONTINUES STATE Â¿WE REVIEWED WORLD LITERATURE CASES BI-ALCL ACCRUED CASES IMMUNOPHENOTYPIC DATA DERIVED USING IMMUNOHISTOCHEMICAL FLOW CYTOMETRY METHODS USED LEAST 5 FOLLOWING 13 MARKERS REPORTED CD3 CD4 CD8 CD30 CD43 CD45 EMATIA-1 GRANZYME-B ALK-1 TCR-Â¿Â¿ TCR-GÂ¿ EBER SITU HYBRIDIZATION LESS 5 MARKERS REPORTED CONTACTED CORRESPONDING AUTHORS AVAILABLE MATERIAL ADDITIONAL STUDIES INCLUDED DATAÂ¿ Â¿CD30 POSITIVE N=64 CASES WHEREAS ALK EBER NEGATIVE TESTED CASES N=56 N=25 RESPECTIVELY CD3 POSITIVE 15 62 24 CASES CD4 4361 70 CD8 657 11 CD43 37 46 80 CD45 2949 59 EMA 2542 60 TIA-1 2846 61 GRANZYME-B 28 47 60 TCR Â¿Â¿ 5 24 21 TCR GÂ¿ 1 23 4 THUS TCR SILENT 1824 75 CASESÂ¿ RECORD CREATED CAPTURE 8 CASES LYMPHOMA TESTING ALK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5672723|45694207|N|1||MEDWATCH SENT FDA 05232016 REPORTER EVENT IDENTIFIED REGULATORY AGENCY ALLERGAN RECEIVED PRODUCT TIME THEREFORE ANALYSIS TESTING DONE EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTER EVENT IDENTIFIED REGULATORY AGENCY THEREFORE ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY REVIEW REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUN NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|05/23/2016||||N|R||0HP|FTR|1.0|09/19/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1139476|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5672723|45694208|D|1||PHYSICIAN REPORTS PATIENT DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL RIGHT BREAST CONCERNS DIAGNOSE ALCL CD30+ ALK- FOLLOWING IDENTIFICATION PERIPROSTHETIC SEROMA BREAST IMPLANT IMPLANTED 10 YEAR AGO CAPSULECTOMY PERFORMED DEVICE EXPLANTED|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|05/23/2016||||N|R||0HP|FTR|1.0|09/19/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1139476|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6153064|61697996|N|1||ARTICLE CITATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA CASE REPORT UNDIAGNOSED FORM MANAGEMENT RECONSTRUCTION ALCL ALHAMAD GUERID EH EL FAKIR P BIRON C TOURASSE E DELAY PUBLISHED 062016 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6153064|61697997|D|1||JOURNAL ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA CASE REPORT UNDIAGNOSED FORM MANAGEMENT RECONSTRUCTION ALCLÂ¿ ABSTRACT STATES Â¿THIS ARTICLE REPORTS CASE PATIENT PROGRESSIVE SWELLING RIGHT BREAST AESTHETIC BREAST IMPLANTS DIAGNOSTIC DELAYED FIRST SURGEON FAMILIAR DISEASE PERFORMED IMPLANT REMOVAL COMPLETE CAPSULECTOMY PATHOLOGIC REPORT CONFIRMS DIAGNOSTIC ONE YEAR NORMAL ULTRASOUND EVALUATION RECONSTRUCTED BREAST LIPOMODELING MASTOPEXYÂ¿ MANUFACTURER DEVICE SPECIFIED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6153076|61697270|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION HEMATOMASEROMA BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ 137 6 1659-1669 HONGHUA HU PHD KHALID JOHANI AHMAD ALMATROUDI KAREN VICKERY PHD BVSC BRUCE VAN NATTA MD MARSHALL E KADIN MD GARRY BRODY MD MARK CLEMENS MD CHAN YOON CHEAH MD STEPHEN LADE MD PREETI AVINASH JOSHI MDPHD H MILES PRINCE MDPHD ANAND K DEVA BSCMED MBBS MS PUBLISHED JUNE 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6153076|61697271|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES GATHERED FOUR CENTERS INTERNATIONAL COLLABORATIVE STUDY TOTAL 22 PATIENTS TABLE 1Â¿ ARTICLE GOES STATE Â¿BOTH BREAST IMPLANTÂ¿ASSOCIATED ALCL NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG TISSUE CAPSULE 49 Ã 106 CELLSMG TISSUE ANALYSIS MICROBIOME BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES SPECIES IDENTIFIED NONTUMOR CAPSULE SPECIMENS SIGNIFICANTLY GREATER PROPORTION RALSTONIA SPP PRESENT ALCL SPECIMENS COMPARED NONTUMOR CAPSULE SPECIMENS P  005 CONTRAST SIGNIFICANTLY STAPHYLOCOCCUS SPP FOUND ASSOCIATED NONTUMOR CAPSULE SPECIMENS COMPARED BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM VISUALIZED SCANNING ELECTRON MICROSCOPY FLUORESCENT SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- CD30+ REPORTED ARTICLE ADDITIONALLY REPORTS Â¿COMPARED CLASSIC SYSTEMIC ALCL BREAST IMPLANTÂ¿ ASSOCIATED ALCL BEHAVES INDOLENT MANNER DIVIDED PATHOLOGIC VARIETIES SEROMA-TYPE CONSISTING EFFUSIONS ENCAPSULATING MARGIN CD30+ MALIGNANT LYMPHOCYTES CURRENTLY WAY DETERMINE CASES DEVICE TYPE TESTED NEGATIVE BACTERIAL INFECTION REPORT CAPTURE 12 CASES ALCL PRESENTED EFFUSION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5793065|54159657|D|1||MEDICAL STAFF REPORTS ALCL RELATED IMPLANT RIGHT SIDE ACL CD30+ ALK NEGATIVE EXPLANT SURGERY CAPSULECTOMY SAMPLING PALPABLE NODULES AXILLARY TAIL RIGHT BREAST AXILLARY HOLLOW RIGHT BREAK PERI-PROSTHETIC SERUM DOUBLE CAPSULE YELLOWING IMPLANT FLUID OUTPOURING CITRINE CLOUDY APPEARANCE TISSUE DEPOSITS DEVICE EXPLANTED RECORD RELATES RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5793065|69889264|D|1||MEDICAL STAFF REPORTS ALCL RELATED IMPLANT RIGHT SIDE ACL CD30+ ALK NEGATIVE EXPLANT SURGERY CAPSULECTOMY SAMPLING PALPABLE NODULES AXILLARY TAIL RIGHT BREAST AXILLARY HOLLOW RIGHT BREAK PERI-PROSTHETIC SERUM DOUBLE CAPSULE YELLOWING IMPLANT FLUID OUTPOURING CITRINE CLOUDY APPEARANCE TISSUE DEPOSITS DEVICE EXPLANTED RECORD RELATES RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5793065|49492130|D|1||MEDICAL STAFF REPORTS ALCL RELATED IMPLANT RIGHT SIDE ACL CD30+ ALK NEGATIVE EXPLANT SURGERY CAPSULECTOMY SAMPLING PALPABLE NODULES AXILLARY TAIL RIGHT BREAST AXILLARY HOLLOW RIGHT BREAK PERI-PROSTHETIC SERUM DOUBLE CAPSULE YELLOWING IMPLANT FLUID OUTPOURING CITRINE CLOUDY APPEARANCE TISSUE DEPOSITS DEVICE EXPLANTED RECORD RELATES RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5793065|68234084|D|1||MEDICAL STAFF REPORTS ALCL RELATED IMPLANT RIGHT SIDE ACL CD30+ ALK NEGATIVE EXPLANT SURGERY CASULECTOMY SAMPLING PALPABLE NODULES AXILLARY TAIL RIGHT BREAST AXILLARY HOLLOW RIGHT BREAK PERI-PROSTHETIC SERUM DOUBLE CAPSULE YELLOWING IMPLANT FLUID OUTPOURING CITRINE CLOUDY APPEARANCE TISSUE DEPOSITS DEVICE EXPLANTED RECORD RELATES RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5793065|49492129|N|1||MEDWATCH SENT FDA 07132016 B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT SERIAL NUMBER AVAILABLE TIME KNOWN DEVICE RETURNED REQUEST INFORMATION PERFORMED DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL DEVICE HISTORY RECORD REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT ORACLE VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUNS NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6143087|61396767|D|1||ABSTRACT LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTED Â¿19 I-ALCLSÂ¿ CASES ONE TWO CLINICAL PRESENTATIONS REPORTED Â¿TUMOR MASSÂ¿ 2 PATIENTS EXPERIENCED ALCL MASS RECORD REPRESENTS 2 CASES ALCL PRESENTED TUMOR MASS HISTOPATHOLOGY REPORTS MALIGNANT CELLS CD30-POSITIVE ALK NEGATIVE ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ REGARDS TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL PERFORMED 17 19 PATIENTS ADDITIONAL TREATMENT BASED MOSTLY CHOP CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 IRRADIATION N = 119 CHOP ALONE ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL GIVEN TWO PATIENTSÂ¿ CURRENTLY WAY DETERMINE TREATMENTS USED 11 CASES MANUFACTURER DEVICES UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/02/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6143087|62805862|D|1||ABSTRACT LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ B6-YEAR-OLD PATIENT IMPLANTED UNKNOWN IMPLANT DEVICE MANUFACTURER UNKNOWN PATIENT DIAGNOSED ALCL CHART ADDITIONALLY PROVIDES PATIENT EXPERIENCED LEFT SIDE MASS UNKNOWN IMPLANT REMOVED TREATMENT REPORTED ADRIAMYCINE BLEOMYCINE VINBLASTINE DACARBAZINE ABVD RADIOTHERAPY 30GY FOLLOW-UP FOUND EVIDENCE DISEASE REPORT INITIALLY SENT REPRESENT TWO PATIENTS DUE DISCOVERY IDENTIFYING INFORMATION SUPPLEMENTAL REPORT REPRESENT B6 YEAR-OLD PATIENT DEVICE MFR  9617229-2016-00195 SENT REPRESENT PATIENT PREVIOUSLY REPRESENTED INITIAL REPORT MFR  9617229-2016-00196|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/02/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6143087|61396766|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL LUMPNODULE PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/02/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6177272|62460335|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED TEXTURED SALINE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED RIGHT SEROMA Â¿DISRUPTED IMPLANTÂ¿ TREATMENT REPORTED IMPLANT REMOVAL Â¿CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP FOUND Â¿NO EVIDENCE DISEASEÂ¿|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6177272|62460334|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6139636|61290118|D|1||PHYSICIAN REPORTED LARGE BLOOD STAINED FLUID COLLECTION LEADING EXPLORATION FIBRINOUS TISSUE REMOVED SENT HISTOLOGY DIAGNOSIS ALCL CONFIRMED EXPERT HAEMATOLOGY PANEL PHYSICIAN REPORTED EXPLANTED DUE PERSISTENT FLUID COLLECTION DIAGNOSIS BI-ALCL MADE PROCEDURE ALCL DIAGNOSED B6 2016|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRLP250|12/01/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2429970|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6139636|61290117|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED DEVICE RETURNED DEVICE RETURNED ANALYZED RESULTS SENT SUPPLEMENTAL REPORT EVENT HEMATOMA PREVIOUSLY REPORTED VIA RESPONSIVE PSR B6 2016 EVENTS LATE SEROMA LYMPHOMA-ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRLP250|12/01/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2429970|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5697584|46502156|D|1||FOLLOWING JOURNAL ARTICLE REVIEWED Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORT 2 CASES REVIEW LITERATUREÂ¿ AUTHORS REPORTED PATIENT Â¿PRESENTED 6-WEEK HISTORY RIGHT BREAST SWELLINGÂ¿ Â¿NINE YEARS EARLIER PATIENT UNDERGONE BILATERAL SUBMUSCULAR BREAST AUGMENTATION 510-CC TEXTURED SALINE BIOCELL IMPLANTS ALLERGAN B64 PATIENTS MEDICAL HISTORY REVEALED RECENT DIAGNOSIS CELIAC DISEASE CONFIRMED DUODENAL BIOPSY CLINICAL EXAMINATION SHOWED SWELLING ERYTHEMA RIGHT BREAST PERCUTANEOUS FLUID ASPIRATION PRODUCED 200 ML CLEAR YELLOW FLUID FLOW CYTOMETRIC IMMUNOPHENOTYPING ASPIRATE DEMONSTRATED PHENOTYPICALLY ABERRANT POPULATION LARGE CELLS EXPRESSED CD2 CD5 CD4 CD30 FAILED EXPRESS CD3 CD7 RESULTS IMMUNOHISTOCHEMICAL STAINING HEMATOXYLIN EOSIN NEGATIVE ANAPLASTIC LYMPHOMA KINASE 1 ALK-L DIAGNOSIS ALKÂ¿ ALCL RESULTS POSITRON EMISSION TOMOGRAPHY SCAN BONE MARROW ASPIRATE BIOPSY DETERMINED NEGATIVE DISEASE PATIENTS LEVEL LACTATE DEHYDROGENASE NORMAL TREATMENT INCLUDED BILATERAL TOTAL CAPSULECTOMY IMPLANT REMOVAL WITHOUT IMPLANT REPLACEMENT APPROXIMATELY SIX MONTHS PRESENTING SYMPTOMS HEALTH PROFESSIONAL REMOVAL IMPLANTS CAPSULES SENT FLOW CYTOMETRY CYTOGENETIC ANALYSIS IMMUNOHISTOCHEMICAL STAINING SHOW UNIQUE CELL POPULATIONS EVIDENCE SILICONE CAPSULE THROUGHOUT 20 MONTHS REGULAR FOLLOW-UP SINCE IMPLANT REMOVAL CAPSULECTOMY PATIENT SYSTEMIC EVIDENCE DISEASEÂ¿ REPORT REPRESENTS RIGHT SIDE SEE MFR REPORT  9617229-2016-00066 LEFT SIDE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5697584|46502155|N|1||B4 CORRESPONDING AUTHOR DECLINED PROVIDE ALLERGAN INFORMATION REGARDING EVENT PRODUCT PRODUCT RETURN PATIENT DETAILS EVENTS FLUID COLLECTION Â¿RECENT HISTORY CELIAC DISEASEÂ¿ ERYTHEMA ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176870|62452744|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA TREATMENT REPORTED IMPLANT REMOVAL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176870|62452743|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011928|56911407|N|1||MEDWATCH SENT FDA 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011928|56911408|D|1||ALLERGANÂ¿S LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALANDÂ¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ TABLE 4 Â¿PRESENTATION BIA-ALCL N=46Â¿ ARTICLE REPORTS FOLLOWING 2 CASES Â¿SEROMA CAPSULAR CONTRACTURE CONTRALATERALÂ¿ RECORD CREATED CAPTURE 2 SEROMAS CONTRALATERAL EVENT CAPSULAR CONTRACTURE CAPTURED MDR  9617229-2016-00146 ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5665954|45480789|D|1||2 BREAST IMPLANTS IMPLANTED B6 2008 SINCE FINE REMAINED INTACT YESTERDAY B6 2016 PT DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL CAUSED 2 IMPLANTS SCHEDULED MEET DOCTOR TODAY PLAN EXPLANTING DEVICES|MEMORY GEL BREAST IMPLANT||05/18/2016||||*|*||0LP|FTR|2.0||MEMORY GEL BREAST IMPLANT|||3041 SKYWAY CIRCLE NORTH||IRVINE|US|MENTOR|75038|TX|75038||||True
5665954|45480789|D|1||2 BREAST IMPLANTS IMPLANTED B6 2008 SINCE FINE REMAINED INTACT YESTERDAY B6 2016 PT DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL CAUSED 2 IMPLANTS SCHEDULED MEET DOCTOR TODAY PLAN EXPLANTING DEVICES|MEMORY GEL BREAST IMPLANT||05/18/2016||||*|*||0LP|FTR|1.0||MEMORY GEL BREAST IMPLANT||5746123|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR|75038|TX|75038||||True
6139164|61260978|N|1||ARTICLE CITATION Â¿MARKED EOSINOPHILIA INITIAL PRESENTATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ NICOLA OROFINO FRANCESCA GUIDOTTI DANIELE CATTANEO MARIARITA SCIUMÃ UMBERTO GIANELLI AGOSTINO CORTELEZZI  ALESSANDRA LURLO PUBLISHED LEUKEMIA  LYMPHOMA PUBLISHED ELECTRONICALLY 17MAR2016 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE SEROMA LYMPHOMA-ALCL PRURITUS EOSINOPHILIA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/01/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6139164|61260979|D|1||JOURNAL ARTICLE MARKED EOSINOPHILIA INITIAL PRESENTATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORTS DESCRIBE CASE BI-ALCL PATIENT PRESENTED HYPEREOSINOPHILIA DIFFUSE PRURITUS PATIENT PRESENTED DISCOMFORT MODERATE PAIN LEFT BREAST DIAGNOSIS CHRONIC SEROMA MADE LEUKEMIA  LYMPHOMA 5711 2712-2715 DEVICE REMOVED REPLACED TEXTURED IMPLANT ALLERGAN PATIENTS SYMPTOMS PERSISTED REPLACEMENT IMPLANT ALSO REMOVED ARTICLE STATES CHRONIC SEROMA CONTINUED TRU-CUT BIOPSY CARRIED THREE YEARS LATER REVEALED CHRONIC INFLAMMATIONÂ¿ ARTICLE GOES STATE HISTOLOGICAL EXAMINATION PSEUDO-CAPSULE SHOWED DIFFUSE INFILTRATION LARGE CELLS IRREGULAR ANAPLASTIC Â¿EMBRYO-LIKEÂ¿ NUCLEI ABUNDANT EOSINOPHILIC GRANULAR CYTOPLASM MALIGNANT POPULATION TESTED CD30+ ALK-1 EXPRESSION BONE MARROW BIOPSY PERFORMED STAGING PURPOSES ALSO NEGATIVE DIAGNOSIS BI-ALCL MADE FILE REPRESENTS DEVICE REMOVED PREVIOUS ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/01/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6196606|63054803|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS CANNOT OBTAINED TIME CONTACTFOLLOW INFORMATION PROVIDED FOUND DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS ARTICLE CITATION ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT NEW CASE ALVARO IBARRA MARCELA JACARD SOLEDAD TORRES PATRICIA FARDELLA MD AMERICAN SOCIETY CLINICAL PATHOLOGY 2016146S1-S26|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/21/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6144474|61423058|N|1||ARTICLE CITATION Â¿WHOLE EXOME SEQUENCING REVEALS ACTIVATING JAK1 STAT3 MUTATIONS BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMA PIERS BLOMBERY ELLA R THOMPSON KATE JONES GISELA MIR ARNAU STEPHEN LADE JOHN F MARKHAM JASON LI ANAND DEVA RICKY W JOHNSTONE AMIT KHOT H MILES PRINCE DAVID WESTERMAN PUBLISHED HAEMATOLOGICA ELECTRONICALLY PUBLISHED SEPTEMBER 2016 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE SEROMA LYMPHOMA-ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/05/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5978073|55648789|D|1||ALCL LEFT BREAST|BREAST IMPLANT||09/23/2016||04/04/2016||R|*||0HP|FTR|1.0||BREAST IMPLANT|||||||ALLERGAN|||||||True
5620587|44062743|N|1||B4 PHYSICIAN NOTED DEVICE LONGER AVAILABLE RETURN THEREFORE ALLERGAN RECEIVE ANALYSIS TESTING DONE REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL Â¿ INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION NECROSIS NECROSIS MAY INHIBIT WOUND HEALING REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION PERMANENT SCAR DEFORMITY MAY OCCUR RESULT NECROSIS USE MICROWAVE DIATHERMY PATIENTS BREAST IMPLANTS MICROWAVE DIATHERMY REPORTED CAUSE TISSUE NECROSIS SKIN EROSION IMPLANT EXTRUSION|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|06/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||306845|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176830|62457611|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 -YEAR-OLD PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA TREATMENT REPORTED IMPLANT REMOVAL FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176830|62457610|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5803927|49896517|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE DEFLATION DECREASED NIPPLE SENSATION LATE PRESENTING SEROMA CAPSULAR CONTRACTURE BAKER GRADE IV TREATMENT OCCURRED PATIENT ADDITIONALLY REPORTED FOLLOWING EXPLANT SURGERY DIAGNOSED ALCL STATED CANCER DEVELOPED ALLERGIC PLASTIC HEALTH PROFESSIONAL CONFIRMED PATIENT CANCER DIAGNOSIS SEPARATE ALCL PATIENT REPORTED EXPERIENCED SWELLING DIMPLING WRINKLING TENDERNESS 10 YEARS EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL YET RECEIVED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-560|07/19/2016||09/25/2015||R|Y||0HP|FWM|1.0|06/26/2006|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||578468|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5803927|49896516|N|1||EVENTS CAPSULAR CONTRACTURE NIPPLE SENSATION INCREASEDECREASE SEROMA DEFLATION PREVIOUSLY REPORTED VIA ASR B6 2016 ADDITION LAB ANALYSIS RESULTS DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-560|07/19/2016||09/25/2015||R|Y||0HP|FWM|1.0|06/26/2006|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||578468|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6153092|61703506|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ 137 6 1659-1669 HONGHUA HU PHD KHALID JOHANI AHMAD ALMATROUDI KAREN VICKERY PHD BVSC BRUCE VAN NATTA MD MARSHALL E KADIN MD GARRY BRODY MD MARK CLEMENS MD CHAN YOON CHEAH MD STEPHEN LADE MD PREETI AVINASH JOSHI MDPHD H MILES PRINCE MDPHD ANAND K DEVA BSCMED MBBS MS PUBLISHED JUNE 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6153092|61703507|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES GATHERED FOUR CENTERS INTERNATIONAL COLLABORATIVE STUDY TOTAL 22 PATIENTS TABLE 1Â¿ ARTICLE GOES STATE Â¿BOTH BREAST IMPLANTÂ¿ASSOCIATED ALCL NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG TISSUE CAPSULE 49 Ã 106 CELLSMG TISSUE ANALYSIS MICROBIOME BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES SPECIES IDENTIFIED NONTUMOR CAPSULE SPECIMENS SIGNIFICANTLY GREATER PROPORTION RALSTONIA SPP PRESENT ALCL SPECIMENS COMPARED NONTUMOR CAPSULE SPECIMENS P  005 CONTRAST SIGNIFICANTLY STAPHYLOCOCCUS SPP FOUND ASSOCIATED NONTUMOR CAPSULE SPECIMENS COMPARED BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM VISUALIZED SCANNING ELECTRON MICROSCOPY FLUORESCENT SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- CD30+ REPORTED ARTICLE ADDITIONALLY REPORTS Â¿COMPARED CLASSIC SYSTEMIC ALCL BREAST IMPLANTÂ¿ ASSOCIATED ALCL BEHAVES INDOLENT MANNER DIVIDED PATHOLOGIC VARIETIESTHE LESS COMMON MASS-TYPE CLINICALLY AGGRESSIVE INFILTRATING TUMORÂ¿ CURRENTLY WAY DETERMINE CASES DEVICE TYPE TESTED NEGATIVE BACTERIAL INFECTION REPORT CAPTURE 5 CASES ALCL PRESENTED TUMOR MASS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6167285|62187250|D|1||ABSTRACT LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTS Â¿19 I-ALCLSÂ¿ CASES ARTICLE ADDITIONALLY STATES Â¿FIVE PATIENTS PRESENTED ERYTHEMATOUS SKIN ERUPTIONÂ¿ RECORD CREATED CAPTURE 5 CASES ALCL Â¿ERYTHEMATOUS SKIN ERUPTIONÂ¿ ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ REGARDS TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL PERFORMED 17 19 PATIENTS ADDITIONAL TREATMENT BASED MOSTLY CHOP CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 IRRADIATION N = 119 CHOP ALONE ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL GIVEN TWO PATIENTSÂ¿ CURRENTLY WAY DETERMINE TREATMENTS USED 65 CASES MANUFACTURER DEVICES UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6167285|62187249|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL ERYTHEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6157808|62108428|D|1||LITERATURE ARTICLE Â¿COMPREHENSIVE IMMUNOPHENOTYPIC ANALYSIS 64 CASES BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA SHOWS ACTIVATED CYTOTOXIC SILENT T-CELL RECEPTOR PATTERNÂ¿ REPORTS Â¿64 CASESÂ¿ ARTICLE CONTINUES STATE Â¿WE REVIEWED WORLD LITERATURE CASES BI-ALCL ACCRUED CASES IMMUNOPHENOTYPIC DATA DERIVED USING IMMUNOHISTOCHEMICAL FLOW CYTOMETRY METHODS USED LEAST 5 FOLLOWING 13 MARKERS REPORTED CD3 CD4 CD8 CD30 CD43 CD45 EMATIA-1 GRANZYME-B ALK-1 TCR-Â¿Â¿ TCR-GÂ¿ EBER SITU HYBRIDIZATION LESS 5 MARKERS REPORTED CONTACTED CORRESPONDING AUTHORS AVAILABLE MATERIAL ADDITIONAL STUDIES INCLUDED DATAÂ¿ Â¿CD30 POSITIVE N=64 CASES WHEREAS ALK EBER NEGATIVE TESTED CASES N=56 N=25 RESPECTIVELY CD3 POSITIVE 15 62 24 CASES CD4 4361 70 CD8 657 11 CD43 37 46 80 CD45 2949 59 EMA 2542 60 TIA-1 2846 61 GRANZYME-B 28 47 60 TCR Â¿Â¿ 5 24 21 TCR GÂ¿ 1 23 4 THUS TCR SILENT 1824 75 CASESÂ¿ CYTOLOGICAL MARKERS ALK- CD30+ REPORTED RECORD CREATED CAPTURE 56 CASES BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6157808|62108427|N|1||EVENT LYMPHOMA ALCL PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED AUTHOR RESPONDED REFUSED PROVIDE INFORMATION DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL Â¿COMPREHENSIVE IMMUNOPHENOTYPIC ANALYSIS 64 CASES BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA SHOWS ACTIVATED CYTOTOXIC SILENT T-CELL RECEPTOR PATTERNÂ¿ ANA CLAUDIA FROTA LOPES L JEFFREY MEDEIROS MARK W CLEMENS MING CHAI HUI LIU ARIANNA DI NAPOLI STEPHEN LADE MITUAL AMIN KEN H YOUNG ROBERTO MIRANDA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5612275|43806327|D|1||DIAGNOSED ALCL SILICONE BREAST IMPLANTS PLACED LEFT BREAST GREW APPROX 50 LARGER PAIN FINE NEEDLE ASPIRATION STRAW COLORED FLUID TWO WEEKS GIVEN DIAGNOSIS ALCL ANAPLASTIC LARGE CELL LYMPHOMA MET LYMPHOMA SPECIALIST BREAST SURGEON B6 2016 B6 2016 UNDERWENT CAPSULECTOMY LEFT BREAST BILATERAL REMOVAL BREAST IMPLANTS PET SCAN REVEALED SYSTEMIC MIGRATION LYMPHOMA|SILICONE BREAST IMPLANTS||04/25/2016||||N|*||I|FTR|1.0||SILICONE BREAST IMPLANTS|||||||nan|||||||True
6143032|61396907|D|1||ABSTRACT LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTED Â¿19 I-ALCLSÂ¿ CASES ONE TWO CLINICAL PRESENTATIONS REPORTED Â¿EFFUSIONÂ¿ ELEVEN PATIENTS EXPERIENCED ALCL EFFUSION RECORD REPRESENTS 11 CASES ALCL PRESENTED EFFUSION HISTOPATHOLOGY REPORTS MALIGNANT CELLS CD30-POSITIVE ALK NEGATIVE ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ REGARDS TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL PERFORMED 17 19 PATIENTS ADDITIONAL TREATMENT BASED MOSTLY CHOP CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 IRRADIATION N = 119 CHOP ALONE ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL GIVEN TWO PATIENTSÂ¿ CURRENTLY WAY DETERMINE TREATMENTS USED 11 CASES MANUFACTURER DEVICES UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6143032|61396906|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL LATE SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011805|56820798|D|1||ALLERGANÂ¿S LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ TABLE 5 Â¿TNM STAGING PATIENTS ANZ COHORTÂ¿ ARTICLE REPORTS ADDITIONAL THREE OCCURRENCES DEATH APPROX 2 CASES Â¿DEATH  MASS EXTENDING BEYOND CAPSULEÂ¿ ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS MANUFACTURER COULD SPECIFIED ARTICLE STATES Â¿BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED 571 IMPLANTS SERIES ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011805|56820797|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011770|56819840|N|1||MEDWATCH SENT FDA 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011770|56819841|D|1||ALLERGANS LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND - HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGY TABLE 4 PRESENTATION BIA-ALCL N=46 ARTICLE REPORTS FOLLOWING 1 CASE MASS METASTATIC DISEASE AXILLA TABLE 4 DEATH  MASS METASTATIC DISEASE ONE LYMPH NODE AXILLA TABLE 5 MANUFACTURER COULD SPECIFIED ARTICLE STATES BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED 571 IMPLANTS SERIES ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS ARTICLE STATES PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6153118|61701317|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES GATHERED FOUR CENTERS INTERNATIONAL COLLABORATIVE STUDY TOTAL 22 PATIENTS TABLE 1Â¿ ARTICLE GOES STATE Â¿BOTH BREAST IMPLANTÂ¿ASSOCIATED ALCL NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG TISSUE CAPSULE 49 Ã 106 CELLSMG TISSUE ANALYSIS MICROBIOME BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES SPECIES IDENTIFIED NONTUMOR CAPSULE SPECIMENS SIGNIFICANTLY GREATER PROPORTION RALSTONIA SPP PRESENT ALCL SPECIMENS COMPARED NONTUMOR CAPSULE SPECIMENS P  005 CONTRAST SIGNIFICANTLY STAPHYLOCOCCUS SPP FOUND ASSOCIATED NONTUMOR CAPSULE SPECIMENS COMPARED BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM VISUALIZED SCANNING ELECTRON MICROSCOPY FLUORESCENT SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- CD30+ REPORTED ACCORDING TABLE 1 Â¿CLINICAL SUMMARY BREAST IMPLANTÂ¿ASSOCIATED ALCL PATIENTSÂ¿ 1 CASE ALCL PRESENT Â¿CAPSULEÂ¿ ARTICLE CLARIFIES Â¿CAPSULEÂ¿ CASE Â¿ONE PATIENT DIAGNOSIS BREAST IMPLANTÂ¿ASSOCIATED ALCL INCIDENTAL FINDING UNDERGOING IMPLANT EXCHANGE CAPSULAR CONTRACTUREÂ¿ CURRENTLY WAY DETERMINE CASES TESTED NEGATIVE BACTERIAL INFECTION REPORT CAPTURE 1 CASE ALCL PRESENTED Â¿CAPSULEÂ¿ REPRESENTED TERM CODE CAPSULAR CONTRACTURE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6153118|61701316|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT DEFLATION ONE COMMON REASONS REOPERATION PATIENTS ALSO ADVISED ADDITIONAL SURGERY MAY NEEDED CASES PAIN ANDOR FIRMNESS SEVERE SURGERY RANGES REMOVAL IMPLANT CAPSULE TISSUE REMOVAL POSSIBLE REPLACEMENT IMPLANT SURGERY MAY RESULT LOSS BREAST TISSUE CAPSULAR CONTRACTURE MAY HAPPEN ADDITIONAL SURGERIES CAPSULAR CONTRACTURE MAY INCREASE RISK DEFLATION B4|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6167248|62147367|D|1||ABSTRACT LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTS Â¿19 I-ALCLSÂ¿ CASES ONE CLINICAL PRESENTATIONS REPORTED Â¿MASS + SEROMAÂ¿ 6 PATIENTS EXPERIENCED  ALCL Â¿MASS + SEROMAÂ¿ RECORD CREATED CAPTURE 6 CASES ALCL Â¿MASS + SEROMAÂ¿ ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿  REGARDS TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL PERFORMED 17 19 PATIENTS ADDITIONAL TREATMENT BASED MOSTLY CHOP CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 IRRADIATION N = 119 CHOP ALONE ABVD FOLLOWING RADIATION WITHOUT  IMPLANT REMOVAL GIVEN TWO PATIENTSÂ¿ CURRENTLY WAY DETERMINE TREATMENTS USED 6 CASES MANUFACTURER DEVICES UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6167248|62147366|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL LATE SEROMA LUMPNODULE PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011872|56922006|N|1||MEDWATCH SENT FDA 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011872|56922007|D|1||ALLERGANÂ¿S LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ TABLE 4 Â¿PRESENTATION BIA-ALCL N=46Â¿ ARTICLE REPORTS FOLLOWING 5 CASES Â¿MASS ONLYÂ¿ TWO RECORDS CAPTURED EVENTS LYMPHOMA-ALCL MASS  IDENTIFIED PREVIOUSLY REPORTED RECORD CREATED CAPTURE REMAINING 3 5 CASES NOTED ARTICLE LYMPHOMA-ALCL MASS MANUFACTURER COULD SPECIFIED ARTICLE STATES Â¿BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED 571 IMPLANTS SERIESÂ¿ ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011849|56929012|D|1||ALLERGANS LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 - HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGY TABLE 4 PRESENTATION BIA-ALCL N=46 ARTICLE REPORTS FOLLOWING 35 CASES SEROMA SPECIFIED ARTICLE UNILATERAL LATE SEROMA EIGHTEEN RECORDS CAPTURED EVENTS LYMPHOMA-ALCL SEROMA  IDENTIFIED PREVIOUSLY REPORTED RECORD CREATED CAPTURE REMAINING 17 35 CASES NOTED ARTICLE LYMPHOMA-ALCL SEROMA MANUFACTURER COULD SPECIFIED ARTICLE STATES BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED B4 IMPLANTS SERIES ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS ARTICLE STATES PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011849|56929011|N|1||MEDWATCH SENT FDA 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5834667|50817904|D|1||ACCORDING INFORMATION PROVIDED PATIENT DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL LEFT PROSTHESIS ASSOCIATED COMPLAINT RETURNED MENTOR ADDITIONAL INFORMATION ANDOR DEVICE BECOME AVAILABLE PE COMPLAINT REEVALUATED TIME BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ACCORDING FDA INCIDENCE ALCL PATIENTS BREAST IMPLANTS SMALL FRACTION 5-10 MILLION WOMEN RECEIVED BREAST IMPLANTS WORLDWIDE INVESTIGATION DEVICE HISTORY RECORD REVEALED IRREGULARITIES REVIEW NC SYSTEM COMPLAINT DATABASE REVEALED COMPLAINTS ASSOCIATED LOT 6438477 MAIN SYMPTOMS ALCL WOMEN BREAST IMPLANTS LATE ONSET PERSISTENT SWELLING PAIN VICINITY IMPLANT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL MENTOR CONCURS FDAS POSITION RISK ALCL APPEARS SMALL FDA BELIEVES TOTALITY EVIDENCE CONTINUES SUPPORT REASONABLE ASSURANCE FDA-APPROVED BREAST IMPLANTS SAFE EFFECTIVE USED LABELED ANAPLASTIC LARGE CELL LYMPHOMA ALCL KNOWN COMPLICATION ASSOCIATED DEVICES REFERENCED IFU|MEMORY GEL SILTEX ROUND MODERATE PLUS PROFILE MAMMARY PROSTHESIS|3544751|07/29/2016|||DA|N|R||I|FTR|1.0||BREAST IMPLANT||6438477|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR|75038|TX|75038||||True
5846884|51173307|D|1||ALCL|MEMORY GEL SILTEX ROUND MODERATE PLUS PROFILE MAMMARY PROSTHESIS|354-2513|08/04/2016||||N|R||0HP|FTR|1.0||BREAST IMPLANT||5933012|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR|75038|TX|75038||||True
5695364|46431599|D|1||HEALTH PROFESSIONAL REPORTED PATIENT SUFFERED SIZE INCREASE RECONSTRUCTED RIGHT BREAST APPROXIMATELY THREE YEARS FOUR MONTHS IMPLANTATION SIZE INCREASE COMPATIBLE SEROMA CONSERVATIVE TREATMENT INITIATED CONSISTING ANTIBIOTIC THERAPY CORTICOSTEROIDS PATIENT ADVISED REST RIGHT ARM PUNCTURED TWICE PERFORM HISTOLOGICAL ANALYSIS GERMINAL CELL RESULTS DETERMINED ATYPICAL CELLS REASON DEVICE EXPLANTED COMPLETE CAPSULECTOMY MADE PATIENT PATHOLOGY REPORT CAPSULE POSITIVE ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA ALCL ASSOCIATED BREAST IMPLANTS CD30 RESULTS PROVIDED CASE CURRENTLY SUSPECTED-ALCL CAPTURED LYMPHOMA PATIENTS CONDITION PROGRESSED FAVOURABLY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX135-445|06/02/2016||||N|R||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2070807|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5695364|46431598|N|1||MEDWATCH SENT FDA 06022016 SEROMA RUPTURE INITIALLY SUBMITTED FDA VIA 410 PSR 01212016 DEVICE FOUND INTACT RUPTURE OCCUR EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT PHYSICIAN CONFIRMED DEVICE RETURNED PHYSICIAN RESPONDED FOLLOW-UP ATTEMPTS COMPLETION ALCL QUESTIONNAIRE PATHOLOGY REPORTS DEVICE HISTORY REVIEW REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT VERIFIED SCRAP RELATED REPORTED EVENT ONE DEVICE SCRAPPED ADDITION DHR SHELL RUNS NUMBER 10008414 10008555 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL Â¿ INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX135-445|06/02/2016||||N|R||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2070807|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5440576|38326420|D|1||ALCL CASE REPORT REPORT CASE B6 WOMAN PREVIOUS HISTORY SMOKING MULTIPLE BREAST AUGMENTATION SURGERIES IMPLANTS FIRST ONE 20 YEARS AGO 15 YEARS AGO LAST 3 YEARS AGO B6 2012 DENIED HISTORY ALLERGIC REACTION TRANSFUSION MEDICAL PROBLEMS TAKING ASPIRIN 81MG MOMENT EVENT ADMITTED HOSPITAL B6 2016 5 MONTH HISTORY PROGRESSIVE SWELLING RIGHT ARM ALSO ERYTHEMATOUS RASH ARM EXTENDING CHEST RIGHT BREAST SKIN INDURATED FIRM LUMP RIGHT EXTERNAL QUADRANT RIGHT BREAST PAIN ARM DIDNT FEVER ORDERED MRI ARM INVOLVING BREAST SHOWED FASCIAL HYPERINTENSITY SWELLING SOFT TISSUE ADDITIONALLY PERFORMED ROUTINE LABORATORIES SHOWED HYPERLEUKOCYTOSIS 38000 SEVERE EOSINOPHILIA 26000 HAEMOGLOBIN PLATELETS NORMAL HS-CRP 292 PROCALCITONIN NEGATIVE LDH 393 BETA-2 MICROGLOBULIN 2000 KIDNEY LIVER FUNCTION TEST UNREMARKABLE PERFORMED PET SCAN SHOWED HYPERMETABOLISM PREVIOUS DESCRIBED SWOLLEN AREA ENLARGEMENT HYPERMETABOLISM PERIHEPATIC LYMPH NODES THEREFORE BIOPSY ARM PERFORMED PATHOLOGIC SPECIMEN INCLUDED SKIN SOFT TISSUE FASCIA MUSCLE PATHOLOGY RESULT CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA CD4+ CD30+ EMA+ ALT- SURGICAL REMOVAL BREAST IMPLANTS CARRIED PATHOLOGY LAB CONFIRMED AROUND IMPLANTS CAPSULE RIGHT BREAST EXTENDED INFILTRATION NEOPLASTIC CELLS CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA IMMUNOHISTOCHEMISTRY PROFILE INTERESTINGLY NEOPLASTIC CELLS SURROUNDED EOSINOPHIL-RICH INFLAMMATORY INFILTRATE LEFT IMPLANT DIDNT NEOPLASTIC CELLS IMPLANTS ALLERGAN MODEL MHP VOLUME 130 CUBIC CENTIMETERS ROUND FILLED COHESIVE SILICONE CURRENTLY PT SYSTEMIC CHEMOTHERAPY CYCLOPHOSPHAMIDE DOXORUBICIN ETOPOSIDE VINCRISTINE PREDNISONE|ALLERGAN SILICONE BREAST IMPLANT||02/11/2016||||*|*||0HP|FTR|1.0||ALLERGAN SILICONE BREAST IMPLANT||||||US|ALLERGAN|||||MHP||True
5440576|38326420|D|1||ALCL CASE REPORT REPORT CASE B6 WOMAN PREVIOUS HISTORY SMOKING MULTIPLE BREAST AUGMENTATION SURGERIES IMPLANTS FIRST ONE 20 YEARS AGO 15 YEARS AGO LAST 3 YEARS AGO B6 2012 DENIED HISTORY ALLERGIC REACTION TRANSFUSION MEDICAL PROBLEMS TAKING ASPIRIN 81MG MOMENT EVENT ADMITTED HOSPITAL B6 2016 5 MONTH HISTORY PROGRESSIVE SWELLING RIGHT ARM ALSO ERYTHEMATOUS RASH ARM EXTENDING CHEST RIGHT BREAST SKIN INDURATED FIRM LUMP RIGHT EXTERNAL QUADRANT RIGHT BREAST PAIN ARM DIDNT FEVER ORDERED MRI ARM INVOLVING BREAST SHOWED FASCIAL HYPERINTENSITY SWELLING SOFT TISSUE ADDITIONALLY PERFORMED ROUTINE LABORATORIES SHOWED HYPERLEUKOCYTOSIS 38000 SEVERE EOSINOPHILIA 26000 HAEMOGLOBIN PLATELETS NORMAL HS-CRP 292 PROCALCITONIN NEGATIVE LDH 393 BETA-2 MICROGLOBULIN 2000 KIDNEY LIVER FUNCTION TEST UNREMARKABLE PERFORMED PET SCAN SHOWED HYPERMETABOLISM PREVIOUS DESCRIBED SWOLLEN AREA ENLARGEMENT HYPERMETABOLISM PERIHEPATIC LYMPH NODES THEREFORE BIOPSY ARM PERFORMED PATHOLOGIC SPECIMEN INCLUDED SKIN SOFT TISSUE FASCIA MUSCLE PATHOLOGY RESULT CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA CD4+ CD30+ EMA+ ALT- SURGICAL REMOVAL BREAST IMPLANTS CARRIED PATHOLOGY LAB CONFIRMED AROUND IMPLANTS CAPSULE RIGHT BREAST EXTENDED INFILTRATION NEOPLASTIC CELLS CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA IMMUNOHISTOCHEMISTRY PROFILE INTERESTINGLY NEOPLASTIC CELLS SURROUNDED EOSINOPHIL-RICH INFLAMMATORY INFILTRATE LEFT IMPLANT DIDNT NEOPLASTIC CELLS IMPLANTS ALLERGAN MODEL MHP VOLUME 130 CUBIC CENTIMETERS ROUND FILLED COHESIVE SILICONE CURRENTLY PT SYSTEMIC CHEMOTHERAPY CYCLOPHOSPHAMIDE DOXORUBICIN ETOPOSIDE VINCRISTINE PREDNISONE|ALLERGAN SILICONE BREAST IMPLANT||02/11/2016||||*|*||0HP|FTR|2.0||ALLERGAN SILICONE BREAST IMPLANT||||||US|ALLERGAN|||||MHP||True
5759530|48466890|D|1||PATIENT REPORTED LEFT BREAST CAPSULAR CONTRACTURE SEROMA TOTAL CAPSULECTOMY LEFT BREAST EXCHANGE PERFORMED SURGICAL LOG REPORTS 200 CC SEROUS FLUID PRESENT LEFT SEROLOGY + ALCL PATHOLOGY + ALCL CYTOLOGY REPORT DATED B6 2016 STATES LEFT BREAST FLUID HIGHLY ATYPICAL LYMPHOCYTES PRESENT CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE COMMENT MORPHOLOGY HIGHLY ATYPICAL CELLS SEEN SPECIMEN B SIMILAR SPECIMEN CELLS DEMONSTRATE STAINING CD30 OVERALL FEATURES CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/29/2016|||DA|N|R||0HP|FTR|1.0|08/30/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180804|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5759530|48466889|N|1||MEDWATCH SENT FDA 06292016 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT KNOWN DEVICE RETURNED PATIENT DECLINED PERMISSION CONTACT DOCTOR INFORMATION TIME DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/29/2016|||DA|N|R||0HP|FTR|1.0|08/30/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180804|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5759530|50477356|D|1||PATIENT REPORTED LEFT BREAST CAPSULAR CONTRACTURE SEROMA TOTAL CAPSULECTOMY LEFT BREAST EXCHANGE PERFORMED SURGICAL LOG REPORTS 200 CC SEROUS FLUID PRESENT LEFT SEROLOGY + ALCL PATHOLOGY + ALCL CYTOLOGY REPORT DATED B6 2016 STATES 62213FT BREAST FLUID HIGHLY ATYPICAL LYMPHOCYTES PRESENT CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE COMMENT MORPHOLOGY HIGHLY ATYPICAL CELLS SEEN SPECIMEN B SIMILAR SPECIMEN CELLS DEMONSTRATE STAINING CD30 OVERALL FEATURES CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE62282|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/29/2016|||DA|N|R||0HP|FTR|1.0|08/30/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180804|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176648|62440610|D|1||LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ ARTICLE REPORTED CASES Â¿INFILTRATIVE I-ALCLÂ¿ SURVIVAL RATE 525 B6 PATIENT IMPLANTED TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN CHART ADDITIONALLY PROVIDES PATIENT EXPERIENCED LEFT SEROMA MASS ARTICLE ADDITIONALLY STATES PATIENT 11 Â¿PRESENTED ERYTHEMATOUS SKIN ERUPTION TREATMENT REPORTED IMPLANT REMOVAL CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP REVEALED PATIENT DIED LYMPHOMA PROGRESSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176648|62440609|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS DEATH LYMPHOMA ALCL SEROMA LUMP ERYTHEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5901883|52941731|D|1||HEALTHCARE PROFESSIONAL REPORTED PATIENT DIAGNOSED LEFT SIDE ALCL B6 2015 PER SCAN HOSPITAL PERI IMPLANT FLUID+ I+D INCISION DRAINAGE PATIENT REFERRED ONCOLOGIST GENERAL SURGEON RECOMMENDED CAPSULECTOMY LEFT SIDE CAPSULECTOMY PERFORMED B6 2015 CAPSULE SENT PATHOLOGY LYMPHOMA CELLS FOUND FIBROUS CAPSULE WITHIN PERI-IMPLANT MASS ALK NEGATIVE CD30 POSITIVE B6 2015 PATHOLOGY REPORT NOTED  TENSIVE NECROSIS ACUTE INFLAMMATORY CELLS B6 2016 RECURRENT MASSES DIISCOVERED REPEAT PET SCAN ORDERED B6 2016 BIOPSY RECURRENT MASSES IMMUNOCHEMISTRY SENT B6 2016 PT EVALUATED PLASTIC SURGEON TREATMENT BEGAN B6 2016 CHEMO CYTOXANADRIAMYCINVINCRISTINEPREDNISONE B6 2016 PATIENT RECOMMENDED PHYSICIAN CHANGE BRENTUXIMAB MONOTHERAPY HEALTH PROFESSIONAL ADDITIONALLY REPORTED PATIENT ALSO EXPERIENCED FOLLOWING SYSTEMIC SYMPTOMS FEVERS NIGHT SWEATS BREAST SKIN LESIONS PAIN REDNESS PALPABLE BREAST MASS PRESENT SURGERY SEROMA CAPSULAR CONTRACTURE BAKER GRADE SPECIFIED DEVICE REMOVED REPLACEMENT|UNK SALINE IMPLANT|UNK SALINE IMPLANT|08/24/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5901883|52941730|N|1||B4 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING DEVICE INFORMATION REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES BREAST SENSATION SEROMA NECROSIS LYMPHADENOPATHY |UNK SALINE IMPLANT|UNK SALINE IMPLANT|08/24/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5415251|38228137|N|1||IDEAL IMPLANT SUBMIT MDR WITHIN 30 DAYS BECOMING AWARE INCIDENT FOLLOWING REASONS PER FDA REGULATIONS REPORTABLE EVENTS SERIOUS INJURY ONE LIFE THREATENING RESULTS PERMANENT IMPAIRMENT BODY FUNCTION PERMANENT DAMAGE BODY STRUCTURE NECESSITATES MEDICAL SURGICAL INTERVENTION PRECLUDE PERMANENT IMPAIRMENT BODY FUNCTION PERMANENT DAMAGE BODY STRUCTURE PER DEFINITION NOTED IDEAL IMPLANT INCORPORATED UNDERSTOOD COMMON SALINE BREAST IMPLANT DEFLATION WOULD FALL WITHIN DEFINITION SERIOUS INJURY WOULD THEREFORE CONSIDERED REPORTABLE ALTHOUGH SURGICAL INTERVENTION MAY PERFORMED REMOVE ANDOR REPLACE BREAST IMPLANT MEDICALLY REQUIRED PRECLUDE PERMANENT IMPAIRMENT BODY FUNCTION PERMANENT DAMAGE BODY STRUCTURE IMPLANTS FILLED NORMAL SALINE HARMLESSLY ABSORBED BODY DEFLATION POSES MINIMAL RISK PATIENT CONSIDERED SERIOUS ABSENCE ADDITIONAL SERIOUS CONDITION EXTRUSION TISSUE NECROSIS SEPSIS LYMPHOMA ALCL NEUROLOGIC PROBLEM BREAST MASS POSSIBLE AFFECT FETUS ETC DEFLATION ABSENT ADDITIONAL SERIOUS PATIENT CONDITION POSE RISK PATIENT DEATH SERIOUS INJURY IDEAL IMPLANT CONSIDER DEFLATION SURGERY REMOVE DEFLATED IMPLANT SURGICAL INTERVENTION PRECLUDE PERMANENT IMPAIRMENT BODY FUNCTION PERMANENT DAMAGE BODY STRUCTURE DEFLATION TYPE DEVICE MALFUNCTION SERIOUS INJURY SERIOUS CONDITION DEATH REPORTED CONSEQUENCE WOULD CONSIDERED REPORTABLE HOWEVER RECENT FDA INSPECTION PERFORMED 212016-232016 OBSERVATION MADE DEFLATION REPORTED FDA UPON LEARNING FDA CONSIDERS DEFLATION EXPLANTED REPORTABLE IDEAL IMPLANT BEGAN SUBMITTING REPORTS PAST DEFLATIONS CONTINUE REPORT INSTANCES EXPLANTED DEFLATIONS FUTURE|IDEAL IMPLANT STRUCTURED BREAST IMPLANT|405|02/06/2016||12/04/2015||R|Y||001|FWM|1.0||SALINE-FILLED BREAST IMPLANT||61042|5005 LYNDON B JOHNSON FREEWAY|SUITE 900|DALLAS|US|IDEAL IMPLANT INCORPORATED|75244|TX|75244||40501||True
6106949|60072476|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE DEVICE REMOVAL DUE SEROMA ADDITIONAL REPORT DX BIA ALCL SEROLOGY IMAGING REPORT PROVIDED RIGHT SILICONE IMPLANT NOTED SOMEWHAT DEFORMED SHAPE SIGNIFICANT AMOUNT FLUID SURROUNDING IMPLANT SEROMA APPEARED B6 2016 ALCL DIAGNOSIS DATE B6 2016 UNKNOWN EXPLANTED DEVICE RETURNED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF125-375|11/16/2016||||*|*||0HP|FTR|1.0|11/08/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1359584|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6106949|60072475|N|1||EVENTS LYMPHOMA SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS CURRENTLY UNKNOWN EXPLANTED DEVICE RETURNED REPORTER CONFIRMED DEVICE SENT PATHOLOGY ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY RECORD DHR REVIEW REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT B4 VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUN NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL IMPLANT PALPABILITYVISIBILITY HEMATOMASEROMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF125-375|11/16/2016||||*|*||0HP|FTR|1.0|11/08/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1359584|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5597788|43347569|D|1||ALCL BREAST IMPLANT ASSOCIATED|MCGHAN||04/20/2016||||N|*||0HP|FWM|1.0||TEXTURED BREAST IMPLANT SALINE||||||US|MCGHAN|||||||True
6141438|61344363|D|1||REPORTED EVENTS Â¿ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ Â¿LATE SEROMAÂ¿ OCCURRING MCGHAN STYLE 153 LUMEN DEVICE FOUND WITHIN JOURNAL ARTICLE Â¿LONG-TERM OUTCOMES MCGHAN STYLE 153 DUAL-LUMEN BREAST IMPLANT IMPLICATIONS FUTURE IMPLANT DESIGNÂ¿ JOURNAL PLASTIC RECONSTRUCTIVE AESTHETIC SURGERY 69 02 JUL 2016 PP 1211-1217 ARTICLE STATES Â¿ONE CASE 075 ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED DEVELOPMENT LATE SEROMA TEN YEARS POST-OPERATIVELYÂ¿ INFORMATION PROVIDED PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CAPTURED LYMPHOMA AFFECTED SIDE SPECIFIED|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|12/02/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6141438|61344362|N|1||ARTICLE CITATION LONG-TERM OUTCOMES MCGHAN STYLE 153 DUAL-LUMEN BREAST IMPLANT IMPLICATIONS FUTURE IMPLANT DESIGNÂ¿ DC HAMMOND WP SCHMITT PUBLISHED J PLAST RECONSTR AESTHET SURG ELECTRONICALLY PUBLISHED 07022016 INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME EVENTS LYMPHOMA SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL - ATTACHMENT ARTICLE - LONG-TERM OUTCOMESPDF|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|12/02/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5962723|55115726|N|1||MEDWATCH SENT FDA 09202016 ALLERGAN INITIATED INVESTIGATION LATE REPORT B4 ARTICLE CITATION FIRST CASE REPORT MEXICO LATIN AMERICA ANAPLASTIC LARGE CELL LYMPHOMA PATIENT MAMMARY IMPLANTS TORRES-RIVERO CESAR RAMOS-GALLARDO GUILLERMO NAMBO-LUCIO DE JESÃS VAQUERO-PÃREZ MAR CIR PLÃST IBEROLATINOAM-VOL 42 Â¿ 2 APRIL Â¿ MAY Â¿ JUNE 2016  P 175-180 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING SERIAL NUMBER LOT NUMBER IMPLANTEXPLANT DATE IMPLANTINGEXPLANTING PHYSICIAN PATIENT DATE BIRTH DEVICE RETURN STATUS DEVICE RELATIONSHIP REPORTED EVENTS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL PAIN VARYING INTENSITY LENGTH TIME MAY OCCUR PERSIST FOLLOWING BREAST IMPLANT SURGERY PATIENTS ADVISED CONTACT SURGEON SIGNIFICANT PAIN PAIN PERSISTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/20/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5962723|55115727|D|1||FOLLOWING JOURNAL ARTICLE REVIEWED Â¿FIRST CASE REPORT MEXICO LATIN AMERICA ANAPLASTIC LARGE CELL LYMPHOMA PATIENT MAMMARY IMPLANTS AUTHORS REPORT KNOWLEDGE PRESENT FIRST CASE REPORTED PLASTIC SURGEON MEXICO LATIN AMERICA PATIENT HISTORY BREAST AUGMENTATION UNILATERAL ASYMMETRY DUE LATE SEROMA 2 UNSUCCESSFUL PUNCTURES REMOVAL BREAST IMPLANT CAPSULECTOMY SCHEDULED DIAGNOSIS ALCL CONFIRMED PERIPROSTHETIC FLUID DEVICE DETAILS SPECIFIED PLACEMENT 290 CC TEXTURED COHESIVE GEL ANATOMICAL IMPLANTS MCGHAN MEDICAL CORPORATION B6 ADDITIONAL EVENT DETAILS INCLUDE YEAR PROCEDURE PATIENT PRESENTED DISCOMFORTS EDEMA RIGHT BREAST CEASED NONSTEROIDAL ANTI-INFLAMMATORY DRUGS DOSE 120 MG DAY 7 DAYS LATER PROGRESS SATISFACTORY 2015 5 YEARS SYMPTOMS 6 FOLLOWING INTERVENTION PATIENT PRESENTED DISCOMFORTS EDEMA RIGHT BREAST IMAGING STUDIES PERFORMED PATIENT MAGNETIC RESONANCE MR DOCUMENTING PRESENCE ABUNDANT PERIPROSTHETIC FLUID AFFECTED BREASTÂ¿ Â¿THE SAMPLE SENT CYTOLOGICAL STUDY INFORMED CHRONIC MASTITIS GRANOMALOTOUS REACTION NEGATIVE CULTURE HOWEVER GRADUAL INCREASE BREAST CONTINUED FOLLOWING MONTHS 2 NEW PUNCTURES PERFORMED UNSUCCESSFULLY SECOND PUNCTURE FLUID SENT MALIGNANCY STUDY SUSPECTED POSSIBLE DUCTAL CARCINOMAÂ¿ Â¿THE PATIENT ASSESSED ULTRASOUND ASSISTED IMAGING STUDIES MR WITHOUT FINDING ANOMALIES MAMMARY PARENCHYMA REASON OPTED WITHDRAWAL IMPLANT CAPSULECTOMY EXAMINATION BREAST TISSUE TRANSOPERATIVE BIOPSYÂ¿ PATIENT REJECTED TREATMENT CURRENTLY ASYMPTOMATIC|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/20/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5846890|51223996|D|1||ACCORDING INFORMATION PROVIDED PATIENT EXPERIENCED RIGHT RUPTURE ALONG ANAPLASTIC LARGE CELL LYMPHOMA ALCL BASED RESULTS LABORATORY EVALUATION PE IDENTIFIED THREE RENTS SHELL DEVICE FIRST RENT MEASURED APPROXIMATELY 3CM LENGTH TWO ADDITIONAL RENTS MEASURED APPROXIMATELY  1CM SHELL DEVICE AREAS SHELL WEAR ALSO OBSERVED SHELL ALTHOUGH ROOT CAUSE RENTS COULD DETERMINED SHELL WEAR SUGGEST IN-VIVO FOLDING CREASING DEVICE ANOMALIES OBSERVED BREAST IMPLANTS LIFETIME DEVICES RUPTURE OCCUR TIME IMPLANTATION RUPTURE KNOWN COMPLICATION ASSOCIATED DEVICES REFERENCED PIDS BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ACCORDING FDA INCIDENCE ALCL PATIENTS BREAST IMPLANTS SMALL FRACTION 5-10 MILLION WOMEN RECEIVED BREAST IMPLANTS WORLDWIDE INVESTIGATION DEVICE HISTORY RECORD REVEALED IRREGULARITIES REVIEW NC SYSTEM COMPLAINT DATABASE REVEALED COMPLAINTS TYPE ASSOCIATED LOT 5746123 MAIN SYMPTOMS ALCL WOMEN BREAST IMPLANTS LATE ONSET PERSISTENT SWELLING PAIN VICINITY IMPLANT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL MENTOR CONCURS FDAS POSITION RISK ALCL APPEARS SMALL FDA BELIEVES TOTALITY EVIDENCE CONTINUES SUPPORT REASONABLE ASSURANCE FDA-APPROVED BREAST IMPLANTS SAFE EFFECTIVE USED LABELED ANAPLASTIC LARGE CELL LYMPHOMA ALCL KNOWN COMPLICATION ASSOCIATED DEVICES REFERENCED PIDS|MEMORY GEL SILTEX ROUND MODERATE PLUS PROFILE MAMMARY PROSTHESIS|354-4507|08/04/2016||06/28/2016||R|Y||0HP|FTR|1.0||BREAST IMPLANT||5746123|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR|75038|TX|75038||||True
5896122|52746118|N|1||MEDWATCH SENT FDA 08232016 EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING DEVICE SERIAL NUMBER IMPLANTEXPLANT DATE IMPLANTINGEXPLANTING PHYSICIAN PATIENT NAME PATIENT DATE BIRTH DEVICE RETURN STATUS PATHOLOGICAL MARKERS DEVICE RELATIONSHIP REPORTED EVENT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/23/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5896122|52746119|D|1||HEALTHCARE PROFESSIONAL REPORTED ALCL UNKNOWN SIDE PATIENT SENT MRI PET SCAN INFORMATION AVAILABLE TIME EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL DIAGNOSIS RECEIVED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/23/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5818741|50320833|D|1||SWELLING RIGHT BREAST 13 YEARS IMPLANTS FNA RETURNED BIA ALCL AKL - NEG BREAST IMPLANTS REMOVED B6 B6 UNIVERSITY RESIDUAL LOCAL CELLS REMAINED FULL CAPSULECTOMY STARTED CHEMO B6 2016|INAMED BREAST IMPLANTS||07/21/2016||||N|*||I|FWM|1.0||INAMED BREAST IMPLANTS|||||||ALLERGAN|||||||True
5818741|50320833|D|1||SWELLING RIGHT BREAST 13 YEARS IMPLANTS FNA RETURNED BIA ALCL AKL - NEG BREAST IMPLANTS REMOVED B6 B6 UNIVERSITY RESIDUAL LOCAL CELLS REMAINED FULL CAPSULECTOMY STARTED CHEMO B6 2016|INAMED BREAST IMPLANTS||07/21/2016||||*|*||I|FWM|2.0||INAMED BREAST IMPLANTS|||||||ALLERGAN|||||||True
6011835|56821577|D|1||ALLERGANÂ¿S LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ TABLE 5 Â¿TNM STAGING PATIENTS ANZ COHORTÂ¿ ARTICLE REPORTS ADDITIONAL THREE OCCURRENCES DEATH ONE CASE Â¿DEATH  MASS METASTATIC DISEASE MULTIPLE LYMPH NODESÂ¿ MANUFACTURER COULD SPECIFIED ARTICLE STATES Â¿BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED 571 IMPLANTS SERIES ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011835|56821576|N|1||MEDWATCH SENT FDA 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL -|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176965|62446268|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA DISRUPTED IMPLANT TREATMENT REPORTED IMPLANT REMOVAL DEXAMETHASONE HIGH-DOSE ARACYTINE OXALIPLATIN DHAOX FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176965|62446267|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5808310|50110352|D|1||THOUSANDS KNOWN WOMEN SICK SILICONE BREAST IMPLANTS KNOWS TRUTH FDA SOMEHOW ALLOWED SILICONE BREAST IMPLANT MFRS HIDE HIGH LEVEL TOXICITY SILICONE PLATINUM 35 + DANGEROUS CHEMICALS USE MAKE SILICONE SALINE BREAST IMPLANTS TRIGGER BIOCHEMICAL MOLECULAR DISRUPTION BRING SICKNESSES PRESENT IMPLANTS GO AWAY EXPLANTS CASES IRREVERSIBLE DAMAGE NOVEMBER 17 2006 FDAS APPROVAL ORDER REQUIRED SIX SPECIFIC POST-APPROVAL STUDIES CONDITIONS TWO STUDIES MONITOR LONG TERM SAFETY TEN YEARS FOLLOWED SAFETY DATA STUDIES ADJUNCT 5-YEAR STUDY LOW FU RATE 138 LARGE STUDY ALLOWED CUT SHORT YEAR 7 INSTEAD 10 LOW FU RATE 201 IGNORED CORE STUDY FU RATE 62 REPORT SCHEDULE STOPS SHORT YEAR 6 INSTEAD 10 NOVEMBER 13 2012 FDA MENTOR PMA MANUFACTURE DOCUMENT STATES SHELF LIFE FIVE YEARS DATE STERILIZATION YET MARKETED 10 YEARS STAY BODY WITHOUT SAFETY EVIDENCE B6 STUDY 2013 RUN B6 FUNDED THREE BREAST IMPLANT MFRS QUALIFY INDEPENDENT STUDY ASTOUNDING CONFLICT INTEREST REGARDS PLASTIC SURGEONS PROFIT LARGELY SILICONE BREAST IMPLANTS MFRS PROFIT SILICONE BREAST IMPLANTS PREVIOUS SILICONE BREAST IMPLANT SYMPTOMS 1990S REPEATING CURRENT SILICONE BREAST IMPLANTS THUS PROVING RECURRING LACK SAFETY PEOPLE FOLLOWING MATTER MYSTERIOUSLY DISAPPEARED THOUSANDS WOMEN GROUPED TOGETHER SHARE RECORDS B6 PROTECTION ALSO TAKEN MEASURES SHARE RECORDS AMONG RECORDS SAFEGUARDED ATTORNEYS PRIVATE INTERESTS CANNOT SILENCE BUY RECORDED MEDICAL EVIDENCE THOUSANDS SICK WOMEN SILICONE BREAST IMPLANTS LONGER FDA RESPONSIBLE PROTECTING PUBLIC HEALTH ASSURING SAFETY EFFICACY SECURITY HUMAN VETERINARY DRUGS BIOLOGICAL PRODUCTS MEDICAL DEVICE NATIONS FOOD SUPPLY COSMETICS PRODUCTS EMIT RADIATION SILICONE PLATINUM 35 + DANGEROUS CHEMICALS USED SILICONE SALINE BREAST IMPLANT MFRS TRIGGER BIOCHEMICAL MOLECULAR DISRUPTION CAUSE SICKNESSES FATIGUE CHRONIC FATIGUE COGNITIVE DYSFUNCTION BRAIN FOG DIFFICULTY CONCENTRATING MEMORY LOSS MUSCLE PAIN WEAKNESS JOINT PAIN HAIR LOSS DRY SKIN HAIR POOR SLEEP INSOMNIA DRY EYES DECLINE VISION VISION DISTURBANCES HYPOHYPER THYROID SYMPTOMS HYPOHYPER ADRENAL SYMPTOMS ESTROGENPROGESTERONE IMBALANCE DIMINISHING HORMONES SLOW HEALING CUTS SCRAPES EASY BRUISING THROAT CLEARING COUGH DIFFICULTY SWALLOWING CHOKING REFLUX VERTIGO GASTROINTESTINAL DIGESTIVE ISSUES FEVERS NIGHT SWEAT INTOLERANT HEAT NEW PERSISTENT BACTERIAL VIRAL INFECTIONS SLOW CLEARING COMMON COLDS FLUES FUNGAL INFECTIONS YEAST INFECTIONS CANDIDA SINUS INFECTIONS SKIN RASHES EAR RINGING SUDDEN FOOD INTOLERANCE ALLERGIES HEADACHES SLOW MUSCLE RECOVERY ACTIVITY HEART PALPITATIONS CHANGES NORMAL HEART RATE HEART PAIN SORE ACHING JOINTS SHOULDERS HIPS BACKBONE HANDS FEET SWOLLEN TENDER LYMPH NODES BREAST AREA UNDERARM THROAT NECK GROIN BOUTS DEHYDRATION REASON FREQUENT URINATION NUMBNESSTINGLING SENSATIONS UPPER LOWER LIMBS COLD DISCOLORED LIMBS HANDS FEET GENERAL CHEST DISCOMFORT SHORTNESS BREATH PAIN BURNING SENSATION AROUND IMPLANT UNDERARM LIVER KIDNEY DYSFUNCTION CRAMPING TOXIC SHOCK SYMPTOMS ANXIETY DEPRESSION PANIC ATTACKS SYMPTOMS DIAGNOSIS FIBROMYALGIA SYMPTOMS DIAGNOSIS LYME DISEASE SYMPTOMS DIAGNOSIS AUTO-IMMUNE DISEASE RAYNAUDS SYNDROME HASHIMOTOS THYROIDITIS RHEUMATOID ARTHRITIS LUPUS NONSPECIFIC CONNECTIVE TISSUE DISEASE MULTIPLE SCLEROSIS SYMPTOMS DIAGNOSIS ALCL LYMPHOMA SILICONE BREAST IMPLANTS BRING ALLERGIES NEVER EXPERIENCED|SILICONE BREAST IMPLANT||07/16/2016||||Y|*||I|FTR|1.0||SILICONE BREAST IMPLANT|||||||MENTOR|||||||True
6153187|61697756|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES GATHERED FOUR CENTERS INTERNATIONAL COLLABORATIVE STUDY TOTAL 22 PATIENTS TABLE 1Â¿ ARTICLE GOES STATE Â¿BOTH BREAST IMPLANTÂ¿ASSOCIATED ALCL NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG TISSUE CAPSULE 49 Ã 106 CELLSMG TISSUE ANALYSIS MICROBIOME BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES SPECIES IDENTIFIED NONTUMOR CAPSULE SPECIMENS SIGNIFICANTLY GREATER PROPORTION RALSTONIA SPP PRESENT ALCL SPECIMENS COMPARED NONTUMOR CAPSULE SPECIMENS P  005 CONTRAST SIGNIFICANTLY STAPHYLOCOCCUS SPP FOUND ASSOCIATED NONTUMOR CAPSULE SPECIMENS COMPARED BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM VISUALIZED SCANNING ELECTRON MICROSCOPY FLUORESCENT SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- CD30+ REPORTED ACCORDING TABLE 1 Â¿CLINICAL SUMMARY BREAST IMPLANTÂ¿ASSOCIATED ALCL PATIENTSÂ¿ 1 CASE ALCL PRESENTED EFFUSION TUMOR CURRENTLY WAY DETERMINE CASES DEVICE TYPE TESTED NEGATIVE BACTERIAL INFECTION REPORT CAPTURE 1 CASE ALCL PRESENTED EFFUSION TUMOR|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6153187|61697755|N|1||B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION HEMATOMASEROMA BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ 137 6 1659-1669 HONGHUA HU PHD KHALID JOHANI AHMAD ALMATROUDI KAREN VICKERY PHD BVSC BRUCE VAN NATTA MD MARSHALL E KADIN MD GARRY BRODY MD MARK CLEMENS MD CHAN YOON CHEAH MD STEPHEN LADE MD PREETI AVINASH JOSHI MDPHD H MILES PRINCE MDPHD ANAND K DEVA BSCMED MBBS MS PUBLISHED JUNE 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5350320|35251015|D|1||ALCL CASE REPORT B6 WOMAN UNDERWENT BREAST IMPLANTATION 8-9 YEARS AGO CENTRAL ASIA AUGMENTATION 2011 FIRST NOTICED SWELLING PAIN AROUND B6 2015 RIGHT BREAST FOUND FLUID COLLECTION B6 ED REFERRED B6 WORKUP MAMMOGRAPHY B6 2015 BIRADS 2 SHOWING FLUID COLLECTIONS NOTED US B6 FLUID ANALYSIS ASPIRATION B6 2015 SHOWED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA|SILICONE BREAST IMPLANT||01/04/2016||||Y|*||0HP|FTR|1.0||SILICONE BREAST IMPLANT|||||||nan|||||||True
5912356|53436714|N|1||RESPONSE FDA REPORT NUMBER B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING PHYSICIAN INFORMATION PERMISSION CONTACT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|08/29/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5912356|53436715|D|1||PATIENT REPORTED VIA VOLUNTARY MEDWATCH SWELLING RIGHT BREAST 13 YEARS IMPLANTS FNA RETURNED BIA ALCL ALK - NEG BREAST IMPLANTS REMOVED B6 B6 UNIVERSITY RESIDUAL LOCAL CELLS REMAINED FULL CAPSULECTOMY STARTED CHEMO B6 2016 DEVICE SALINE INAMED DEVICE PATHOLOGICAL MARKERS RECEIVED EVENTS CONFIRMED PHYSICIAN EVENT CAPTURED LYMPHOMA|UNK SALINE IMPLANT|UNK SALINE IMPLANT|08/29/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5697379|46493992|N|1||MEDWATCH SENT FDA 06032016 LITERATURE CITATION HART ALEXANDRA LECHOWICZ MARY JO PETERS KENDALL K HOLDEN JEANNINE CARLSON GRANT W Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORT 2 CASES REVIEW LITERATUREÂ¿ AESTHETIC SURGERY JOURNAL 2014 VOL 346 884-894 FIRST PUBLISHED ONLINE 01AUG2014 CORRESPONDING AUTHOR DECLINED PROVIDE ALLERGAN INFORMATION REGARDING EVENT PRODUCT PRODUCT RETURN PATIENT DETAILS EVENTS SEROMA ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5697379|46493993|D|1||FOLLOWING JOURNAL ARTICLE REVIEWED Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORT 2 CASES REVIEW LITERATUREÂ¿ AUTHORS REPORTED PATIENT UNDERGONE BILATERAL BREAST AUGMENTATION 16 YEARS EARLIER 425-CC TEXTURED ROUND SALINE IMPLANTS PLACED SUBGLANDULARLY MANUFACTURER IMPLANTS KNOWN PATIENT PRESENTED ACUTE ENLARGEMENT RIGHT BREAST ULTRASONOGRAPHY SHOWED FLUID COLLECTION AROUND RIGHT INTACT BREAST IMPLANT ULTRASOUND-GUIDED FLUID ASPIRATION SHOWED CD30+ ALKÂ¿ ALCL CELLS POSITIVE CD45 CD5 CD4 FAILED EXPRESS CD34 CD20 CD68 CD10 PATIENT UNDERWENT BILATERAL CAPSULECTOMIES IMPLANT REMOVAL APPROXIMATELY TWO MONTHS PRESENTATION IMMEDIATELY REMOVAL IMPLANTS CAPSULES EXAMINED MALIGNANCY FLOW CYTOMETRY CYTOGENETIC ANALYSIS IMMUNOHISTOCHEMICAL STAINING FAILED IDENTIFY UNIQUE CELL POPULATIONS PATIENT RECEIVE ADDITIONAL TREATMENT FREE DISEASE PATIENTS 15-MONTH FOLLOW-UP VISIT PATIENT CONTINUES MONITORED CLOSELY CHRONIC PAIN AFFECTED BREASTÂ¿|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5725674|47409581|N|1||MEDWATCH SENT FDA 06152016 B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE SERIAL LOT NUMBER AVAILABLE EXACT IMPLANT DATE COULD SPECIFIED DEVICE RETURNED DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/15/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5725674|47409582|D|1||VOLUNTARY MEDWATCH 5061844 REPORTED ALCL BREAST IMPLANT ASSOCIATED SIDE UNSPECIFIED DEVICE DESCRIPTION PROVIDED MCGHAN TEXTURED BREAST IMPLANT SALINE FOLLOW-UP HEALTH PROFESSIONAL REPORTS Â¿AUGMENTATION MCGHAN TEXTURED SALINE IMPLANT 360 CC IMPLANTED SUB MUSCULARÂ¿ ULTRASOUND FOUND Â¿CONTIGUOUS MEDIAL ASPECT PATIENTÂ¿S LEFT BREAST IMPLANT APPEARS ELLIPTICAL FLUID COLLECTIONÂ¿AREAS DENSE SHADOWING SEEN WITHIN TWELVE OÂ¿CLOCK RAY LEFT BREAST CORRESPOND PREVIOUSLY IDENTIFIED BENIGN APPEARING CALCIFICATIONS WITHIN REGION LEFT BREASTÂ¿ PHYSICIAN REFERRAL NOTE DESCRIBES Â¿BREAST MASSÂ¿ PHYSICIAN BELIEVES Â¿INFLAMMATORY RESPONSE BREAST IMPLANT LEFT BREASTÂ¿ ULTRASOUND LEFT BREAST STATES Â¿PALPABLE LUMP LEFT BREAST SWELLINGITCHING ALONG SURGICAL SCARÂ¿ FINDINGS STATE Â¿SMALL BENIGN OIL CYSTS IMAGED 1100 1200 POSITIONS LEFT BREAST BENIGN FLUID PERIPHERY IMPLANTÂ¿ OPERATIVE REPORT STATES Â¿PATIENT PRESENTED OFFICE SWELLING DISCOMFORT LEFT BREAST PATIENT DIAGNOSED LEFT BREAST SEROMA SENT CULTURE CYTOLOGY NEGATIVEÂ¿ DEVICE REMOVED REPLACED PATIENT Â¿CAPSULECTOMY BIOPSYÂ¿ ADDITION CHEMOTHERAPY ADDITIONAL OPERATIVE REPORT FOLLOWING PRIOR DEVICE REMOVAL DETAILS REMOVAL Â¿LEFT BREAST MASS CHEST WALL MASSÂ¿ DESCRIBED Â¿VERY LARGE 3 CM HARD FAIRLY WELL CIRCUMSCRIBEDÂ¿ SURGICAL PATHOLOGY REPORT NOTES Â¿LARGE CELLS POSITIVE CD30Â¿NEGATIVE ALK1Â¿ DIAGNOSIS PROVIDED Â¿BREAST IMPLANT Â¿ ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ ALCL DIAGNOSIS OCCURRED APPROXIMATELY 5 MONTHS EXPLANT SURGERY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/15/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
